{
    "NCT00422162": {
        "briefTitle": "A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression",
        "officialTitle": "An Eight-Week, Randomized, Double Blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 Per Day in Patients Hospitalized for Severe Depression",
        "lillyAlias": [
            "F1J-BI-HMES"
        ]
    },
    "NCT06440980": {
        "briefTitle": "A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight",
        "officialTitle": "A Multiple-Dose Study to Investigate the Bioequivalence of Orforglipron (LY3502970) Capsules and Orforglipron Tablets in Participants With Obesity or Overweight Who Are Otherwise Healthy.",
        "lillyAlias": [
            "J2A-MC-GZPI"
        ]
    },
    "NCT00042562": {
        "briefTitle": "Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression",
        "officialTitle": "Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression",
        "lillyAlias": [
            "F1J-US-HMBZ"
        ]
    },
    "NCT00211562": {
        "briefTitle": "Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids",
        "officialTitle": "Reduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids",
        "lillyAlias": []
    },
    "NCT00192062": {
        "briefTitle": "A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer",
        "officialTitle": "A Phase II Trial of Gemcitabine (Gemzar) Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-EY-S372"
        ]
    },
    "NCT00157560": {
        "briefTitle": "Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma",
        "officialTitle": "A Phase II Trial of ModifiedTriple Doublet Therapy in the Treatment of Women With Newly Diagnosed Carcinoma of M\u00fcllerian Origin",
        "lillyAlias": []
    },
    "NCT01202760": {
        "briefTitle": "A Rheumatoid Arthritis Study in Participants",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)",
        "lillyAlias": [
            "H9B-MC-BCDO",
            "CTRI/2011/07/001867"
        ]
    },
    "NCT05362760": {
        "briefTitle": "Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management",
        "officialTitle": "Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management. The MINERVA Trial - A Phase IV Trial",
        "lillyAlias": [
            "2021-000287-30"
        ]
    },
    "NCT00045760": {
        "briefTitle": "The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis",
        "officialTitle": null,
        "lillyAlias": [
            "F1K-MC-EVCL",
            "F1K-MC-EVCM"
        ]
    },
    "NCT00612794": {
        "briefTitle": "A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes",
        "officialTitle": "Multiple-Dose Study to Examine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2148568 Long-Acting Release in Japanese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01204294": {
        "briefTitle": "Comprehensive Add on Study in Japan",
        "officialTitle": "An Open Label, Randomised, Parallel Group Safety and Efficacy Study of Linagliptin (5 mg Administered Orally Once Daily) Over 52 Weeks in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Background Mono-therapy With an Approved Antidiabetic Drug",
        "lillyAlias": []
    },
    "NCT00830960": {
        "briefTitle": "A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome",
        "officialTitle": "A Comparison of Platelet Inhibition Following Prasugrel or Clopidogrel Administration in Asian Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention",
        "lillyAlias": [
            "H7T-MC-TACE"
        ]
    },
    "NCT05080660": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain",
        "lillyAlias": [
            "H0P-MC-OA02"
        ]
    },
    "NCT00201760": {
        "briefTitle": "Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer",
        "officialTitle": "A Randomized Phase II Study of Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT00953862": {
        "briefTitle": "Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility",
        "officialTitle": "Efficacy of Atomoxetine in Adults With ADHD and Substance Abuse Disorder Being Treated in a Residential Treatment Facility",
        "lillyAlias": [
            "BAZ-US-X031"
        ]
    },
    "NCT04605991": {
        "briefTitle": "A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)",
        "officialTitle": "A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring",
        "lillyAlias": [
            "I8B-MC-ITSW"
        ]
    },
    "NCT02734160": {
        "briefTitle": "A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer",
        "officialTitle": "A Phase 1b Dose-Escalation and Cohort-Expansion Study of the Safety, Tolerability, and Efficacy of a Novel Transforming Growth Factor-\u03b2 Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination With the Anti-PD-L1 Antibody Durvalumab (MEDI4736) in Recurrent or Refractory Metastatic Pancreatic Cancer",
        "lillyAlias": [
            "H9H-MC-JBEG",
            "2015-005295-26"
        ]
    },
    "NCT00191360": {
        "briefTitle": "Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency",
        "officialTitle": "Extended Clinical Study of LY137998 [Somatropin (Recombinant DNA Origin)] in Adults With Growth Hormone Deficiency",
        "lillyAlias": [
            "B9R-JE-K03A"
        ]
    },
    "NCT06169982": {
        "briefTitle": "A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 1, Open-Label, Multiple-Dose Study to Investigate Steady-State Pharmacokinetics and Pharmacodynamics During a Euglycemic Clamp of LY3209590 in Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-MC-BDDG",
            "2023-508008-39-00"
        ]
    },
    "NCT01004731": {
        "briefTitle": "Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer",
        "officialTitle": "Phase Ib, IIa Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Chemotherapy-Naive Stage IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "UAB 9909"
        ]
    },
    "NCT01965782": {
        "briefTitle": "A Study of [14C]-LY3023703 in Healthy Participants",
        "officialTitle": "Disposition of [14C]-LY3023703 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I6H-MC-MCBD"
        ]
    },
    "NCT00768131": {
        "briefTitle": "A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel",
        "officialTitle": "A Randomized Phase II Trial to Assess the Predictive Value of Increased EGFR Copy Number by FISH in Patients With Advanced / Metastatic NSCLC Treated With Cetuximab and Carboplatin / Paclitaxel",
        "lillyAlias": []
    },
    "NCT00437125": {
        "briefTitle": "Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease",
        "officialTitle": "An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease",
        "lillyAlias": [
            "F1J-IT-HMFQ"
        ]
    },
    "NCT00316225": {
        "briefTitle": "Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen",
        "officialTitle": "A Phase 2 Study of ALIMTA in Solid Tumor Patients With Stable Third-Space Fluid",
        "lillyAlias": [
            "H3E-MC-JMHX"
        ]
    },
    "NCT03726125": {
        "briefTitle": "A Study of LY3374849 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Glucodynamic Effects of LY3374849 in Healthy Subjects",
        "lillyAlias": [
            "I9R-MC-BSDA"
        ]
    },
    "NCT00040625": {
        "briefTitle": "ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-US-JMFE"
        ]
    },
    "NCT00233025": {
        "briefTitle": "Duloxetine Versus Placebo in the Treatment of FMS",
        "officialTitle": "Duloxetine 60/120mg Versus Placebo in the Treatment of Fibromyalgia Syndrome",
        "lillyAlias": [
            "F1J-MC-HMEF"
        ]
    },
    "NCT06186622": {
        "briefTitle": "A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants",
        "officialTitle": "A Drug-Drug Interaction Study to Assess the Effect of Orforglipron on the Pharmacokinetics of Digoxin, Simvastatin, Rosuvastatin, Acetaminophen, and Midazolam in Healthy Overweight and Obese Participants",
        "lillyAlias": [
            "J2A-MC-GZPG"
        ]
    },
    "NCT00034125": {
        "briefTitle": "Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.",
        "officialTitle": "a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.",
        "lillyAlias": [
            "H4Z-MC-JWXD"
        ]
    },
    "NCT00614822": {
        "briefTitle": "Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer",
        "officialTitle": "A Phase II Trial of Carboplatin, Bevacizumab and Pemetrexed in Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "Eli Lilly H3E-US-X072"
        ]
    },
    "NCT04220892": {
        "briefTitle": "Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma",
        "officialTitle": "Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for the Treatment of Patients With High Grade Glioma",
        "lillyAlias": []
    },
    "NCT05341089": {
        "briefTitle": "A Study of Two Different Formulations of LY3502970 in Healthy Participants",
        "officialTitle": "A Phase 1 Multiple-Dose Study to Investigate the Pharmacokinetics, Safety, and Tolerability of 2 Different Formulations of LY3502970 in Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZGH"
        ]
    },
    "NCT00375492": {
        "briefTitle": "Effect on Weight Loss of Exenatide Versus Placebo",
        "officialTitle": "Effect on Weight Loss of Exenatide Versus Placebo in Subjects With Type 2 Diabetes Participating in a Lifestyle Modification Program",
        "lillyAlias": []
    },
    "NCT05086289": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain",
        "officialTitle": "Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back Pain",
        "lillyAlias": [
            "H0P-MC-BP02"
        ]
    },
    "NCT01057589": {
        "briefTitle": "A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer",
        "officialTitle": "Phase 2 Study of Pemetrexed in Combination With Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck",
        "lillyAlias": [
            "H3E-MC-S123"
        ]
    },
    "NCT01160289": {
        "briefTitle": "A Study of LY900010 in Erectile Dysfunction",
        "officialTitle": "A Study of LY900010 (LY2452473 + Tadalafil) in the Treatment of Men With Erectile Dysfunction",
        "lillyAlias": [
            "I4K-MC-GPEC"
        ]
    },
    "NCT04611789": {
        "briefTitle": "A Study of LY3832479 (LY-CoV016) in Healthy Participants 1",
        "officialTitle": "A Randomized, Placebo-Controlled, Participant- and Investigator-Blind, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of LY3832479 Administered Subcutaneously to Healthy Participants",
        "lillyAlias": [
            "J2Z-MC-PGAB"
        ]
    },
    "NCT00034489": {
        "briefTitle": "A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.",
        "officialTitle": "A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.",
        "lillyAlias": [
            "H3E-MC-JMCF"
        ]
    },
    "NCT01025089": {
        "briefTitle": "Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma",
        "officialTitle": "A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (BMS #CA225-331/Lilly Trial Alias I4E-US-X007)",
        "lillyAlias": []
    },
    "NCT05338489": {
        "briefTitle": "A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants",
        "officialTitle": "A 2-Part, Open-Label, Fixed-Sequence Study to Evaluate the Effects of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of LOXO-292 in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-OX-JZJP",
            "LOXO-RET-18014"
        ]
    },
    "NCT00105989": {
        "briefTitle": "Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder",
        "officialTitle": "Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMDI"
        ]
    },
    "NCT02989389": {
        "briefTitle": "A Study of LY3323795 in Healthy Participants",
        "officialTitle": "Single-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3323795 in Healthy Subjects",
        "lillyAlias": [
            "I9F-MC-SCAA"
        ]
    },
    "NCT04085289": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants",
        "officialTitle": "A Randomized, Placebo-Controlled, Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Galcanezumab in Healthy Chinese Subjects",
        "lillyAlias": [
            "I5Q-MC-CGAY"
        ]
    },
    "NCT06709820": {
        "briefTitle": "A Study of LY4060874 in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4060874 in Healthy Participants",
        "lillyAlias": [
            "J5X-MC-YJAA"
        ]
    },
    "NCT04396574": {
        "briefTitle": "A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine",
        "officialTitle": "A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2",
        "lillyAlias": [
            "H8H-MC-LAHW",
            "2019-004379-38"
        ]
    },
    "NCT00267020": {
        "briefTitle": "Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer",
        "officialTitle": "A Randomized, Open-Label Phase 2 Study of 2 Regimens, Gemcitabine Plus Enzastaurin and Single-Agent Gemcitabine, in Patients With Locally Advanced or Metastatic Pancreatic Cancer",
        "lillyAlias": [
            "H6Q-US-S002"
        ]
    },
    "NCT00191022": {
        "briefTitle": "Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder",
        "officialTitle": "A Randomized, Double-Blind Comparison of LY686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder",
        "lillyAlias": [
            "H8R-MC-HJAG"
        ]
    },
    "NCT06739122": {
        "briefTitle": "A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)",
        "officialTitle": "A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 mg and 4.5 mg in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-MC-GBGS"
        ]
    },
    "NCT06630325": {
        "briefTitle": "A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer",
        "officialTitle": "Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART): Adaptive Clinical Treatment (ACT)",
        "lillyAlias": [
            "NCI-2024-07664",
            "STUDY00026643"
        ]
    },
    "NCT00894322": {
        "briefTitle": "A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension",
        "officialTitle": "A Two-Cohort, Single- and Repeat Dose Study to Examine the Pharmacokinetics, Tolerability, and Safety of Ready to Use Exenatide Once Weekly in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01655225": {
        "briefTitle": "A Study of LY3023414 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 First-in-Human Dose Study of LY3023414 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I6A-MC-CBBA"
        ]
    },
    "NCT00126139": {
        "briefTitle": "Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis",
        "officialTitle": "Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS)",
        "lillyAlias": []
    },
    "NCT00191139": {
        "briefTitle": "Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomized Study of Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation Therapy in Stage III Unresectable NSCLC",
        "lillyAlias": [
            "B9E-US-S182"
        ]
    },
    "NCT06672939": {
        "briefTitle": "A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities",
        "officialTitle": "Efficacy, Safety, and Pharmacokinetics of Orforglipron Once Daily Oral Versus Placebo in Adolescent Participants Who Have Obesity, or Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind Trial (ADVANCE-ATTAIN-ADOLESCENTS)",
        "lillyAlias": [
            "J4M-MC-PW01",
            "J4M-MC-PWMP Master Protocol",
            "2024-514081-40-00"
        ]
    },
    "NCT03792139": {
        "briefTitle": "An Interaction Study of LY3200882 in Healthy Participants",
        "officialTitle": "Effects of CYP3A4 Inhibition by Itraconazole on the Pharmacokinetics of LY3200882 in Healthy Subjects",
        "lillyAlias": [
            "I8X-MC-JECC"
        ]
    },
    "NCT01214239": {
        "briefTitle": "Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug na\u00efve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control",
        "officialTitle": "A Randomized, db, Placebo Controlled Parallel Group Efficacy and Safety Study Over 24 Weeks in T2D Patients in China",
        "lillyAlias": []
    },
    "NCT01107925": {
        "briefTitle": "Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease",
        "officialTitle": "A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight Aspirin-Treated Subjects With Stable Coronary Artery Disease",
        "lillyAlias": [
            "H7T-MC-TADI"
        ]
    },
    "NCT00157339": {
        "briefTitle": "Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD",
        "officialTitle": "A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma",
        "lillyAlias": [
            "H7U-MC-IDAS"
        ]
    },
    "NCT04258826": {
        "briefTitle": "A Study to Evaluate LY3154207 on the Brain of Healthy Participants",
        "officialTitle": "A Single-Dose Study Using Functional Magnetic Resonance Imaging to Evaluate the Effect of LY3154207 in Healthy Subjects",
        "lillyAlias": [
            "I7S-MC-HBEM"
        ]
    },
    "NCT02100826": {
        "briefTitle": "A Study of Cephalexin in Healthy Participants",
        "officialTitle": "Randomized, Open-label, 2-period, 2-treatment, 2-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of 2 Oral Preparations in Tablets With 1g of Cephalexin (Keflex\u00ae Made in Mexico by Eli Lilly vs. Keflex\u00ae Made in Italy by Facta) in Fasting Healthy Participants",
        "lillyAlias": [
            "A3Q-ME-AFBO"
        ]
    },
    "NCT04616326": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study",
        "lillyAlias": [
            "2018-004622-28",
            "I5Q-MC-CGAT"
        ]
    },
    "NCT05026866": {
        "briefTitle": "A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)",
        "officialTitle": "A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACM"
        ]
    },
    "NCT03023826": {
        "briefTitle": "A Study of LY3202626 in Healthy Participants",
        "officialTitle": "Relative Bioavailability and Food Effect Study in Healthy Subjects Administered Two Different Formulations of LY3202626",
        "lillyAlias": [
            "I7X-MC-LLCE"
        ]
    },
    "NCT06132126": {
        "briefTitle": "A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Single and Multiple-Ascending Dose Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J4P-MC-IYAA"
        ]
    },
    "NCT06092931": {
        "briefTitle": "A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants",
        "officialTitle": "A Phase 1, Single-Center, Open-Label, Fixed-Sequence Study to Evaluate the Effect of DC-806 on the Single Dose Pharmacokinetics of CYP450 Enzyme and Transporter Substrates in Healthy Participants",
        "lillyAlias": []
    },
    "NCT00855582": {
        "briefTitle": "A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil 2.5 and 5 mg Once Daily Dosing for 12 Weeks for the Treatment of Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia in Men With Both Erectile Dysfunction and Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVHR"
        ]
    },
    "NCT01662882": {
        "briefTitle": "A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)",
        "officialTitle": "An Open Label, Parallel Group, Multicenter Study, Evaluating the Safety and Imaging Characteristics of Florbetapir (18F) in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)",
        "lillyAlias": [
            "I6E-AV-AVBB"
        ]
    },
    "NCT02152631": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer",
        "officialTitle": "JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy",
        "lillyAlias": [
            "I3Y-MC-JPBK",
            "2013-004662-33"
        ]
    },
    "NCT04809220": {
        "briefTitle": "A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes",
        "officialTitle": "A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Two Doses of Dulaglutide in Combination With a Single Oral Antihyperglycemic Medication or as Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus (AWARD-JPN: Assessment of Weekly Administration of LY2189265 in Diabetes - JAPAN)",
        "lillyAlias": [
            "H9X-JE-GBGQ"
        ]
    },
    "NCT02197520": {
        "briefTitle": "A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics",
        "officialTitle": "The Effect of Treatment With Basal Insulin Peglispro or Insulin Glargine on Insulin Sensitivity and the Effect of Prandial Insulin Lispro in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIDV"
        ]
    },
    "NCT00308282": {
        "briefTitle": "A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis",
        "officialTitle": "Phase II Study of Safety and Efficacy of Intravenous LY2127399 in Patients With Rheumatoid Arthritis Treated With Methotrexate",
        "lillyAlias": [
            "H9B-MC-BCDF"
        ]
    },
    "NCT02221882": {
        "briefTitle": "A Study of LY3164530 in Participants With Cancer",
        "officialTitle": "A Phase 1 Study of LY3164530, a Bispecific Antibody Targeting Mesenchymal-Epithelial Transition Factor (MET) and Epidermal Growth Factor Receptor (EGFR), in Patients With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I7H-MC-JNBA"
        ]
    },
    "NCT01648582": {
        "briefTitle": "A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus",
        "officialTitle": "The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Compared to Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea",
        "lillyAlias": [
            "H9X-CR-GBDK"
        ]
    },
    "NCT00390182": {
        "briefTitle": "Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)",
        "officialTitle": "GCC 0319: Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)",
        "lillyAlias": []
    },
    "NCT03870620": {
        "briefTitle": "Metastatic Breast Cancer in Austria",
        "officialTitle": "Metastatic Breast Cancer in Austria",
        "lillyAlias": []
    },
    "NCT01520220": {
        "briefTitle": "Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms",
        "officialTitle": "A Phase 1 Study of LY2784544 Testing Alternative Dosing Regimens in Patients With Myeloproliferative Neoplasms",
        "lillyAlias": [
            "I3X-MC-JHTC"
        ]
    },
    "NCT01263782": {
        "briefTitle": "BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer",
        "officialTitle": "BATTLE-FL: A Biomarker-Integrated Study in Patients With Advanced Non-Small Cell Lung Cancer Treated in the Front-Line (FL) Setting",
        "lillyAlias": [
            "NCI-2011-00301"
        ]
    },
    "NCT00287820": {
        "briefTitle": "Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism",
        "officialTitle": "Independent Investigator Grant Study-Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism",
        "lillyAlias": []
    },
    "NCT00982020": {
        "briefTitle": "Study in Adolescents With Schizophrenia or Bipolar Disorder",
        "officialTitle": "A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents With Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia",
        "lillyAlias": [
            "F1D-MC-HGMX"
        ]
    },
    "NCT01134120": {
        "briefTitle": "A Study in Myeloproliferative Disorders",
        "officialTitle": "A Phase 1 Study of LY2784544 in Patients With JAK2 V617F-Positive Myeloproliferative Disorders",
        "lillyAlias": [
            "I3X-MC-JHTA"
        ]
    },
    "NCT03977974": {
        "briefTitle": "A Study of LY3526318 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, Pharmacokinetic, and Pilot Food Effect Study of Single- and Multiple-Ascending Doses of LY3526318 in Healthy Participants",
        "lillyAlias": [
            "J2D-MC-CVAA",
            "2019-001902-80"
        ]
    },
    "NCT00383266": {
        "briefTitle": "A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer",
        "officialTitle": "A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer",
        "lillyAlias": []
    },
    "NCT01301066": {
        "briefTitle": "A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects",
        "officialTitle": "A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects With Dyslipidemia, Followed by a 40-Week Safety Extension Study",
        "lillyAlias": []
    },
    "NCT01788566": {
        "briefTitle": "A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer",
        "officialTitle": "A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4X-MC-JFCK"
        ]
    },
    "NCT06229366": {
        "briefTitle": "[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer",
        "officialTitle": "[Ac-225]-PSMA-62 Phase I/II Clinical Trial to Characterize Efficacy, Safety, Tolerability, and Dosimetry in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer (ACCEL)",
        "lillyAlias": []
    },
    "NCT01588366": {
        "briefTitle": "The Effects of LY2409021 on the Liver",
        "officialTitle": "Effects of LY2409021 on Hepatic Metabolism in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-FW-GLBK"
        ]
    },
    "NCT02763566": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare NSAI (Anastrozole or Letrozole) Plus Abemaciclib, a CDK4 and CDK6 Inhibitor, or Plus Placebo, and to Compare Fulvestrant Plus Abemaciclib or Plus Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-CR-JPBQ"
        ]
    },
    "NCT00191282": {
        "briefTitle": "Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes",
        "officialTitle": "Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes (HEART2D)",
        "lillyAlias": [
            "F3Z-MC-IONM"
        ]
    },
    "NCT00658931": {
        "briefTitle": "Cymbalta for Depression as a Complication of Bereavement",
        "officialTitle": "Cymbalta for Depression as a Complication of Bereavement",
        "lillyAlias": []
    },
    "NCT01543620": {
        "briefTitle": "Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis",
        "officialTitle": "Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis",
        "lillyAlias": []
    },
    "NCT00099320": {
        "briefTitle": "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin",
        "officialTitle": "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin",
        "lillyAlias": []
    },
    "NCT01975220": {
        "briefTitle": "Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets",
        "officialTitle": "Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (25mg/1000mg and 12.5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)",
        "lillyAlias": []
    },
    "NCT03182920": {
        "briefTitle": "A Study of Lasmiditan in Healthy Participants",
        "officialTitle": "Effect of Age on the Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Healthy Subjects",
        "lillyAlias": [
            "H8H-MC-LAHA"
        ]
    },
    "NCT05074420": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Children With COVID-19",
        "officialTitle": "A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients From 1 Year to Less Than 18 Years Old Hospitalized With COVID-19",
        "lillyAlias": [
            "I4V-MC-KHAB",
            "2021-001338-21"
        ]
    },
    "NCT05463731": {
        "briefTitle": "A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)",
        "officialTitle": "Assessment of Safety, Tolerability, and Efficacy Measured by Amyloid Reduction of LY3372993 in Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "J1G-MC-LAKC"
        ]
    },
    "NCT01075282": {
        "briefTitle": "A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)",
        "officialTitle": "A Randomized, Open-Label, Parallel-Arm, Noninferiority Comparison of the Effects of Two Doses of LY2189265 and Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Stable Doses of Metformin and Glimepiride",
        "lillyAlias": [
            "H9X-MC-GBDB"
        ]
    },
    "NCT00906282": {
        "briefTitle": "Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",
        "officialTitle": "Phase II Trial of Preoperative Pemetrexed and Carboplatin in Patients With Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT02678182": {
        "briefTitle": "Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial",
        "officialTitle": "Planning Treatment for Oesophago-gastric Cancer: a Randomised Maintenance Therapy Trial",
        "lillyAlias": []
    },
    "NCT00191620": {
        "briefTitle": "Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.",
        "officialTitle": "Randomized Phase II Study of Cisplatin + Gemcitabine Administered Either as Short Infusion or at a Fixed Dose Rate in Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-LA-S350"
        ]
    },
    "NCT02439320": {
        "briefTitle": "Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:",
        "officialTitle": "A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study",
        "lillyAlias": [
            "H8H-CD-LAHJ",
            "COL MIG-301"
        ]
    },
    "NCT02659020": {
        "briefTitle": "A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma",
        "officialTitle": "A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma",
        "lillyAlias": [
            "I5B-MC-JGDL",
            "2015-001316-34"
        ]
    },
    "NCT01663220": {
        "briefTitle": "Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00129220": {
        "briefTitle": "Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder",
        "officialTitle": "Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder",
        "lillyAlias": [
            "F1D-JE-BMAC"
        ]
    },
    "NCT00377520": {
        "briefTitle": "A Trial for Patients With Advanced/Recurrent Endometrial Cancer",
        "officialTitle": "A Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Endometrial Carcinoma",
        "lillyAlias": [
            "H3E-US-JMGT"
        ]
    },
    "NCT01168973": {
        "briefTitle": "A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy",
        "officialTitle": "A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy",
        "lillyAlias": [
            "I4T-MC-JVBA",
            "2010-021297-11",
            "CP12-1027",
            "CTRI/2011/08/001942"
        ]
    },
    "NCT00637273": {
        "briefTitle": "A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)",
        "officialTitle": "A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Long-Acting Release(Once Weekly) to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Mellitus Treated With Metformin",
        "lillyAlias": []
    },
    "NCT00789373": {
        "briefTitle": "A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer",
        "officialTitle": "A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.",
        "lillyAlias": [
            "H3E-EW-S124",
            "CTRI/2009/091/000113"
        ]
    },
    "NCT01773473": {
        "briefTitle": "Comparison of Insulin Mix25 Versus Mix50",
        "officialTitle": "Comparison Between Low Mixed Insulin and Mid Mixed Insulin AS Starter Insulin For Patients With TYpe 2 Diabetes Mellitus (CLASSIFY Study)",
        "lillyAlias": [
            "F3Z-CR-IOQI"
        ]
    },
    "NCT03944031": {
        "briefTitle": "A Study of the Effects of LY3372689 on the Brain in Healthy Participants",
        "officialTitle": "Assessment of Brain O-GlcNAcase (OGA) Enzyme Occupancy After Single Oral Doses of LY3372689 as Measured by Positron Emission Tomography (PET) With the Radioligand [18F]LSN3316612 in Healthy Subjects",
        "lillyAlias": [
            "I9X-MC-MTAB"
        ]
    },
    "NCT00490373": {
        "briefTitle": "Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic",
        "officialTitle": "A Phase 2 Trial of ALIMTA in Pretreated Patients With Unresectable or Metastatic Cancer of the Pancreas",
        "lillyAlias": [
            "H3E-SB-S041"
        ]
    },
    "NCT05572073": {
        "briefTitle": "Otoferlin Gene-mediated Hearing Loss Natural History Study",
        "officialTitle": "A Natural History Study in Individuals With Otoferlin Gene-mediated Hearing Loss",
        "lillyAlias": []
    },
    "NCT02161731": {
        "briefTitle": "Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants",
        "officialTitle": "Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIBN"
        ]
    },
    "NCT00804973": {
        "briefTitle": "Study in Participants With Acute Migraines Headaches",
        "officialTitle": "A Safety, Tolerability, and Efficacy Study of LY2590443 in the Treatment of Acute Migraine Headache",
        "lillyAlias": [
            "I2W-MC-DMAB"
        ]
    },
    "NCT00489073": {
        "briefTitle": "Duloxetine Versus Placebo for Fibromyalgia",
        "officialTitle": "Duloxetine Versus Placebo in the Treatment of Fibromyalgia Patients With or Without Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMCA"
        ]
    },
    "NCT03037073": {
        "briefTitle": "Duloxetine for Succinylcholine-induced Postoperative Myalgia",
        "officialTitle": "Impact of Duloxetine on Succinylcholine-induced Postoperative Myalgia During Direct Microlaryngoscopic Surgeries: Randomized Controlled Double-blind Study",
        "lillyAlias": []
    },
    "NCT05548231": {
        "briefTitle": "A Study of LY3437943 in Chinese Participants With Obesity Or Overweight",
        "officialTitle": "A Multiple Dose Escalation Study in Chinese Participants With Overweight BMI or Obesity to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3437943",
        "lillyAlias": [
            "J1I-MC-GZBE"
        ]
    },
    "NCT03322631": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes",
        "officialTitle": "A Multiple-Ascending Dose Study in Japanese Patients With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176",
        "lillyAlias": [
            "I8F-JE-GPGC"
        ]
    },
    "NCT05757531": {
        "briefTitle": "A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants",
        "officialTitle": "Disposition of [14C]-LY3437943 Following Subcutaneous Administration in Healthy Male Participants",
        "lillyAlias": [
            "J1I-MC-GZBG"
        ]
    },
    "NCT00375973": {
        "briefTitle": "Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome",
        "officialTitle": "A Randomized, Placebo-Controlled, Double-Blind Trial of Duloxetine in the Treatment of Patients With Chronic Fatigue Syndrome",
        "lillyAlias": []
    },
    "NCT00547573": {
        "briefTitle": "Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection",
        "officialTitle": "A Multinational, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil Administered \"On Demand\" to Asian Men With Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVDY"
        ]
    },
    "NCT03370276": {
        "briefTitle": "Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma",
        "officialTitle": "A Phase I/II Study of Concurrent Cetuximab and Nivolumab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma",
        "lillyAlias": []
    },
    "NCT03222427": {
        "briefTitle": "A Study of LY3314814 in Healthy Participants",
        "officialTitle": "An Absolute Bioavailability Study of LY3314814 in Healthy Subjects Using an Intravenous Tracer Method",
        "lillyAlias": [
            "I8D-MC-AZEP",
            "2017-001181-18"
        ]
    },
    "NCT03994627": {
        "briefTitle": "Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma",
        "officialTitle": "An Open-Label, Multi-Center Patient Access Program of Olaratumab for the Treatment of Soft Tissue Sarcoma",
        "lillyAlias": [
            "I5B-MC-Y001"
        ]
    },
    "NCT02432976": {
        "briefTitle": "Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients",
        "officialTitle": "Impact of Intravenous Exenatide Versus Insulin on Quality of Life in Cardiac Surgery Patients: an Ancillary Study of the ExSTRESS Phase II/III Clinical Trial",
        "lillyAlias": []
    },
    "NCT00438776": {
        "briefTitle": "Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling",
        "officialTitle": null,
        "lillyAlias": []
    },
    "NCT05620576": {
        "briefTitle": "A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3857210 for the Treatment of Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "H0P-MC-NP05"
        ]
    },
    "NCT00097227": {
        "briefTitle": "Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT00193076": {
        "briefTitle": "Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer",
        "officialTitle": "A Phase II Trial of Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-US-S324",
            "H3036S"
        ]
    },
    "NCT00520676": {
        "briefTitle": "Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-CR-S380"
        ]
    },
    "NCT01131676": {
        "briefTitle": "BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).",
        "officialTitle": "A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk",
        "lillyAlias": [
            "2009-016178-33"
        ]
    },
    "NCT00482976": {
        "briefTitle": "Effect of LY333531 on Vascular and Neural Functions",
        "officialTitle": "The Effects of a Protein Kinase C Beta Inhibitor, LY333531, on Vascular and Neural Functions in Type 2 Diabetes Mellitus - Study B7A-MC-MBDM",
        "lillyAlias": [
            "B7A-MC-MBDM"
        ]
    },
    "NCT00052273": {
        "briefTitle": "LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors",
        "officialTitle": "A Phase I Dose Escalation Study With Oral LY317615 in Combination With Capecitabine in Advanced Cancer Patients",
        "lillyAlias": [
            "UCLA-0206061",
            "LILLY-H6Q-MC-JCAH",
            "NCI-G02-2132"
        ]
    },
    "NCT01035073": {
        "briefTitle": "Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome",
        "officialTitle": "Functional Change and Efficacy of Duloxetine in Patients With Major Depression and Co-Morbid Soft Tissue Discomfort Symptoms",
        "lillyAlias": []
    },
    "NCT04585776": {
        "briefTitle": "A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes",
        "officialTitle": "An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes",
        "lillyAlias": [
            "I8B-MC-ITSZ"
        ]
    },
    "NCT01454973": {
        "briefTitle": "Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects",
        "officialTitle": "Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects",
        "lillyAlias": []
    },
    "NCT02397473": {
        "briefTitle": "A Study Of Galcanezumab In Participants With Episodic Cluster Headache",
        "officialTitle": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache",
        "lillyAlias": [
            "I5Q-MC-CGAL",
            "2015-000149-22"
        ]
    },
    "NCT03518073": {
        "briefTitle": "A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease",
        "officialTitle": "Assessment of Safety, Tolerability, and Efficacy of LY3303560 in Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I8G-MC-LMDC"
        ]
    },
    "NCT00580073": {
        "briefTitle": "Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum",
        "officialTitle": "A Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of the Rectum",
        "lillyAlias": [
            "NCI-2011-00476",
            "A534260",
            "SMPH/MEDICINE",
            "H-2007-0197"
        ]
    },
    "NCT05896527": {
        "briefTitle": "A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis",
        "officialTitle": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis",
        "lillyAlias": [
            "2022-502249-90-00",
            "J5B-MC-FHAG"
        ]
    },
    "NCT00330473": {
        "briefTitle": "A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options",
        "lillyAlias": [
            "H7U-MC-IDAW"
        ]
    },
    "NCT00906373": {
        "briefTitle": "A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver",
        "officialTitle": "A Multicenter, Phase 2 Study Evaluating IMC-A12 in Combination With Sorafenib as First-Line Therapy for Patients With Advanced Hepatocellular Carcinoma (HCC)",
        "lillyAlias": [
            "CP13-0812",
            "I5A-IE-JAEG"
        ]
    },
    "NCT02783573": {
        "briefTitle": "A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia",
        "lillyAlias": [
            "I8D-MC-AZET",
            "2015-005625-39"
        ]
    },
    "NCT01484431": {
        "briefTitle": "A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension",
        "officialTitle": "A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension",
        "lillyAlias": [
            "H6D-MC-LVIG"
        ]
    },
    "NCT03906331": {
        "briefTitle": "Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation",
        "officialTitle": "Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation",
        "lillyAlias": [
            "Selpercatinib EAP",
            "J2G-OX-Y001"
        ]
    },
    "NCT01129674": {
        "briefTitle": "A Long-Term, Open-Label, Study on Schizophrenia",
        "officialTitle": "A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBBO"
        ]
    },
    "NCT00167765": {
        "briefTitle": "Abciximab in Wake-up Stroke",
        "officialTitle": "Does Abciximab Save Hypoperfused Ischemic Brain Tissue in Wake-Up Stroke: A Placebo-Controlled, Randomized, MR Imaging Study",
        "lillyAlias": []
    },
    "NCT01017874": {
        "briefTitle": "A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer",
        "officialTitle": "A Randomized Ph 3 Study Comparing First-Line Pemetrexed/Cisplatin Followed by Gefitinib With Gefitinib Alone in East Asian Never Smoker or Light Ex-Smoker Patients With Locally Advanced or Metastatic Nonsquamous NSCLC",
        "lillyAlias": [
            "H3E-CR-S131"
        ]
    },
    "NCT00716274": {
        "briefTitle": "Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia",
        "officialTitle": "Neurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tasks Pre- and Post-Atomoxetine Treatment",
        "lillyAlias": [
            "B4Z-US-LYEI",
            "2019-000419-98"
        ]
    },
    "NCT06258174": {
        "briefTitle": "A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants",
        "officialTitle": "A Phase I, Open-Label, Randomized, 2-Way Crossover Study to Compare the PK of Pirtobrutinib (LOXO-305) Tablets",
        "lillyAlias": [
            "J2N-OX-JZNV"
        ]
    },
    "NCT06362265": {
        "briefTitle": "A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Single Dose Study to Evaluate the Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-MC-BDDB"
        ]
    },
    "NCT00642174": {
        "briefTitle": "Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)",
        "officialTitle": "A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus High Dose Clopidogrel in Subjects With Type 2 Diabetes Mellitus and Coronary Artery Disease.",
        "lillyAlias": [
            "H7T-MC-TACA"
        ]
    },
    "NCT00007774": {
        "briefTitle": "To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia",
        "officialTitle": "CSP #451 - The Clinical and Economic Impact of Olanzapine in the Treatment of Schizophrenia",
        "lillyAlias": []
    },
    "NCT00734474": {
        "briefTitle": "A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin",
        "officialTitle": "A Phase 2/3, Placebo-Controlled, Efficacy and Safety Study of Once-Weekly, Subcutaneous LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin",
        "lillyAlias": [
            "H9X-MC-GBCF",
            "CTRI/2009/091/000969"
        ]
    },
    "NCT00696774": {
        "briefTitle": "Switching to Duloxetine in Patients With Depression",
        "officialTitle": "Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study)",
        "lillyAlias": [
            "F1J-CR-S022"
        ]
    },
    "NCT06003465": {
        "briefTitle": "A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices",
        "officialTitle": "A Relative Bioavailability Study to Compare the Pharmacokinetics of LY3437943 Administered Subcutaneously by a Test Device (Test Formulation) Versus Reference Device (Reference Formulation) in Healthy Participants",
        "lillyAlias": [
            "J1I-MC-GZBX"
        ]
    },
    "NCT02367131": {
        "briefTitle": "Daily Use of JARDIANCE\u00ae Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "Post Marketing Surveillance in Japan on Drug Use of JARDIANCE\u00ae Tablets in Elderly Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT02084082": {
        "briefTitle": "Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release (5 mg/1000 mg) Compared With the Free Combination of Linagliptin and Metformin Extended Release Tablets in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Trial)",
        "lillyAlias": [
            "2013-005142-11"
        ]
    },
    "NCT04586920": {
        "briefTitle": "A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants",
        "officialTitle": "A Phase 1, Randomized, Participant-and Investigator-Blind, Placebo-Controlled, Single-and Multiple-Ascending Dose, Drug-Drug Interaction and Food Effect Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3509754 in Healthy Non-Japanese and Japanese Participants",
        "lillyAlias": [
            "J3D-MC-FNAA",
            "2020-003957-30"
        ]
    },
    "NCT00919282": {
        "briefTitle": "Gemcitabine (GFF) in Patients With Pancreatic Cancer",
        "officialTitle": "A Multi Center Phase II Study of 5-Fluorouracil/ Folinic Acid Plus Gemcitabine in Patients With Advanced Pancreatic Cancer.",
        "lillyAlias": []
    },
    "NCT00485420": {
        "briefTitle": "eCare for Moods: An Internet-based Management Program",
        "officialTitle": "Using the Internet to Provide Disease Management and Improve Compliance Among Bipolar and Depressed Patients",
        "lillyAlias": []
    },
    "NCT03148431": {
        "briefTitle": "A Study of LY3002815 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3002815 in Healthy Subjects",
        "lillyAlias": [
            "I9G-MC-CCBA",
            "2016-004453-33"
        ]
    },
    "NCT01287520": {
        "briefTitle": "A Study of LY2090314 in Patients With Advanced or Metastatic Cancer",
        "officialTitle": "Phase 1 Dose Escalation Study of LY2090314 in Patients With Advanced or Metastatic Cancer in Combination With Pemetrexed and Carboplatin",
        "lillyAlias": [
            "I2H-MC-JWYA"
        ]
    },
    "NCT01373931": {
        "briefTitle": "A Study of LY2216684 in Healthy Females",
        "officialTitle": "Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects",
        "lillyAlias": [
            "H9P-EW-LNCX"
        ]
    },
    "NCT00190931": {
        "briefTitle": "A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder",
        "officialTitle": "A Double-Blind Study of Functional Outcomes With Atomoxetine-Hydrochloride and Placebo in Adult Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-MC-LYBV"
        ]
    },
    "NCT04667182": {
        "briefTitle": "A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes",
        "officialTitle": "Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections",
        "lillyAlias": [
            "F3Z-MC-IORN"
        ]
    },
    "NCT06085482": {
        "briefTitle": "A Phase I Study of LY3502970 in Healthy Participants",
        "officialTitle": "A Single-Group, Open-Label, Single-Period, Phase 1 Study to Determine the Absolute Bioavailability of LY3502970 in Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZGO"
        ]
    },
    "NCT01908582": {
        "briefTitle": "A Study of Evacetrapib and Rifampin in Healthy Participants",
        "officialTitle": "Effect of Rifampin on the Pharmacokinetics of Evacetrapib in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAZ"
        ]
    },
    "NCT00329082": {
        "briefTitle": "Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers",
        "officialTitle": "LY2062430: Multiple-Dose Safety in Subjects With Mild-to-Moderate Alzheimer's Disease and Single-Dose Safety in Healthy Volunteers",
        "lillyAlias": [
            "H8A-MC-LZAJ"
        ]
    },
    "NCT04152382": {
        "briefTitle": "A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis",
        "officialTitle": "A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis",
        "lillyAlias": [
            "J1A-MC-KDAC"
        ]
    },
    "NCT00363766": {
        "briefTitle": "Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer",
        "officialTitle": "A Phase 2 Study of LY573636-Sodium Administered as an Intravenous Infusion on Day 1 of a 21-Day Cycle as Third-line Treatment in Patients With Unresectable, Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H8K-MC-JZAC"
        ]
    },
    "NCT06345066": {
        "briefTitle": "A Study of LY3841136 in Overweight and Obese Participants",
        "officialTitle": "A Multiple Dose Combination Study to Evaluate the Safety and Tolerability of Tirzepatide and LY3841136 in Overweight and Obese Participants",
        "lillyAlias": [
            "J3R-MC-YDAC"
        ]
    },
    "NCT00575666": {
        "briefTitle": "Intranasal Insulin Treatment in Patients With Schizophrenia",
        "officialTitle": "Intranasal Insulin Treatment in Patients With Schizophrenia",
        "lillyAlias": []
    },
    "NCT00190866": {
        "briefTitle": "Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome",
        "officialTitle": "Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome",
        "lillyAlias": [
            "F1J-MC-HMCJ"
        ]
    },
    "NCT02194465": {
        "briefTitle": "A Study of LY2623091 in Participants With High Blood Pressure",
        "officialTitle": "A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension",
        "lillyAlias": [
            "I7T-MC-RMAH"
        ]
    },
    "NCT01051466": {
        "briefTitle": "A Study of the Neurobiology of Depression",
        "officialTitle": "Neurobiological Correlates of Antidepressant Response After Duloxetine Hydrochloride Treatment in Subjects With Major Depressive Disorder",
        "lillyAlias": [
            "F1J-US-HMGO"
        ]
    },
    "NCT01632566": {
        "briefTitle": "A Multiple-dose Study of LY3031207 in Healthy Participants",
        "officialTitle": "A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3031207 in Healthy Subjects",
        "lillyAlias": [
            "I5W-EW-LBCB"
        ]
    },
    "NCT00400166": {
        "briefTitle": "Recovery Guide Intervention for Recurrent Psychiatric Hospitalization",
        "officialTitle": "Recovery Guide Intervention for Recurrent Psychiatric Hospitalization",
        "lillyAlias": []
    },
    "NCT00509366": {
        "briefTitle": "Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer",
        "officialTitle": "Phase II Prospective Study Evaluating the Role of Personalized Chemotherapy Regimens for Chemo-Naive Select Stage IIIB and IV Non-Small Cell Lung Cancer (NSCLC) in Patients Using a Genomic Predictor of Platinum Resistance to Guide Therapy",
        "lillyAlias": []
    },
    "NCT04648865": {
        "briefTitle": "A Study of LY3537031 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3537031 in Healthy Participants",
        "lillyAlias": [
            "J2S-MC-GZMA"
        ]
    },
    "NCT02065765": {
        "briefTitle": "International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer",
        "officialTitle": "An International Single-Arm Protocol to Provide Expanded Access to Ramucirumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression After Prior Fluoropyrimidine and/or Platinum-Containing Chemotherapy",
        "lillyAlias": [
            "I4T-MC-JVCP"
        ]
    },
    "NCT03706365": {
        "briefTitle": "A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer",
        "officialTitle": "A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer",
        "lillyAlias": [
            "I3Y-MC-JPCM",
            "2016-004276-21"
        ]
    },
    "NCT06444165": {
        "briefTitle": "Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis",
        "officialTitle": "Study to Assess Lebrikizumab Pen Ease of Use in Patients With Atopic Dermatitis",
        "lillyAlias": [
            "J2T-MC-KGBY"
        ]
    },
    "NCT03703466": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer",
        "officialTitle": "An Open-Label, Randomized Phase 2 Study of the Impact of Food on Tolerability When Receiving Abemaciclib for Patients With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPCP",
            "2018-001853-28"
        ]
    },
    "NCT05918666": {
        "briefTitle": "National Register of Actionable Mutations",
        "officialTitle": "National Register of Actionable Mutations - Rational Study",
        "lillyAlias": []
    },
    "NCT02963766": {
        "briefTitle": "A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes",
        "officialTitle": "A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)",
        "lillyAlias": [
            "H9X-MC-GBGC",
            "2016-000361-22"
        ]
    },
    "NCT00042666": {
        "briefTitle": "A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.",
        "officialTitle": "A Phase 2 Evaluation of Oral LY317615 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",
        "lillyAlias": [
            "H6Q-MC-JCAI"
        ]
    },
    "NCT04426474": {
        "briefTitle": "A Study of LY3502970 in Participants With Type 2 Diabetes",
        "officialTitle": "A Multiple-Dose Study in Participants With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of LY3502970",
        "lillyAlias": [
            "J2A-MC-GZGC",
            "2020-000125-86"
        ]
    },
    "NCT00191074": {
        "briefTitle": "Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature",
        "officialTitle": "Phase III Study of Humatrope in Non-Growth Hormone Deficient Children With Short Stature",
        "lillyAlias": [
            "B9R-MC-GDCH"
        ]
    },
    "NCT00623974": {
        "briefTitle": "Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia",
        "officialTitle": "A Phase II Study of Short-Term Use of Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia",
        "lillyAlias": []
    },
    "NCT00129974": {
        "briefTitle": "Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer",
        "officialTitle": "A Phase II Trial of Pemetrexed in Combination With Gemcitabine as First Line Treatment in Extensive-Stage Small Cell Lung Carcinoma",
        "lillyAlias": []
    },
    "NCT00088465": {
        "briefTitle": "Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder",
        "officialTitle": "An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder",
        "lillyAlias": [
            "F1D-MC-HGKB"
        ]
    },
    "NCT00191165": {
        "briefTitle": "Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency",
        "officialTitle": "Efficacy and Safety of a High Dosage Compared to the Label Dosage of Humatrope in Early Pubertal Stage Children With Growth Hormone Deficiency",
        "lillyAlias": [
            "B9R-IT-GDFU"
        ]
    },
    "NCT01389765": {
        "briefTitle": "A Study to Evaluate the Effect of Food on LY2216684",
        "officialTitle": "Effect of Food on the Pharmacokinetics of LY2216684 in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNDC"
        ]
    },
    "NCT00384774": {
        "briefTitle": "A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine",
        "officialTitle": "A Placebo-Controlled, Group Sequential, Adaptive Treatment Assignment Study of Intravenous COL-144 (LY573144) in the Acute Treatment of Migraine",
        "lillyAlias": [
            "2006-003903-38",
            "COL MIG-201",
            "H8H-CD-LAHM"
        ]
    },
    "NCT03764774": {
        "briefTitle": "A Study of LY3463251 in Healthy Participants",
        "officialTitle": "A Randomized, Placebo-Controlled, Subject- and Investigator-Blind, Single and Multiple Dose, Safety, Tolerability, and Pharmacokinetics Study of LY3463251 in Healthy and Overweight Healthy Subjects",
        "lillyAlias": [
            "J1D-MC-GZAA"
        ]
    },
    "NCT00516074": {
        "briefTitle": "A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes",
        "officialTitle": "A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT00920582": {
        "briefTitle": "Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab (MGA031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT05872620": {
        "briefTitle": "A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes",
        "officialTitle": "A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)",
        "lillyAlias": [
            "J2A-MC-GZGQ",
            "2022-502837-24-00",
            "U1111-1289-8799"
        ]
    },
    "NCT04165031": {
        "briefTitle": "A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation",
        "officialTitle": "A Phase 1/2 Study of LY3499446 Administered to Patients With Advanced Solid Tumors With KRAS G12C Mutation",
        "lillyAlias": [
            "J2K-MC-JZKA",
            "2019-003070-53"
        ]
    },
    "NCT01117831": {
        "briefTitle": "An Analysis of Diabetes Control in Puerto Rico",
        "officialTitle": "An Analysis of Variables That Affect Quality of Diabetes Control in Puerto Rico",
        "lillyAlias": []
    },
    "NCT01017731": {
        "briefTitle": "Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes",
        "officialTitle": "A Study to Evaluate the Relationship Between Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes in Patients With Advanced Cancer",
        "lillyAlias": [
            "CP12-0712",
            "I4T-IE-JVBK"
        ]
    },
    "NCT02614131": {
        "briefTitle": "A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)",
        "officialTitle": "Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease",
        "lillyAlias": [
            "I2L-MC-ALCA"
        ]
    },
    "NCT05292040": {
        "briefTitle": "A Study of LY3857210 in Healthy Participants",
        "officialTitle": "An Adaptive Design, Phase 1, Open-label Study to Investigate Receptor Occupancy in Brain After Single Oral Doses of LY3857210 as Measured by Positron Emission Tomography (PET) With the Radioligand [18F]-LY3818850 in Healthy Participants",
        "lillyAlias": [
            "J3O-MC-LSBA"
        ]
    },
    "NCT00523640": {
        "briefTitle": "A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma",
        "officialTitle": "A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma",
        "lillyAlias": []
    },
    "NCT01297062": {
        "briefTitle": "A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects",
        "officialTitle": "A Randomized, Phase 1, Three-Period, Placebo- and Positive-Controlled, Double-Blind, Crossover Study to Assess the Electrophysiological Effects of Exenatide at Therapeutic and Supratherapeutic Concentrations on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects",
        "lillyAlias": []
    },
    "NCT01367262": {
        "briefTitle": "Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants",
        "officialTitle": "Disposition of [14C]-LY2886721 Following Oral Administration in Healthy Human Subjects",
        "lillyAlias": [
            "I4O-MC-BACD"
        ]
    },
    "NCT00146276": {
        "briefTitle": "Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer",
        "officialTitle": "Adjuvant vs. Progression-Triggered Treatment With Gemcitabine After Radical Cystectomy for Locally Advanced Transitional Cell Carcinoma of the Bladder in Patients Not Suitable for Cisplatin-Based Chemotherapy - A Phase 3 Study",
        "lillyAlias": [
            "AB 22/00"
        ]
    },
    "NCT00408876": {
        "briefTitle": "Duloxetine Versus Placebo in Chronic Low Back Pain",
        "officialTitle": "Protocol F1J-MC-HMEO Duloxetine Versus Placebo in the Treatment of Chronic Low Back Pain",
        "lillyAlias": [
            "F1J-MC-HMEO"
        ]
    },
    "NCT04515576": {
        "briefTitle": "A Study of LY3493269 in Participants With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Subcutaneous Doses of LY3493269 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J1X-MC-GZHC"
        ]
    },
    "NCT02041091": {
        "briefTitle": "A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus",
        "officialTitle": "Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus",
        "lillyAlias": [
            "H9B-MC-BCEI"
        ]
    },
    "NCT02580591": {
        "briefTitle": "Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)",
        "officialTitle": "A Phase III, Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy, Safety and Tolerability Trial of Once Daily, Oral Doses of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-3)",
        "lillyAlias": [
            "2014-005256-26"
        ]
    },
    "NCT02308020": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain",
        "officialTitle": "A Phase 2 Study of Abemaciclib in Patients With Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma",
        "lillyAlias": [
            "I3Y-MC-JPBO",
            "2014-004010-28"
        ]
    },
    "NCT00190840": {
        "briefTitle": "A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer",
        "officialTitle": "Open-Label Single-Arm Phase 2 Study of ALIMTA in Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy",
        "lillyAlias": [
            "H3E-AA-S037"
        ]
    },
    "NCT01185340": {
        "briefTitle": "A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor",
        "officialTitle": "A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment",
        "lillyAlias": [
            "H9P-MC-LNBR"
        ]
    },
    "NCT03830840": {
        "briefTitle": "Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos",
        "officialTitle": "Mil Familias: an Observational Cohort Study to Understand the Impact of Genetics, Biology, Behavior, Psychology, and Society/Environment on Diabetes and Its Complications Among US Latinos",
        "lillyAlias": []
    },
    "NCT00466440": {
        "briefTitle": "A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients",
        "officialTitle": "A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study With and Without Enzastaurin in Combination With Docetaxel and Prednisone, Followed By Enzastaurin Maintenance as First-Line Treatment in Hormone Refractory Metastatic Prostate Cancer Patients",
        "lillyAlias": [
            "H6Q-MC-S032"
        ]
    },
    "NCT04956640": {
        "briefTitle": "Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)",
        "officialTitle": "A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors",
        "lillyAlias": [
            "2021-000595-12",
            "J3M-OX-JZQA",
            "MK-3475-E27/KEYNOTE E27"
        ]
    },
    "NCT00383331": {
        "briefTitle": "Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer",
        "officialTitle": "A Phase II Study of ALIMTA\u00ae (Pemetrexed) and GEMZAR\u00ae (Gemcitabine) Every 14 Days Versus Pemetrexed and Gemcitabine Every 21 Days in Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-US-S061"
        ]
    },
    "NCT04441931": {
        "briefTitle": "A Study of LY3832479 (LY-CoV016) in Healthy Participants",
        "officialTitle": "A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Immunogenicity of LY3832479 Given as a Single Intravenous Dose in Healthy Participants",
        "lillyAlias": [
            "J2Z-MC-PGAA"
        ]
    },
    "NCT06598631": {
        "briefTitle": "Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease",
        "lillyAlias": [
            "J3E-MC-EZDC",
            "2024-513895-16-00"
        ]
    },
    "NCT05916560": {
        "briefTitle": "A Study of LY3437943 in Participants With Impaired and Normal Liver Function",
        "officialTitle": "A Parallel-Group, Single-Dose, Phase 1, Open-Label Study to Investigate the Pharmacokinetics of LY3437943 in Participants With Hepatic Impairment Compared With Healthy Participants",
        "lillyAlias": [
            "J1I-MC-GZBT"
        ]
    },
    "NCT02604160": {
        "briefTitle": "A Study of LY3113593 in Participants With Chronic Kidney Disease",
        "officialTitle": "A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis",
        "lillyAlias": [
            "I7C-MC-FEAC"
        ]
    },
    "NCT01958489": {
        "briefTitle": "A Study of Evacetrapib in Japanese and Non-Japanese Participants",
        "officialTitle": "Effect of Evacetrapib on the Pharmacokinetics of Pravastatin in Healthy Japanese and Non-Japanese Subjects",
        "lillyAlias": [
            "I1V-MC-EIAW"
        ]
    },
    "NCT01602289": {
        "briefTitle": "A Study of LY2875358 in Japanese Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2875358 in Japanese Patients With Advanced Malignancies",
        "lillyAlias": [
            "I4C-JE-JTBD"
        ]
    },
    "NCT01825889": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants",
        "officialTitle": "Pharmacokinetics of Evacetrapib (LY2484595) Following Administration to Subjects With Impaired Renal Function",
        "lillyAlias": [
            "I1V-MC-EIAR"
        ]
    },
    "NCT00607789": {
        "briefTitle": "Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression",
        "officialTitle": "A 12-Week, Double-Blind, Placebo-Controlled, Trial of Duloxetine Versus Placebo in the Treatment of Binge Eating Disorder and Comorbid Depressive Disorder.",
        "lillyAlias": []
    },
    "NCT00803231": {
        "briefTitle": "Follow-up Data of Patients Treated With XIGRIS\u00ae in France",
        "officialTitle": "Follow-up Data of Patients Treated With XIGRIS\u00ae DROTRECOGIN ALFA (ACTIVATED) in France",
        "lillyAlias": [
            "F1K-FR-B009"
        ]
    },
    "NCT02675231": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer",
        "officialTitle": "monarcHER: A Phase 2, Randomized, Multicenter, 3-Arm, Open-Label Study to Compare the Efficacy of Abemaciclib Plus Trastuzumab With or Without Fulvestrant to Standard-of-Care Chemotherapy of Physician's Choice Plus Trastuzumab in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPBZ",
            "2015-003400-24"
        ]
    },
    "NCT01463631": {
        "briefTitle": "A Study of LY3007113 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY3007113, a p38 MAPK Inhibitor, in Patients With Advanced Cancer",
        "lillyAlias": [
            "I5Z-MC-JKBA"
        ]
    },
    "NCT01086748": {
        "briefTitle": "A Study in Schizophrenia Patients",
        "officialTitle": "A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Comparator Study of 2 Doses of LY2140023 Versus Placebo in Patients With DSM-IV-TR Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBBM"
        ]
    },
    "NCT00181948": {
        "briefTitle": "Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy",
        "officialTitle": "A Pilot Study of Strattera Treatment in Children With Attention-Deficit/Hyperactivity Disorder Who Have Poor Response to Stimulant Therapy",
        "lillyAlias": []
    },
    "NCT01258348": {
        "briefTitle": "A Phase 1b Trial in Patients With Renal Cell Cancer",
        "officialTitle": "A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer",
        "lillyAlias": [
            "H8K-MC-JZAI"
        ]
    },
    "NCT03334448": {
        "briefTitle": "A Study to Compare 2 Formulations of LY900014 in Healthy Participants",
        "officialTitle": "Bioequivalence Study Comparing the Pharmacokinetics and Glucodynamics of LY900014 U-200 Formulation With LY900014 U-100 Formulation in Healthy Subjects",
        "lillyAlias": [
            "I8B-MC-ITRQ"
        ]
    },
    "NCT01606748": {
        "briefTitle": "A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin",
        "officialTitle": "An Open-Label, Non-controlled, Non-randomized Sequential Design, Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin in Patients With Advanced Solid Cancers",
        "lillyAlias": [
            "CP11-1115",
            "I4X-IE-JFCJ"
        ]
    },
    "NCT00869726": {
        "briefTitle": "A Study for Patients With Secondary Progressive Multiple Sclerosis",
        "officialTitle": "A Double-Blind, Placebo Controlled Multicentre Study To Evaluate The Efficacy And Safety Of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis",
        "lillyAlias": [
            "I3E-BM-MSAB",
            "MBP8298-01"
        ]
    },
    "NCT05929066": {
        "briefTitle": "A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight",
        "officialTitle": "A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1)",
        "lillyAlias": [
            "J1I-MC-GZBJ",
            "J1I-MC-GOA1",
            "J1I-MC-GSA1",
            "2023-503657-35-00"
        ]
    },
    "NCT00479726": {
        "briefTitle": "Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)",
        "officialTitle": "Lilly's Emotional and Physical Symptoms of Depression Study",
        "lillyAlias": [
            "F1J-MC-HMCY"
        ]
    },
    "NCT00540826": {
        "briefTitle": "Treatment Compliance in Children and Adolescents on ADHD Medication",
        "officialTitle": "Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice",
        "lillyAlias": [
            "B4Z-SB-B012"
        ]
    },
    "NCT06039826": {
        "briefTitle": "A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese",
        "officialTitle": "A Phase 1 Study to Investigate the Effect of LY3437943 on the Pharmacokinetics of the Combined Oral Contraceptive Ethinyl Estradiol and Drospirenone in Female Participants",
        "lillyAlias": [
            "J1I-MC-GZBV"
        ]
    },
    "NCT00083720": {
        "briefTitle": "Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy",
        "officialTitle": "A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Refractory, EGFR-Negative Metastatic Colorectal Carcinoma",
        "lillyAlias": []
    },
    "NCT03220126": {
        "briefTitle": "A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants",
        "officialTitle": "An Assessment of the Absolute and Relative Bioavailability of Subcutaneous Doses of LY3074828 When Coadministered With LY9999QS to Healthy Subjects",
        "lillyAlias": [
            "I9O-MC-AABA",
            "2017-001242-10"
        ]
    },
    "NCT00533026": {
        "briefTitle": "Duloxetine - Warfarin Pharmacodynamic Study",
        "officialTitle": "Evaluation of the Effect of Duloxetine on the Pharmacodynamics of Warfarin at Steady-State in Healthy Subjects",
        "lillyAlias": [
            "F1J-MC-HMFP"
        ]
    },
    "NCT01253226": {
        "briefTitle": "A Study for Japanese Participants With Rheumatoid Arthritis (RA)",
        "officialTitle": "Multiple-Dose, Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2127399 in Japanese Patients With Rheumatoid Arthritis Treated With Methotrexate",
        "lillyAlias": [
            "H9B-JE-BCDK"
        ]
    },
    "NCT01663857": {
        "briefTitle": "A Study LY2228820 for Recurrent Ovarian Cancer",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Study of LY2228820, a p38 MAPK Inhibitor, Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin for Women With Platinum-Sensitive Ovarian Cancer",
        "lillyAlias": [
            "I1D-MC-JIAE"
        ]
    },
    "NCT01561430": {
        "briefTitle": "Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease",
        "officialTitle": "Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease",
        "lillyAlias": [
            "I4O-MC-BACC",
            "2011-005217-37"
        ]
    },
    "NCT03745430": {
        "briefTitle": "RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma",
        "officialTitle": "Phase Ib-II Study of Ramucirumab Combined With Standard Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma",
        "lillyAlias": [
            "2017-004792-30"
        ]
    },
    "NCT00403130": {
        "briefTitle": "Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer",
        "officialTitle": "Phase II Open Label Study of Gemcitabine, Paclitaxel and Bevacizumab Combination as First Line Treatment for Metastatic Breast Cancer",
        "lillyAlias": [
            "96052",
            "BRSMTS0007"
        ]
    },
    "NCT04408625": {
        "briefTitle": "Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)",
        "officialTitle": "A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)",
        "lillyAlias": []
    },
    "NCT05749848": {
        "briefTitle": "A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants",
        "officialTitle": "Open-Label Study to Assess the Disposition of [14C]-LY3372689 Following Oral Administration in Healthy Male Participants",
        "lillyAlias": [
            "I9X-MC-MTAF"
        ]
    },
    "NCT00355030": {
        "briefTitle": "Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature",
        "officialTitle": "Efficacy and Safety of Somatropin in Combination With Leuprorelin Compared to Somatropin Alone in Pubertal Children With Idiopathic Short Stature",
        "lillyAlias": [
            "B9R-FP-GDGI"
        ]
    },
    "NCT00067730": {
        "briefTitle": "A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation",
        "officialTitle": "A Safety Evaluation of Xigris Drotrecogin Alfa Activated in Hematopoietic Stem Cell Transplant Patients With Severe Sepsis",
        "lillyAlias": [
            "F1K-US-EVCE"
        ]
    },
    "NCT01449630": {
        "briefTitle": "A Study of LY3031207 in Healthy Subjects",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3031207 in Healthy Subjects",
        "lillyAlias": [
            "I5W-EW-LBCA"
        ]
    },
    "NCT05573230": {
        "briefTitle": "A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants",
        "officialTitle": "A Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Multiple Doses of Cyclosporine on the Pharmacokinetics of LY3502970 in Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZGL"
        ]
    },
    "NCT03843125": {
        "briefTitle": "A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)",
        "officialTitle": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)",
        "lillyAlias": [
            "I4V-MC-JAIM",
            "2017-005028-11"
        ]
    },
    "NCT06028425": {
        "briefTitle": "A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LOXO-783 in Healthy Adult Subjects",
        "lillyAlias": [
            "J4C-OX-JZUC"
        ]
    },
    "NCT00384930": {
        "briefTitle": "Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, 5-Group, Multinational Study to Evaluate the Efficacy, Dose Response, and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVHG"
        ]
    },
    "NCT02605174": {
        "briefTitle": "Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine",
        "officialTitle": "A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)",
        "lillyAlias": [
            "H8H-CD-LAHK",
            "2015-005689-40",
            "COL MIG-302"
        ]
    },
    "NCT01900665": {
        "briefTitle": "Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo",
        "officialTitle": "Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo",
        "lillyAlias": [
            "H8A-MC-LZAX"
        ]
    },
    "NCT02659865": {
        "briefTitle": "A Study of LY3039478 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose Study for the Evaluation of the Effects of LY3039478 on the QT/Corrected QT Interval in Healthy Subjects and Pilot Relative Bioavailability",
        "lillyAlias": [
            "I6F-MC-JJCE"
        ]
    },
    "NCT05288166": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)",
        "officialTitle": "CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer",
        "lillyAlias": [
            "I3Y-MC-JPEG",
            "2022-500461-28-06"
        ]
    },
    "NCT02623465": {
        "briefTitle": "A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel Insulin Lispro Formulation in Patients With Type 2 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy",
        "lillyAlias": [
            "F3Z-FW-ITCC",
            "2015-003353-18"
        ]
    },
    "NCT00072865": {
        "briefTitle": "Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer",
        "officialTitle": "A Phase II Study of Alimta and Carboplatin in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "H3E-MW-JMGJ"
        ]
    },
    "NCT02104765": {
        "briefTitle": "A Study of LY2951742 in Healthy Japanese and Caucasian Participants",
        "officialTitle": "A Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2951742 Administered Subcutaneously to Japanese and Caucasian Healthy Subjects",
        "lillyAlias": [
            "I5Q-MC-CGAE"
        ]
    },
    "NCT01634165": {
        "briefTitle": "A Study of LY2963016 in Healthy Participants",
        "officialTitle": "Pharmacokinetics and Pharmacodynamics of LY2963016 Compared to Lantus\u00ae in Healthy Subjects Following Two Single Subcutaneous Doses",
        "lillyAlias": [
            "I4L-MC-ABEM"
        ]
    },
    "NCT00004865": {
        "briefTitle": "Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy",
        "officialTitle": "Phase II Study of Cetuximab Anti-Epidermal Growth Factor Receptor (EGFr) Antibody in Combination With Chemotherapy in Patients With Metastatic or Recurrent Squamous Cell Head and Neck Carcinoma",
        "lillyAlias": [
            "UCLA-9906095",
            "IMCL-CP02-9816",
            "UAB-9917",
            "NCI-G00-1667"
        ]
    },
    "NCT01877265": {
        "briefTitle": "A Study of LY2605541 in Healthy Participants",
        "officialTitle": "Assessment of the Impact of Monomethoxy Polyethylene Glycols on the Pharmacokinetics and Glucodynamics of Single Doses of LY2605541 in Healthy Subjects",
        "lillyAlias": [
            "I2R-MC-BIDH"
        ]
    },
    "NCT00950365": {
        "briefTitle": "Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase II Study of Schedule-Modulated Concomitant Pemetrexed (Alimta) and Erlotinib (Tarceva) vs Single Agent Pemetrexed (Alimta\u00ae) in Patients With Progressive or Recurrent Non-small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "NCI-2013-01128",
            "05277",
            "05-10-277",
            "P30CA013330"
        ]
    },
    "NCT02589665": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis",
        "officialTitle": "A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis",
        "lillyAlias": [
            "I6T-MC-AMAC",
            "2015-003123-57"
        ]
    },
    "NCT05051566": {
        "briefTitle": "A Multiple Dose Study of LY3502970 in Healthy Participants",
        "officialTitle": "A Multiple Dose Study in Healthy Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970",
        "lillyAlias": [
            "J2A-MC-GZGD",
            "QSC202755",
            "2020-005750-15"
        ]
    },
    "NCT05630274": {
        "briefTitle": "A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants",
        "officialTitle": "A Single-Dose, Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Way Crossover Study to Evaluate the Effect of LOXO-292 on the QTc Interval in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-OX-JZJG",
            "LOXO-RET-18032"
        ]
    },
    "NCT03773965": {
        "briefTitle": "A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis",
        "officialTitle": "A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)",
        "lillyAlias": [
            "I4V-MC-JAHX",
            "2017-004471-31"
        ]
    },
    "NCT00018174": {
        "briefTitle": "Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers",
        "officialTitle": "Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers",
        "lillyAlias": []
    },
    "NCT00391274": {
        "briefTitle": "Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "Phase 3 Study of Pemetrexed Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy",
        "lillyAlias": [
            "H3E-MC-JMID"
        ]
    },
    "NCT04509674": {
        "briefTitle": "EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)",
        "officialTitle": "EMPACT-MI: A Streamlined, Multicentre, Randomised, Parallel Group, Double-blind Placebo-controlled Superiority Trial to Evaluate the Effect of EMPAgliflozin on Hospitalisation for Heart Failure and Mortality in Patients With aCuTe Myocardial Infarction",
        "lillyAlias": [
            "2019-001037-13"
        ]
    },
    "NCT01253265": {
        "briefTitle": "A Study in Rheumatoid Arthritis",
        "officialTitle": "Multiple-Dose, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2439821 in Japanese Patients With Rheumatoid Arthritis on Concomitant Methotrexate Treatment",
        "lillyAlias": [
            "I1F-JE-RHAL"
        ]
    },
    "NCT00169065": {
        "briefTitle": "Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia",
        "officialTitle": "Clozapine vs. Olanzapine: An Effectiveness Study",
        "lillyAlias": [
            "R01MH049891"
        ]
    },
    "NCT00510276": {
        "briefTitle": "Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes",
        "officialTitle": "A Double-Blind Study of Atomoxetine Hydrochloride Versus Placebo for the Treatment of ADHD in Young Adults With an Assessment of Associated Functional Outcomes",
        "lillyAlias": [
            "B4Z-US-LYDZ"
        ]
    },
    "NCT04161976": {
        "briefTitle": "A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900027 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy",
        "lillyAlias": [
            "J2H-MC-IUAA",
            "2019-002318-37"
        ]
    },
    "NCT00700427": {
        "briefTitle": "A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "Maintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study",
        "lillyAlias": [
            "B4Z-MC-LYDO"
        ]
    },
    "NCT05002127": {
        "briefTitle": "A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06)",
        "officialTitle": "A Phase 2/3 Study of Evorpacept (ALX148) in Patients with Advanced HER2-Overexpressing Gastric/Gastroesophageal Junction Adenocarcinoma (ASPEN-06)",
        "lillyAlias": []
    },
    "NCT01202773": {
        "briefTitle": "A Study in Participants With Rheumatoid Arthritis",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to One or More TNF-\u03b1 Inhibitors (FLEX V)",
        "lillyAlias": [
            "H9B-MC-BCDV"
        ]
    },
    "NCT00703976": {
        "briefTitle": "Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer",
        "officialTitle": "Phase II Randomized Trial of Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer",
        "lillyAlias": []
    },
    "NCT00229476": {
        "briefTitle": "Study of Medication and Placebo Response in Major Depression",
        "officialTitle": null,
        "lillyAlias": [
            "H6U-US-X002",
            "04012549"
        ]
    },
    "NCT05123976": {
        "briefTitle": "Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.",
        "officialTitle": "A Comparative, Open-label, Randomized, Two-period Bioequivalence Study of Olanzapine Film-coated Tablets 5 mg (JSC Farmak, Ukraine) vs Zyprexa\u00ae Coated Tablets 5 mg (Eli Lilly, Nederland B V) in Healthy Subjects Under Fasted Conditions.",
        "lillyAlias": []
    },
    "NCT00193427": {
        "briefTitle": "Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer",
        "officialTitle": "Phase II Trial of Preoperative (Neo-adjuvant) Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT00310427": {
        "briefTitle": "Effect of LY686017 on Alcohol Craving",
        "officialTitle": "NK1 Receptor Antagonism for Treatment of Anxiety and Craving in Anxious Alcohol Dependent Subjects During Early Abstinence",
        "lillyAlias": [
            "06-AA-0129"
        ]
    },
    "NCT00954876": {
        "briefTitle": "Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer",
        "officialTitle": "Phase II, Multi-Center, Open-Label, Prospective Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type KRAS Colorectal Cancer Who Are Considered Nonoptimal Candidates or Are Intolerant to a First-Line Oxaliplatin/Irinotecan Regimen",
        "lillyAlias": []
    },
    "NCT01825876": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants",
        "officialTitle": "Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAO"
        ]
    },
    "NCT05267327": {
        "briefTitle": "A Prospective Post-Marketing Observational Safety Study of Verzenios\u00ae (Abemaciclib) Among Breast Cancer Patients in China Verzenios\u00ae (Abemaciclib) Among Breast",
        "officialTitle": "A Prospective Post-Marketing Observational Safety Study of Verzenios\u00ae (Abemaciclib) Among Breast Cancer Patients in China",
        "lillyAlias": []
    },
    "NCT00550927": {
        "briefTitle": "Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer",
        "officialTitle": "A Phase 1 Safety Evaluation of Oral Enzastaurin in Combination With Bevacizumab in Patients With Advanced/Metastatic Cancer",
        "lillyAlias": [
            "JHOC-J0688",
            "JHOC-NA_00004943",
            "CDR0000571514",
            "H6Q-MC-S029"
        ]
    },
    "NCT03485976": {
        "briefTitle": "Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)",
        "officialTitle": "Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)",
        "lillyAlias": []
    },
    "NCT00661427": {
        "briefTitle": "Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer",
        "officialTitle": "A Phase II Randomized Study of Cetuximab at Either 500 or 750 mg/m^2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer.",
        "lillyAlias": []
    },
    "NCT04472676": {
        "briefTitle": "A Study of LY3473329 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of Single-and Multiple-Ascending Doses of LY3473329 in Healthy Subjects",
        "lillyAlias": [
            "J2O-MC-EKBA",
            "2020-002522-91"
        ]
    },
    "NCT00034476": {
        "briefTitle": "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis",
        "officialTitle": "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis",
        "lillyAlias": [
            "J4A-MC-EZZI"
        ]
    },
    "NCT00491127": {
        "briefTitle": "Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma",
        "officialTitle": "Phase II Study of Cisplatin With Gemcitabine in Fixed Dose Rate Infusion and Dexamethasone in Second-Line in Patients With Aggressive Non-Hodgkin's Lymphoma",
        "lillyAlias": [
            "B9E-XM-S315"
        ]
    },
    "NCT01340976": {
        "briefTitle": "A Phase 1 Study of LY2787106 in Cancer and Anemia",
        "officialTitle": "A Phase 1 Safety Study of LY2787106 in Patients With Cancer and Anemia",
        "lillyAlias": [
            "I3S-MC-JABA"
        ]
    },
    "NCT01199822": {
        "briefTitle": "Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors",
        "officialTitle": "A Phase 1 Study Evaluating the Safety and Pharmacokinetic Profiles of IMC-3G3 Administered in a 2-week, or 3-week Schedule to Japanese Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "CP15-0907",
            "I5B-IE-JGDF",
            "21-3720"
        ]
    },
    "NCT00538122": {
        "briefTitle": "Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment",
        "officialTitle": "Evaluating the Risks of Arrhythmia and Sudden Death Associated With Antipsychotic Drugs by Assessing the T Wave Abnormalities in the Holter Electrocardiogram",
        "lillyAlias": []
    },
    "NCT00215930": {
        "briefTitle": "The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer",
        "officialTitle": "Phase II Study on the Use of Molecular Analyses-Based Customized Chemotherapy in Patients With Stage IV/IIIB (Malignant Pleural Effusion) Non-Small-Cell Lung Cancer (NSCLC)",
        "lillyAlias": []
    },
    "NCT00916630": {
        "briefTitle": "Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)",
        "officialTitle": "A Phase I Study of the Treatment of Recurrent Primary or Secondary CNS Lymphoma With ALIMTA (Pemetrexed), a Novel Anti-Folate",
        "lillyAlias": [
            "H3-US-X059"
        ]
    },
    "NCT03926130": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease",
        "lillyAlias": [
            "I6T-MC-AMAM",
            "2018-004614-18"
        ]
    },
    "NCT03758430": {
        "briefTitle": "A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes",
        "officialTitle": "Technology-supported, Meal-centric, Insulin Dosing for Optimized Post-prandial Glucose Control",
        "lillyAlias": [
            "F3Z-MC-IORA"
        ]
    },
    "NCT00630825": {
        "briefTitle": "A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "The Effect of Dose Titration of LY2189265 in Overweight and Obese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-MC-GBCJ"
        ]
    },
    "NCT01779830": {
        "briefTitle": "A Study of LY2624803 in Participants With Transient Insomnia",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Crossover Study of Single Doses of LY2624803 in a 5-hour Phase Advance Model of Transient Insomnia in Healthy Subjects",
        "lillyAlias": [
            "I2K-MC-ZZAA"
        ]
    },
    "NCT02271425": {
        "briefTitle": "A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants",
        "officialTitle": "An Absolute Bioavailability Study of Evacetrapib in Healthy Subjects Using the Intravenous Tracer Method",
        "lillyAlias": [
            "I1V-MC-EIAT"
        ]
    },
    "NCT02426125": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients With Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After Platinum-Based Therapy",
        "lillyAlias": [
            "I4T-MC-JVDC",
            "2014-003655-66"
        ]
    },
    "NCT03626922": {
        "briefTitle": "Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients",
        "officialTitle": "A Phase IB Study of Pembrolizumab in Combination With Pemetrexed and Oxaliplatin in Patients With Chemo-Refractory Metastatic Colorectal Cancer",
        "lillyAlias": []
    },
    "NCT03053622": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) Injection in Healthy Participants",
        "officialTitle": "A Phase 1, Single-Dose Study to Assess the Relative Bioavailability, Absolute Bioavailability, and Tolerability of LY3074828 Formulations in Healthy Subjects",
        "lillyAlias": [
            "I6T-MC-AMAL",
            "2016-003584-18"
        ]
    },
    "NCT00457730": {
        "briefTitle": "A Study to Test the Use of Duloxetine for Pain in MS",
        "officialTitle": "A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis",
        "lillyAlias": [
            "WIRB Protocol Number: 20061712"
        ]
    },
    "NCT00547625": {
        "briefTitle": "Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems",
        "officialTitle": "A Multicenter, Parallel-Arm, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Tadalafil Administered Once Daily to Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVGC"
        ]
    },
    "NCT05609825": {
        "briefTitle": "A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia",
        "lillyAlias": [
            "J4D-MC-EZFA"
        ]
    },
    "NCT00191425": {
        "briefTitle": "2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis",
        "officialTitle": "Comparison of a 2-Year Therapy of Teriparatide Alone and Its Sequential Use for 1 Year, With or Without Raloxifene HCl, in the Treatment of Severe Postmenopausal Osteoporosis",
        "lillyAlias": [
            "B3D-EW-GHCA"
        ]
    },
    "NCT06260722": {
        "briefTitle": "Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)",
        "officialTitle": "A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)",
        "lillyAlias": [
            "J1I-MC-GZBZ"
        ]
    },
    "NCT00668148": {
        "briefTitle": "A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma",
        "officialTitle": "A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously-Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET",
        "lillyAlias": [
            "2007-006719-21",
            "CP13-0707",
            "I5A-IE-JAEC"
        ]
    },
    "NCT00470548": {
        "briefTitle": "Abraxane and Alimta in Advanced Solid Tumors",
        "officialTitle": "Phase I/II Trial of Abraxane\u00ae (ABI-007) and Alimta\u00ae (Pemetrexed) in Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer",
        "lillyAlias": [
            "224355",
            "ABX027",
            "H3E-US-I017"
        ]
    },
    "NCT03559257": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study",
        "lillyAlias": [
            "I5Q-MC-CGAW",
            "2018-000600-42"
        ]
    },
    "NCT04991766": {
        "briefTitle": "A Study of [\u00b9\u2074C]-LY3484356 in Healthy Female Participants",
        "officialTitle": "An Open-label, Two-part Study of the Disposition and Absolute Bioavailability of [\u00b9\u2074C]-LY3484356 in Healthy Females of Non-Childbearing Potential",
        "lillyAlias": [
            "J2J-MC-JZLE"
        ]
    },
    "NCT00181766": {
        "briefTitle": "Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)",
        "officialTitle": "A Pilot Study of Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified",
        "lillyAlias": []
    },
    "NCT01914666": {
        "briefTitle": "An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain",
        "officialTitle": "Phase 3 Clinical Study of Duloxetine Hydrochloride in Patients With CLBP - Open Label Long Term Extension Study",
        "lillyAlias": [
            "F1J-JE-HMHC"
        ]
    },
    "NCT06692348": {
        "briefTitle": "A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants",
        "officialTitle": "A Phase 1, Open-Label, Multiple-Dose Study to Investigate the Comparability of the Pharmacokinetics of Orforglipron (LY3502970) Single Capsule and Multiple Capsules in Healthy Participants",
        "lillyAlias": [
            "J2A-JE-GZPM"
        ]
    },
    "NCT03841630": {
        "briefTitle": "A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3437943 in Healthy Subjects",
        "lillyAlias": [
            "J1I-MC-GZBA"
        ]
    },
    "NCT00420030": {
        "briefTitle": "Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock",
        "officialTitle": "Routine Upfront Abciximab Versus Standard Peri-Procedural Therapy in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock PRAGUE-7 Trial.",
        "lillyAlias": [
            "MSM 0021620817"
        ]
    },
    "NCT01722825": {
        "briefTitle": "Study of LY2157299 in Japanese Participants With Cancer",
        "officialTitle": "Phase 1 Dose-Escalation Study of LY2157299 Monotherapy in Patients With Solid Tumors",
        "lillyAlias": [
            "H9H-JE-JBAN"
        ]
    },
    "NCT04188548": {
        "briefTitle": "A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer",
        "officialTitle": "EMBER: A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers",
        "lillyAlias": [
            "J2J-MC-JZLA",
            "2019-003581-41"
        ]
    },
    "NCT01391130": {
        "briefTitle": "A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma",
        "officialTitle": "Randomized, Multicenter, Open-label, Active-Controlled, Phase 2 Study of LY2510924 and Sunitinib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma",
        "lillyAlias": [
            "I2V-MC-CXAB"
        ]
    },
    "NCT01241448": {
        "briefTitle": "A Study of LY2409021 in Patients With Type 2 Diabetes",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-MC-GLBG"
        ]
    },
    "NCT03720548": {
        "briefTitle": "A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)",
        "officialTitle": "A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Healthy Subjects and Patients With Alzheimer's Disease",
        "lillyAlias": [
            "J1G-MC-LAKA"
        ]
    },
    "NCT01505530": {
        "briefTitle": "A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer",
        "officialTitle": "A Randomized Phase 2 Placebo-Controlled Study of LY2495655 in Patients With Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy",
        "lillyAlias": [
            "I1Q-MC-JDDG"
        ]
    },
    "NCT00135330": {
        "briefTitle": "An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "An Evaluation of the Metabolic Effects of Exenatide, Rosiglitazone, and Exenatide Plus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus Treated With Metformin",
        "lillyAlias": []
    },
    "NCT00386425": {
        "briefTitle": "Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)",
        "officialTitle": "A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients With Severe Sepsis and Multiple Organ Dysfunction",
        "lillyAlias": [
            "F1K-MC-EVDK"
        ]
    },
    "NCT02754830": {
        "briefTitle": "A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)",
        "officialTitle": "Single-Dose, Dose-Escalation Study With LY3303560 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease",
        "lillyAlias": [
            "I8G-MC-LMDA"
        ]
    },
    "NCT02171130": {
        "briefTitle": "Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia",
        "officialTitle": "A Multiple Center, Open Label, Prospective, Observational Study to Evaluate the Effectiveness and Ease-of-Use of AMG504-1 Administered in the Home or Work Environments for Treating Episodes of Hypoglycemia in Patients With Type 1 Diabetes",
        "lillyAlias": [
            "I8R-MC-B002",
            "AMG108"
        ]
    },
    "NCT02438826": {
        "briefTitle": "A Study of Galcanezumab in Participants With Chronic Cluster Headache",
        "officialTitle": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache",
        "lillyAlias": [
            "I5Q-MC-CGAM",
            "2014-005429-11"
        ]
    },
    "NCT05469126": {
        "briefTitle": "A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants",
        "officialTitle": "A Phase 1, Open-label, Drug Interaction Study to Investigate the Effect of Multiple Doses of Clarithromycin on the Pharmacokinetics of LY3502970 in Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZGM"
        ]
    },
    "NCT04386057": {
        "briefTitle": "LY3214996 +/- HCQ in Pancreatic Cancer",
        "officialTitle": "Phase II Trial of ERK Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer",
        "lillyAlias": []
    },
    "NCT00609557": {
        "briefTitle": "A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain",
        "officialTitle": "A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain",
        "lillyAlias": [
            "F1J-MC-X007"
        ]
    },
    "NCT00729326": {
        "briefTitle": "Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione",
        "officialTitle": "Comparison of the Effect of Exenatide vs. Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione",
        "lillyAlias": []
    },
    "NCT02891226": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease",
        "officialTitle": "A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)",
        "lillyAlias": [
            "I6T-MC-AMAG",
            "2016-002204-84"
        ]
    },
    "NCT00447057": {
        "briefTitle": "Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Phase 2 Study of Pemetrexed Versus Pemetrexed Plus Erlotinib in Second-Line Treatment in Patients With Nonsquamous NSCLC",
        "lillyAlias": [
            "H3E-MC-S102"
        ]
    },
    "NCT04612257": {
        "briefTitle": "Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes.",
        "officialTitle": "A Pilot Study to Assess Closed-loop Insulin Delivery to Regulate Glucose Levels in Children With Type 1 Diabetes in Outpatient Free-living Settings.",
        "lillyAlias": []
    },
    "NCT01552057": {
        "briefTitle": "A Study of Duloxetine in Fibromyalgia",
        "officialTitle": "A Phase III Clinical Trial of Duloxetine in Participants With Fibromyalgia",
        "lillyAlias": [
            "F1J-JE-HMGZ"
        ]
    },
    "NCT01807026": {
        "briefTitle": "A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease",
        "officialTitle": "A Safety, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects and Patients Diagnosed With Alzheimer's Disease",
        "lillyAlias": [
            "I4O-EW-BACX"
        ]
    },
    "NCT04591626": {
        "briefTitle": "A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes",
        "officialTitle": "A Randomized, Double-Blind Trial Comparing the Effect of the Addition of Dulaglutide 1.5 mg Versus the Addition of Placebo to Titrated Basal Insulin on Glycemic Control in Chinese Patients With Type 2 Diabetes",
        "lillyAlias": [
            "H9X-MC-GBGO"
        ]
    },
    "NCT00844857": {
        "briefTitle": "A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression",
        "officialTitle": "Study to Assess the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar I Disorder",
        "lillyAlias": [
            "H6P-MC-HDAX"
        ]
    },
    "NCT04119557": {
        "briefTitle": "A Study of LY3471851 in Participants With Psoriasis",
        "officialTitle": "A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis",
        "lillyAlias": [
            "J1P-MC-KFAC"
        ]
    },
    "NCT00190957": {
        "briefTitle": "Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse",
        "officialTitle": "Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial",
        "lillyAlias": [
            "B4Z-MC-LYBY"
        ]
    },
    "NCT01185548": {
        "briefTitle": "A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma",
        "officialTitle": "The Effect of Tasisulam on the CYP2C9-Mediated Metabolism of Tolbutamide: A Pharmacokinetic Interaction Study in Cancer Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma",
        "lillyAlias": [
            "H8K-MC-JZAR"
        ]
    },
    "NCT03334422": {
        "briefTitle": "Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Patients With Moderate to Severe Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAHM",
            "2017-000871-10"
        ]
    },
    "NCT03130439": {
        "briefTitle": "Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer",
        "officialTitle": "A Phase 2 Study of Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT05963022": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)",
        "officialTitle": "A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Tirzepatide Monotherapy Compared With Placebo in Chinese Participants With Type 2 Diabetes",
        "lillyAlias": [
            "I8F-MC-GPIU"
        ]
    },
    "NCT01232439": {
        "briefTitle": "A Study of Brain Receptor Occupancy in Healthy Subjects",
        "officialTitle": "Assessment of Brain Kappa Opioid Receptor Occupancy After Single Oral Doses of LY2456302 as Measured by PET With Radioligand LY2879788 in Healthy Subjects",
        "lillyAlias": [
            "I2Z-MC-LAFC"
        ]
    },
    "NCT00383422": {
        "briefTitle": "Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis",
        "officialTitle": "The Comparison of the Efficacy and Safety of Arzoxifene Versus Raloxifene in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "H4Z-MC-GJAR"
        ]
    },
    "NCT02918539": {
        "briefTitle": "Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials",
        "officialTitle": "Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials",
        "lillyAlias": [
            "PRA Study Code: 446601"
        ]
    },
    "NCT03485222": {
        "briefTitle": "Are the \"Cardiac Benefits\" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).",
        "officialTitle": "EMPA-TROPISM Trial: Are the \"Cardiac Benefits\" of Empagliflozin Independent of Its Hypoglycemic Activity?",
        "lillyAlias": []
    },
    "NCT03955939": {
        "briefTitle": "A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body",
        "officialTitle": "A Phase 1b Study of Aurora A Kinase Inhibitor LY3295668 Erbumine in Monotherapy and Combination Therapy in Patients With Metastatic Breast Cancer Post CDK4/6 Inhibitor and Endocrine Therapy",
        "lillyAlias": [
            "J1O-MC-JZHC",
            "2018-004183-61"
        ]
    },
    "NCT00933439": {
        "briefTitle": "Assessment of Cognitive Functioning Before and After Treatment With Duloxetine",
        "officialTitle": "Assessment of Cognitive Functioning Before and After Treatment With Duloxetine",
        "lillyAlias": []
    },
    "NCT00845039": {
        "briefTitle": "A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab",
        "officialTitle": "A Randomized Phase II Clinical Trial Investigating Irinotecan Plus Cetuximab With or Without Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody (IMC-A12) for the Treatment of Patients With Metastatic K-Ras Wild Type Carcinoma of the Colon or Rectum That Has Progressed on Oxaliplatin and Bevacizumab Given as First-Line Therapy",
        "lillyAlias": [
            "CP13-0708",
            "I5A-IE-JAED",
            "NSABP FC-4"
        ]
    },
    "NCT05623839": {
        "briefTitle": "A Study of LY3305677 in Participants With Obesity Or Overweight",
        "officialTitle": "A Multiple Dose Titration Study in Participants With Obesity or Overweight to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677",
        "lillyAlias": [
            "I8P-MC-OXAG"
        ]
    },
    "NCT00536939": {
        "briefTitle": "Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer",
        "officialTitle": "A Randomized, Double-Blind, Phase 2 Trial of Paclitaxel Plus Bevacizumab and Enzastaurin Versus Paclitaxel Plus Bevacizumab and Placebo for Locally Recurrent or Metastatic Breast Cancer",
        "lillyAlias": [
            "H6Q-MC-S038"
        ]
    },
    "NCT02589639": {
        "briefTitle": "Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A 52-week Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Empagliflozin Once Daily, as an add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control",
        "lillyAlias": []
    },
    "NCT00603239": {
        "briefTitle": "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin",
        "officialTitle": "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin",
        "lillyAlias": []
    },
    "NCT01189422": {
        "briefTitle": "Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes",
        "officialTitle": "A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Subcutaneously Administered Teplizumab (MGA031) in Adults With Type 1 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT03125239": {
        "briefTitle": "Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia",
        "officialTitle": "A Phase 1 Study of Merestinib in Combination With LY2874455 in Relapsed or Refractory Acute Myeloid Leukemia",
        "lillyAlias": []
    },
    "NCT02450539": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Study of Abemaciclib (LY2835219) Versus Docetaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy",
        "lillyAlias": [
            "I3Y-MC-JPBX",
            "2014-004832-20"
        ]
    },
    "NCT05108922": {
        "briefTitle": "A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)",
        "officialTitle": "A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACN"
        ]
    },
    "NCT05588622": {
        "briefTitle": "Meru Health Program for Cancer Patients With Depression and Anxiety",
        "officialTitle": "Feasibility of a Therapist-Supported Digital Mental Health Intervention in Addressing Mental Health Symptoms Among People With Cancer: A Mixed Methods Study",
        "lillyAlias": []
    },
    "NCT05564039": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)",
        "officialTitle": "A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes",
        "lillyAlias": [
            "I8F-MC-GPIH",
            "2022-500101-41-00"
        ]
    },
    "NCT00634439": {
        "briefTitle": "Safety Study of Atomoxetine and Cerebrovascular Outcomes",
        "officialTitle": "Atomoxetine and Cerebrovascular Outcomes in Adults",
        "lillyAlias": [
            "B4Z-MC-B014"
        ]
    },
    "NCT00382239": {
        "briefTitle": "A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes",
        "officialTitle": "A Dose Response Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) But Not Well Controlled",
        "lillyAlias": []
    },
    "NCT03760822": {
        "briefTitle": "Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients",
        "officialTitle": "Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients",
        "lillyAlias": []
    },
    "NCT00244322": {
        "briefTitle": "Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease",
        "officialTitle": "LY450139: Tolerability and Biomarker Assessment in Subjects With Mild to Moderate Alzheimer's Disease",
        "lillyAlias": [
            "H6L-MC-LFAJ"
        ]
    },
    "NCT04230122": {
        "briefTitle": "A Study of LY3478006 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3478006 in Healthy Subjects",
        "lillyAlias": [
            "J2F-MC-OHAA"
        ]
    },
    "NCT03305822": {
        "briefTitle": "A Study of LY900014 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog Following a Single Dose in Patients With T2DM",
        "lillyAlias": [
            "I8B-MC-ITRU",
            "2017-001305-33"
        ]
    },
    "NCT01695239": {
        "briefTitle": "A Study of Ixekizumab in Participants With Active Psoriatic Arthritis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis",
        "lillyAlias": [
            "I1F-MC-RHAP"
        ]
    },
    "NCT04184622": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight",
        "officialTitle": "Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)",
        "lillyAlias": [
            "I8F-MC-GPHK"
        ]
    },
    "NCT00486122": {
        "briefTitle": "Evaluation of Continuous Symptom Treatment of ADHD",
        "officialTitle": "Evaluation of Continuous Symptom Treatment of ADHD: A Placebo-Controlled Double-Blind Assessment of Morning-Dosed or Evening-Dosed Strattera",
        "lillyAlias": [
            "B4Z-US-LYCC"
        ]
    },
    "NCT02182830": {
        "briefTitle": "24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension",
        "officialTitle": "A Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Empagliflozin (10mg, 25mg) Administered Orally, Once Daily Over 24 Weeks in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT02451930": {
        "briefTitle": "A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC",
        "officialTitle": "An Open-Label, Multicenter, Phase 1b Study With an Expansion Cohort to Evaluate Safety and Efficacy of the Combination of Necitumumab With Pembrolizumab in Patients With Stage IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "I4X-MC-JFCQ",
            "2015-001291-22",
            "KEYNOTE -099"
        ]
    },
    "NCT02124148": {
        "briefTitle": "A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1b Trial of LY2606368 in Combination With Chemotherapy or Targeted Agents in Advanced and/or Metastatic Tumors",
        "lillyAlias": [
            "I4D-MC-JTJF"
        ]
    },
    "NCT06191848": {
        "briefTitle": "Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)",
        "officialTitle": "Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial",
        "lillyAlias": []
    },
    "NCT06215430": {
        "briefTitle": "A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants",
        "officialTitle": "A Phase I, Open-label, Fixed-sequence, Drug Interaction Study to Investigate the Effect of Multiple Oral Doses of LOXO-305 on CYP1A2, CYP2C9, and CYP2C19 Substrates Using a Probe Drug Cocktail in Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZNE"
        ]
    },
    "NCT02260648": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia",
        "officialTitle": "A Double-Blind Efficacy and Safety Study of Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia",
        "lillyAlias": [
            "I1V-JE-EIBG"
        ]
    },
    "NCT00046930": {
        "briefTitle": "Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia",
        "officialTitle": "A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts",
        "lillyAlias": [
            "E3999",
            "U10CA021115"
        ]
    },
    "NCT01153425": {
        "briefTitle": "\u00b5MRI of Therapeutic Intervention in Postmenopausal Osteoporosis",
        "officialTitle": "NMR Imaging and Stereological Analysis of Trabecular Bone in Female Subjects 60 and Older at Risk of Fracture Receiving Either Zoledronic Acid or Teriparatide",
        "lillyAlias": [
            "R01AR041443"
        ]
    },
    "NCT00516048": {
        "briefTitle": "An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes",
        "officialTitle": "An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT02411448": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)",
        "officialTitle": "A Multicenter, Randomized, Double-Blind Study of Erlotinib in Combination With Ramucirumab or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "I4T-MC-JVCY",
            "2014-004824-22"
        ]
    },
    "NCT00266630": {
        "briefTitle": "Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder",
        "officialTitle": "Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder",
        "lillyAlias": [
            "F1D-JE-BMEX"
        ]
    },
    "NCT03997448": {
        "briefTitle": "Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149",
        "officialTitle": "Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149",
        "lillyAlias": []
    },
    "NCT03099148": {
        "briefTitle": "A Study of LY3337641 in Healthy Participants",
        "officialTitle": "Relative Bioavailability and the Effect of Food on the Bioavailability of LY3337641 in Healthy Subjects",
        "lillyAlias": [
            "I8K-MC-JPDF"
        ]
    },
    "NCT03952130": {
        "briefTitle": "A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes",
        "lillyAlias": [
            "I8B-FH-ITSD"
        ]
    },
    "NCT00592930": {
        "briefTitle": "Olanzapine in the Treatment of Anorexia Nervosa",
        "officialTitle": "Pilot Study of the Efficacy of Olanzapine in the Treatment of Anorexias Nervosa",
        "lillyAlias": [
            "Lilly F1D-US-X166"
        ]
    },
    "NCT01995526": {
        "briefTitle": "A Study of Insulin Peglispro in Healthy Male Japanese Participants",
        "officialTitle": "A Single Dose Study to Evaluate the Pharmacokinetics and Glucodynamics of Insulin Peglispro (LY2605541) in Healthy Male Japanese Subjects",
        "lillyAlias": [
            "I2R-JE-BIDK"
        ]
    },
    "NCT00406926": {
        "briefTitle": "The Effect of Growth Hormone in Very Young Girls With Turner Syndrome",
        "officialTitle": "The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome",
        "lillyAlias": [
            "B9R-US-GDFG"
        ]
    },
    "NCT00150657": {
        "briefTitle": "Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer",
        "officialTitle": "Phase II Trial of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT00742157": {
        "briefTitle": "Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)",
        "officialTitle": "An Open-label Evaluation of the Long-term Efficacy and Safety of a Standardized Regimen of Growth Hormone, Glutamine and a Modified Diet in the Treatment of Patients With Short Bowel Syndrome",
        "lillyAlias": []
    },
    "NCT01968057": {
        "briefTitle": "A Study of Baricitinib and Ciclosporin in Healthy Participants",
        "officialTitle": "A Study to Investigate the Effect of Ciclosporin on the Pharmacokinetics of Baricitinib (LY3009104) in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGH"
        ]
    },
    "NCT00887926": {
        "briefTitle": "Study of IMC-EB10 in Participant With Leukemia",
        "officialTitle": "An Open-label, Dose Escalation, Phase I Study of IMC-EB10 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
        "lillyAlias": [
            "CP17-0801",
            "I5C-IE-JEBA"
        ]
    },
    "NCT01243957": {
        "briefTitle": "A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.",
        "officialTitle": "LY2216684 and Fluoxetine Pharmacokinetic Interaction Study in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCH"
        ]
    },
    "NCT04647526": {
        "briefTitle": "Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment",
        "officialTitle": "A Phase 3, Open-Label, Randomized Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)",
        "lillyAlias": []
    },
    "NCT01896726": {
        "briefTitle": "A Study of Baricitinib and Birth Control Pills in Healthy Females",
        "officialTitle": "The Effects of Multiple Doses of Baricitinib on the Pharmacokinetics of a Single Dose of an Oral Contraceptive in Healthy Female Subjects",
        "lillyAlias": [
            "I4V-MC-JAGD"
        ]
    },
    "NCT01721057": {
        "briefTitle": "A Study in Moderate to Severe Rheumatoid Arthritis Participants",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis",
        "lillyAlias": [
            "I4V-MC-JADX"
        ]
    },
    "NCT00191126": {
        "briefTitle": "Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC",
        "officialTitle": "Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages(T2N0, T1 - 2N1, T3N0 AND T3N1) Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "B9E-MC-S132"
        ]
    },
    "NCT00845026": {
        "briefTitle": "A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients",
        "officialTitle": "A Long-Term, Phase 2, Multicenter, Randomized, Open-Label Comparative Safety Study of LY2140023 Versus Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBBR"
        ]
    },
    "NCT04847557": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)",
        "lillyAlias": [
            "I8F-MC-GPID"
        ]
    },
    "NCT00666757": {
        "briefTitle": "A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression",
        "officialTitle": "TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode",
        "lillyAlias": [
            "F1J-US-HMFT"
        ]
    },
    "NCT00494026": {
        "briefTitle": "Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)",
        "officialTitle": "Phase II Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage of Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-MC-S095"
        ]
    },
    "NCT01937026": {
        "briefTitle": "A Study of Baricitinib and Probenecid in Healthy Participants",
        "officialTitle": "A Study to Investigate the Potential Impact of Organic Anion Transporter 3 Inhibition by Probenecid on the Pharmacokinetics of Baricitinib (LY3009104) in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGG"
        ]
    },
    "NCT00703326": {
        "briefTitle": "Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer",
        "officialTitle": "A Multicenter, Multinational, Randomized, Double-Blind, Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally-Recurrent or Metastatic Breast Cancer",
        "lillyAlias": [
            "2008-001727-65",
            "TRIO-012",
            "TRIO-CIRG-012",
            "CP12-0606",
            "I4T-IE-JVBC"
        ]
    },
    "NCT00110357": {
        "briefTitle": "Study of Erbitux\u2122 (Cetuximab) in Pediatric Patients With Refractory Solid Tumors",
        "officialTitle": "Phase I Study of Erbitux\u2122 (Cetuximab) in Pediatric Patients With Refractory Solid Tumors",
        "lillyAlias": []
    },
    "NCT00452257": {
        "briefTitle": "A Study of Enzastaurin in Patients With Leukemia",
        "officialTitle": "A Phase 1b Pharmacokinetic-Pharmacodynamic-Pharmacogenomic Study of Enzastaurin in Patients With B-Cell Chronic Lymphocytic Leukemia (B-CLL)",
        "lillyAlias": [
            "H6Q-MC-S022"
        ]
    },
    "NCT03518086": {
        "briefTitle": "An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)",
        "lillyAlias": [
            "I6T-MC-AMAN",
            "2017-003229-14"
        ]
    },
    "NCT02709486": {
        "briefTitle": "Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.",
        "officialTitle": "A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE",
        "lillyAlias": [
            "2013-004508-21",
            "OA 6-MONTH EU STUDY"
        ]
    },
    "NCT05824858": {
        "briefTitle": "A Study of the Effect of Food on LY3537982 in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Effect of Food on the LY3537982 Pharmacokinetics in Health Adult Subjects",
        "lillyAlias": [
            "J3M-OX-JZQI"
        ]
    },
    "NCT00036335": {
        "briefTitle": "Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain",
        "officialTitle": "Duloxetine Hydrochloride (LY248686) Protocol F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain",
        "lillyAlias": [
            "F1J-US-HMCB"
        ]
    },
    "NCT02417935": {
        "briefTitle": "A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)",
        "officialTitle": "A Japan Post-Marketing, Randomized, Double-Blind, Parallel-Group, Flexible Dose Comparative Study to Assess the Non-Inferiority of Duloxetine Compared With Pregabalin in Patients With Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "F1J-JE-HMHA"
        ]
    },
    "NCT00530335": {
        "briefTitle": "Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "An Open-Label Pilot Study for Atomoxetine in Adult Subjects With Attention Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-JE-LYED"
        ]
    },
    "NCT01703286": {
        "briefTitle": "Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)",
        "officialTitle": "Randomized, Three Period Cross Over, Double Blind, Double Dummy Study in Type 2 Diabetic Patients to Assess the Endothelial Effects of Linagliptin, Glimepiride and Placebo Therapy for 28 Days ('ENDOTHELINA')",
        "lillyAlias": [
            "2012-003317-33"
        ]
    },
    "NCT00193063": {
        "briefTitle": "Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer",
        "officialTitle": "Phase II Trial of Weekly Gemcitabine and Herceptin in the Treatment of Patients With HER-2 Overexpressing Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT00475358": {
        "briefTitle": "Efficacy and Safety Stress Urinary Incontinence Study",
        "officialTitle": "Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBBT"
        ]
    },
    "NCT00701935": {
        "briefTitle": "Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin",
        "officialTitle": "Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin",
        "lillyAlias": []
    },
    "NCT00115635": {
        "briefTitle": "Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer",
        "officialTitle": "A Phase I/II Study With Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer",
        "lillyAlias": [
            "EudraCT number: 2004-002353-31"
        ]
    },
    "NCT05614739": {
        "briefTitle": "A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3",
        "officialTitle": "An Open-Label, Multicenter Study of LOXO-435 (LY3866288) In Advanced Solid Tumor Malignancies With FGFR3 Alterations",
        "lillyAlias": [
            "J4G-OX-JZVA",
            "2022-502755-59-00",
            "KEYNOTE-F35",
            "MK-3475-F35"
        ]
    },
    "NCT00960986": {
        "briefTitle": "A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder",
        "officialTitle": "A Phase 4 Comparison of Duloxetine Dosing Strategies in the Treatment of Korean Patients With Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMFL"
        ]
    },
    "NCT00869986": {
        "briefTitle": "A Study for Patients With Relapsing Remitting Multiple Sclerosis",
        "officialTitle": "A Double Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of MBP8298 in Relapsing Remitting Multiple Sclerosis",
        "lillyAlias": [
            "I3E-BM-MSAE",
            "2006-001947-70",
            "MBP8298-RR01"
        ]
    },
    "NCT01313286": {
        "briefTitle": "A Study to Compare Two Forms of LY2608204 in Healthy People",
        "officialTitle": "The Relative Bioavailability of a Proposed Phase 2 LY2608204 Test Formulation Compared With the Current Phase 1 LY2608204 Reference Formulation After Administration of a Single Oral 80-mg Dose in Healthy Subjects",
        "lillyAlias": [
            "I3P-FW-GKBG"
        ]
    },
    "NCT01567163": {
        "briefTitle": "A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors",
        "officialTitle": "A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Docetaxel in Patients With Advanced Malignant Solid Tumors",
        "lillyAlias": [
            "CP12-0713",
            "I4T-IE-JVCC"
        ]
    },
    "NCT04151563": {
        "briefTitle": "A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy",
        "officialTitle": "A Phase 1/2, Randomized Study Evaluating Multiple Nivolumab Combination Therapies in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy and Anti-PD-1 (L)1 Immunotherapy",
        "lillyAlias": [
            "2018-004283-65"
        ]
    },
    "NCT01316263": {
        "briefTitle": "A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors",
        "officialTitle": "A Phase 2 Study of a Human Anti-PDGFR\u03b1 Monoclonal Antibody (IMC-3G3) in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors (GIST)",
        "lillyAlias": [
            "CP15-1008",
            "I5B-IE-JGDH",
            "2010-022560-12"
        ]
    },
    "NCT00351039": {
        "briefTitle": "Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer",
        "officialTitle": "Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in the First-Line Treatment of Elderly Patients With Advanced (Stage IIIB(With Malignant Pleural Effusion) or IV) Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": []
    },
    "NCT01029886": {
        "briefTitle": "Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes",
        "officialTitle": "Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes and Inadequate Glycemic Control Treated With Lifestyle Modification and Oral Antidiabetic Medications",
        "lillyAlias": []
    },
    "NCT00191763": {
        "briefTitle": "Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer",
        "officialTitle": "Phase II Trial of Gemcitabine and Cisplatin as Neo-Adjuvant Chemotherapy for Operable Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-VI-S314"
        ]
    },
    "NCT02443922": {
        "briefTitle": "Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM",
        "officialTitle": "Dynamic Responsiveness of Insulin Secretory Parameters to Sitagliptin and Glimeperide Administration in Subjects With Type 2 Diabetes Mellitus: An Open Label Study",
        "lillyAlias": []
    },
    "NCT00587639": {
        "briefTitle": "An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression",
        "officialTitle": "An Evaluation of Safety and Feasibility Using rTMS in Adolescents With Depression",
        "lillyAlias": []
    },
    "NCT02562326": {
        "briefTitle": "A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog\u00ae U-100 in Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomised, Monocentric, Double-blind, Multiple Daily Dose, Two-period 14 Day Cross-over Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Individualised Doses of BioChaperone Insulin Lispro in Comparison to Humalog\u00ae U-100 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00157326": {
        "briefTitle": "Tadalafil in Subjects With Mild to Moderate Hypertension",
        "officialTitle": "A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Tadalafil (5mg and 20mg) Administered Once Daily to Subjects With Mild to Moderate Hypertension",
        "lillyAlias": [
            "H6D-MC-LVGU"
        ]
    },
    "NCT06635057": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan",
        "officialTitle": "A Phase 4, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Effectiveness and Safety of Tirzepatide Once Weekly in Adult Participants With Type 2 Diabetes During Ramadan",
        "lillyAlias": [
            "I8F-MC-GPIY"
        ]
    },
    "NCT00475657": {
        "briefTitle": "Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer",
        "officialTitle": "Phase II Study of Pemetrexed Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-XM-S113"
        ]
    },
    "NCT00191048": {
        "briefTitle": "Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD",
        "officialTitle": "Open-Label Treatment With Atomoxetine Hydrochloride in Child and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia",
        "lillyAlias": [
            "B4Z-US-LYCE"
        ]
    },
    "NCT00861757": {
        "briefTitle": "Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "officialTitle": "A Phase 3, Randomized, Double Blind, Placebo and Tamsulosin Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil Once a Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVHB"
        ]
    },
    "NCT01341457": {
        "briefTitle": "A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors",
        "officialTitle": "A Phase 1 Dose-Escalation Study of LY2603618 in Combination With Gemcitabine in Japanese Patients With Solid Tumors",
        "lillyAlias": [
            "I2I-JE-JMME"
        ]
    },
    "NCT00191230": {
        "briefTitle": "Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase II Trial of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/ Cisplatin)When Used as Preoperative Chemotherapy for Patients With Stage I and II NSCLC",
        "lillyAlias": [
            "B9E-US-S236"
        ]
    },
    "NCT00895648": {
        "briefTitle": "Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma",
        "officialTitle": "Phase II Study of Neo-adjuvant Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Malignant Pleural Mesothelioma",
        "lillyAlias": []
    },
    "NCT00682448": {
        "briefTitle": "Metformin for the Prevention of the Metabolic Side-effects of Zyprexa",
        "officialTitle": "Metformin to Prevent the Metabolic Complications of Olanzapine",
        "lillyAlias": []
    },
    "NCT01591330": {
        "briefTitle": "A Study of LY2140023 in Healthy Males and Females",
        "officialTitle": "A Particle Size Study of 3 Different Particle Size Test Tablet Formulations Compared to the Reference Tablet Formulation in Healthy Subjects",
        "lillyAlias": [
            "H8Y-MC-HBCY"
        ]
    },
    "NCT02117648": {
        "briefTitle": "A Study of LY2835219 in Participants With Cancer",
        "officialTitle": "Effects of CYP3A Inhibition by Clarithromycin on the Pharmacokinetics of LY2835219 and Its Metabolites in Cancer Patients",
        "lillyAlias": [
            "I3Y-MC-JPBE"
        ]
    },
    "NCT05822830": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities",
        "officialTitle": "A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Compared to Semaglutide in Adults Who Have Obesity or Overweight With Weight Related Comorbidities",
        "lillyAlias": [
            "I8F-MC-GPHJ",
            "U1111-1283-5404"
        ]
    },
    "NCT00545948": {
        "briefTitle": "Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer",
        "officialTitle": "Phase II Prospective Study Evaluating the Role of Directed Cisplatin Based Chemo With Either Vinorelbine or Pemetrexed for the Adj Tx of Early Stage NSCLC in Patients Using Genomic Expression Profiles of Chemo Sensitivity to Guide Therapy",
        "lillyAlias": []
    },
    "NCT02059148": {
        "briefTitle": "A Study of LY2835219 in Healthy Participants",
        "officialTitle": "Effect of Food on the Pharmacokinetics of LY2835219 in Healthy Subjects",
        "lillyAlias": [
            "I3Y-MC-JPBG"
        ]
    },
    "NCT01194830": {
        "briefTitle": "Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study",
        "officialTitle": "A Phase IIIb, 24-week, Randomised, Placebo-controlled, Double-blinded, Efficacy and Safety Study of Linagliptin (BI 1356) in Black/African American Patients With Type 2 Diabetes With a MTT Sub-study",
        "lillyAlias": []
    },
    "NCT00406848": {
        "briefTitle": "A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients",
        "officialTitle": "Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression",
        "lillyAlias": [
            "F1J-US-HMFA"
        ]
    },
    "NCT00618748": {
        "briefTitle": "Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed",
        "officialTitle": "Safety and Efficacy of Olanzapine (LY170053) in the Long-term Treatment for Patients With Bipolar I Disorder, Depressed",
        "lillyAlias": [
            "F1D-JE-HGMS"
        ]
    },
    "NCT01681186": {
        "briefTitle": "A Study of LY2940680 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose and Relative Bioavailability Study of LY2940680 in Healthy Subjects",
        "lillyAlias": [
            "I4J-MC-HHBG"
        ]
    },
    "NCT00697463": {
        "briefTitle": "Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women",
        "officialTitle": "Teriparatide for the Treatment of Idiopathic Osteoporosis in Premenopausal Women",
        "lillyAlias": []
    },
    "NCT05440786": {
        "briefTitle": "CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma",
        "officialTitle": "A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Irinotecan and Temozolomide in Participants With Relapsed or Refractory Ewing's Sarcoma",
        "lillyAlias": [
            "J1S-MC-JP04",
            "2023-506772-28-00"
        ]
    },
    "NCT00461786": {
        "briefTitle": "A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer",
        "officialTitle": "A Phase II Evaluation of Pemetrexed (Alimta, LY231514l, IND # 40061) in the Treatment of Recurrent or Persistent Platinum Resistant Ovarian or Primary Peritoneal Carcinoma",
        "lillyAlias": [
            "H3E-US-JMGP"
        ]
    },
    "NCT00415363": {
        "briefTitle": "Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy",
        "officialTitle": "A Double-blind, Randomized, Placebo-controlled Multicentre Phase II Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases From Lung Cancer",
        "lillyAlias": [
            "H6Q-MC-S020"
        ]
    },
    "NCT04521686": {
        "briefTitle": "Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations",
        "officialTitle": "A Phase 1 Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations",
        "lillyAlias": [
            "2020-002863-77",
            "I9Y-OX-JDHC"
        ]
    },
    "NCT01020786": {
        "briefTitle": "A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients",
        "officialTitle": "Post-marketing Clinical Trial of Induction Chemotherapy of Pemetrexed Plus Carboplatin Followed by Pemetrexed Maintenance Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-JE-JMII"
        ]
    },
    "NCT03432286": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study",
        "lillyAlias": [
            "I5Q-MC-CGAS",
            "2017-004351-23"
        ]
    },
    "NCT00324363": {
        "briefTitle": "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin",
        "officialTitle": "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin",
        "lillyAlias": []
    },
    "NCT00034463": {
        "briefTitle": "ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer",
        "officialTitle": "A Phase 1 Trial of ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer",
        "lillyAlias": [
            "H3E-MC-JMAS"
        ]
    },
    "NCT02674386": {
        "briefTitle": "Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement",
        "officialTitle": "A PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT",
        "lillyAlias": [
            "2013-002549-12",
            "TJR FOLLOW-UP"
        ]
    },
    "NCT02972658": {
        "briefTitle": "A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia",
        "officialTitle": "A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)",
        "lillyAlias": [
            "I8D-MC-AZFD",
            "2016-003440-36"
        ]
    },
    "NCT01042158": {
        "briefTitle": "A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis",
        "officialTitle": "A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis",
        "lillyAlias": [
            "P50HL084946"
        ]
    },
    "NCT03334435": {
        "briefTitle": "A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis",
        "officialTitle": "A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAHN",
            "2017-000873-35"
        ]
    },
    "NCT01688635": {
        "briefTitle": "A Study to Compare LY2963016 and US-approved Lantus\u00ae After Single Dose Administration to Healthy Participants",
        "officialTitle": "Comparative Pharmacokinetics and Pharmacodynamics of LY2963016 and US-Approved Lantus\u00ae After Single-Dose Subcutaneous Administration to Healthy Subjects",
        "lillyAlias": [
            "I4L-MC-ABEO"
        ]
    },
    "NCT01284335": {
        "briefTitle": "A Safety Study in Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1 Multicenter, Dose-escalation Study of LY573636-sodium in Combination With 1) Gemcitabine HCl or 2) Docetaxel or 3) Temozolomide or 4) Cisplatin, or 5) Erlotinib in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "H8K-MC-JZAK"
        ]
    },
    "NCT01581658": {
        "briefTitle": "Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes",
        "officialTitle": "A Phase I, Open-label, Parallel-group Study to Investigate Pharmacokinetics, Pharmacodynamics and Safety of a Single 25 mg Dose of Empagliflozin in Japanese Type 2 Diabetes Patients With Different Degrees of Renal Impairment in Comparison to Type 2 Diabetes Patients With Normal Renal Function",
        "lillyAlias": []
    },
    "NCT01388335": {
        "briefTitle": "A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin",
        "officialTitle": "The Effect of Enzastaurin on CYP2C9: Enzastaurin - S-Warfarin Drug Interaction Study in Patients With Cancer",
        "lillyAlias": [
            "H6Q-MC-JCAX"
        ]
    },
    "NCT00401258": {
        "briefTitle": "An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome",
        "officialTitle": "An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome Without Comorbid Major Depressive Disorder",
        "lillyAlias": []
    },
    "NCT00913835": {
        "briefTitle": "A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer",
        "officialTitle": "Randomized Phase 2 Trial Investigating Liposomal Doxorubicin With or Without Anti-Platelet Derived Growth Factor Receptor-Alpha (PDGFR\u03b1) Monoclonal Antibody IMC-3G3 in Patients With Platinum-Refractory or Platinum-Resistant Advanced Ovarian Cancer",
        "lillyAlias": [
            "2009-009035-30",
            "CP15-0802",
            "I5B-IE-JGDA"
        ]
    },
    "NCT01569126": {
        "briefTitle": "A Study of LY110140 in Healthy Japanese Male Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY110140 in Healthy Japanese Male Subjects",
        "lillyAlias": [
            "B1Y-JE-HCLX"
        ]
    },
    "NCT04707157": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "H0P-MC-NP03"
        ]
    },
    "NCT05611957": {
        "briefTitle": "A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function",
        "officialTitle": "A Parallel-group, Phase 1, Open-label Study to Investigate the Pharmacokinetics of LY3437943 in Participants With Renal Impairment Compared With Healthy Participants",
        "lillyAlias": [
            "J1I-MC-GZBL"
        ]
    },
    "NCT00759226": {
        "briefTitle": "Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer",
        "officialTitle": "An Open Labeled Phase 2 Study of Gemcitabine in Combination With Cisplatin, 5-FU (24h CI) and Folinic Acid in Patients With Inoperable Esophageal Cancer",
        "lillyAlias": []
    },
    "NCT01107457": {
        "briefTitle": "A Study in Participants With Moderate to Severe Psoriasis",
        "officialTitle": "A Dose-Ranging And Efficacy Study of LY2439821 (An Anti-IL-17 Antibody) In Patients With Moderate-To-Severe Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHAJ"
        ]
    },
    "NCT02778126": {
        "briefTitle": "A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer",
        "officialTitle": "Disposition of [\u00b9\u2074C]LY2606368 Following Intravenous Administration in Patients With Advanced and/or Metastatic Solid Tumours",
        "lillyAlias": [
            "I4D-EW-JTJG",
            "2015-003126-13"
        ]
    },
    "NCT01925157": {
        "briefTitle": "A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)",
        "officialTitle": "A Single-Dose, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3090106 in Healthy Subjects and Subjects With Rheumatoid Arthritis",
        "lillyAlias": [
            "I6M-MC-SSAC"
        ]
    },
    "NCT00245648": {
        "briefTitle": "Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI",
        "officialTitle": "Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI; Results of the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries - V Trial",
        "lillyAlias": []
    },
    "NCT00989157": {
        "briefTitle": "Effects of Gastric Bypass on Blood Levels of Duloxetine",
        "officialTitle": "A Preliminary Comparison of the Effect of Roux-en-Y Bariatric Surgery on Blood Levels of Duloxetine",
        "lillyAlias": []
    },
    "NCT01275157": {
        "briefTitle": "Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects",
        "officialTitle": "Disposition of [14C]-LY2452473 Following Oral Administration in Healthy Human Subjects",
        "lillyAlias": [
            "I2N-MC-GPBF"
        ]
    },
    "NCT00618826": {
        "briefTitle": "A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer",
        "officialTitle": "A Phase II Trial of Biweekly Gemcitabine, Paclitaxel, and Avastin as Frontline Therapy for Metastatic Breast Cancer",
        "lillyAlias": [
            "2007-050",
            "B9E-US-I158",
            "AVF3734s"
        ]
    },
    "NCT04456686": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis",
        "lillyAlias": [
            "H0P-MC-OA01"
        ]
    },
    "NCT01246986": {
        "briefTitle": "A Study of LY2157299 in Participants With Hepatocellular Carcinoma",
        "officialTitle": "Phase 2 Study of LY2157299 in Patients With Hepatocellular Carcinoma",
        "lillyAlias": [
            "H9H-MC-JBAK",
            "2010-022338-10"
        ]
    },
    "NCT01473563": {
        "briefTitle": "A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "Home Delivery of Pemetrexed as Maintenance Treatment in Patients Who Have Not Progressed After Induction Therapy for Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Feasibility Study",
        "lillyAlias": [
            "H3E-EW-S133"
        ]
    },
    "NCT03375463": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Healthy Participants",
        "officialTitle": "Pharmacokinetics, Safety, and Tolerability of a Solution Formulation of LY3298176 in Healthy Subjects",
        "lillyAlias": [
            "I8F-MC-GPGE"
        ]
    },
    "NCT01241435": {
        "briefTitle": "A Study of LY2216684 in Participants With Impaired Hepatic Function",
        "officialTitle": "The Effect of Impaired Hepatic Function on the Pharmacokinetics of LY2216684",
        "lillyAlias": [
            "H9P-EW-LNCM"
        ]
    },
    "NCT00035035": {
        "briefTitle": "A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.",
        "officialTitle": "A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.",
        "lillyAlias": [
            "H3E-MC-JMES"
        ]
    },
    "NCT00356135": {
        "briefTitle": "Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event",
        "officialTitle": "A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus Clopidogrel in Subjects With Acute Coronary Syndrome Who Are Receiving Clopidogrel",
        "lillyAlias": [
            "H7T-MC-TABM"
        ]
    },
    "NCT05848258": {
        "briefTitle": "An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis",
        "officialTitle": "An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis",
        "lillyAlias": [
            "J3P-MC-FTAF",
            "2022-502994-40-00"
        ]
    },
    "NCT02365558": {
        "briefTitle": "A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants",
        "officialTitle": "Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Pharmacokinetics of Evacetrapib in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIBO"
        ]
    },
    "NCT00377858": {
        "briefTitle": "Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)",
        "officialTitle": "Comparison of Two Approaches to Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control on Oral Therapy: Comparison of Premixed Insulin Lispro Mid Mixture With Separate Basal and Bolus Insulin Injections",
        "lillyAlias": [
            "F3Z-MC-IOOX"
        ]
    },
    "NCT01099358": {
        "briefTitle": "Study in Advanced Solid Tumors",
        "officialTitle": "Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I4E-MC-JXBA"
        ]
    },
    "NCT02795858": {
        "briefTitle": "A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors",
        "officialTitle": "A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors",
        "lillyAlias": []
    },
    "NCT00981058": {
        "briefTitle": "First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin",
        "officialTitle": "A Randomized, Multicenter, Open-Label Phase 3 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Gemcitabine-Cisplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "CP11-0806",
            "I4X-IE-JFCC",
            "2009-013838-25"
        ]
    },
    "NCT01346358": {
        "briefTitle": "A Study of IMC-CS4 in Subjects With Advanced Solid Tumors",
        "officialTitle": "Phase 1 Study of IMC-CS4, a Monoclonal Antibody Targeted to the CSF-1 Receptor (CSF-1R), In Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available",
        "lillyAlias": [
            "CP24-1001",
            "I5F-IE-JSCA"
        ]
    },
    "NCT02233296": {
        "briefTitle": "Food-Effect Study in Healthy Participants",
        "officialTitle": "A Randomized Open Label Study to Compare the Bioavailability of Lasmiditan 200 mg Under Fed and Fasted Conditions in Healthy Male and Female Subjects",
        "lillyAlias": [
            "H8H-CD-LAHR",
            "COL MIG-104"
        ]
    },
    "NCT01515358": {
        "briefTitle": "A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Subjects",
        "lillyAlias": [
            "I5U-MC-ANBB"
        ]
    },
    "NCT00429858": {
        "briefTitle": "Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer",
        "officialTitle": "Individualized Management of Pancreatic Cancer With Targeted Therapeutics (IMPACTT): A Phase II Clinical Trial",
        "lillyAlias": [
            "NCI-2011-01215",
            "UCSF-H12191-29556-01"
        ]
    },
    "NCT02327286": {
        "briefTitle": "Randomized Clinical Trial of Lifestyle Interventions to Prevent Diabetes in Women With Previous Gestational Diabetes",
        "officialTitle": "Preven\u00e7\u00e3o do Diabetes em Mulheres Com Diabetes Gestacional pr\u00e9vio: Estudo multic\u00eantrico de mudan\u00e7as Intensivas de Estilo de Vida: LINDA-Brasil",
        "lillyAlias": [
            "U1111-1165-0608",
            "00914312.0.1001.5327"
        ]
    },
    "NCT02536586": {
        "briefTitle": "A Study of LY3023414 in Japanese Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY3023414 in Japanese Patients With Advanced Malignancies",
        "lillyAlias": [
            "I6A-JE-CBBH"
        ]
    },
    "NCT05127486": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine",
        "officialTitle": "A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine",
        "lillyAlias": [
            "I5Q-MC-CGBD"
        ]
    },
    "NCT05123586": {
        "briefTitle": "A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus",
        "lillyAlias": [
            "J1V-MC-BT01",
            "2021-001406-30"
        ]
    },
    "NCT00804986": {
        "briefTitle": "A Study for Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A 12-Week,Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1I-MC-GECD",
            "CTRI/2009/091/000091"
        ]
    },
    "NCT02565186": {
        "briefTitle": "An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine",
        "officialTitle": "An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)",
        "lillyAlias": [
            "H8H-CD-LAHL",
            "2015-005674-37",
            "COL MIG-305"
        ]
    },
    "NCT05063539": {
        "briefTitle": "A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease",
        "officialTitle": "Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I9X-MC-MTAE",
            "2021-000170-29"
        ]
    },
    "NCT01088386": {
        "briefTitle": "Zyprexa\u00ae Relprevv\u2122 Patient Care Program",
        "officialTitle": "Zyprexa\u00ae Relprevv\u2122 Patient Care Program",
        "lillyAlias": [
            "F1D-MC-B041"
        ]
    },
    "NCT00473486": {
        "briefTitle": "Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib",
        "officialTitle": "A Randomized (PhaseII), Double-blind, Multicenter Phase I/II Trial of Pemetrexed, Carboplatin Plus or Minus Sorafenib in the First-line Treatment of Patients With Stage IIIb or IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "KKS / INNERE_A / NSCLC2006"
        ]
    },
    "NCT05738486": {
        "briefTitle": "A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)",
        "officialTitle": "Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults With Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACQ",
            "2022-502268-18-00",
            "U1111-1285-9438"
        ]
    },
    "NCT00612586": {
        "briefTitle": "Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer",
        "officialTitle": "A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of Enzastaurin With 5-FU/LV Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colorectal Cancer",
        "lillyAlias": [
            "H6Q-MC-S064"
        ]
    },
    "NCT00191386": {
        "briefTitle": "Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)",
        "officialTitle": "Long-Term Extension, Open-Label Study of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-JE-LYDA"
        ]
    },
    "NCT00927186": {
        "briefTitle": "Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women",
        "officialTitle": "Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy",
        "lillyAlias": [
            "B3D-US-GHDL"
        ]
    },
    "NCT00122863": {
        "briefTitle": "Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder",
        "officialTitle": "Duloxetine 60 to 120 mg Once Daily Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder",
        "lillyAlias": [
            "F1J-MC-HMDV"
        ]
    },
    "NCT00191035": {
        "briefTitle": "Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD",
        "officialTitle": "Maintenance of Benefit After 8-Week and 52-Week Treatment With Atomoxetine Hydrochloride in Adolescents With ADHD",
        "lillyAlias": [
            "B4Z-US-LYCD"
        ]
    },
    "NCT03736486": {
        "briefTitle": "Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community",
        "officialTitle": "Mil Familias- Santa Barbara Operational Pilot",
        "lillyAlias": []
    },
    "NCT00356525": {
        "briefTitle": "Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor",
        "officialTitle": "Phase II, Randomized, Open-Label Trial of Biweekly Pemetrexed Plus Gemcitabine vs. Pemetrexed or Pemetrexed Plus Carboplatin in Relapsed Non Small Cell Lung Cancer After Neoadjuvant or Adjuvant Chemotherapy",
        "lillyAlias": [
            "H3E-US-S082"
        ]
    },
    "NCT03886948": {
        "briefTitle": "A Study of Injections of LY3074828 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 1-mL Autoinjector in Healthy Subjects",
        "lillyAlias": [
            "I6T-MC-AMBE"
        ]
    },
    "NCT00488163": {
        "briefTitle": "Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia",
        "officialTitle": "Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia",
        "lillyAlias": []
    },
    "NCT01247363": {
        "briefTitle": "A Study of LY2608204 in Patients With Type 2 Diabetes",
        "officialTitle": "Safety and Tolerability of Multiple Ascending Doses of LY2608204 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I3P-FW-GKBE"
        ]
    },
    "NCT00391235": {
        "briefTitle": "White Matter in Pediatric Bipolar Disorder: A DTI Study",
        "officialTitle": "White Matter Connectivity in Pediatric Bipolar Disorder: A Diffusion Tensor Imaging Study",
        "lillyAlias": []
    },
    "NCT00211263": {
        "briefTitle": "Bipolar Disorder Research Study for Ages 12 and Older",
        "officialTitle": "Bipolar Disorder Center for Pennsylvanians (BDCP) Research Study",
        "lillyAlias": [
            "SAP# 4100010612"
        ]
    },
    "NCT01282463": {
        "briefTitle": "Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma",
        "officialTitle": "An Open-Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Docetaxel in Combination With Ramucirumab (IMC-1121B) Drug Product or IMC-18F1 or Without Investigational Therapy as Second-line Therapy in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Bladder, Urethra, Ureter, or Renal Pelvis Following Disease Progression on First-line Platinum-based Therapy",
        "lillyAlias": [
            "CP20-0902",
            "I4Y-IE-JCDC"
        ]
    },
    "NCT05395481": {
        "briefTitle": "A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Nonalcoholic Fatty Liver Disease",
        "officialTitle": "A Single-Ascending and Repeated Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3849891 in Participants With Nonalcoholic Fatty Liver Disease Who Have the PNPLA3 I148M Genotype",
        "lillyAlias": [
            "J3W-MC-GZOA"
        ]
    },
    "NCT00970281": {
        "briefTitle": "A Study of Olanzapine in Patients With Schizophrenia",
        "officialTitle": "A Double-Blind Confirmatory Study Comparing Rapid-Acting Intramuscular Olanzapine and Rapid-Acting Intramuscular Placebo in Patients With an Exacerbation of Schizophrenia With Acute Psychotic Agitation",
        "lillyAlias": [
            "F1D-JE-RACD"
        ]
    },
    "NCT06338995": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)",
        "officialTitle": "A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Efficacy and Safety Study of Lebrikizumab/ LY3650150 in Adults With Chronic Rhinosinusitis With Nasal Polyps on a Background Therapy With Intranasal Corticosteroids",
        "lillyAlias": [
            "J2T-MC-KGBU",
            "2023-508760-29-00"
        ]
    },
    "NCT05444569": {
        "briefTitle": "A Study of LY3537021 in Healthy Participants",
        "officialTitle": "A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Safety and Tolerability of LY3537021 When Combined With GLP-1 Receptor Agonist in Healthy Participants",
        "lillyAlias": [
            "J2R-MC-YAAC"
        ]
    },
    "NCT00262769": {
        "briefTitle": "Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors",
        "officialTitle": "Gemcitabine, Alone or in Combination With Cisplatin, in Patients With Advanced or Metastatic Cholangiocarcinomas and Other Biliary Tract Tumors: A Multicentre, Randomized Phase III Study",
        "lillyAlias": [
            "CRUK-ABC-02",
            "EU-205103",
            "ISRCTN82956140",
            "EUDRACT-2004-004882-14",
            "CTA-21266/0005/001"
        ]
    },
    "NCT05999968": {
        "briefTitle": "Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment",
        "officialTitle": "A Phase 1b Study of Abemaciclib Plus Darolutamide in Men With Metastatic Castration-Resistant Prostate Cancer",
        "lillyAlias": [
            "I3Y-MC-JPEI",
            "2023-503919-15-00",
            "U1111-1294-1466"
        ]
    },
    "NCT00034268": {
        "briefTitle": "A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer",
        "officialTitle": "A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H7X-MC-JVAA"
        ]
    },
    "NCT01214668": {
        "briefTitle": "Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors",
        "officialTitle": "A Phase 1b, Multicenter, Dose-Escalation Study of LY573636-sodium in Combination With Liposomal Doxorubicin in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "H8K-MC-JZAN"
        ]
    },
    "NCT01582269": {
        "briefTitle": "A Study in Recurrent Glioblastoma (GB)",
        "officialTitle": "A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma",
        "lillyAlias": [
            "H9H-MC-JBAL"
        ]
    },
    "NCT00191269": {
        "briefTitle": "Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen",
        "officialTitle": "A Multicenter Study of LY188011 in Anthracyclines and Taxanes Pre-treated Metastatic/Recurrent Breast Cancer",
        "lillyAlias": [
            "B9E-JE-MB21"
        ]
    },
    "NCT00191568": {
        "briefTitle": "Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer",
        "officialTitle": "A Phase II Trial of Adjuvant Treatment With Gemcitabine and Oxaliplatin Followed by Concomitant Gemcitabine and Radiation Therapy in Patients With Resected Pancreatic Adenocarcinoma",
        "lillyAlias": [
            "B9E-MC-S298"
        ]
    },
    "NCT04559568": {
        "briefTitle": "A Study of LY3522348 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Single- and Multiple-Ascending Doses of LY3522348 in Healthy Participants",
        "lillyAlias": [
            "J2U-MC-YBAA"
        ]
    },
    "NCT00258869": {
        "briefTitle": "Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests",
        "officialTitle": "Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP",
        "lillyAlias": [
            "U01AI066569"
        ]
    },
    "NCT06657768": {
        "briefTitle": "A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)",
        "officialTitle": "A Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, PK and PD of LY4006895 in Healthy Volunteers and Patients With Early Symptomatic AD",
        "lillyAlias": [
            "J5K-MC-OQAA"
        ]
    },
    "NCT04681768": {
        "briefTitle": "Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients",
        "officialTitle": "Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients With Symp-tomatic Visceral Metastases or High Tumor Burden",
        "lillyAlias": []
    },
    "NCT06176768": {
        "briefTitle": "A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3972406 in Adults With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "J4H-MC-FVAA",
            "2023-504485-39-00"
        ]
    },
    "NCT03086369": {
        "briefTitle": "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer",
        "officialTitle": "A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer",
        "lillyAlias": [
            "I5B-MC-JGDP",
            "2016-001099-31"
        ]
    },
    "NCT00357968": {
        "briefTitle": "Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting",
        "officialTitle": "Protocol H7T-MC-TABL(a) PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation (PRINCIPLE) - TIMI 44",
        "lillyAlias": [
            "H7T-MC-TABL"
        ]
    },
    "NCT01011868": {
        "briefTitle": "Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase IIb, Randomized, Double-blind, Placebo-controlled, Parallel Group, Safety and Efficacy Study of BI 10773 (10 mg and 25 mg) Administered Orally, Once Daily Over 78 Weeks in Type 2 Diabetic Patients Receiving Treatment With Basal Insulin (Glargine, Detemir, or NPH Insulin Only) With or Without Concomitant Metformin and/or Sulfonylurea Therapy and Insufficient Glycemic Control",
        "lillyAlias": [
            "2009-013668-38"
        ]
    },
    "NCT00003669": {
        "briefTitle": "Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer",
        "officialTitle": "Phase II Nonrandomized Study of LY353381-HC1 in Patients With Recurrent or Advanced Endometrial Cancer",
        "lillyAlias": [
            "LILLY-H4Z-MC-JWWI",
            "MSKCC-99001",
            "CDR0000066766"
        ]
    },
    "NCT00437268": {
        "briefTitle": "A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer",
        "officialTitle": "A Randomized Phase 2 Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Recurrent Colorectal Cancer",
        "lillyAlias": [
            "H6Q-MC-S018"
        ]
    },
    "NCT02562768": {
        "briefTitle": "A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease",
        "officialTitle": "Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease",
        "lillyAlias": [
            "I7S-EW-HBEC"
        ]
    },
    "NCT01018680": {
        "briefTitle": "A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis",
        "officialTitle": "A Randomized, Placebo-Controlled Trial of Duloxetine Added to Nonsteroidal Anti-inflammatory Drugs in Patients With Knee Pain Due to Osteoarthritis Who Have Had Suboptimal Response to Nonsteroidal Anti-inflammatory Drug Treatment.",
        "lillyAlias": [
            "F1J-US-HMGL"
        ]
    },
    "NCT00485680": {
        "briefTitle": "Olanzapine Versus Comparator in the Treatment of Bipolar Disorder",
        "officialTitle": "Olanzapine Versus Lithium Carbonate in the Treatment of Bipolar Disorder, Manic or Mixed Episodes",
        "lillyAlias": [
            "F1D-GH-LOBV"
        ]
    },
    "NCT00117962": {
        "briefTitle": "Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "U10CA031946",
            "CDR0000434616"
        ]
    },
    "NCT00532480": {
        "briefTitle": "Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine",
        "officialTitle": "Duloxetine Effects on Brain fMRI Response to Emotionally Valenced Pictures in the Treatment of Patients With Major Depression",
        "lillyAlias": []
    },
    "NCT01126580": {
        "briefTitle": "A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)",
        "officialTitle": "The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)",
        "lillyAlias": [
            "H9X-MC-GBDC",
            "CTRI/2010/091/003036"
        ]
    },
    "NCT01183780": {
        "briefTitle": "A Study in Second Line Metastatic Colorectal Cancer",
        "officialTitle": "A Randomized, Double-blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine",
        "lillyAlias": [
            "I4T-MC-JVBB",
            "CP12-0920",
            "2010-021037-32",
            "CTRI/2011/07/001900"
        ]
    },
    "NCT01654380": {
        "briefTitle": "A Study of LY2605541 Versus Insulin Glargine on Blood Sugar",
        "officialTitle": "Comparison of the Effects of LY2605541 and Insulin Glargine on Endogenous Glucose Output and Peripheral Glucose Disposal in Healthy Subjects and Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIAV"
        ]
    },
    "NCT02977780": {
        "briefTitle": "INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)",
        "officialTitle": "INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)",
        "lillyAlias": []
    },
    "NCT01107444": {
        "briefTitle": "Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Were Previously Treated With First Line Chemotherapy",
        "lillyAlias": [
            "H8Z-MC-JACW",
            "2009-017591-24"
        ]
    },
    "NCT01275144": {
        "briefTitle": "A Study of the Effect of LY2216684 on Lorazepam",
        "officialTitle": "Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of Lorazepam in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCG"
        ]
    },
    "NCT01897480": {
        "briefTitle": "A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations",
        "officialTitle": "A Randomized, Controlled Phase 2 Study Evaluating LY2875358 Plus Erlotinib Versus Erlotinib as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations Who Have Disease Control After an 8-Week Lead-In Treatment With Erlotinib",
        "lillyAlias": [
            "I4C-MC-JTBB",
            "2024-514268-18-00"
        ]
    },
    "NCT00191880": {
        "briefTitle": "Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder",
        "officialTitle": "A Phase IIIb Open-Label Trial of Atomoxetine Hydrochloride to Evaluate Academic Outcome in Children Ages 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-CA-LYCS"
        ]
    },
    "NCT01722292": {
        "briefTitle": "A Study of LY2940680 in Small Cell Lung Cancer",
        "officialTitle": "A Phase 1b/2 Double-Blind Randomized Trial of the Hedgehog/SMO Antagonist LY2940680 in Combination With Carboplatin and Etoposide Followed by LY2940680 Versus Carboplatin and Etoposide Plus Placebo Followed by Placebo in Patients With Extensive-Stage Small Cell Lung Cancer",
        "lillyAlias": [
            "I4J-MC-HHBE",
            "2012-003174-83"
        ]
    },
    "NCT01925989": {
        "briefTitle": "A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics",
        "officialTitle": "Evaluation of the Effects of Insulin Peglispro (LY2605541) on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIDO"
        ]
    },
    "NCT00034580": {
        "briefTitle": "Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder",
        "officialTitle": "Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed",
        "lillyAlias": [
            "F1D-US-HGJT"
        ]
    },
    "NCT02860780": {
        "briefTitle": "A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer",
        "officialTitle": "A Phase 1 Dose-Escalation Study of LY2606368 in Combination With Ralimetinib in Patients With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I4D-MC-JTJL",
            "2015-005611-33"
        ]
    },
    "NCT00136929": {
        "briefTitle": "Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly",
        "officialTitle": "A Prospective Randomized Trial of Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly \"Senior PAMI\"",
        "lillyAlias": []
    },
    "NCT04751929": {
        "briefTitle": "Abemaciclib With or Without Atezolizumab for mCRPC",
        "officialTitle": "A Phase II Multi-Center Trial of Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer",
        "lillyAlias": []
    },
    "NCT03050229": {
        "briefTitle": "SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)",
        "officialTitle": null,
        "lillyAlias": []
    },
    "NCT05931380": {
        "briefTitle": "A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease",
        "officialTitle": "A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Japanese Adult Participants With Obesity Disease",
        "lillyAlias": [
            "J2A-JE-GZPD"
        ]
    },
    "NCT04052594": {
        "briefTitle": "A Study of LY3475766 in Healthy Participants",
        "officialTitle": "A Randomized, Double-Blind, Single Dose, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3475766",
        "lillyAlias": [
            "J1T-MC-GZEA"
        ]
    },
    "NCT00112294": {
        "briefTitle": "Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Multicenter Phase III Study of Taxane/Carboplatin/Cetuximab Versus Taxane/Carboplatin as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT04450394": {
        "briefTitle": "A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Na\u00efve Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-MC-BDCL",
            "2019-003339-53"
        ]
    },
    "NCT03831191": {
        "briefTitle": "A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study",
        "lillyAlias": [
            "I9N-MC-FCAB",
            "2018-002401-56"
        ]
    },
    "NCT00191191": {
        "briefTitle": "To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)",
        "officialTitle": "LY231514 500 mg/m2 and LY231514 1000 mg/m2 in Patients With Advanced Non-Small Cell Lung Cancer Who Were Previously Treated With Prior Systemic Anti Cancer Therapy: A Randomized Phase II Trial",
        "lillyAlias": [
            "H3E-JE-NS01"
        ]
    },
    "NCT00113594": {
        "briefTitle": "Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder",
        "officialTitle": "Population Pharmacokinetic Study in Adolescent Patients With Schizophrenia or Bipolar I Disorder Treated With Olanzapine",
        "lillyAlias": [
            "F1D-MC-HGMF"
        ]
    },
    "NCT00535860": {
        "briefTitle": "Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis",
        "officialTitle": "A Multicenter, Randomized, Parallel Study to Assess the Clinical Efficacy, Safety, and Tolerability of ViaDerm-hPTH (1-34) in Comparison to Subcutaneous Injection of Forteo in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "I2Y-MC-GHFE"
        ]
    },
    "NCT01246960": {
        "briefTitle": "A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer",
        "officialTitle": "Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach",
        "lillyAlias": [
            "I4T-MC-JVBT"
        ]
    },
    "NCT00417794": {
        "briefTitle": "Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD",
        "officialTitle": "A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects",
        "lillyAlias": []
    },
    "NCT00563160": {
        "briefTitle": "Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery",
        "officialTitle": "Phase II Study of the Response Rate of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small Cell Lung Cancer Before Surgery",
        "lillyAlias": [
            "HARECCTR0500015",
            "000904",
            "B9E-IH-O333"
        ]
    },
    "NCT05999994": {
        "briefTitle": "A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer",
        "officialTitle": "CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research",
        "lillyAlias": [
            "J1S-MC-JAAA"
        ]
    },
    "NCT01300260": {
        "briefTitle": "Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose",
        "officialTitle": "The Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose Infusion",
        "lillyAlias": [
            "H9X-MC-GBCI"
        ]
    },
    "NCT03137160": {
        "briefTitle": "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum",
        "officialTitle": "An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum",
        "lillyAlias": []
    },
    "NCT03406260": {
        "briefTitle": "A Study of Lasmiditan in Healthy Elderly Participants",
        "officialTitle": "A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects",
        "lillyAlias": [
            "H8H-MC-LAIG"
        ]
    },
    "NCT03898791": {
        "briefTitle": "A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer",
        "officialTitle": "Phase 1b Study of LY3295668 Erbumine Monotherapy in Patients With Platinum-Sensitive, Extensive-Stage Small-Cell Lung Cancer",
        "lillyAlias": [
            "J1O-MC-JZHB",
            "2018-003485-14"
        ]
    },
    "NCT00088491": {
        "briefTitle": "Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia",
        "officialTitle": "A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-MC-HGKA"
        ]
    },
    "NCT00234494": {
        "briefTitle": "Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer",
        "officialTitle": "A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75",
        "lillyAlias": []
    },
    "NCT05110794": {
        "briefTitle": "A Multiple-Dose Study of LY3502970 in Healthy Participants",
        "officialTitle": "A Phase 1 Multiple Dose Study to Investigate the Pharmacokinetics, Safety, and Tolerability of LY3502970 in Fed and Fasted Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZGJ"
        ]
    },
    "NCT04614194": {
        "briefTitle": "Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib",
        "officialTitle": "Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib and Letrozole in Hormone Receptor Positive Breast Cancer",
        "lillyAlias": []
    },
    "NCT01067794": {
        "briefTitle": "Chemotherapy in Treating Patients With Lung Cancer",
        "officialTitle": "First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study on Overall Survival",
        "lillyAlias": [
            "H3E-EW-B012"
        ]
    },
    "NCT02831491": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer",
        "officialTitle": "A Single-Arm, Phase 2 Study of Ramucirumab in Combination With Weekly Docetaxel in Patients With Stage IV Non-Small Cell Lung Cancer Following Disease Progression After Prior Platinum-Based Chemotherapy",
        "lillyAlias": [
            "I4T-MC-JVDN",
            "2016-001317-25"
        ]
    },
    "NCT01556594": {
        "briefTitle": "Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia",
        "officialTitle": "Phase II Study to Investigate the Safety and Efficacy of 2 Dose Levels of a Novel Glucagon Formulation Compared to Commercially Available Glucagon in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia",
        "lillyAlias": [
            "I8R-MC-IGBA",
            "AMG102"
        ]
    },
    "NCT02411591": {
        "briefTitle": "A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Single-Arm, Multicenter, Phase 1b Study With an Expansion Cohort to Evaluate Safety and Efficacy of Necitumumab in Combination With Abemaciclib in Treatment of Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4X-MC-JFCU"
        ]
    },
    "NCT00768391": {
        "briefTitle": "Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available",
        "officialTitle": "Phase I Study of Anti-Platelet Derived Growth Factor Receptor Alpha (PDGFRa) Monoclonal Antibody IMC-3G3 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom no Standard Therapy is Available",
        "lillyAlias": [
            "CP15-0601",
            "I5B-IE-JGDC"
        ]
    },
    "NCT00870194": {
        "briefTitle": "A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin",
        "officialTitle": "A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin",
        "lillyAlias": []
    },
    "NCT01769391": {
        "briefTitle": "A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4X-MC-JFCL",
            "2012-003214-13"
        ]
    },
    "NCT01742091": {
        "briefTitle": "A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women",
        "officialTitle": "A Multiple Dose Study of LY2541546 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy Postmenopausal Women",
        "lillyAlias": [
            "I2M-MC-GSDE"
        ]
    },
    "NCT03535194": {
        "briefTitle": "A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2",
        "lillyAlias": [
            "I6T-MC-AMAJ",
            "2017-003286-10"
        ]
    },
    "NCT01430091": {
        "briefTitle": "A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet",
        "officialTitle": "Relative Bioavailability of a Prasugrel Paediatric Orally Disintegrating Tablet Formulation Compared to the Tablet in Healthy Adult Subjects",
        "lillyAlias": [
            "H7T-EW-TADQ"
        ]
    },
    "NCT00576394": {
        "briefTitle": "Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients",
        "officialTitle": "Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients",
        "lillyAlias": []
    },
    "NCT00744991": {
        "briefTitle": "A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma",
        "officialTitle": "A Phase 2, Open-Label, Multicenter Study of Single-Agent Enzastaurin in Patients With Relapsed Cutaneous T-Cell Lymphoma",
        "lillyAlias": [
            "H6Q-MC-JCCB"
        ]
    },
    "NCT06345794": {
        "briefTitle": "A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants",
        "officialTitle": "A Phase 1, Single-Center, Open-Label, 3-Cohort, Fixed-Sequence, Drug-Drug Interaction Study To Assess The Pharmacokinetics Of LY4100511 (DC-853) When Orally Administered Alone, When Coadministered With Itraconazole, Fluconazole, Or Carbamazepine In Healthy Adult Participants",
        "lillyAlias": [
            "J5C-MC-FOAG"
        ]
    },
    "NCT04137380": {
        "briefTitle": "A Study of Mirikizumab in Healthy Chinese Participants",
        "officialTitle": "A Single-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of LY3074828 in Healthy Chinese Subjects",
        "lillyAlias": [
            "I6T-MC-AMBD"
        ]
    },
    "NCT03009162": {
        "briefTitle": "Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function",
        "officialTitle": "A Phase I, Multicenter, Open-Label, Parallel-Group Adaptive Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Renal Function",
        "lillyAlias": [
            "CUD-P4-001",
            "COl MIG-113",
            "H8H-CD-LAHN"
        ]
    },
    "NCT04106362": {
        "briefTitle": "Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma",
        "officialTitle": "Randomized Phase II Trial of Radiotherapy With Concurrent Cisplatin +/- Concurrent Cetuximab for HPV-Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) in KRAS-Variant Patients",
        "lillyAlias": [
            "NCI-2019-03636"
        ]
    },
    "NCT05023980": {
        "briefTitle": "A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)",
        "officialTitle": "A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "lillyAlias": [
            "J2N-OX-JZNP"
        ]
    },
    "NCT00533429": {
        "briefTitle": "Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy",
        "officialTitle": "Protocol H6Q-MC-S034(a) Randomized, Double-Blind, Phase 2 Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Chemonaive Patients With Stage IIIB or IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H6Q-MC-S034"
        ]
    },
    "NCT00133380": {
        "briefTitle": "A Study in People With High Cholesterol",
        "officialTitle": "PPAR Alpha (LY518674): A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia",
        "lillyAlias": [
            "H8D-MC-EMBF"
        ]
    },
    "NCT04469062": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis",
        "officialTitle": "A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active- Controlled Treat-Through Study of Mirikizumab and Vedolizumab in Participants With Moderately to Severely Active Ulcerative Colitis",
        "lillyAlias": [
            "I6T-MC-AMBI",
            "2019-001653-99"
        ]
    },
    "NCT03214380": {
        "briefTitle": "A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D",
        "lillyAlias": [
            "I8B-MC-ITRN",
            "2015-005357-12"
        ]
    },
    "NCT00436280": {
        "briefTitle": "Chemotherapy for Participants With Lymphoma",
        "officialTitle": "An Open-label, Single Arm, Phase 2 Study of Rituximab, Gemcitabine and Oxaliplatin Plus Enzastaurin as Treatment for Patients With Relapsed Diffuse Large B-Cell Lymphoma",
        "lillyAlias": [
            "H6Q-MC-S013"
        ]
    },
    "NCT04527380": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis",
        "officialTitle": "Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis",
        "lillyAlias": [
            "I1F-MC-RHCG",
            "2018-000681-10"
        ]
    },
    "NCT01000480": {
        "briefTitle": "A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer",
        "officialTitle": "Phase 2 Study of Pemetrexed and Cisplatin as Induction, Followed by Pemetrexed and Cisplatin With Concurrent Thoracic Radiotherapy, in Patients With Unresectable, Locally Advanced, Stage III, Nonsquamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-EW-S128"
        ]
    },
    "NCT00193362": {
        "briefTitle": "Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer",
        "officialTitle": "Phase III Randomized Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine as First-Line Chemotherapy for Stage IIIB and IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-MC-X338",
            "VNR-R47"
        ]
    },
    "NCT00485862": {
        "briefTitle": "Combination Therapy in Patients With Depression",
        "officialTitle": "Noradrenergic Augmentation of SSRI Therapy in Patients With Depression Unresponsive or Incompletely Responsive to SSRI Monotherapy",
        "lillyAlias": [
            "B4Z-MC-LYBN"
        ]
    },
    "NCT05668962": {
        "briefTitle": "Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC",
        "officialTitle": "Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: a Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)",
        "lillyAlias": []
    },
    "NCT06001762": {
        "briefTitle": "TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer",
        "officialTitle": "The TRADE Study: a Phase 2 Trial to Assess the ToleRability of Abemaciclib Dose Escalation in Patients with Early-Stage HR-positive and HER2-negative Breast Cancer",
        "lillyAlias": []
    },
    "NCT01139762": {
        "briefTitle": "A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms",
        "officialTitle": "A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-CR-LVIW"
        ]
    },
    "NCT03040362": {
        "briefTitle": "Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration",
        "officialTitle": "A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Lasmiditan Following Single Oral Dose Administration in Healthy Male and Female Subjects",
        "lillyAlias": [
            "H8H-CD-LAHH",
            "COL MIG-110"
        ]
    },
    "NCT00191529": {
        "briefTitle": "Growth Hormone Treatment in Short Children Born Small for Gestational Age",
        "officialTitle": "Optimization of Growth Hormone Treatment in Short Children Born Small for Gestational Age Based on a Growth Prediction Model-The OPTIMA Trial",
        "lillyAlias": [
            "B9R-EW-GDGB"
        ]
    },
    "NCT04285229": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Chinese Patients With Radiographic Axial Spondyloarthritis",
        "lillyAlias": [
            "I1F-MC-RHCH"
        ]
    },
    "NCT02109029": {
        "briefTitle": "A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue",
        "officialTitle": "Use of Open-Flow Microperfusion to Measure LY2605541 and Human Insulin Concentrations in Adipose Tissue Interstitial Fluid",
        "lillyAlias": [
            "I2R-MC-BIDP"
        ]
    },
    "NCT01528189": {
        "briefTitle": "Effect of High Dose Insulin on Infectious Complications Following Major Surgery",
        "officialTitle": "Effect of Hyperinsulinemic Normoglycemic Clamp (HINC) on Infectious Complications Following Major Abdominal Surgery. A Randomized Controlled Trial.",
        "lillyAlias": []
    },
    "NCT03942029": {
        "briefTitle": "A Drug Interaction Study of LY3154207 in Healthy Participants",
        "officialTitle": "Safety and Tolerability of LY3154207 in Combination With a CYP3A4 Inhibitor and Assessment of Pharmacokinetics of LY3154207 After Administration of Capsule and Tablet Formulations in Healthy Subjects",
        "lillyAlias": [
            "I7S-MC-HBEF"
        ]
    },
    "NCT01118780": {
        "briefTitle": "A Study of Duloxetine in Elderly Generalized Anxiety Disorder",
        "officialTitle": "Duloxetine Versus Placebo in the Treatment of Elderly Patients With Generalized Anxiety Disorder",
        "lillyAlias": [
            "F1J-MC-HMGF"
        ]
    },
    "NCT02014129": {
        "briefTitle": "A Study of LY2835219 in Japanese Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2835219 in Japanese Patients With Advanced Cancer",
        "lillyAlias": [
            "I3Y-JE-JPBC"
        ]
    },
    "NCT01319929": {
        "briefTitle": "A Study of LY2828360 in Patients With Osteoarthritic Knee Pain",
        "officialTitle": "A Proof of Concept Study of the Effects of LY2828360 in the Treatment of Patients With Osteoarthritic Knee Pain.",
        "lillyAlias": [
            "I4F-EW-CCAC"
        ]
    },
    "NCT03315780": {
        "briefTitle": "A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 4 Study to Evaluate Glucodynamic Effects of Dulaglutide in Japanese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-JE-GBGK"
        ]
    },
    "NCT00490880": {
        "briefTitle": "Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer",
        "officialTitle": "The Evaluation of Efficacy and Toxicity of Combined Treatment: Neoadjuvant Chemotherapy (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer Stage T2b-T3 NO/Nx M0",
        "lillyAlias": [
            "B9E-MC-S341"
        ]
    },
    "NCT00222729": {
        "briefTitle": "Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer",
        "officialTitle": "Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer",
        "lillyAlias": [
            "12,158"
        ]
    },
    "NCT02240680": {
        "briefTitle": "Linagliptin as Add on to Basal Insulin in the Elderly",
        "officialTitle": "A 24 Week Randomized, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Trial of Once Daily Linagliptin, 5 Milligrams Orally, as Add on to Basal Insulin in Elderly Type 2 Diabetes Mellitus Patients With Insufficient Glycaemic Control",
        "lillyAlias": [
            "2014-000904-88"
        ]
    },
    "NCT04032080": {
        "briefTitle": "LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer",
        "officialTitle": "Pilot Clinical Trial of Treatment With LY3023414 and Prexasertib to Inhibit Homologous Recombination (HR) in Patients With Chemotherapy-Pretreated Metastatic Triple Negative Breast Cancer (Amendment 1)",
        "lillyAlias": []
    },
    "NCT00517829": {
        "briefTitle": "Docetaxel+Oxali+/-Cetux Met Gastric/GEJ",
        "officialTitle": "Phase II Trial of Docetaxel Plus Oxaliplatin (DOCOX) With or Without Cetuximab in Patients With Metastatic Gastric and/or Gastroesophageal Junction Adenocarcinoma",
        "lillyAlias": []
    },
    "NCT06119529": {
        "briefTitle": "A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis",
        "officialTitle": "A Phase 1, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending Dose Study of LY3872386 in Healthy Participants, a Multiple-Ascending Dose Study of LY3872386 in Patients With Atopic Dermatitis, and an Open-Label Multiple-Dose Evaluation of the Safety and Tolerability of Prednisone in Healthy Participants.",
        "lillyAlias": [
            "J4L-MC-KMAA"
        ]
    },
    "NCT01214629": {
        "briefTitle": "A Study for Participants With Advanced Cancer",
        "officialTitle": "A Phase I Study of LY2523355 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I1Y-MC-JFBA"
        ]
    },
    "NCT00102804": {
        "briefTitle": "Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment for Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-MC-JMEN"
        ]
    },
    "NCT02981940": {
        "briefTitle": "A Study of Abemaciclib in Recurrent Glioblastoma",
        "officialTitle": "A Phase 0/2 Study of Abemaciclib in Recurrent Glioblastoma",
        "lillyAlias": []
    },
    "NCT05565729": {
        "briefTitle": "A Phase I Study of LY3471851 in Healthy Participants",
        "officialTitle": "A Phase 1, Randomized, Placebo-controlled, Participant- and Investigator-blind, Single-dose Study of the Pharmacokinetics of LY3471851 Following Subcutaneous Dosing of LY3471851 in Healthy Participants",
        "lillyAlias": [
            "J1P-MC-KFAN"
        ]
    },
    "NCT02951780": {
        "briefTitle": "A Study of LY3185643 and rGlucagon in Healthy Participants",
        "officialTitle": "A Randomized, 9-Way, Single-Dose, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of LY3185643 and rGlucagon in Healthy Subjects",
        "lillyAlias": [
            "I8Z-MC-APCA"
        ]
    },
    "NCT06180980": {
        "briefTitle": "A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participants",
        "officialTitle": "A Phase I, Open-Label, Randomized, 2-Way Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Pirtobrutinib (LOXO-305) in Healthy Subjects",
        "lillyAlias": [
            "J2N-MC-JZNK"
        ]
    },
    "NCT03482362": {
        "briefTitle": "Vinorelbine in Advanced BRAF-like Colon Cancer",
        "officialTitle": "MoTriColor: A Phase II Study of Vinorelbine in Advanced BRAF-like Colon Cancer",
        "lillyAlias": []
    },
    "NCT00369629": {
        "briefTitle": "Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or S\u00e9zary Syndrome",
        "officialTitle": "Phase I/II Trial of Gemcitabine/Pemetrexed Combination in Patients With Advanced Cutaneous T-Cell Lymphoma",
        "lillyAlias": [
            "P30CA060553",
            "STU00006771"
        ]
    },
    "NCT01724580": {
        "briefTitle": "Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes",
        "officialTitle": "Compassionate Use Treatment Protocol I4V-MC-JAGA: Treatment of Conditions Expected to Benefit From JAK 1/2 Inhibition: CANDLE, CANDLE-Related Conditions, SAVI and Severe Juvenile Dermatomyositis",
        "lillyAlias": [
            "I4V-MC-JAGA"
        ]
    },
    "NCT02091362": {
        "briefTitle": "A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "The Effect of LY2409021 on Blood Pressure and Pulse Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-MC-GLDI",
            "2013-003834-33"
        ]
    },
    "NCT00260962": {
        "briefTitle": "Olanzapine in the Treatment of Patients With Anorexia Nervosa",
        "officialTitle": "Olanzapine in the Treatment of Low Weight and Obsessional Thinking Among Those With Anorexia Nervosa: A Double Blind Placebo Controlled Study",
        "lillyAlias": [
            "F1D-CA-O092"
        ]
    },
    "NCT04881760": {
        "briefTitle": "A Study of LY3437943 in Participants Who Have Obesity or Are Overweight",
        "officialTitle": "A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities",
        "lillyAlias": [
            "J1I-MC-GZBF"
        ]
    },
    "NCT00437294": {
        "briefTitle": "Enzastaurin in Combination of Capecitabine to Treat Breast Cancer",
        "officialTitle": "A Double-Blind, Randomized, Phase 2 Trial of Capecitabine Plus Enzastaurin Versus Capecitabine Plus Placebo in Patients With Metastatic or Recurrent Breast Cancer Previously Treated With an Anthracycline and a Taxane",
        "lillyAlias": [
            "H6Q-MC-S035"
        ]
    },
    "NCT05177094": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "H0P-MC-NP02"
        ]
    },
    "NCT03590860": {
        "briefTitle": "A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure)",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of Single and Multiple Ascending Doses of LY3322207 in Healthy Subjects and Subjects With Hypertension on ACE I/ARB Therapy",
        "lillyAlias": [
            "I9K-MC-UCAA",
            "2018-002337-38"
        ]
    },
    "NCT00712660": {
        "briefTitle": "Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia",
        "officialTitle": "ITAREPS Trial: A Prospective Randomized Double-blind Controlled Study in IT-aided Mobile Phone-based Relapse Prevention Program in Schizophrenia.",
        "lillyAlias": []
    },
    "NCT06354660": {
        "briefTitle": "Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)",
        "officialTitle": "A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)",
        "lillyAlias": [
            "J1I-MC-GZBY"
        ]
    },
    "NCT00078260": {
        "briefTitle": "A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer",
        "officialTitle": "A Randomized Phase 3 Study of Two Doses of Alimta in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy",
        "lillyAlias": [
            "H3E-MC-JMGX"
        ]
    },
    "NCT03913260": {
        "briefTitle": "A Study of Different Injectable Formulations of LY3375880 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of Different Solution Formulations of LY3375880 Using Investigational Injection Devices in Healthy Subjects",
        "lillyAlias": [
            "I9N-MC-FCAC"
        ]
    },
    "NCT00433160": {
        "briefTitle": "Phase 3 Clinical Trial of Teriparatide in Japan",
        "officialTitle": "Efficacy and Safety of LY333334 in Japanese Patients With Osteoporosis",
        "lillyAlias": [
            "B3D-JE-GHDB"
        ]
    },
    "NCT02806960": {
        "briefTitle": "A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes",
        "officialTitle": "A Single Center, Randomized, 4-Period Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Single or Repeated 3 mg Doses of Intranasally Administered Glucagon in Adults With Type 1 or Type 2 Diabetes",
        "lillyAlias": [
            "I8R-MC-IGBH",
            "AMG110",
            "AMG-P4-459"
        ]
    },
    "NCT00414960": {
        "briefTitle": "A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers",
        "officialTitle": "Phase IIB Randomized, Placebo-Controlled, Double-Blind Study of Enzastaurin HCL (LY317615) for Lung Cancer Prevention in Former Smokers",
        "lillyAlias": [
            "H6Q-MC-S009"
        ]
    },
    "NCT00842660": {
        "briefTitle": "Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical Cancer",
        "officialTitle": "Phase III Trial for Primary Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in PET/CT Defined Poor-Prognostic Cervical Cancer Patients",
        "lillyAlias": []
    },
    "NCT03936660": {
        "briefTitle": "A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease",
        "officialTitle": "COOrdinating CaRDIology CliNics RAndomized Trial of Interventions to Improve OutcomEs (COORDINATE) - Diabetes",
        "lillyAlias": []
    },
    "NCT00895180": {
        "briefTitle": "Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme",
        "officialTitle": "An Open Label, Phase 2 Study Evaluating the Safety and Efficacy of IMC-3G3 or IMC-1121B in Patients With Recurrent Glioblastoma Multiforme",
        "lillyAlias": [
            "U01CA137443",
            "ABTC-0901",
            "IMCL-CP-19-0801"
        ]
    },
    "NCT02735980": {
        "briefTitle": "A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer",
        "officialTitle": "A Phase 2 Study of LY2606368 in Patients With Extensive Stage Disease Small Cell Lung Cancer",
        "lillyAlias": [
            "I4D-MC-JTJH",
            "2015-005069-21"
        ]
    },
    "NCT04071262": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer",
        "lillyAlias": [
            "I3Y-JE-JPCQ"
        ]
    },
    "NCT01777191": {
        "briefTitle": "Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis",
        "officialTitle": "Pharmacokinetic Evaluations of Ixekizumab Following Subcutaneous Administration Using Prefilled Syringe or Auto-Injector in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBL"
        ]
    },
    "NCT00490191": {
        "briefTitle": "Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency",
        "officialTitle": "Comparison of an Incremental Weight-Based Dose Regimen With an Individualized Dosage Adjusted According to the IGF-I Response in Adults With Growth Hormone Deficiency",
        "lillyAlias": [
            "B9R-EW-T002"
        ]
    },
    "NCT00190762": {
        "briefTitle": "A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma",
        "officialTitle": "A Randomized Phase 3 Trial Comparing ALIMTA Plus Best Supportive Care Versus Best Supportive Care Alone in Previously Treated Patients With Locally Advanced or Metastatic Malignant Pleural Mesothelioma",
        "lillyAlias": [
            "H3E-MC-JMEW"
        ]
    },
    "NCT00337662": {
        "briefTitle": "Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia",
        "officialTitle": "Predicting Response to Risperidone Treatment Through Identification of Early-onset of Antipsychotic Drug Action in Schizophrenia.",
        "lillyAlias": [
            "F1D-US-HGMN"
        ]
    },
    "NCT01005680": {
        "briefTitle": "A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 3 Study Comparing Pemetrexed Plus Cisplatin With Gemcitabine Plus Cisplatin as First-Line Treatment in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer.",
        "lillyAlias": [
            "H3E-CR-JMIL"
        ]
    },
    "NCT06052462": {
        "briefTitle": "A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants",
        "officialTitle": "Disposition of [14C]-LY3556050 Following Oral Administration in Healthy Male Participants",
        "lillyAlias": [
            "J2P-MC-LXBC"
        ]
    },
    "NCT02497391": {
        "briefTitle": "A Study of Different Particle Sizes of Evacetrapib in Healthy Participants",
        "officialTitle": "A Bioequivalence Study in Healthy Subjects Administered Evacetrapib Tablets of Varying Particle Sizes",
        "lillyAlias": [
            "I1V-MC-EIBA"
        ]
    },
    "NCT01621191": {
        "briefTitle": "An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)",
        "officialTitle": "An Open Label Extension Study of Phase 3 Trial of Duloxetine in Patients With Fibromyalgia",
        "lillyAlias": [
            "F1J-JE-HMHB"
        ]
    },
    "NCT00415194": {
        "briefTitle": "A Study for Patients With Head and Neck Cancer",
        "officialTitle": "A Randomized Phase 3 Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer",
        "lillyAlias": [
            "H3E-MC-JMHR"
        ]
    },
    "NCT00149591": {
        "briefTitle": "The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)",
        "officialTitle": "Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.",
        "lillyAlias": [
            "H4S-UT-O017"
        ]
    },
    "NCT01404091": {
        "briefTitle": "A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects",
        "officialTitle": "Assessment of Nociceptin/Orphanin FQ Peptide Receptor Occupancy After Single Oral Doses of LY2940094 as Measured by Positron Emission Tomography With the Radioligand LY2959530 in Healthy Subjects",
        "lillyAlias": [
            "I5J-MC-NOAB"
        ]
    },
    "NCT01660191": {
        "briefTitle": "A Study Comparing CoQ10 Levels While Taking 3 Different Statins",
        "officialTitle": "A Study Comparing the Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on Plasma Levels of CoQ10 (SPARQ)",
        "lillyAlias": []
    },
    "NCT01253291": {
        "briefTitle": "A Study of Japanese Rheumatoid Arthritis Participants",
        "officialTitle": "An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Japanese Patients With Rheumatoid Arthritis Treated With Methotrexate",
        "lillyAlias": [
            "H9B-JE-BCDL"
        ]
    },
    "NCT02248480": {
        "briefTitle": "A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan",
        "officialTitle": "Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan",
        "lillyAlias": [
            "F1J-JE-HMGX"
        ]
    },
    "NCT06074562": {
        "briefTitle": "A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "J2P-MC-LXBD",
            "2023-506127-29-00"
        ]
    },
    "NCT03730662": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk",
        "officialTitle": "Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)",
        "lillyAlias": [
            "I8F-MC-GPGM",
            "2018-002618-11"
        ]
    },
    "NCT00450762": {
        "briefTitle": "Gemcitabine + Carboplatin in Breast Cancer",
        "officialTitle": "Gemcitabine Plus Carboplatin in Patients With Pretreated Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT05325294": {
        "briefTitle": "Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev\u00ae",
        "officialTitle": "Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev\u00ae Insulin Lispro-aabc",
        "lillyAlias": []
    },
    "NCT00783094": {
        "briefTitle": "Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Efficacy and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks Followed by an Open-Label Extension to Evaluate the Long-Term Safety and Efficacy of Tadalafil in Japanese Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-JE-LVIA"
        ]
    },
    "NCT01380691": {
        "briefTitle": "A Study of LY2216684 in Healthy Participants",
        "officialTitle": "A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction of LY2216684 With Alcohol in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCV"
        ]
    },
    "NCT00183794": {
        "briefTitle": "Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma",
        "officialTitle": "Phase II Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma",
        "lillyAlias": []
    },
    "NCT00191594": {
        "briefTitle": "Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials",
        "officialTitle": "Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial",
        "lillyAlias": [
            "F1J-XM-HMED"
        ]
    },
    "NCT03770494": {
        "briefTitle": "A Study of LY3405105 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1a/1b Study of LY3405105 Administered to Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "J1F-MC-JZFA",
            "2018-002668-23"
        ]
    },
    "NCT02189694": {
        "briefTitle": "Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp",
        "officialTitle": "An Open-label, Randomized, Three-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Pump Therapy in Regulating Overnight Glucose Levels in Children With Type 1 Diabetes in a Diabetes Camp",
        "lillyAlias": []
    },
    "NCT02632994": {
        "briefTitle": "Master Rollover Protocol for Continued Safety Assessment of Study Drug",
        "officialTitle": "Master Rollover Protocol for Continued Safety Assessment of Study Drug",
        "lillyAlias": [
            "I8I-MC-JYAA"
        ]
    },
    "NCT04656691": {
        "briefTitle": "At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19",
        "officialTitle": "At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19",
        "lillyAlias": []
    },
    "NCT01703091": {
        "briefTitle": "A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized, Double-Blind, Phase 2 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy",
        "lillyAlias": [
            "I4T-JE-JVCG"
        ]
    },
    "NCT00343291": {
        "briefTitle": "A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC",
        "officialTitle": "Phase II Randomized, Open-Label Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Patients With Stage IIIB/IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "I4E-MC-S001",
            "CP02-0554"
        ]
    },
    "NCT06190691": {
        "briefTitle": "Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants",
        "officialTitle": "An Open-label, Nonrandomized, Single-dose, Parallel-group, Safety, Tolerance, and Pharmacokinetic Study of LOXO-305 Administered to Fasted Hepatically Impaired Male and Female Subjects and Fasted Matched-control Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZNF"
        ]
    },
    "NCT02791191": {
        "briefTitle": "A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia",
        "officialTitle": "Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral \u00b9\u2078F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia",
        "lillyAlias": [
            "I7X-MC-LLCF"
        ]
    },
    "NCT03126591": {
        "briefTitle": "A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma",
        "officialTitle": "An Open-Label, Multicenter, Phase 1a/1b Study of Olaratumab (LY3012207) Plus Pembrolizumab (MK3475) in Patients With Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma (STS) Who Have Failed Standard Treatments",
        "lillyAlias": [
            "I5B-MC-JGDQ",
            "2016-001949-19",
            "KEYNOTE-505",
            "MK-3475-505"
        ]
    },
    "NCT00097591": {
        "briefTitle": "A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention",
        "officialTitle": "A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention",
        "lillyAlias": [
            "H7T-MC-TAAL"
        ]
    },
    "NCT01196091": {
        "briefTitle": "A Study of LY2127399 in Participants With Systemic Lupus Erythematosus",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Participants With Systemic Lupus Erythematosus (SLE)",
        "lillyAlias": [
            "H9B-MC -BCDS"
        ]
    },
    "NCT00036062": {
        "briefTitle": "A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury",
        "officialTitle": "A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury",
        "lillyAlias": [
            "H6W-MC-MCAA"
        ]
    },
    "NCT00721162": {
        "briefTitle": "Study of Ramucirumab in Ovarian Cancer",
        "officialTitle": "A Phase 2, Non-randomized, Open-label, Multicenter Study of IMC-1121B in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma",
        "lillyAlias": [
            "2007-006717-17",
            "CP12-0711",
            "I4T-IE-JVBR"
        ]
    },
    "NCT00359762": {
        "briefTitle": "Exenatide Versus Glimepiride in Patients With Type 2 Diabetes",
        "officialTitle": "Long Term Treatment With Exenatide Versus Glimepiride in Patients With Type 2 Diabetes Pretreated With Metformin (EUREXA: European Exenatide Study)",
        "lillyAlias": []
    },
    "NCT01133392": {
        "briefTitle": "Bioequivalence of Two Lispro Formulations",
        "officialTitle": "Evaluation of the Bioequivalence of Two Formulations of Insulin Lispro in Healthy Subjects",
        "lillyAlias": [
            "F3Z-EW-IOPY"
        ]
    },
    "NCT01473589": {
        "briefTitle": "Effect of Teriparatide on Hip Fracture Healing",
        "officialTitle": "Effect of Teriparatide on Femoral Neck Fracture Healing",
        "lillyAlias": [
            "B3D-MC-GHDN"
        ]
    },
    "NCT00370292": {
        "briefTitle": "Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "Pemetrexed Monochemotherapy in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer. A Pilot Study to Define the Best Dosing Schedule for a Planned Phase II Randomized Trial",
        "lillyAlias": [
            "H3E-IT-S105"
        ]
    },
    "NCT02156492": {
        "briefTitle": "A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants",
        "officialTitle": "A Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Study of Evacetrapib With Selected Statins in Healthy Chinese Subjects",
        "lillyAlias": [
            "I1V-MC-EIAM"
        ]
    },
    "NCT03524092": {
        "briefTitle": "A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)",
        "lillyAlias": [
            "I6T-MC-AMBG",
            "2017-003238-96"
        ]
    },
    "NCT00191789": {
        "briefTitle": "Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer",
        "officialTitle": "Neoadjuvant Administration of Gemcitabine Plus Doxorubicin Followed by Gemcitabine Plus Cisplatin in Large or Locally Advanced Operable Breast Cancer: A Phase II Study",
        "lillyAlias": [
            "B9E-MC-S329"
        ]
    },
    "NCT00383292": {
        "briefTitle": "A Study of Tasisulam in Treating Participants With Malignant Melanoma",
        "officialTitle": "A Phase 2 Study of LY573636 Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle as Second-Line Treatment in Patients With Unresectable or Metastatic Melanoma",
        "lillyAlias": [
            "H8K-MC-JZAF"
        ]
    },
    "NCT02549989": {
        "briefTitle": "Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer",
        "officialTitle": "Single-Arm, Open-Label, Phase II Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer",
        "lillyAlias": []
    },
    "NCT01416389": {
        "briefTitle": "A Study of LY2523355 in Participants With Breast Cancer",
        "officialTitle": "A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy",
        "lillyAlias": [
            "I1Y-MC-JFBE"
        ]
    },
    "NCT04081324": {
        "briefTitle": "A Study of Lasmiditan in Healthy Chinese Participants",
        "officialTitle": "Safety, Tolerability, and Pharmacokinetics of Lasmiditan in Healthy Chinese Subjects",
        "lillyAlias": [
            "H8H-MC-LAIC"
        ]
    },
    "NCT00299234": {
        "briefTitle": "Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL",
        "officialTitle": "Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for Acute Lymphocytic Leukemia",
        "lillyAlias": []
    },
    "NCT03166124": {
        "briefTitle": "A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single Dose Administration in Elderly and Younger Adults With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I8B-MC-ITRR"
        ]
    },
    "NCT01503424": {
        "briefTitle": "Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study",
        "officialTitle": "An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Olanzapine Tablets 5 mg With Zyprexa\u00ae Tablets 5 mg in Healthy Subjects Under Fed Conditions",
        "lillyAlias": []
    },
    "NCT03954834": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone",
        "officialTitle": "A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone",
        "lillyAlias": [
            "I8F-MC-GPGK"
        ]
    },
    "NCT04311424": {
        "briefTitle": "Study of Tirzepatide in Healthy Participants",
        "officialTitle": "Disposition of [14C]-Tirzepatide Following Subcutaneous Administration in Healthy Male Subjects",
        "lillyAlias": [
            "I8F-MC-GPHX",
            "2019-003664-44"
        ]
    },
    "NCT01175824": {
        "briefTitle": "Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies",
        "officialTitle": "Comparison of Twice-Daily Insulin Lispro Low Mixture Versus Once-Daily Basal Insulin Glargine and Once-Daily Prandial Insulin Lispro as Insulin Intensification Strategies in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Basal Insulin Glargine and Metformin and/or Pioglitazone",
        "lillyAlias": [
            "F3Z-CR-IOQE"
        ]
    },
    "NCT00617734": {
        "briefTitle": "Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck",
        "officialTitle": "A Randomized Phase 2 Open-Label Study of IMC-A12, as a Single Agent or in Combination With Cetuximab, in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Disease Progression on Prior Platinum-Based Chemotherapy",
        "lillyAlias": [
            "CP13-0706",
            "CP02-0758",
            "I5A-IE-JAEB"
        ]
    },
    "NCT00251524": {
        "briefTitle": "A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC",
        "officialTitle": "A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC",
        "lillyAlias": []
    },
    "NCT02890134": {
        "briefTitle": "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort",
        "officialTitle": "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort",
        "lillyAlias": []
    },
    "NCT03092934": {
        "briefTitle": "A Study of AK-01 (LY3295668) in Solid Tumors",
        "officialTitle": "A Phase I/II Open-Label Multicenter Study to Evaluate the Safety and Efficacy of AK-01 as Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumors",
        "lillyAlias": [
            "AURA-001",
            "J1O-MC-JZHA"
        ]
    },
    "NCT02766517": {
        "briefTitle": "Biomarker Study in Participants With Migraine",
        "officialTitle": "LY2951742 Biomarker Study in Patients With Migraine",
        "lillyAlias": [
            "I5Q-MC-S001"
        ]
    },
    "NCT02121834": {
        "briefTitle": "A Study of LY3050258 in Healthy Participants",
        "officialTitle": "A Multiple-Dose, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of LY3050258",
        "lillyAlias": [
            "I6R-MC-DLAB"
        ]
    },
    "NCT05324124": {
        "briefTitle": "A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participants",
        "officialTitle": "An Open-Label, Randomized, Two-Period Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of Selpercatinib in Healthy Participants",
        "lillyAlias": [
            "J2G-MC-JZPA"
        ]
    },
    "NCT00353834": {
        "briefTitle": "The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes",
        "officialTitle": "The Effect of Exenatide Compared to Lantus Insulin on Vascular Function Before and After a Meal Tolerance Test in Patients With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT05241834": {
        "briefTitle": "A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment",
        "officialTitle": "A Phase 1 Study of Oral LOXO-260 in Patients With RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation Refractory to Selective RET Inhibitors",
        "lillyAlias": [
            "J3T-OX-JZTA"
        ]
    },
    "NCT03909334": {
        "briefTitle": "Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-na\u00efve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC",
        "lillyAlias": []
    },
    "NCT01337596": {
        "briefTitle": "A Study of LY2951742 in Healthy Volunteers",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of Single, Escalating Subcutaneous Doses of LY2951742 in Healthy Volunteers",
        "lillyAlias": [
            "I5Q-MC-CGAA"
        ]
    },
    "NCT01400516": {
        "briefTitle": "Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial",
        "officialTitle": "Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial",
        "lillyAlias": []
    },
    "NCT00190996": {
        "briefTitle": "Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence",
        "officialTitle": "The Safety and Effectiveness of Duloxetine Compared With Placebo and Its Long-Term Safety and Efficacy in the Treatment of Predominant Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-EW-SBCC"
        ]
    },
    "NCT01459016": {
        "briefTitle": "A Non-drug Methods Study in Participants With Alzheimer's Disease",
        "officialTitle": "An Exploratory Study of Brain Imaging Biomarkers in Patients With Alzheimer's Pathology Receiving Standard of Care",
        "lillyAlias": [
            "I4O-MC-BACH"
        ]
    },
    "NCT06584916": {
        "briefTitle": "A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)",
        "officialTitle": "A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Orforglipron Once Daily Versus Placebo for Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities",
        "lillyAlias": [
            "J2A-MC-GZPN"
        ]
    },
    "NCT04133116": {
        "briefTitle": "A Study of LY3471851 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3471851 in Japanese and Caucasian Healthy Subjects",
        "lillyAlias": [
            "J1P-MC-KFAI"
        ]
    },
    "NCT00475696": {
        "briefTitle": "Urge Incontinence Bladder Overactivity Study",
        "officialTitle": "Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Bladder Overactivity",
        "lillyAlias": [
            "F1J-MC-SBBX"
        ]
    },
    "NCT04849416": {
        "briefTitle": "A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)",
        "officialTitle": "A Phase 2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)",
        "lillyAlias": [
            "J2N-MC-JZNJ"
        ]
    },
    "NCT06342596": {
        "briefTitle": "A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants",
        "officialTitle": "A Phase 1, Open-Label, Two-Part Study of the Disposition and Absolute Bioavailability of [14C]-LY3473329 in Healthy Male Participants",
        "lillyAlias": [
            "J2O-MC-EKBD"
        ]
    },
    "NCT02359058": {
        "briefTitle": "A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer",
        "officialTitle": "Phase 1b Study of Ramucirumab in Combination With Fluoropyrimidines and Platinum-Based Agents in Japanese Patients With Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma",
        "lillyAlias": [
            "I4T-JE-JVCX"
        ]
    },
    "NCT05516758": {
        "briefTitle": "A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis",
        "officialTitle": "A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis",
        "lillyAlias": [
            "J1A-MC-KDAF",
            "2022-501425-20-00",
            "U1111-1283-9566"
        ]
    },
    "NCT05582096": {
        "briefTitle": "A Study of LY3457263 in Obese Participants",
        "officialTitle": "A Dose-Escalation Treatment, Phase 1, Investigator- and Participant-Blind, Placebo-controlled Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of LY3457263 in Combination With Tirzepatide in Overweight or Obese Participants",
        "lillyAlias": [
            "J1R-MC-GZFC"
        ]
    },
    "NCT01109316": {
        "briefTitle": "Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use",
        "officialTitle": "An Open-Label, Randomized, Crossover Trial of CSII Reservoir In-use Comparing Insulin Lispro Formulation to Insulin Aspart in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IOPV"
        ]
    },
    "NCT00749216": {
        "briefTitle": "Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease",
        "officialTitle": "Multiple-Dose Safety in Japanese Subjects With Mild-to-Moderate Alzheimer's Disease",
        "lillyAlias": [
            "H8A-JE-LZAK"
        ]
    },
    "NCT06690996": {
        "briefTitle": "A Study of LY4005130 in Healthy Participants",
        "officialTitle": "A Phase 1, Randomized, Placebo-controlled, Investigator and Participant Blinded, Single-ascending Dose and Multiple-ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY4005130 in Healthy Participants.",
        "lillyAlias": [
            "J5D-MC-FPAB"
        ]
    },
    "NCT04707196": {
        "briefTitle": "A Study of Abemaciclib in Indian Women With Advanced Breast Cancer",
        "officialTitle": "A Single-Arm, Phase 4 Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, in Combination With Endocrine Therapy (Anastrozole/Letrozole or Fulvestrant) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Locally Advanced and/or Metastatic Breast Cancer in India",
        "lillyAlias": [
            "I3Y-IN-JPEC"
        ]
    },
    "NCT00207116": {
        "briefTitle": "An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma",
        "officialTitle": "An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma",
        "lillyAlias": []
    },
    "NCT03848416": {
        "briefTitle": "A Study of Ixekizumab in Healthy Participants",
        "officialTitle": "Relative Bioavailability of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation in Healthy Subjects",
        "lillyAlias": [
            "I1F-MC-RHCT"
        ]
    },
    "NCT02677116": {
        "briefTitle": "A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer",
        "officialTitle": "A Phase 1, Open-Label, Dose-Escalation Study of Olaratumab as a Single Agent and in Combination With Doxorubicin, Vincristine/Irinotecan, or High-Dose Ifosfamide in Pediatric Patients With Relapsed or Refractory Solid Tumors",
        "lillyAlias": [
            "I5B-MC-JGDN"
        ]
    },
    "NCT01435616": {
        "briefTitle": "A Study in Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study",
        "lillyAlias": [
            "I2R-MC-BIAJ"
        ]
    },
    "NCT03283696": {
        "briefTitle": "A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma",
        "officialTitle": "A Phase 1b Study of Olaratumab, Doxorubicin and Ifosfamide in the Treatment of Patients With Advanced or Metastatic Soft Tissue Sarcoma",
        "lillyAlias": [
            "I5B-MC-JGDR",
            "2016-004287-19"
        ]
    },
    "NCT00753896": {
        "briefTitle": "Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin",
        "officialTitle": "Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin",
        "lillyAlias": []
    },
    "NCT02920996": {
        "briefTitle": "Merestinib In Non-Small Cell Lung Cancer And Solid Tumors",
        "officialTitle": "A Phase II Study of Merestinib in Non-Small Cell Lung Cancers Harboring MET Exon 14 Mutations and Solid Tumors With NTRK Rearrangements",
        "lillyAlias": [
            "I30-MC-E001"
        ]
    },
    "NCT00216216": {
        "briefTitle": "Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer",
        "officialTitle": "Pemetrexed (Alimta) in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study (LUN04-78)",
        "lillyAlias": []
    },
    "NCT03311724": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 2, Double-Blind, Placebo-Controlled, 3-Month Trial of LY3298176 Versus Placebo in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-MC-GPGF"
        ]
    },
    "NCT01903434": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) in Healthy Participants",
        "officialTitle": "A Bioequivalence Study in Healthy Subjects Administered Evacetrapib Tablets of Varying Tablet Solid Fractions",
        "lillyAlias": [
            "I1V-MC-EIAU"
        ]
    },
    "NCT06704763": {
        "briefTitle": "A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants",
        "officialTitle": "A Drug-Drug Interaction, Single-arm, Open-label Study to Assess the Effect of Quinidine on the Pharmacokinetics of Orforglipron in Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZPP"
        ]
    },
    "NCT00855439": {
        "briefTitle": "Evaluation of Exenatide in Patients With Diabetic Neuropathy",
        "officialTitle": "A Single-center,Proof of Concept,Randomized,Controlled Parallel Group Clinical Trial of the Effects of Exenatide vs. a Long Acting Insulin Analog to Evaluate the Efficacy of Exenatide in Patients With Diabetic Neuropathy and Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT01109524": {
        "briefTitle": "Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer",
        "officialTitle": "Cisplatin and Vinorelbine in Combination With Cetuximab as First Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): a Single Arm Multicenter Safety Phase 2 Study",
        "lillyAlias": []
    },
    "NCT00763724": {
        "briefTitle": "Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults",
        "officialTitle": "A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population",
        "lillyAlias": [
            "F1J-MC-B027"
        ]
    },
    "NCT01360424": {
        "briefTitle": "Teriparatide Treatment in Patients With Inherited Osteoporosis",
        "officialTitle": "Efficacy of Teriparatide Treatment in Patients With New Forms of Inherited Low-Turnover Osteoporosis",
        "lillyAlias": [
            "2010-019297-32"
        ]
    },
    "NCT00127634": {
        "briefTitle": "Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes",
        "officialTitle": "A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "H7U-MC-IDAH"
        ]
    },
    "NCT00191724": {
        "briefTitle": "Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study",
        "officialTitle": "Drotrecogin Alfa (Activated) (LY203638)] Exploratory, Safety Study, Multi-Center, Randomized, Placebo-Controlled, Dose Escalating Study Design, Comparing a Standard Therapy (Enoxaparin Sodium) for Submassive Pulmonary Embolism to a Combined Therapy of Drotrecogin Alfa (Activated) Plus Enoxaparin Sodium.",
        "lillyAlias": [
            "F1K-MC-O014"
        ]
    },
    "NCT02323334": {
        "briefTitle": "A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease",
        "officialTitle": "Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626",
        "lillyAlias": [
            "I7X-EW-LLCA"
        ]
    },
    "NCT04407234": {
        "briefTitle": "A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide",
        "officialTitle": "The Impact of Tirzepatide on Gastric Emptying (GE) in Overweight/Obese Non-diabetic Subjects and in Overweight/Obese Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-MC-GPHU"
        ]
    },
    "NCT01959334": {
        "briefTitle": "Evaluate the Immunogenicity of a Novel Glucagon Formulation",
        "officialTitle": "A Single Center, Randomized, Parallel Safety Study To Evaluate The Immunogenicity Of A Novel Glucagon Formulation Compared To Commercially Available Glucagon Administered By Intramuscular Injection In Adults With Type 1 OR Type 2 Diabetes",
        "lillyAlias": [
            "I8R-MC-IGBF",
            "AMG105"
        ]
    },
    "NCT01250834": {
        "briefTitle": "LY2189265 and Atorvastatin Interaction Study",
        "officialTitle": "Effect of LY2189265 on the Pharmacokinetics of Atorvastatin in Healthy Subjects",
        "lillyAlias": [
            "H9X-MC-GBCP",
            "2010-021657-39"
        ]
    },
    "NCT00577824": {
        "briefTitle": "Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)",
        "officialTitle": "Efficacy and Safety of LY2148568 in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) But Not Well Controlled",
        "lillyAlias": []
    },
    "NCT00191334": {
        "briefTitle": "Gemcitabine in Ovarian Cancer",
        "officialTitle": "Phase II Study of Gemcitabine Plus Cisplatin as First-Line Therapy in Patients With Epithelial Ovarian Cancer",
        "lillyAlias": [
            "B9E-MW-S368"
        ]
    },
    "NCT04758234": {
        "briefTitle": "A Study of LY3549492 in Healthy Participants",
        "officialTitle": "A Randomized, Double-Blind, Single-Ascending Dose and Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3549492 in Healthy Subjects",
        "lillyAlias": [
            "J3H-MC-GZNA"
        ]
    },
    "NCT02703324": {
        "briefTitle": "A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy",
        "lillyAlias": [
            "I8B-FW-ITRF",
            "2015-004705-16"
        ]
    },
    "NCT00325234": {
        "briefTitle": "Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer",
        "officialTitle": "A Randomized Phase II Study of Two Chemotherapy Regimens, Pemetrexed-Carboplatin, and Gemcitabine-Vinorelbine, in Anthracycline and Taxanes Pretreated Advanced Breast Cancer Patients",
        "lillyAlias": [
            "H3E-EW-S098"
        ]
    },
    "NCT04380324": {
        "briefTitle": "A Study of NKTR-358 (LY3471851) in Healthy Participants",
        "officialTitle": "A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous Dose of NKTR-358 in Healthy Volunteers",
        "lillyAlias": [
            "J1P-MC-KFAA",
            "16-358-01"
        ]
    },
    "NCT04408924": {
        "briefTitle": "Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer",
        "officialTitle": "CYCLONE 1: A Phase 2 Study of Abemaciclib in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With a Novel Hormonal Agent and Taxane-based Chemotherapy",
        "lillyAlias": [
            "I3Y-MC-JPCY",
            "2020-000290-24"
        ]
    },
    "NCT01640834": {
        "briefTitle": "Study of LY2409021 in Participants With Type 1 Diabetes",
        "officialTitle": "Pilot Study of the Effects of LY2409021 in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-MC-GLBR",
            "2011-006178-19"
        ]
    },
    "NCT03554434": {
        "briefTitle": "An Expanded Access Program for AM0010 (Pegilodecakin)",
        "officialTitle": "An Expanded Access Program for AM0010 (Pegilodecakin) Subcutaneous Injection",
        "lillyAlias": []
    },
    "NCT03141034": {
        "briefTitle": "Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma",
        "officialTitle": "Ramucirumab Plus Irinotecan in Patients With Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma",
        "lillyAlias": []
    },
    "NCT00762034": {
        "briefTitle": "A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer",
        "officialTitle": "Randomized, Open-Label, Phase 3 Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-MC-JMHD"
        ]
    },
    "NCT00267696": {
        "briefTitle": "Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer",
        "officialTitle": "A Phase II Study of Gemcitabine/Carboplatin/Bevacizumab in Platinum Sensitive Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients.",
        "lillyAlias": []
    },
    "NCT02919696": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers",
        "officialTitle": "A Phase 1 Study of Abemaciclib in Native Chinese Patients With Advanced and/or Metastatic Cancers",
        "lillyAlias": [
            "I3Y-CR-JPBR"
        ]
    },
    "NCT00109096": {
        "briefTitle": "Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy",
        "officialTitle": "A Randomized, Double-Blind Phase 2 Study of Two Doses of Pemetrexed in the Treatment of Platinum-Resistant, Epithelial Ovarian or Primary Peritoneal Cancer",
        "lillyAlias": [
            "H3E-MC-JMHF"
        ]
    },
    "NCT00735696": {
        "briefTitle": "A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer",
        "officialTitle": "A Phase 2, Open-label Study of IMC-1121B in Combination With Paclitaxel and Carboplatin as First-line Therapy in Patients With Stage IIIB/IV Non-small Cell Lung Cancer",
        "lillyAlias": [
            "2007-006715-22",
            "CP12-0708",
            "I4T-IE-JVBJ"
        ]
    },
    "NCT00244296": {
        "briefTitle": "To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms",
        "officialTitle": "A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms of Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.",
        "lillyAlias": [
            "F1J-MC-SBCM"
        ]
    },
    "NCT02302716": {
        "briefTitle": "A Study of LY2963016 Compared to LANTUS\u00ae in Adult Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to LANTUS\u00ae in Adult Patients With Type 2 Diabetes Mellitus: The ELEMENT 5 Study",
        "lillyAlias": [
            "I4L-MC-ABER"
        ]
    },
    "NCT02528396": {
        "briefTitle": "To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog\u00ae U-100 in Patients With Type 1 Diabetes Mellitus",
        "officialTitle": "A Randomized, Monocentric, Double-blind, Multiple Daily Dose, Two-period, 14 Day Cross-over Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog\u00ae U-100 in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00636896": {
        "briefTitle": "Effects of Modafinil on Olanzapine Weight Gain",
        "officialTitle": "A Comparison of the Effects of Modafinil on Olanzapine Associated Eating Behaviors in Normal Human Subjects",
        "lillyAlias": []
    },
    "NCT05509816": {
        "briefTitle": "A Study of Imlunestrant (LY3484356) in Healthy Women",
        "officialTitle": "The Effect of Repeat Dosing of Imlunestrant on CYP3A Activity in Healthy Women of Non-childbearing Potential",
        "lillyAlias": [
            "J2J-MC-JZLK"
        ]
    },
    "NCT06297616": {
        "briefTitle": "A Study of LY3841136 in Japanese Participants With Obesity or Overweight",
        "officialTitle": "A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3841136 Monotherapy, and LY3841136 in Combination With Tirzepatide, in Japanese Participants With Obesity or Overweight",
        "lillyAlias": [
            "J3R-JE-YDAB"
        ]
    },
    "NCT00191516": {
        "briefTitle": "An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder",
        "officialTitle": "An Open-Label Study on Effectiveness and Tolerability of Atomoxetine as Perceived by Patients, Parents, and Physicians in Children With Attention-Deficit/Hyperactivity Disorder in Germany",
        "lillyAlias": [
            "B4Z-SB-LYDD"
        ]
    },
    "NCT06280716": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 3 Trial to Investigate the Efficacy and Safety of Lebrikizumab When Used With/Without Topical Corticosteroid Treatment in Participants With Moderate-To-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-MC-KGBW"
        ]
    },
    "NCT05959096": {
        "briefTitle": "A Study of LY3437943 in Healthy Participants With a High Body Mass Index",
        "officialTitle": "Effect of Injection Site on the Relative Bioavailability of a Single Dose of LY3437943 in Healthy Participants With a High Body Mass Index",
        "lillyAlias": [
            "J1I-MC-GZBS"
        ]
    },
    "NCT00193596": {
        "briefTitle": "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site",
        "officialTitle": "A Randomized, Phase III Comparison of Gemcitabine/Irinotecan Followed by IRESSA Versus Paclitaxel/Carboplatin/Etoposide Followed by IRESSA in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site",
        "lillyAlias": []
    },
    "NCT01867216": {
        "briefTitle": "A Study of Multiple Doses of LY2922470 in Participants With Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of LY2922470 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I6K-FW-GLEB"
        ]
    },
    "NCT04657016": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program",
        "officialTitle": "Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)",
        "lillyAlias": [
            "I8F-MC-GPHM"
        ]
    },
    "NCT02014116": {
        "briefTitle": "A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body",
        "officialTitle": "A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I6X-MC-JBDA"
        ]
    },
    "NCT04088396": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)",
        "officialTitle": "Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.",
        "lillyAlias": [
            "I4V-MC-JAHU",
            "2017-004495-60",
            "2023-507883-38-00"
        ]
    },
    "NCT02614196": {
        "briefTitle": "Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study",
        "lillyAlias": [
            "I5Q-MC-CGAH",
            "2015-001882-17"
        ]
    },
    "NCT03994796": {
        "briefTitle": "Genetic Testing in Guiding Treatment for Patients with Brain Metastases",
        "officialTitle": "Genomically-Guided Treatment Trial in Brain Metastases",
        "lillyAlias": [
            "NCI-2019-00744",
            "U10CA180821"
        ]
    },
    "NCT03489616": {
        "briefTitle": "Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients",
        "officialTitle": "Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients Without Progression After First-line Chemotherapy: a Prospective Randomized Controlled Study",
        "lillyAlias": []
    },
    "NCT03549416": {
        "briefTitle": "BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Dermatitis",
        "officialTitle": "BioDay Registry: Prospective, Observational Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Diseases in Daily Practice",
        "lillyAlias": []
    },
    "NCT06538116": {
        "briefTitle": "A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease",
        "officialTitle": "A Randomized, Double-Blinded Study to Evaluate the Efficacy and Safety of Mevidalen in Patients With Alzheimer's Disease",
        "lillyAlias": [
            "I7S-MC-HBEO"
        ]
    },
    "NCT01524224": {
        "briefTitle": "A Dose-Escalation Study in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Dose-Escalation Study of LY2495655, an Anti-Myostatin Monoclonal Antibody, in Patients With Advanced Cancer",
        "lillyAlias": [
            "I1Q-MC-JDDB"
        ]
    },
    "NCT02669524": {
        "briefTitle": "Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes",
        "officialTitle": "Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes - the Role of Glucagon",
        "lillyAlias": []
    },
    "NCT00360334": {
        "briefTitle": "A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients",
        "officialTitle": "An Open Label Study Comparing Exenatide With Basal Insulin in Achieving an HbA1c of \u2264 7.4% With Minimum Weight Gain, in Type 2 Diabetes Patients Who Are Not Achieving Adequate HbA1c Control on Oral Anti Diabetic Therapies Alone",
        "lillyAlias": []
    },
    "NCT00664534": {
        "briefTitle": "Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast",
        "officialTitle": "Comparison of Premixed Insulin Lispro Low-Mixture and Mid-Mixture Regimens With Separate Basal and Bolus Insulin Injections in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Oral Therapy Who Consume Light Breakfast",
        "lillyAlias": [
            "F3Z-EW-S020",
            "CTRI/2009/091/000609"
        ]
    },
    "NCT02925234": {
        "briefTitle": "The Drug Rediscovery Protocol (DRUP Trial)",
        "officialTitle": "A Dutch National Study on Behalf of the CPCT to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to Determine the Potential Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile",
        "lillyAlias": []
    },
    "NCT00402324": {
        "briefTitle": "A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients",
        "officialTitle": "A Double-Blind Placebo Controlled Trial of Divalproex and Olanzapine in Bipolar I Disorder, Mixed Episode",
        "lillyAlias": [
            "F1D-US-HGMO"
        ]
    },
    "NCT01243424": {
        "briefTitle": "CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes",
        "officialTitle": "A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.",
        "lillyAlias": [
            "2009-013157-15"
        ]
    },
    "NCT00360724": {
        "briefTitle": "Duloxetine for Chronic Depression: a Double-blind Study",
        "officialTitle": "Duloxetine for Chronic Depression: a Double-blind Study",
        "lillyAlias": []
    },
    "NCT03012334": {
        "briefTitle": "The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants",
        "officialTitle": "A Phase I, Randomized, Double-Blind, Placebo-Controlled, 5-Period, Cross-Over Study Assessing the Effects of Lasmiditan on Simulated Driving Performance in Normal Healthy Volunteers",
        "lillyAlias": [
            "COL MIG-106",
            "H8H-CD-LAHG"
        ]
    },
    "NCT05305924": {
        "briefTitle": "Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer",
        "officialTitle": "Phase II Trial Of Fulvestrant Plus Abemaciclib In Er-Positive, Her2-Negative Metastatic Breast Cancer Immediately After Failure Of A Cdk4/6 Inhibitor",
        "lillyAlias": []
    },
    "NCT02443324": {
        "briefTitle": "A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer",
        "officialTitle": "An Open-Label, Multicenter, Phase 1 Study of Ramucirumab Plus Pembrolizumab in Patients With Locally Advanced and Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Non-Small Cell Lung Cancer, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer",
        "lillyAlias": [
            "I4T-MC-JVDF",
            "2015-001473-40",
            "KEYNOTE -098"
        ]
    },
    "NCT01373216": {
        "briefTitle": "Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass",
        "officialTitle": "EXEnatide in Patients Undergoing Coronary Artery Bypass Grafting for Improved glUcose conTrol and hemodynamIc ValuEs",
        "lillyAlias": []
    },
    "NCT06588296": {
        "briefTitle": "Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight",
        "officialTitle": "Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Active Psoriatic Arthritis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsA)",
        "lillyAlias": [
            "I1F-MC-RHDB"
        ]
    },
    "NCT05069896": {
        "briefTitle": "A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants",
        "officialTitle": "A Bioequivalence Study of Injections of Mirikizumab Solution Using Investigational 1-mL and 2-mL Pre-Filled Syringes and Investigational 1-mL and 2-mL Autoinjectors in Healthy Participants",
        "lillyAlias": [
            "I6T-MC-AMBX"
        ]
    },
    "NCT01394016": {
        "briefTitle": "A Phase 1 Study of LY2835219 In Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of a CDK 4/6 Dual Inhibitor in Participants With Advanced Cancer",
        "lillyAlias": [
            "I3Y-MC-JPBA"
        ]
    },
    "NCT00489996": {
        "briefTitle": "Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer",
        "officialTitle": "A Multicenter, Randomized Trial Comparing a Combined Gemcitabine and Cisplatin 3-Week Regimen With a 4-Week Regimen in Non-Small Cell Lung Cancer Patients",
        "lillyAlias": [
            "B9E-GH-JHSE"
        ]
    },
    "NCT02072096": {
        "briefTitle": "A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)",
        "officialTitle": "An Individualized treatMent aPproach for oldER patIents: A Randomized, Controlled stUdy in Type 2 Diabetes Mellitus (IMPERIUM)",
        "lillyAlias": [
            "F3Z-MC-IOQL",
            "2013-001473-24"
        ]
    },
    "NCT04529096": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain",
        "lillyAlias": [
            "H0P-MC-BP01"
        ]
    },
    "NCT01354496": {
        "briefTitle": "A Study of LY2409021 Formulations and the Effect of Food",
        "officialTitle": "LY2409021 Formulation Bridging and Food Effect Study",
        "lillyAlias": [
            "I1R-FW-GLBQ"
        ]
    },
    "NCT04003896": {
        "briefTitle": "A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma",
        "officialTitle": "A Pilot Study to Evaluate the Response and Tolerability of Verzenio (Abemaciclib) in Patients With Advanced Biliary Tract Carcinoma",
        "lillyAlias": []
    },
    "NCT01476696": {
        "briefTitle": "A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease",
        "officialTitle": "An Open-Label, Dose-Ranging Study of Prasugrel in Pediatric Patients With Sickle Cell Disease",
        "lillyAlias": [
            "H7T-MC-TACX"
        ]
    },
    "NCT04243096": {
        "briefTitle": "Wearable Sensors in Knee OA",
        "officialTitle": "Wearable Sensor-based Outcomes Following Physical Therapy in Knee Osteoarthritis: A Feasibility Study (WESENS-OA)",
        "lillyAlias": []
    },
    "NCT02111096": {
        "briefTitle": "A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-MC-GLDJ",
            "2013-004275-12"
        ]
    },
    "NCT01106534": {
        "briefTitle": "XIENCE V\u00ae USA Dual Antiplatelet Therapy (DAPT) Cohort",
        "officialTitle": "XIENCE V\u00ae Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V\u00ae USA DAPT Cohort) (XVU-AV DAPT)",
        "lillyAlias": []
    },
    "NCT00377117": {
        "briefTitle": "Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II",
        "officialTitle": "Diabetes Screening, Risk Management, and Disease Management in a High-Risk Mental Health Population.",
        "lillyAlias": []
    },
    "NCT02314117": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (RAINFALL)",
        "lillyAlias": [
            "I4T-MC-JVCU",
            "2014-002240-40"
        ]
    },
    "NCT00547417": {
        "briefTitle": "To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections",
        "officialTitle": "An Open-Label Study to Evaluate the Efficacy and Safety of Tadalafil Administered \"On Demand\" to Men of Various Populations With Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVFN"
        ]
    },
    "NCT00840034": {
        "briefTitle": "A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder",
        "officialTitle": "A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment",
        "lillyAlias": [
            "H9P-MC-LNDK"
        ]
    },
    "NCT00422734": {
        "briefTitle": "Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life",
        "officialTitle": "Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life",
        "lillyAlias": [
            "H6D-MC-LVGH"
        ]
    },
    "NCT02326025": {
        "briefTitle": "A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma",
        "officialTitle": "An Open-Label Study to Evaluate the Pharmacokinetics of Doxorubicin Following the Concomitant Intravenous Administration of Olaratumab (IMC-3G3) to Patients With Advanced Soft Tissue Sarcoma",
        "lillyAlias": [
            "I5B-EW-JGDI"
        ]
    },
    "NCT02792725": {
        "briefTitle": "Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer",
        "officialTitle": "An Open-Label, Multi-Center Expanded Access Program of Abemaciclib for the Treatment of Hormone Receptor Positive, HER2 Negative Advanced or Metastatic Breast Cancer in Patients With Disease Progression on Prior Therapies",
        "lillyAlias": [
            "I3Y-MC-JPCD"
        ]
    },
    "NCT02539225": {
        "briefTitle": "A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of S-1 and Oxaliplatin With or Without Ramucirumab as First-line Therapy Followed by Paclitaxel With Ramucirumab as Second-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma",
        "lillyAlias": [
            "I4T-JE-JVCW"
        ]
    },
    "NCT01253525": {
        "briefTitle": "Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas",
        "officialTitle": "A Phase 1b Study of Weekly Paclitaxel With Ramucirumab (IMC-1121B) Drug Product in Patients With Advanced Gastric Adenocarcinomas",
        "lillyAlias": [
            "CP12-1026",
            "I4T-IE-JVBW"
        ]
    },
    "NCT00992225": {
        "briefTitle": "A Study of LY573636-sodium in Patients With Metastatic Breast Cancer",
        "officialTitle": "Phase 2 Evaluation of a Once Every 28 Days Dosing Regimen for LY573636-sodium in Patients With Metastatic Breast Cancer",
        "lillyAlias": [
            "H8K-MC-JZAL"
        ]
    },
    "NCT00123825": {
        "briefTitle": "Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer",
        "officialTitle": "A Phase II Trial of Gemcitabine and Cisplatin In Unresectable Or Metastatic Biliary Tract and Gallbladder Cancer",
        "lillyAlias": []
    },
    "NCT01638325": {
        "briefTitle": "A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants",
        "officialTitle": "A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Single Subcutaneous Injections of Insulin Lispro With BioChaperone Excipient in Healthy Volunteers",
        "lillyAlias": [
            "H9D-MC-ITAG"
        ]
    },
    "NCT00231725": {
        "briefTitle": "Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin",
        "officialTitle": "Complaints Associated With Use of Pre-Filled Pen B When Used by Patients With Type 2 Diabetes on Twice-Daily Insulin Therapy",
        "lillyAlias": [
            "H9D-MC-ITAB"
        ]
    },
    "NCT00330044": {
        "briefTitle": "Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer",
        "officialTitle": "A Phase I Study of Premetrexed (Alimta) and Carboplatin and Radiation Therapy in Patients With Inoperable Non Small Cell Lung Cancer.",
        "lillyAlias": [
            "2005-19"
        ]
    },
    "NCT04194892": {
        "briefTitle": "A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants",
        "officialTitle": "An Open Label, Randomized, Single Dose, 2-Way Crossover Study to Evaluate the Pharmacokinetics of Pre-filled Syringe Versus Vial Formulations of AM0010 in Healthy Adult Subjects",
        "lillyAlias": [
            "J1L-AM-JZGG",
            "AM0010-803"
        ]
    },
    "NCT01160744": {
        "briefTitle": "A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "An Open-label, Multicenter, Randomized, Phase 2 Study of a Recombinant Human Anti-VEGFR-2 Monoclonal Antibody, IMC-1121B in Combination With Platinum-based Chemotherapy Versus Platinum-based Chemotherapy Alone as First-line Treatment of Patients With Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4T-IE-JVBL",
            "CP12-0917",
            "2009-016784-11"
        ]
    },
    "NCT00190892": {
        "briefTitle": "Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania",
        "officialTitle": "Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder",
        "lillyAlias": [
            "F1D-MC-HGKR"
        ]
    },
    "NCT00320489": {
        "briefTitle": "Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia",
        "officialTitle": "A Randomized, Open-label Study Comparing the Effects of Olanzapine Pamoate Depot With Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia",
        "lillyAlias": [
            "F1D-MC-HGLQ"
        ]
    },
    "NCT02346344": {
        "briefTitle": "Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01301092": {
        "briefTitle": "A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.",
        "officialTitle": "A Study to Evaluate the Safety, Tolerability, and Absolute Bioavailability of Subcutaneous LY2189265",
        "lillyAlias": [
            "H9X-MC-GBDR"
        ]
    },
    "NCT01288989": {
        "briefTitle": "A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors",
        "officialTitle": "Phase 1 Study of the Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available",
        "lillyAlias": [
            "CP23-1001",
            "I5G-IE-JBCA"
        ]
    },
    "NCT00190944": {
        "briefTitle": "Effects of Teriparatide on Distal Radius Fracture Healing",
        "officialTitle": "Effects of Teriparatide on Distal Radius Fracture Healing",
        "lillyAlias": [
            "B3D-MC-GHCN"
        ]
    },
    "NCT02884089": {
        "briefTitle": "A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy Participants",
        "officialTitle": "Effect of Abemaciclib on Metformin Pharmacokinetics and Iohexol Clearance",
        "lillyAlias": [
            "I3Y-MC-JPCK"
        ]
    },
    "NCT00475644": {
        "briefTitle": "A Study of Enzastaurin in Participants With Follicular Lymphoma",
        "officialTitle": "A Phase 2 Study of Enzastaurin in Participants With Follicular Lymphoma",
        "lillyAlias": [
            "H6Q-MC-S011"
        ]
    },
    "NCT00696644": {
        "briefTitle": "A Study for Teriparatide in Severe Osteoporosis",
        "officialTitle": "An Italian Observational Study to Evaluate Fracture Outcomes, Compliance to Treatment, Back Pain, Health-related Quality of Life in Patients With Severe Osteoporosis Treated According to Common Clinical Practice",
        "lillyAlias": [
            "B3D-IT-B014"
        ]
    },
    "NCT00125892": {
        "briefTitle": "A Study of Duloxetine in the Treatment of Fibromyalgia",
        "officialTitle": "A 1-Year Safety Study of Duloxetine in Patients With Fibromyalgia Syndrome",
        "lillyAlias": [
            "F1J-MC-HMEH"
        ]
    },
    "NCT01925144": {
        "briefTitle": "A Study of Baricitinib and Omeprazole in Healthy Participants",
        "officialTitle": "Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Absorption of Baricitinib in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGF"
        ]
    },
    "NCT03715192": {
        "briefTitle": "A Safety Study of LY3462817 in Healthy Participants",
        "officialTitle": "Single-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3462817",
        "lillyAlias": [
            "J1A-MC-KDAB"
        ]
    },
    "NCT00635492": {
        "briefTitle": "CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy",
        "officialTitle": "CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy - A European Observational Study of Patients With Type 2 Diabetes Initiating Injectable Therapy to Determine Time to Treatment Change, Factors Associated With Treatment Changes and Outcomes Over 24 Months",
        "lillyAlias": []
    },
    "NCT05508789": {
        "briefTitle": "A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)",
        "officialTitle": "Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACO",
            "2021-006395-17"
        ]
    },
    "NCT00529789": {
        "briefTitle": "Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder",
        "officialTitle": "F1J-MC-HMFN (a) An Open-Label Study of Tolerability, Safety, and Pharmacokinetics of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMFN"
        ]
    },
    "NCT04023669": {
        "briefTitle": "Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors",
        "officialTitle": "St. Jude ELIOT: Phase 1 Evaluation of LY2606368, a Molecularly-Targeted CHK1/2 Inhibitor Therapy, in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors",
        "lillyAlias": [
            "NCI-2019-04787"
        ]
    },
    "NCT05154968": {
        "briefTitle": "A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants",
        "officialTitle": "A Study to Evaluate Injection-Site Pain of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Subjects",
        "lillyAlias": [
            "J3G-MC-S003"
        ]
    },
    "NCT01439568": {
        "briefTitle": "A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma",
        "officialTitle": "A Randomized Phase 2 Study of LY2510924 and Carboplatin/Etoposide Versus Carboplatin/Etoposide in Extensive-Stage Small Cell Lung Carcinoma",
        "lillyAlias": [
            "I2V-MC-CXAC"
        ]
    },
    "NCT01191268": {
        "briefTitle": "A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)",
        "officialTitle": "The Impact of LY2189265 Versus Insulin Glargine in Combination With Insulin Lispro for the Treatment to Target of Type 2 Diabetes Mellitus (AWARD-4: Assessment of Weekly AdministRation of LY2189265 in Diabetes - 4)",
        "lillyAlias": [
            "H9X-MC-GBDD"
        ]
    },
    "NCT00058968": {
        "briefTitle": "A Study for the Treatment of Painful Diabetic Neuropathy",
        "officialTitle": "Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy",
        "lillyAlias": [
            "F1J-MC-HMAV"
        ]
    },
    "NCT01427972": {
        "briefTitle": "A Study of LY2623091 in Male and Females With Chronic Kidney Disease",
        "officialTitle": "Study of the Safety and Efficacy of LY2623091 in Chronic Kidney Disease Patients",
        "lillyAlias": [
            "I4M-MC-MRAC"
        ]
    },
    "NCT00958568": {
        "briefTitle": "A Study in Relapse Prevention of Treatment-Resistant Depression",
        "officialTitle": "A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression",
        "lillyAlias": [
            "H6P-MC-HDAY",
            "CTRI/2009/091/000654"
        ]
    },
    "NCT00259272": {
        "briefTitle": "Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine",
        "officialTitle": "Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)",
        "lillyAlias": [
            "F1D-FP-S057"
        ]
    },
    "NCT01358968": {
        "briefTitle": "A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine",
        "officialTitle": "A Study in Cancer Patients to Evaluate the Ability of LY2603618 to Act as an Inhibitor of CYP2D6 Using Desipramine as a Probe Substrate",
        "lillyAlias": [
            "I2I-MC-JMMI"
        ]
    },
    "NCT06354101": {
        "briefTitle": "The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.",
        "officialTitle": "The VITALITY Registry",
        "lillyAlias": []
    },
    "NCT01256567": {
        "briefTitle": "A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer",
        "officialTitle": "A Phase 1b Study of Docetaxel in Combination With Ramucirumab (IMC-1121B) Drug Product in Patients With Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "CP12-1028",
            "I4T-IE-JVBX"
        ]
    },
    "NCT06085144": {
        "briefTitle": "Emgality for Migraine in Breastmilk",
        "officialTitle": "Prospective Evaluation of Emgality (Galcanezumab) in Breastmilk in Adult Women With Migraine",
        "lillyAlias": []
    },
    "NCT05440344": {
        "briefTitle": "A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function",
        "officialTitle": "Pharmacokinetics of Imlunestrant in Participants With Hepatic Impairment",
        "lillyAlias": [
            "J2J-MC-JZLG"
        ]
    },
    "NCT00547092": {
        "briefTitle": "Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection",
        "officialTitle": "A Multicenter Open-Label Study to Determine Treatment Preference of Tadalafil (IC351, LY450190) or Sildenafil Citrate in the Oral Treatment of Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVFL"
        ]
    },
    "NCT00508144": {
        "briefTitle": "Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer",
        "officialTitle": "Single Agent Alimta in Poor Performance Status in Patients With Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "NCI-2012-01581"
        ]
    },
    "NCT00380692": {
        "briefTitle": "Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder",
        "officialTitle": "A Randomized, Double-blind Comparison of Atomoxetine Hydrochloride and Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Autism Spectrum Disorder",
        "lillyAlias": [
            "B4Z-UT-S017"
        ]
    },
    "NCT00385944": {
        "briefTitle": "The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)",
        "officialTitle": "A Randomized Double-Blind Cross-Over Study Comparing the Pharmacodynamic (PD)Response in Subjects With ACS Receiving 14 Days 10-mg Maintenance Dose (MD) Prasugrel vs 14 Days 150-mg MD Clopidogrel After Using a 900-mg Loading Dose (LD) of Clopidogrel to Reduce Ongoing Platelet Activation",
        "lillyAlias": [
            "H7T-MC-TABN"
        ]
    },
    "NCT01024244": {
        "briefTitle": "A Study of LY2599506 in Patients With Type 2 Diabetes",
        "officialTitle": "A 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2599506 in Patients With Type 2 Diabetes Mellitus Treated With Diet and Exercise, With or Without Metformin",
        "lillyAlias": [
            "I2Q-MC-GMAH"
        ]
    },
    "NCT00149292": {
        "briefTitle": "Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo",
        "officialTitle": "A Randomized, Double-Blind Comparison of LY2140023, Olanzapine, and Placebo in the Treatment of Patients With Schizophrenia",
        "lillyAlias": [
            "H8Y-BD-HBBD"
        ]
    },
    "NCT01721044": {
        "briefTitle": "A Moderate to Severe Rheumatoid Arthritis Study",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors",
        "lillyAlias": [
            "I4V-MC-JADW"
        ]
    },
    "NCT03026504": {
        "briefTitle": "Baricitinib in Relapsing Giant Cell Arteritis",
        "officialTitle": "Baricitinib in Relapsing Giant Cell Arteritis (GCA): A Phase II, Single-institution, Open-label Pilot Study",
        "lillyAlias": []
    },
    "NCT00190567": {
        "briefTitle": "Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence",
        "officialTitle": "Biomechanical Effects of Duloxetine on Bladder Function and Sphincter Resistance During the Emptying Phase and on Urethral Function During the Filling Phase of the Micturition Cycle in Women With Pure Genuine Stress Incontinence",
        "lillyAlias": [
            "F1J-MC-SBAB"
        ]
    },
    "NCT06075667": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities",
        "officialTitle": "Efficacy, Safety, and Pharmacokinetics of Tirzepatide Once Weekly Versus Placebo in Adolescent Participants Who Have Obesity, or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind Trial (SURMOUNT-ADOLESCENTS)",
        "lillyAlias": [
            "I8F-MC-GPHP",
            "2023-504413-80-00"
        ]
    },
    "NCT00917267": {
        "briefTitle": "A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects",
        "officialTitle": "A Comparator-Controlled Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control (HbA1c) and Safety in Asian Subjects With Type 2 Diabetes Mellitus Managed With Oral Antidiabetic Medications",
        "lillyAlias": []
    },
    "NCT02046304": {
        "briefTitle": "PP-Gemcitabine & External Beam Radiation-Sarcomas",
        "officialTitle": "A Phase I Study of Preoperative Concomitant Gemcitabine and External-Beam Radiation Therapy and Surgical Resection for Patients With Extremity and Trunk Soft Tissue Sarcomas",
        "lillyAlias": []
    },
    "NCT00034801": {
        "briefTitle": "Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia",
        "officialTitle": "A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression",
        "lillyAlias": [
            "F1D-US-HGJU"
        ]
    },
    "NCT03733301": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7",
        "lillyAlias": [
            "I4V-MC-JAIY",
            "2018-001726-26"
        ]
    },
    "NCT01104701": {
        "briefTitle": "A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension",
        "officialTitle": "A Randomized, Multi-dose, Controlled Trial Investigating the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension.",
        "lillyAlias": []
    },
    "NCT01436201": {
        "briefTitle": "A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants",
        "officialTitle": "Effect of Dulaglutide (LY2189265) on the Pharmacokinetics of Digoxin in Healthy Subjects",
        "lillyAlias": [
            "H9X-MC-GBCR"
        ]
    },
    "NCT00485901": {
        "briefTitle": "Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia",
        "officialTitle": "A Double-Blind Randomized Comparison of the Efficacy and Safety of Intramuscular Olanzapine and Intramuscular Haloperidol in Acutely Agitated Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-TW-S025"
        ]
    },
    "NCT02252367": {
        "briefTitle": "Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms",
        "officialTitle": "Double-blind, Placebo-controlled Study on Men With Lower Urinary Tract Symptoms to Assess Changes in Pressure Flow Study and in Molecular Profile of Prostatic Tissue After 12 Weeks Treatment With Tadalafil.",
        "lillyAlias": []
    },
    "NCT01001104": {
        "briefTitle": "A Study of LY2189265 in Japanese Patients With Type 2 Diabetes",
        "officialTitle": "Assessment of Dose-Dependent Effects of LY2189265 on Glycemic Control in Japanese Patients With Type 2 Diabetes",
        "lillyAlias": [
            "H9X-JE-GBCZ"
        ]
    },
    "NCT00985504": {
        "briefTitle": "A Study of Patients With Major Depressive Disorder and Residual Apathy",
        "officialTitle": "A Phase 4, 8-week, Double-blind, Randomized Study Comparing Switching to Duloxetine or Escitalopram in Patients With Major Depressive Disorder and Residual Apathy in the Absence of Depressed Mood",
        "lillyAlias": [
            "F1J-CR-HMGM"
        ]
    },
    "NCT00191204": {
        "briefTitle": "Open Label Phase III Duloxetine Study for Stress Urinary Incontinence",
        "officialTitle": "Long Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBBM"
        ]
    },
    "NCT01210001": {
        "briefTitle": "Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin",
        "officialTitle": "A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Trial of BI 10773 (10 and 25 mg Administered Orally Once Daily) Over 24 Weeks in Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite a Background Therapy of Pioglitazone Alone or in Combination With Metformin",
        "lillyAlias": [
            "2009-016154-40"
        ]
    },
    "NCT01477567": {
        "briefTitle": "A First-in-Human Study of LY3009385 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose (SAD) Study of LY3009385 in Healthy Volunteers",
        "lillyAlias": [
            "I5O-FW-GTCA"
        ]
    },
    "NCT01173601": {
        "briefTitle": "A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder",
        "officialTitle": "A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684 Fixed-Dose 12 Milligrams (mg) and 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment",
        "lillyAlias": [
            "H9P-MC-LNBM"
        ]
    },
    "NCT00275301": {
        "briefTitle": "PET Imaging and Olanzapine Treatment in Borderline Personality Disorder",
        "officialTitle": "Brain Correlates of Olanzapine Treatment Response in BPD",
        "lillyAlias": []
    },
    "NCT00879801": {
        "briefTitle": "Genetic Physiopathology and Evolution of Type 2 Diabetes",
        "officialTitle": "Evaluation of Genetic, Biochemical and Clinical Determinants of Type 2 Diabetes Progression in Subjects at High Risk",
        "lillyAlias": []
    },
    "NCT04427501": {
        "briefTitle": "A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness",
        "officialTitle": "A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness",
        "lillyAlias": [
            "J2W-MC-PYAB"
        ]
    },
    "NCT05615467": {
        "briefTitle": "A Study of Effect of LY3556050 on Metformin in Healthy Participants",
        "officialTitle": "An Open-Label Study in Healthy Participants to Evaluate the Effect of LY3556050 on Metformin Pharmacokinetics",
        "lillyAlias": [
            "J2P-MC-LXBE"
        ]
    },
    "NCT05855967": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants Aged \u226518 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India",
        "officialTitle": "A 24-Week Multicenter, Open-label, Single-arm, Phase 4 Study to Evaluate the Safety of Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis or Active Psoriatic Arthritis in India",
        "lillyAlias": [
            "I1F-IN-RHCZ"
        ]
    },
    "NCT04680767": {
        "briefTitle": "A Study of LY3502970 in Healthy Male Participants",
        "officialTitle": "Disposition of [\u00b9\u2074C]-LY3502970 Following Oral Administration in Healthy Male Participants",
        "lillyAlias": [
            "J2A-MC-GZGF",
            "2020-003160-60"
        ]
    },
    "NCT00142467": {
        "briefTitle": "Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma",
        "officialTitle": "Phase II Study of Gemcitabine, Oxaliplatin in Combination With Bevacizumab (Avastin) in Patients With Hepatocellular Carcinoma",
        "lillyAlias": []
    },
    "NCT00063401": {
        "briefTitle": "Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer",
        "officialTitle": "A Phase II Study of Cetuximab (C225)/Paclitaxel/Carboplatin for the Initial Treatment of Advanced Stage Ovarian, Primary Peritoneal, and Fallopian Tube Cancer",
        "lillyAlias": []
    },
    "NCT03214367": {
        "briefTitle": "A Study of LY900014 in Participants With Type 1 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D",
        "lillyAlias": [
            "I8B-MC-ITRM",
            "2015-005356-99"
        ]
    },
    "NCT04840901": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants",
        "officialTitle": "A Phase 1, Open-Label, Single-Dose Bioequivalence Study of Injections of Lebrikizumab Using a 2-mL Pre-Filled Syringe With Needle Safety Device and an Investigational 2-mL Autoinjector in Healthy Participants",
        "lillyAlias": [
            "J2T-MC-KGBG"
        ]
    },
    "NCT02181101": {
        "briefTitle": "Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial",
        "officialTitle": null,
        "lillyAlias": [
            "2005-000490-21"
        ]
    },
    "NCT01996501": {
        "briefTitle": "Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition",
        "officialTitle": "An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Olanzapine Orally Disintegrating 5mg Tablets (Test Formulation; Torrent Pharmaceuticals Ltd., India) Versus Zyprexa\u00ae Zydis\u00ae 5 mg Tablets (Reference Formulation; Eli Lilly and Company, USA) in Healthy Human Volunteers Under Fed Condition",
        "lillyAlias": []
    },
    "NCT01164501": {
        "briefTitle": "Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment",
        "officialTitle": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg and 25 mg Administered Once Daily) as Add on to Pre-existing Antidiabetic Therapy Over 52 Weeks in Patients With Type 2 Diabetes Mellitus and Renal Impairment and Insufficient Glycaemic Control",
        "lillyAlias": [
            "2009-016179-31"
        ]
    },
    "NCT06033001": {
        "briefTitle": "Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
        "officialTitle": "Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
        "lillyAlias": []
    },
    "NCT00192101": {
        "briefTitle": "Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes",
        "officialTitle": "Randomized Phase II Study of the Combination of Gemcitabine (Gemzar) Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines an/or Taxanes",
        "lillyAlias": [
            "B9E-SI-S371"
        ]
    },
    "NCT05492201": {
        "briefTitle": "A Study of LY3873862 in Healthy Participants",
        "officialTitle": "A Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3873862 in Healthy Participants",
        "lillyAlias": [
            "J3X-MC-LYGA",
            "2022-000500-36"
        ]
    },
    "NCT00617201": {
        "briefTitle": "Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial",
        "officialTitle": "Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial",
        "lillyAlias": [
            "R01DA022191"
        ]
    },
    "NCT02634801": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment",
        "officialTitle": "A 24-Week Multicenter, Randomized, Open-Label, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate-to-Severe Plaque Psoriasis Who Are Naive to Systemic Treatment With an Extension Period",
        "lillyAlias": [
            "I1F-EW-RHBZ",
            "2015-002649-69"
        ]
    },
    "NCT04027101": {
        "briefTitle": "BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica",
        "officialTitle": "BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica (BACHELOR Study)",
        "lillyAlias": []
    },
    "NCT02387801": {
        "briefTitle": "A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis",
        "officialTitle": "Early Onset of Clinical Improvement With Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-US-RHBO"
        ]
    },
    "NCT00307268": {
        "briefTitle": "Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD",
        "officialTitle": "Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adolescents With ADHD: An Observational, Long-Term Follow-up Study of Routine Clinical Care",
        "lillyAlias": []
    },
    "NCT00131469": {
        "briefTitle": "Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta",
        "officialTitle": "A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)",
        "lillyAlias": [
            "UL1RR024140"
        ]
    },
    "NCT05692869": {
        "briefTitle": "A Study of Continuous Blood Pressure Monitoring in Healthy Participants",
        "officialTitle": "A Study to Investigate Continuous Blood Pressure Monitoring Using Traditional Device (ABPM) Versus Novel Devices (Biobeat and Aktiia)",
        "lillyAlias": [
            "H6O-MC-O017"
        ]
    },
    "NCT06465069": {
        "briefTitle": "A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors",
        "lillyAlias": [
            "J5I-OX-JZYA",
            "2024-512927-36-00"
        ]
    },
    "NCT01460368": {
        "briefTitle": "A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart",
        "officialTitle": "A Placebo- and Positive-Controlled Study of the Electrophysiological Effects of a Supratherapeutic Dose of LY2409021 in Healthy Subjects",
        "lillyAlias": [
            "I1R-FW-GLBP"
        ]
    },
    "NCT02540668": {
        "briefTitle": "A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants",
        "officialTitle": "Effect of LY3314814 on the Pharmacokinetics of Warfarin in Healthy Subjects",
        "lillyAlias": [
            "I8D-MC-AZEO"
        ]
    },
    "NCT00889369": {
        "briefTitle": "Duloxetine for Major Depression in Peri-/Postmenopausal Women",
        "officialTitle": "Duloxetine for the Treatment of Major Depression in Midlife Women: Effects on Brain Structure and Functioning, Mood, and Quality of Life",
        "lillyAlias": []
    },
    "NCT00044668": {
        "briefTitle": "Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination",
        "officialTitle": "An Open-Label Study to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety of AC2993 Given Two Times a Day to Subjects With Type 2 Diabetes Treated With Metformin, a Sulfonylurea, or Metformin and Sulfonylurea Combination",
        "lillyAlias": []
    },
    "NCT02489968": {
        "briefTitle": "Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase III, Randomised, Double-blind, Parallel Group, 24-week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg and Linagliptin 5 mg Fixed Dose Combination Compared With Empagliflozin 10 mg Plus Placebo and a 52-week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin 25 mg and Linagliptin 5 mg Fixed Dose Combination Compared With Empagliflozin 25 mg Plus Placebo in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16-week Treatment With Empagliflozin (10 mg or 25 mg) Alone Once Daily.",
        "lillyAlias": []
    },
    "NCT00661869": {
        "briefTitle": "Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness",
        "officialTitle": "Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness",
        "lillyAlias": []
    },
    "NCT06678269": {
        "briefTitle": "A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer",
        "officialTitle": "A Phase I Study of Concurrent Abemaciclib and Radiation Therapy (RT) for Patients With Metastatic Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Breast Cancer",
        "lillyAlias": []
    },
    "NCT05780268": {
        "briefTitle": "LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)",
        "officialTitle": "A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19 (Trial H1: LY3819253 (LY-CoV555))",
        "lillyAlias": []
    },
    "NCT06165146": {
        "briefTitle": "A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants",
        "officialTitle": "A Phase I, Open-label, Fixed-sequence, Drug Interaction Study to Investigate the Effect of Multiple Oral Doses of Pirtobrutinib (LOXO-305) on the Pharmacokinetics of Repaglinide (CYP2C8 Substrate) in Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZNL"
        ]
    },
    "NCT00089869": {
        "briefTitle": "A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia",
        "officialTitle": null,
        "lillyAlias": [
            "H6U-MC-HGLM"
        ]
    },
    "NCT02714569": {
        "briefTitle": "A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Oral Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY3202328",
        "lillyAlias": [
            "I8Q-MC-GSEA"
        ]
    },
    "NCT01624467": {
        "briefTitle": "A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors",
        "officialTitle": "A Study to Determine Whether Necitumumab (IMC-11F8) Monotherapy Affects the Corrected QT (QTc) Interval in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "CP11-1114",
            "I4X-IE-JFCI"
        ]
    },
    "NCT00918567": {
        "briefTitle": "Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD",
        "officialTitle": "Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "lillyAlias": []
    },
    "NCT00190801": {
        "briefTitle": "Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma",
        "officialTitle": "Open-Label Single-Arm Phase 2 Study of ALIMTA Plus Cisplatin in Korean Patients With Advanced Gastric Carcinoma",
        "lillyAlias": [
            "H3E-KL-JMFK"
        ]
    },
    "NCT00191867": {
        "briefTitle": "Clinical Trial of Teriparatide in Japan",
        "officialTitle": "Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-JE-GHCS"
        ]
    },
    "NCT01383967": {
        "briefTitle": "A Study of LY2979165 in Healthy Subjects",
        "officialTitle": "Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Multiple-Ascending Doses of LY2979165 in Healthy Subjects",
        "lillyAlias": [
            "I4S-EW-HHCB"
        ]
    },
    "NCT05463744": {
        "briefTitle": "A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy",
        "lillyAlias": [
            "I8H-MC-BDCY",
            "2021-005892-38"
        ]
    },
    "NCT00380744": {
        "briefTitle": "A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis",
        "officialTitle": "A Phase 1b/2 Multiple-Dose Safety Study and Pharmacokinetic/ Pharmacodynamic Study of LY2189102 in Patients With Rheumatoid Arthritis",
        "lillyAlias": [
            "H9C-MC-BBDE"
        ]
    },
    "NCT02525744": {
        "briefTitle": "A Study of a New LY900014 Formulation in Healthy Participants",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel LY900014 Formulation",
        "lillyAlias": [
            "I8B-FW-ITRE"
        ]
    },
    "NCT03929744": {
        "briefTitle": "A Study of LY3502970 in Healthy Participants",
        "officialTitle": "A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3502970 in Healthy Subjects",
        "lillyAlias": [
            "J2A-MC-GZGA"
        ]
    },
    "NCT03270644": {
        "briefTitle": "A Study of Lasmiditan and Propranolol in Healthy Participants",
        "officialTitle": "Effect of Lasmiditan on Heart Rate and Blood Pressure in Healthy Subjects Receiving Oral Doses of Propranolol",
        "lillyAlias": [
            "H8H-MC-LAHD"
        ]
    },
    "NCT00105092": {
        "briefTitle": "Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.",
        "officialTitle": "A Phase II Evaluation of Oral Enzastaurin HCl in Second-and Third- Line Treatment of Patients With Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H6Q-MC-JCAQ"
        ]
    },
    "NCT02677844": {
        "briefTitle": "A Study of Abemaciclib in Healthy Participants",
        "officialTitle": "A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Determine the Exposure-Response Relationship Between Abemaciclib and QT Interval in Healthy Subjects",
        "lillyAlias": [
            "I3Y-MC-JPCA"
        ]
    },
    "NCT00350792": {
        "briefTitle": "Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients",
        "officialTitle": "A Phase II Trial Pemetrexed Carboplatin as First Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC) in Elderly Patients",
        "lillyAlias": [
            "H3E-FP-S099"
        ]
    },
    "NCT00661492": {
        "briefTitle": "Mitoxantrone \u00b1 Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)",
        "officialTitle": "A Randomized Phase II Study of Mitoxantrone vs. Mitoxantrone With Cetuximab in Metastatic Androgen Independent Prostate Cancer (AIPC) Previously Treated With Docetaxel-based Chemotherapy",
        "lillyAlias": []
    },
    "NCT00485810": {
        "briefTitle": "Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia",
        "officialTitle": "A Study Examining Clinical Therapeutic Dose of Rapid Acting Intra-Muscular Olanzapine in Japanese Agitated Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-JE-RA01"
        ]
    },
    "NCT04992312": {
        "briefTitle": "A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes",
        "officialTitle": "An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years",
        "lillyAlias": [
            "I8R-MC-IGBO",
            "2021-006088-61"
        ]
    },
    "NCT03332212": {
        "briefTitle": "A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin",
        "officialTitle": "EMPA-VISION: A Randomised, Double-blind, Placebo-controlled, Mechanistic Cardiac Magnetic Resonance Study to Investigate the Effects of Empagliflozin Treatment on Cardiac Physiology and Metabolism in Patients With Heart Failure",
        "lillyAlias": [
            "2017-000376-28"
        ]
    },
    "NCT05784246": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis",
        "officialTitle": "A Multicenter, Phase 3, Open-Label Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age With Moderately to Severely Active Ulcerative Colitis",
        "lillyAlias": [
            "I6T-MC-AMBA",
            "2022-502183-20-00"
        ]
    },
    "NCT05042310": {
        "briefTitle": "A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants",
        "officialTitle": "A Phase 1, Randomized, Participant- and Investigator-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3541860 in Healthy Japanese and Non-Japanese Participants",
        "lillyAlias": [
            "J3K-MC-KIAA"
        ]
    },
    "NCT01709110": {
        "briefTitle": "VERtebral Fracture Treatment Comparisons in Osteoporotic Women",
        "officialTitle": "Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures",
        "lillyAlias": [
            "B3D-EW-GHDW",
            "2012-000123-41"
        ]
    },
    "NCT01088412": {
        "briefTitle": "Observational Study of Somatropin Treatment in Children",
        "officialTitle": "The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)",
        "lillyAlias": [
            "B9R-EW-GDFC"
        ]
    },
    "NCT03459612": {
        "briefTitle": "A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants",
        "officialTitle": "A Phase I, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, 4-Period Cross-Over Study Assessing the Duration of Effect of Lasmiditan on Simulated Driving Performance in Healthy Volunteers",
        "lillyAlias": [
            "H8H-MC-LAIF"
        ]
    },
    "NCT01458210": {
        "briefTitle": "A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants",
        "officialTitle": "Effect of Dulaglutide (LY2189265) on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects",
        "lillyAlias": [
            "H9X-MC-GBCQ"
        ]
    },
    "NCT02335346": {
        "briefTitle": "An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)",
        "officialTitle": "An Open Label Extension Study of Phase 3 Trial of Duloxetine in Patients With Osteoarthritis and Knee Pain",
        "lillyAlias": [
            "F1J-JE-HMHD"
        ]
    },
    "NCT04537910": {
        "briefTitle": "A Study of LY3819253 (LY-CoV555) in Healthy Participants",
        "officialTitle": "A Randomized, Placebo-Controlled, Participant- and Investigator-Blind, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of LY3819253 Administered Subcutaneously to Healthy Participants",
        "lillyAlias": [
            "J2X-MC-PYAG"
        ]
    },
    "NCT04183712": {
        "briefTitle": "Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA",
        "officialTitle": "A Multicentre, Open-label, Randomised, Controlled Study of Target Therapy Based on Tumor Molecular Profiling With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA.",
        "lillyAlias": []
    },
    "NCT04259346": {
        "briefTitle": "A Study of Two Formulations of Ixekizumab in Healthy Participants",
        "officialTitle": "Bioequivalence of an Alternate Ixekizumab Formulation Compared to the Commercial Formulation in Healthy Subjects",
        "lillyAlias": [
            "I1F-MC-RHCU"
        ]
    },
    "NCT04914546": {
        "briefTitle": "A Study of LY3819469 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3819469",
        "lillyAlias": [
            "J3L-MC-EZEA"
        ]
    },
    "NCT05932446": {
        "briefTitle": "A Study to Compare Two Formulations of LY3819469 in Healthy Participants",
        "officialTitle": "A Single Dose Study to Assess the Pharmacokinetics of 2 Formulations of LY3819469 in Healthy Participants",
        "lillyAlias": [
            "J3L-MC-EZEE"
        ]
    },
    "NCT00965081": {
        "briefTitle": "A Study for Adult Patients With Fibromyalgia",
        "officialTitle": "A Randomized, Double-Blind Comparison of Duloxetine 30 mg QD and Placebo in Adult Patients With Fibromyalgia",
        "lillyAlias": [
            "F1J-MC-HMGG"
        ]
    },
    "NCT03435081": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAIW"
        ]
    },
    "NCT00532246": {
        "briefTitle": "Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo",
        "officialTitle": "A Study of Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene HCl or Placebo",
        "lillyAlias": [
            "H3S-MC-GGLE"
        ]
    },
    "NCT00112346": {
        "briefTitle": "Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Multicenter Phase II Study of Gemcitabine/Platinum/Cetuximab Versus Gemcitabine/Platinum as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT05217446": {
        "briefTitle": "A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer",
        "officialTitle": "A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY OF ENCORAFENIB AND CETUXIMAB PLUS PEMBROLIZUMAB VERSUS PEMBROLIZUMAB ALONE IN PARTICIPANTS WITH PREVIOUSLY UNTREATED BRAF V600E-MUTANT, MSI H/DMMR METASTATIC COLORECTAL CANCER",
        "lillyAlias": [
            "SEAMARK",
            "2024-512119-34-00",
            "MK-3475-D31",
            "KEYNOTE-D31"
        ]
    },
    "NCT00121446": {
        "briefTitle": "Which Therapy for Acute Heart Attacks? (The WEST Study)",
        "officialTitle": "Which Early ST Elevation Myocardial Infarction Therapy? The WEST Study",
        "lillyAlias": []
    },
    "NCT03520946": {
        "briefTitle": "RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients",
        "officialTitle": "A Phase III Study of RAMucirumab in Combination With TAS102 vs. TAS102 Monotherapy in Chemotherapy Refractory Metastatic Colorectal Cancer Patients",
        "lillyAlias": [
            "2017-004162-99"
        ]
    },
    "NCT01676701": {
        "briefTitle": "Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)",
        "officialTitle": "Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate",
        "lillyAlias": [
            "H9B-MC-BCEF"
        ]
    },
    "NCT03763604": {
        "briefTitle": "Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer",
        "officialTitle": "Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-Y001"
        ]
    },
    "NCT02941601": {
        "briefTitle": "A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Na\u00efve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Multicenter, Phase 2 Study of Gemcitabine-Carboplatin Plus Necitumumab in Chemotherapy-Na\u00efve Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4X-MC-JFDA",
            "2016-002041-31"
        ]
    },
    "NCT00894504": {
        "briefTitle": "Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer",
        "officialTitle": "A Phase II Trial of Panitumumab, Gemcitabine, and Carboplatin in Triple-Negative Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT00420004": {
        "briefTitle": "A Study for Participants With Major Depression",
        "officialTitle": "A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression",
        "lillyAlias": [
            "H9P-MC-LNBD"
        ]
    },
    "NCT05872204": {
        "briefTitle": "Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer",
        "officialTitle": "A Phase II, Open-label, Multicenter Study of Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer",
        "lillyAlias": []
    },
    "NCT04159701": {
        "briefTitle": "A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Crossover Study to Evaluate the Efficacy and Safety of LY3454738 in Adults With Chronic Spontaneous Urticaria Inadequately Controlled With H1-Antihistamines",
        "lillyAlias": [
            "J1B-MC-FRCF",
            "2019-002495-13"
        ]
    },
    "NCT01113801": {
        "briefTitle": "A Study in Participants With Diabetic Kidney Disease",
        "officialTitle": "A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes",
        "lillyAlias": [
            "H9V-MC-GFRF"
        ]
    },
    "NCT00670501": {
        "briefTitle": "Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis",
        "officialTitle": "Effects of LY333334 in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-MC-GHAC"
        ]
    },
    "NCT01746004": {
        "briefTitle": "A Study of LY2157299 Monohydrate in Healthy Volunteers",
        "officialTitle": "Disposition of [14C]-LY2157299 Monohydrate Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "H9H-MC-JBAM"
        ]
    },
    "NCT05136404": {
        "briefTitle": "A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants",
        "officialTitle": "An Open-Label, Randomized Study to Evaluate the Relative Bioavailability of Selpercatinib in 3 Formulations for Pediatric Use",
        "lillyAlias": [
            "J2G-MC-JZJU"
        ]
    },
    "NCT00529204": {
        "briefTitle": "Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease",
        "officialTitle": "Effects Of Exenatide (Byetta\u00ae) On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Non-Alcoholic Fatty Liver Disease",
        "lillyAlias": [
            "H80-MC-X006"
        ]
    },
    "NCT05412004": {
        "briefTitle": "Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea",
        "officialTitle": "A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial",
        "lillyAlias": [
            "I8F-MC-GPIF",
            "I8F-MC-GPI1",
            "I8F-MC-GPI2",
            "2021-004552-41"
        ]
    },
    "NCT04603001": {
        "briefTitle": "Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations",
        "officialTitle": "A Phase 1 Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations",
        "lillyAlias": [
            "2020-002830-33",
            "I9Y-OX-JDHB"
        ]
    },
    "NCT05515601": {
        "briefTitle": "A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants",
        "officialTitle": "A Bioequivalence Study of Subcutaneous Injections of Mirikizumab Reference Solution Using an Investigational 1-mL Autoinjector and Mirikizumab Test Solution Formulation Using an Investigational 1-mL Autoinjector in Healthy Participants",
        "lillyAlias": [
            "I6T-MC-AMBT"
        ]
    },
    "NCT01223001": {
        "briefTitle": "Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury",
        "officialTitle": "Prevention of Depression and Enhancement of Cognitive Recovery Following Traumatic Brain Injury With Duloxetine",
        "lillyAlias": [
            "F1J-US-X025"
        ]
    },
    "NCT00725101": {
        "briefTitle": "Fibromyalgia Health Outcome Study on Cost of Treatments",
        "officialTitle": "Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (The REFLECTIONS Study)",
        "lillyAlias": [
            "F1J-MC-B020"
        ]
    },
    "NCT05501704": {
        "briefTitle": "ETHAN - ET for Male BC",
        "officialTitle": "ETHAN: a Phase II Study Comparing Different Endocrine THerapies for MAle Breast CaNcer",
        "lillyAlias": []
    },
    "NCT06010004": {
        "briefTitle": "A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Long-term Safety Study of LY3502970 in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone or in Combination With Oral Antihyperglycemic Medications (ACHIEVE-J)",
        "lillyAlias": [
            "J2A-JE-GZPE"
        ]
    },
    "NCT01111604": {
        "briefTitle": "A Study of Ramucirumab or Icrucumab in Colorectal Cancer",
        "officialTitle": "An Open-label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of 5 FU/FA and Oxaliplatin (Modified FOLFOX 6) in Combination With Ramucirumab or IMC-18F1 or Without Investigational Therapy as Second Line Therapy in Patients With Metastatic Colorectal Cancer Following Disease Progression on First Line Irinotecan-based Therapy",
        "lillyAlias": [
            "CP20-0801",
            "I4Y-IE-JCDB"
        ]
    },
    "NCT06046729": {
        "briefTitle": "A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa",
        "officialTitle": "A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa",
        "lillyAlias": [
            "I7P-MC-DSAF",
            "2023-505608-43-00",
            "U1111-1292-6255"
        ]
    },
    "NCT01070329": {
        "briefTitle": "A Study in Depression and Associated Painful Physical Symptoms",
        "officialTitle": "Duloxetine Versus Placebo in the Acute Treatment of Patients With Major Depressive Disorder and Associated Painful Physical Symptoms",
        "lillyAlias": [
            "F1J-US-HMGU"
        ]
    },
    "NCT00239629": {
        "briefTitle": "Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial",
        "officialTitle": "Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-EW-GHCX"
        ]
    },
    "NCT03899792": {
        "briefTitle": "A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors",
        "officialTitle": "A Phase 1/2 Study of the Oral RET Inhibitor LOXO 292 in Pediatric Patients With Advanced RET-Altered Solid or Primary Central Nervous System Tumors",
        "lillyAlias": [
            "J2G-OX-JZJJ",
            "LOXO-RET-18036",
            "2019-000212-28"
        ]
    },
    "NCT03905889": {
        "briefTitle": "A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma",
        "officialTitle": "Targeting PIM1 and CDK4/6 Kinases in Renal Cell Carcinoma (PICKRCC): A Phase Ib Study of Abemaciclib (VerzenioTM) in Combination With Sunitinib in Metastatic Renal Cell Carcinoma",
        "lillyAlias": []
    },
    "NCT05986292": {
        "briefTitle": "A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain",
        "officialTitle": "A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain",
        "lillyAlias": [
            "H0P-MC-CPMP"
        ]
    },
    "NCT06475729": {
        "briefTitle": "A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants",
        "officialTitle": "A Bioequivalence Study of Subcutaneous Injections of Citrate-Free Mirikizumab Solution Using a 1-mL Autoinjector and an Investigational 2-mL Autoinjector in Healthy Participants",
        "lillyAlias": [
            "I6T-MC-AMCB"
        ]
    },
    "NCT03740529": {
        "briefTitle": "A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL",
        "officialTitle": "A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)",
        "lillyAlias": [
            "2018-003340-24",
            "J2N-OX-JZNA"
        ]
    },
    "NCT04199767": {
        "briefTitle": "SNIFF Multi-Device Study 2",
        "officialTitle": "SNIFF Multi-Device Study 2 - Study of Nasal Insulin to Fight Forgetfulness",
        "lillyAlias": []
    },
    "NCT02291367": {
        "briefTitle": "Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition",
        "officialTitle": "Single Dose Crossover Comparative Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg in Healthy Adult Human Subjects Under Fasting Conditions",
        "lillyAlias": []
    },
    "NCT06180967": {
        "briefTitle": "A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy Participants",
        "officialTitle": "A Phase I, Open Label, Fixed-sequence Drug Interaction Study to Investigate the Effect of Multiple Oral Doses of LOXO-305 on the Pharmacokinetics of a Single Dose of Intravenous and Oral Midazolam (CYP3A4 Substrate) in Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZND"
        ]
    },
    "NCT05971940": {
        "briefTitle": "A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone",
        "officialTitle": "A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone",
        "lillyAlias": [
            "J2A-MC-GZGT",
            "U1111-1290-5157"
        ]
    },
    "NCT05169567": {
        "briefTitle": "Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer",
        "officialTitle": "postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy",
        "lillyAlias": [
            "I3Y-MC-JPEF",
            "2021-002301-10",
            "2023-506771-10-00"
        ]
    },
    "NCT01960140": {
        "briefTitle": "A Study of Baricitinib and Simvastatin in Healthy Participants",
        "officialTitle": "Effects of Multiple Baricitinib (LY3009104) Doses on the Pharmacokinetics of a Cytochrome P450 3A Substrate, Simvastatin, in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGI"
        ]
    },
    "NCT00849901": {
        "briefTitle": "A Study in the Treatment of Children and Adolescents With Major Depressive Disorder",
        "officialTitle": "A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMCK"
        ]
    },
    "NCT02256267": {
        "briefTitle": "A Study of LY2835219 in Healthy Participants",
        "officialTitle": "Effects of CYP3A Induction by Rifampin on the Pharmacokinetics of LY2835219 and Its Metabolites in Healthy Subjects",
        "lillyAlias": [
            "I3Y-MC-JPBF"
        ]
    },
    "NCT03760640": {
        "briefTitle": "A Study of LY900014 in a Medtronic Pump",
        "officialTitle": "Evaluation of LY900014 in a Medtronic Pump",
        "lillyAlias": [
            "I8B-MC-ITSM"
        ]
    },
    "NCT05931367": {
        "briefTitle": "A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee",
        "officialTitle": "A Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Trial",
        "lillyAlias": [
            "J1I-MC-GZBN",
            "2023-503660-17-00"
        ]
    },
    "NCT01890967": {
        "briefTitle": "A Study of LY3015014 in Participants With High Cholesterol",
        "officialTitle": "A Phase 2 Efficacy and Safety Dose-Ranging Study of LY3015014 in Patients With Primary Hypercholesterolemia",
        "lillyAlias": [
            "I5S-MC-EFJE"
        ]
    },
    "NCT01742767": {
        "briefTitle": "Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC",
        "officialTitle": "Randomized Phase II Trial of Three-weekly Cisplatinum and Pemetrexed Versus Split-dose d1 and d8 Cisplatinum and Pemetrexed In Advanced and Inoperable Non-squamous Non-small-cell Lung Cancer (NSCLC)",
        "lillyAlias": []
    },
    "NCT00279201": {
        "briefTitle": "The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)",
        "officialTitle": "The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine When Added to Existing Oral Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control",
        "lillyAlias": [
            "F3Z-US-IOOV"
        ]
    },
    "NCT03848767": {
        "briefTitle": "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges",
        "officialTitle": "An Early Feasibility Study to Evaluate the Functionality and Safety of an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus During Meal Challenges",
        "lillyAlias": [
            "F3Z-MC-IORD"
        ]
    },
    "NCT00487240": {
        "briefTitle": "Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes",
        "officialTitle": "Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemir) in Basal-Bolus Therapy for Patients With Type 1 Diabetes",
        "lillyAlias": [
            "F3Z-MC-IOOZ"
        ]
    },
    "NCT04178967": {
        "briefTitle": "Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis",
        "officialTitle": "A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.",
        "lillyAlias": [
            "2019-002933-12",
            "J2T-DM-KGAC",
            "DRM06-AD05"
        ]
    },
    "NCT03655444": {
        "briefTitle": "Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy",
        "officialTitle": "A Prospective Phase I and II Trial of Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy",
        "lillyAlias": []
    },
    "NCT02555644": {
        "briefTitle": "A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer",
        "officialTitle": "A Phase 1b Trial of LY2606368 in Combination With Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Cancer",
        "lillyAlias": [
            "I4D-MC-JTJI",
            "2015-001215-12"
        ]
    },
    "NCT04194944": {
        "briefTitle": "A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer",
        "officialTitle": "LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy With or Without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "J2G-MC-JZJC",
            "2019-001979-36"
        ]
    },
    "NCT00309140": {
        "briefTitle": "An Open Label Study of Oral Enzastaurin in Participants With Cancer",
        "officialTitle": "An Open-Label Study of Oral Enzastaurin HCl in Patients With Advanced or Metastatic Malignancies",
        "lillyAlias": [
            "H6Q-MC-S001"
        ]
    },
    "NCT05295940": {
        "briefTitle": "A Study of LY3841136 in Healthy and Overweight Participants",
        "officialTitle": "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3841136 in Healthy and Overweight Participants",
        "lillyAlias": [
            "J3R-MC-YDAA"
        ]
    },
    "NCT02745769": {
        "briefTitle": "A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents",
        "officialTitle": "An Open-Label, Phase 1a/1b Study of Ramucirumab in Combination With Other Targeted Agents in Advanced Cancers",
        "lillyAlias": [
            "I4T-MC-JVDK",
            "2015-004381-28"
        ]
    },
    "NCT05007769": {
        "briefTitle": "Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC",
        "officialTitle": "A Phase II, Single-center, Open-label Study of Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC (RAN)",
        "lillyAlias": []
    },
    "NCT00747968": {
        "briefTitle": "The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET",
        "officialTitle": "The Effect of the GLP-1 Analogue Exenatide on Glucose Metabolism in the CNS and Heart During Hyperglycemia in Type-2 Diabetic Patients Assessed by PET",
        "lillyAlias": []
    },
    "NCT03047369": {
        "briefTitle": "The Myelin Disorders Biorepository Project",
        "officialTitle": "The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network",
        "lillyAlias": [
            "U54NS115052",
            "U01NS106845"
        ]
    },
    "NCT05577169": {
        "briefTitle": "Incorporating Mind-body Skills with Diabetes Education in Adolescents with Type 1 Diabetes",
        "officialTitle": "Incorporating Mind-body Skills with Diabetes Education in Adolescents with Type 1 Diabetes",
        "lillyAlias": []
    },
    "NCT04923269": {
        "briefTitle": "A Study of LY3532226 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3532226 in Healthy Participants",
        "lillyAlias": [
            "J2V-MC-GZLA"
        ]
    },
    "NCT00475969": {
        "briefTitle": "Duloxetine vs Placebo in the Treatment of General Anxiety",
        "officialTitle": "Duloxetine Hydrochloride Once Daily Compared With Placebo in the Treatment of Generalized Anxiety Disorder",
        "lillyAlias": [
            "F1J-MC-HMDT"
        ]
    },
    "NCT06220669": {
        "briefTitle": "A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis",
        "officialTitle": "An Adaptive Phase 2a/2b, Randomized, Double-Blind, Parallel-Group Study to Investigate the Safety and Efficacy of LY3541860 Compared to Placebo in Slowing the Occurrence of New T1 Gadolinium-Enhancing Lesions in Adult Participants With Relapsing Multiple Sclerosis",
        "lillyAlias": [
            "J3K-MC-KIAB",
            "2023-503289-22-00"
        ]
    },
    "NCT00810069": {
        "briefTitle": "Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder",
        "officialTitle": "Comparison of Two Different Treatment Strategies in Patients With Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy",
        "lillyAlias": [
            "F1J-EW-HMGD"
        ]
    },
    "NCT00323869": {
        "briefTitle": "Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer",
        "officialTitle": "Phase II Trial of Bevacizumab in Combination With Gemcitabine and Carboplatin in Patients With Newly Diagnosed Non-Small Cell Lung Cancer (Excluding Squamous Cell Carcinoma)",
        "lillyAlias": [
            "96655",
            "AVF3576s",
            "LUN0013",
            "NCT00323869"
        ]
    },
    "NCT00085969": {
        "briefTitle": "Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT03308669": {
        "briefTitle": "A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate",
        "officialTitle": "Safety, Tolerability, and Pharmacokinetics of Lasmiditan When Co-administered With Topiramate in Healthy Subjects",
        "lillyAlias": [
            "H8H-MC-LAHT"
        ]
    },
    "NCT01490372": {
        "briefTitle": "Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring",
        "officialTitle": "Is Gestational Diabetes Mellitus (GDM) an Independent Risk Factor for Cardiometabolic Syndrome in Offspring?",
        "lillyAlias": []
    },
    "NCT02144272": {
        "briefTitle": "Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis",
        "officialTitle": "A Phase 1 Single-Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of LY3114062 in Subjects With Inflammatory Arthritis",
        "lillyAlias": [
            "I6W-MC-TNAA"
        ]
    },
    "NCT01769404": {
        "briefTitle": "A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes",
        "officialTitle": "Evaluation of the Counter-Regulatory Response to Hypoglycaemia Following LY2605541 Administration Compared to Insulin Glargine in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIDM"
        ]
    },
    "NCT02340104": {
        "briefTitle": "A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants",
        "officialTitle": "An Absolute Bioavailability Study of Baricitinib in Healthy Subjects Using the Intravenous Tracer Method",
        "lillyAlias": [
            "I4V-MC-JAGM"
        ]
    },
    "NCT00734604": {
        "briefTitle": "A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.",
        "officialTitle": "A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.",
        "lillyAlias": [
            "H6D-CR-S024"
        ]
    },
    "NCT03652272": {
        "briefTitle": "Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy",
        "officialTitle": "Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy (Phase 2)",
        "lillyAlias": []
    },
    "NCT00797472": {
        "briefTitle": "Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease",
        "officialTitle": "A Phase II Open Label, Multicenter, Randomized, Parallel Study Comparing the Efficacy of R-mabHD Alone and a Combination of Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD)in Treating Patients With Hodgkin's Disease.",
        "lillyAlias": []
    },
    "NCT00073372": {
        "briefTitle": "A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)",
        "officialTitle": "Abciximab (ReoPro) in Acute Ischemic Stroke: A Phase III, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Trial.",
        "lillyAlias": []
    },
    "NCT05536804": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes",
        "officialTitle": "Tirzepatide Study of Renal Function in People With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease Using Multiparametric Magnetic Resonance Imaging",
        "lillyAlias": [
            "I8F-MC-GPIG",
            "2021-005273-47",
            "2023-506082-60-00"
        ]
    },
    "NCT00848081": {
        "briefTitle": "A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Efficacy of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant Alpha1-Adrenergic Blocker Therapy",
        "lillyAlias": [
            "H6D-MC-LVHS"
        ]
    },
    "NCT00386581": {
        "briefTitle": "Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder",
        "officialTitle": "Phase III Multicenter, Randomized, Double-Blind Placebo-Controlled Outpatient Study of Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-MW-LYCZ"
        ]
    },
    "NCT00191581": {
        "briefTitle": "Local Registration Trial in China Humalog Mix 50",
        "officialTitle": "Comparison of 2-Hour Postprandial Blood Glucose Excursion in Response to a Standard Test Meal in Insulin-Requiring Diabetic Patients Treated Twice Daily With Either Insulin Lispro Mix 50/50 or Human Insulin Mix 50/50",
        "lillyAlias": [
            "F3Z-MC-IOOR"
        ]
    },
    "NCT04280081": {
        "briefTitle": "A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation",
        "officialTitle": "A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation",
        "lillyAlias": [
            "J2G-GH-JZJK"
        ]
    },
    "NCT01893281": {
        "briefTitle": "The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel",
        "officialTitle": "The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel",
        "lillyAlias": [
            "I5E-US-TSBC"
        ]
    },
    "NCT01460381": {
        "briefTitle": "A Study to Evaluate the Effect of Genotype on LY2216684",
        "officialTitle": "A Study to Investigate the Effect of CYP2C19 Phenotype on the Pharmacokinetics of LY2216684 in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNDZ"
        ]
    },
    "NCT00477581": {
        "briefTitle": "A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized, Double-Blind, Crossover Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00420381": {
        "briefTitle": "Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer",
        "officialTitle": "A Phase II Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Carcinoma",
        "lillyAlias": [
            "H6Q-MC-S025"
        ]
    },
    "NCT04153981": {
        "briefTitle": "A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India",
        "officialTitle": "A Multicenter, Open-Label, Single-Arm, Phase 4 Study to Assess the Safety of Basaglar in Subjects With Type 2 Diabetes Mellitus in India",
        "lillyAlias": [
            "I4L-IN-ABEX"
        ]
    },
    "NCT01894568": {
        "briefTitle": "A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment",
        "officialTitle": "A Phase 3, Open Label, Randomized, Parallel, 26 Week Treatment Study Comparing LY2605541 With Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti Hyperglycemia Medications in Asian Insulin Na\u00efve Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-JE-BIAQ"
        ]
    },
    "NCT01774968": {
        "briefTitle": "Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes",
        "officialTitle": "Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial",
        "lillyAlias": [
            "B5K-US-IBHC"
        ]
    },
    "NCT02896868": {
        "briefTitle": "A Study of LY3041658 in Participants With Skin Diseases",
        "officialTitle": "A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients With Skin Diseases",
        "lillyAlias": [
            "I7P-MC-DSAB"
        ]
    },
    "NCT06553872": {
        "briefTitle": "Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL",
        "officialTitle": "A Phase 2, Open-Label, Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma",
        "lillyAlias": [
            "J2N-US-I010"
        ]
    },
    "NCT00905372": {
        "briefTitle": "Effect of LY2062430 on the Progression of Alzheimer's Disease",
        "officialTitle": "Effect of LY2062430, an Anti-Amyloid Beta Monoclonal Antibody, on the Progression of Alzheimer's Disease as Compared With Placebo",
        "lillyAlias": [
            "H8A-MC-LZAM"
        ]
    },
    "NCT01215968": {
        "briefTitle": "A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Study to Evaluate the Effect of LY2189265 on Gastric Emptying Using Scintigraphy in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "2009-017305-11",
            "H9X-EW-GBDM"
        ]
    },
    "NCT00594568": {
        "briefTitle": "Effect of LY450139 on the Long Term Progression of Alzheimer's Disease",
        "officialTitle": "Effect of \u03b3-Secretase Inhibition on the Progression of Alzheimer's Disease: LY450139 Versus Placebo",
        "lillyAlias": [
            "H6L-MC-LFAN",
            "CTRI/2009/091/000090"
        ]
    },
    "NCT02937272": {
        "briefTitle": "A Study of LY3200882 in Participants With Solid Tumors",
        "officialTitle": "A Phase 1 Study of LY3200882 in Patients With Solid Tumors",
        "lillyAlias": [
            "I8X-MC-JECA",
            "2016-001431-12"
        ]
    },
    "NCT00415168": {
        "briefTitle": "Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer",
        "officialTitle": "Phase 2 Study of ALIMTA\u00ae (Pemetrexed) Plus Cisplatin as First-Line Treatment of Gastric Cancer",
        "lillyAlias": [
            "H3E-MW-S108"
        ]
    },
    "NCT05727072": {
        "briefTitle": "A Study of LY3848575 in Healthy Participants",
        "officialTitle": "A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate Safety, Tolerability, and Pharmacokinetics With Single Intravenous Ascending Doses and Single and Multiple Subcutaneous Doses of LY3848575 in Healthy Participants, Including First-generation Japanese Participants",
        "lillyAlias": [
            "J4F-MC-CYAA"
        ]
    },
    "NCT00374868": {
        "briefTitle": "Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)",
        "officialTitle": "Phase 1/2 Study of Biweekly ALIMTA Plus Cisplatin in Patients With Locally, Advanced, Non-Resectable or Metastatic Urothelial Cancer",
        "lillyAlias": [
            "H3E-ES-S085"
        ]
    },
    "NCT01179672": {
        "briefTitle": "A Study in Participants With Diabetic Peripheral Neuropathic Pain in China",
        "officialTitle": "Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China: Duloxetine Versus Placebo",
        "lillyAlias": [
            "F1J-MC-HMGV"
        ]
    },
    "NCT01296568": {
        "briefTitle": "C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors",
        "officialTitle": "Disposition of [14C]LY2603618 Following Intravenous Administration in Patients With Advanced and/or Metastatic Solid Tumors",
        "lillyAlias": [
            "I2I-MC-JMMH"
        ]
    },
    "NCT04653168": {
        "briefTitle": "A Study of LY3041658 in Healthy Participants",
        "officialTitle": "A Single Dose, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Injections of LY3041658 in Healthy Participants",
        "lillyAlias": [
            "I7P-MC-DSAE"
        ]
    },
    "NCT06400472": {
        "briefTitle": "A Study of LY4170156 in Participants With Selected Advanced Solid Tumors",
        "officialTitle": "A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4170156, an Antibody-Drug Conjugate Targeting Folate Receptor \u03b1-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors",
        "lillyAlias": [
            "2024-511238-11-00",
            "J5E-OX-JZXA"
        ]
    },
    "NCT03603704": {
        "briefTitle": "A Study of LY3209590 in Japanese Participants With Type 2 Diabetes",
        "officialTitle": "A Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 in Japanese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-JE-BDCF"
        ]
    },
    "NCT03736772": {
        "briefTitle": "A Study of LY3090106 in Japanese and Caucasian Healthy Participants",
        "officialTitle": "A Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3090106 in Japanese and Caucasian Healthy Subjects",
        "lillyAlias": [
            "I6M-JE-SSAA"
        ]
    },
    "NCT06148272": {
        "briefTitle": "A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension",
        "officialTitle": "A Single-ascending and Multiple-ascending Dose Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension and Participants With Decreased Estimated Glomerular Filtration Rate",
        "lillyAlias": [
            "J4O-MC-EZHA"
        ]
    },
    "NCT00759772": {
        "briefTitle": "The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa",
        "officialTitle": "The Role of PTH in Low Bone Mass in Anorexia Nervosa",
        "lillyAlias": []
    },
    "NCT01775904": {
        "briefTitle": "A Study of Two Dosage Forms of LY2886721 in Healthy Participants",
        "officialTitle": "A Comparison Study of Capsule and Orally Disintegrating Tablet and to Determine the Effect of Food and Water on the Pharmacokinetics of LY2886721 in Healthy Subjects",
        "lillyAlias": [
            "I4O-MC-BACG"
        ]
    },
    "NCT01299272": {
        "briefTitle": "A Study in Prevention of Re-emergence of Depression Symptoms",
        "officialTitle": "LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder",
        "lillyAlias": [
            "H9P-MC-LNBN"
        ]
    },
    "NCT00568672": {
        "briefTitle": "Optimal Duration of Olanzapine Add-on Therapy in Major Depression",
        "officialTitle": "Optimal Duration of Olanzapine Add-on Therapy in Major Depression: a Placebo-controlled, Randomized, Phase III, Pilot Study in Parallel Group Design",
        "lillyAlias": []
    },
    "NCT01131104": {
        "briefTitle": "A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors",
        "officialTitle": "A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)",
        "lillyAlias": [
            "H6D-MC-LVHQ"
        ]
    },
    "NCT02747004": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer",
        "officialTitle": "A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPCG",
            "2016-000288-18"
        ]
    },
    "NCT00871572": {
        "briefTitle": "A Study for Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-MC-GLBE"
        ]
    },
    "NCT01109472": {
        "briefTitle": "Improving Osteoporosis Care in a Home Health Setting",
        "officialTitle": null,
        "lillyAlias": [
            "B3D-US-X016"
        ]
    },
    "NCT02123472": {
        "briefTitle": "A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants",
        "officialTitle": "A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Suspension With 125 mg/5 ml of Cephalexin (Keflex\u00ae Pediatrico Made in Mexico by Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V. vs. Keflex\u00ae Pediatrico Made in Italy by Facta Farmaceutici S.p.A. for Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V.) in Fasting Healthy Volunteers",
        "lillyAlias": [
            "A3Q-ME-AFBR"
        ]
    },
    "NCT04031872": {
        "briefTitle": "LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)",
        "officialTitle": "MoTriColor: Phase I/II Study With LY3200882 Combined With Capecitabine in Patients With Advanced Chemotherapy Resistant Colorectal Cancer and an Activated TGF-beta Signature",
        "lillyAlias": []
    },
    "NCT01430104": {
        "briefTitle": "A Study of Teriparatide in Japanese Osteoporosis Patients",
        "officialTitle": "A Study to Assess the Effects on Serum Calcium When Teriparatide is Used With Active Vitamin D in Osteoporosis Patients",
        "lillyAlias": [
            "B3D-JE-GHDT"
        ]
    },
    "NCT02737072": {
        "briefTitle": "A Study of LY2510924 and Durvalumab in Participants With Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of CXCR4 Peptide Antagonist (LY2510924) Administered in Combination With the Anti-PD-L1 Antibody, Durvalumab (MEDI4736), in Advanced Refractory Solid Tumors",
        "lillyAlias": [
            "I2V-MC-CXAD"
        ]
    },
    "NCT00191672": {
        "briefTitle": "A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer",
        "officialTitle": "A Phase II Randomized Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Patients With Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-US-S308"
        ]
    },
    "NCT00962104": {
        "briefTitle": "Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder",
        "officialTitle": "A Double-Blind Placebo-Controlled Asian Study of Atomoxetine Hydrochloride in the Treatment of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "lillyAlias": [
            "B4Z-JE-LYEE"
        ]
    },
    "NCT00036504": {
        "briefTitle": "Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin",
        "officialTitle": "Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients New to Insulin Therapy Who Were Inadequately Controlled on Oral Agents",
        "lillyAlias": [
            "F3Z-MC-IOND"
        ]
    },
    "NCT03579940": {
        "briefTitle": "A Study of Lasmiditan in Healthy Japanese and Caucasian Participants",
        "officialTitle": "Safety, Tolerability, and Pharmacokinetics of Lasmiditan in Healthy Japanese and Caucasian Subjects",
        "lillyAlias": [
            "H8H-JE-LAIE"
        ]
    },
    "NCT00094640": {
        "briefTitle": "Pharmacokinetic Characterization of Intramuscular Olanzapine Depot",
        "officialTitle": null,
        "lillyAlias": [
            "F1D-EW-LOBS"
        ]
    },
    "NCT03748940": {
        "briefTitle": "Study of LY3074828 in Healthy Participants",
        "officialTitle": "A Study to Investigate the Tolerability of Subcutaneous Injections of LY3074828 Compared to Placebo",
        "lillyAlias": [
            "I9O-MC-AABC",
            "2018-000773-68"
        ]
    },
    "NCT04047940": {
        "briefTitle": "A Study of LY900020 in Healthy Chinese Participants",
        "officialTitle": "A Relative Bioavailability Study of Three LY900020 Tablet Formulations in Healthy Chinese Subjects",
        "lillyAlias": [
            "I9J-MC-DIPA"
        ]
    },
    "NCT01351246": {
        "briefTitle": "Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD): A Feasibility and Effectiveness Study",
        "lillyAlias": []
    },
    "NCT06373146": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity",
        "lillyAlias": [
            "I8F-MC-GPIV"
        ]
    },
    "NCT03382912": {
        "briefTitle": "Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1",
        "lillyAlias": [
            "J1L-AM-JZGD",
            "AM0010-202"
        ]
    },
    "NCT03220646": {
        "briefTitle": "Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors",
        "officialTitle": "A Phase 2 Study of Abemaciclib in Patients With Recurrent Primary Brain Tumors",
        "lillyAlias": []
    },
    "NCT00090012": {
        "briefTitle": "Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder",
        "officialTitle": "The Comparison of Efficacy and Safety of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder",
        "lillyAlias": [
            "F1D-US-HGLR"
        ]
    },
    "NCT00191646": {
        "briefTitle": "An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy",
        "officialTitle": "Phase III Randomized Trial of Induction Chemotherapy With Gemcitabine and Carboplatin Followed by Elective Paclitaxel Consolidation Versus Paclitaxel and Carboplatin Followed by Elective Paclitaxel Consolidation in Patients With Primary Epithelial Ovarian, Primary Peritoneal Cancer or Fallopian Tube Carcinoma",
        "lillyAlias": [
            "B9E-US-S302"
        ]
    },
    "NCT01538446": {
        "briefTitle": "Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel",
        "officialTitle": "The ANTARCTIC Study - Assessment of a Normal Versus Tailored Dose of Prasugrel After Stenting in Patients Aged > 75 Years to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications",
        "lillyAlias": []
    },
    "NCT01994746": {
        "briefTitle": "Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults",
        "officialTitle": "Efficacy and Safety of Nasal Glucagon for Treatment of Insulin Induced Hypoglycemia in Adults With Diabetes",
        "lillyAlias": [
            "INGluc001",
            "I8R-MC-IGBC",
            "AMG106"
        ]
    },
    "NCT02154646": {
        "briefTitle": "A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body",
        "officialTitle": "A Phase 1b Study of LY2157299 in Combination With Gemcitabine in Patients With Advanced or Metastatic Unresectable Pancreatic Cancer",
        "lillyAlias": [
            "H9H-JE-JBAO"
        ]
    },
    "NCT01167881": {
        "briefTitle": "Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III Randomised, Double-blind, Active-controlled Parallel Group Efficacy and Safety Study of BI 10773 Compared to Glimepiride Administered Orally During 104 Weeks With a 104 Week Extension Period in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Metformin Treatment",
        "lillyAlias": [
            "2009-016244-39"
        ]
    },
    "NCT00333281": {
        "briefTitle": "A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months",
        "officialTitle": "A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evaluate the Effects of 5 mg Tadalafil (IC351, LY450190) and 50 mg Sildenafil Administered Once Daily for 6 Months on Visual Function in Healthy Subjects or Subjects With Mild Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVGO"
        ]
    },
    "NCT02242981": {
        "briefTitle": "A Study of How the Body Breaks Down and Eliminates LY2623091",
        "officialTitle": "Disposition of [14C]-LY2623091 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I7T-MC-RMAA"
        ]
    },
    "NCT03830281": {
        "briefTitle": "A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion",
        "lillyAlias": [
            "I8B-MC-ITRO",
            "2015-005358-36"
        ]
    },
    "NCT00709995": {
        "briefTitle": "A Study for Participants With Metastatic Renal Cell Carcinoma",
        "officialTitle": "Dose Finding and Randomized, Multicenter, Placebo-Controlled, Phase 2 Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell Carcinoma",
        "lillyAlias": [
            "H6Q-MC-S061"
        ]
    },
    "NCT06119581": {
        "briefTitle": "A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer",
        "officialTitle": "SUNRAY-01, A Global Pivotal Study in Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those With PD-L1 Expression \u226550% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum Regardless of PD-L1 Expression",
        "lillyAlias": [
            "J3M-MC-JZQB",
            "U1111-1288-0565",
            "2023-503412-33-00"
        ]
    },
    "NCT00363376": {
        "briefTitle": "A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain",
        "officialTitle": "A Double-Blind, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain",
        "lillyAlias": [
            "F1D-MC-X269"
        ]
    },
    "NCT04782076": {
        "briefTitle": "A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants",
        "officialTitle": "An Open-Label Study to Investigate the Effect of Selpercatinib on the Pharmacokinetics of Dabigatran in Healthy Volunteers",
        "lillyAlias": [
            "J2G-MC-JZJV"
        ]
    },
    "NCT00191373": {
        "briefTitle": "A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease",
        "officialTitle": "Phase II Study of Gemcitabine and Trastuzumab Therapy in Patients With HER2 Overexpressing Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-US-S270"
        ]
    },
    "NCT04166773": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)",
        "lillyAlias": [
            "I8F-MC-GPHR",
            "2019-001550-26"
        ]
    },
    "NCT01936376": {
        "briefTitle": "A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers",
        "officialTitle": "A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers",
        "lillyAlias": []
    },
    "NCT00401973": {
        "briefTitle": "Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine",
        "officialTitle": "The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia",
        "lillyAlias": [
            "F1D-US-HGMM"
        ]
    },
    "NCT01422876": {
        "briefTitle": "Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment na\u00efve and Metformin Treated Type 2 Diabetes Patients",
        "officialTitle": "A Phase III Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Once Daily Oral Administration of BI 10773 25 mg/Linagliptin 5 mg and BI 10773 10 mg/Linagliptin 5 mg Fixed Dose Combination Tablets Compared With the Individual Components (BI 10773 25 mg, BI 10773 10 mg, and Linagliptin 5 mg) for 52 Weeks in Treatment na\u00efve and Metformin Treated Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control",
        "lillyAlias": [
            "2011-000383-10"
        ]
    },
    "NCT05338476": {
        "briefTitle": "A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants",
        "officialTitle": "An Open-Label, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of LOXO-292 on the Single Dose Pharmacokinetics of Midazolam in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-OX-JZJR",
            "LOXO-RET-18017"
        ]
    },
    "NCT00190827": {
        "briefTitle": "Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)",
        "officialTitle": "The Effectiveness of Duloxetine Compared With Placebo in the Treatment of Predominant Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBBR"
        ]
    },
    "NCT01250873": {
        "briefTitle": "A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline",
        "officialTitle": "LY2216684 and Sertraline Pharmacokinetic Interaction Study in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCT"
        ]
    },
    "NCT00062673": {
        "briefTitle": "Study of Duloxetine in Elderly Patients With Major Depressive Disorder",
        "officialTitle": "Duloxetine Versus Placebo in the Treatment of Elderly Patients With Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMBV"
        ]
    },
    "NCT00414973": {
        "briefTitle": "A Study for Patients With Osteoporosis",
        "officialTitle": "Comparison of Teriparatide and Calcitonin in the Treatment of Men and Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-MC-GHDG"
        ]
    },
    "NCT03742973": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA",
        "lillyAlias": [
            "I4V-MC-JAIV"
        ]
    },
    "NCT04421027": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With COVID-19",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection",
        "lillyAlias": [
            "I4V-MC-KHAA",
            "2020-001517-21"
        ]
    },
    "NCT02806973": {
        "briefTitle": "A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes",
        "officialTitle": "A Single Center, Randomized, 4-Period Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Single or Repeated 3 mg Doses of Intranasally Administered Glucagon in Adults With Type 1 or Type 2 Diabetes",
        "lillyAlias": [
            "I8R-MC-IGBG",
            "AMG112",
            "AGL-P5-310"
        ]
    },
    "NCT01534273": {
        "briefTitle": "A Study of LY2886721 in Healthy Participants",
        "officialTitle": "Single- and Multiple-Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects",
        "lillyAlias": [
            "I4O-MC-BACJ"
        ]
    },
    "NCT01147627": {
        "briefTitle": "Effect of Different Interventions on Glycemic Control and \u03b2-cell Function in Newly Diagnosed Type 2 Diabetic Patients",
        "officialTitle": "Comparison of Exenatide, Insulin or Pioglitazone on Glycaemic Control and \u03b2-cell Function in Drug-na\u00efve Type 2 Diabetic Patients: A Multicentre Randomized Parallel-group Trial",
        "lillyAlias": []
    },
    "NCT02148627": {
        "briefTitle": "Safety Study of LY3041658 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects",
        "lillyAlias": [
            "I7P-MC-DSAA"
        ]
    },
    "NCT00550173": {
        "briefTitle": "A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed Alone, and Erlotinib Alone, as Second-Line Treatment for Non-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-MC-S103"
        ]
    },
    "NCT00100776": {
        "briefTitle": "Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder",
        "officialTitle": "Efficacy of High Dose Olanzapine in a Controlled Fixed Dose-Response Trial for the Treatment of Schizophrenia and Schizoaffective Disorder",
        "lillyAlias": [
            "F1D-US-HGLF"
        ]
    },
    "NCT01736241": {
        "briefTitle": "A Study of LY3053102 in Healthy Participants",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of LY3053102 in Healthy Subjects",
        "lillyAlias": [
            "I6I-MC-LMRA"
        ]
    },
    "NCT04548219": {
        "briefTitle": "A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants",
        "officialTitle": "Relative Bioavailability of a Mirikizumab Test Formulation Compared to the Reference Formulation in Healthy Subjects",
        "lillyAlias": [
            "I6T-MC-AMBV"
        ]
    },
    "NCT01837641": {
        "briefTitle": "A Study of LY3002813 in Participants With Alzheimer's Disease",
        "officialTitle": "A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACC"
        ]
    },
    "NCT05048719": {
        "briefTitle": "A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo and Once-Weekly Dulaglutide in Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J2A-MC-GZGE",
            "2021-002806-29"
        ]
    },
    "NCT05089019": {
        "briefTitle": "A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants",
        "officialTitle": "An Open-Label, Randomized Study to Evaluate the Bioequivalence of Selpercatinib Formulations",
        "lillyAlias": [
            "J2G-MC-JZJZ"
        ]
    },
    "NCT04682119": {
        "briefTitle": "A Safety Study of LY3526318 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Doses of LY3526318 in Healthy Participants",
        "lillyAlias": [
            "2020-004290-46",
            "J2D-MC-CVAC"
        ]
    },
    "NCT00063141": {
        "briefTitle": "Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer",
        "officialTitle": "Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma",
        "lillyAlias": []
    },
    "NCT00227019": {
        "briefTitle": "Phase 2 Trial of Bevacizumab in Combination With Pemetrexed",
        "officialTitle": "Phase II Trial of Bevacizumab in Combination With Pemetrexed as Second Line Therapy in Patients With Stable Brain Metastases From Non-small Cell Lung Cancer (NSCLC) (Excluding Squamous Cell Carcinoma)",
        "lillyAlias": [
            "95913",
            "LUN0014"
        ]
    },
    "NCT00698841": {
        "briefTitle": "Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors",
        "officialTitle": "A Study to Evaluate the Relationship Between Cetuximab Therapy and Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors",
        "lillyAlias": []
    },
    "NCT00055419": {
        "briefTitle": "A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer",
        "officialTitle": "A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer",
        "lillyAlias": []
    },
    "NCT02752919": {
        "briefTitle": "Study of Galunisertib in Healthy Participants",
        "officialTitle": "A Single Dose Study to Evaluate the Exposure-Response Relationship Between Galunisertib (LY2157299) and QT Interval in Healthy Japanese and Non-Japanese Subjects",
        "lillyAlias": [
            "H9H-MC-JBEI",
            "2015-005261-23"
        ]
    },
    "NCT03987919": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "I8F-MC-GPGL",
            "2018-004422-29"
        ]
    },
    "NCT05911841": {
        "briefTitle": "A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 52 Week Study to Evaluate the Efficacy and Safety of LY3454738 in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J4E-MC-FR01",
            "FR01 ISA",
            "J4E-MC-IMMB Master Protocol",
            "2022-502888-38-00"
        ]
    },
    "NCT03050619": {
        "briefTitle": "Characteristics of Empagliflozin Initiators",
        "officialTitle": "Characteristics of Patients Initiating Empagliflozin or Other Non-insulin Glucose Lowering Drugs in the United Kingdom",
        "lillyAlias": []
    },
    "NCT00841919": {
        "briefTitle": "Insulin Therapy in the Hospital Comparing Two Protocols",
        "officialTitle": "Basal/Bolus Insulin Therapy in the Hospital Ward Comparison of Two Protocols: Feasibility Study",
        "lillyAlias": []
    },
    "NCT00034619": {
        "briefTitle": "A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-MC-JMEP"
        ]
    },
    "NCT00641719": {
        "briefTitle": "A Long-term Study for the Treatment of Painful Diabetic Neuropathy",
        "officialTitle": "A Superiority Study of LY248686 Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain - Extension Phase",
        "lillyAlias": [
            "F1J-JE-HMFY"
        ]
    },
    "NCT00785941": {
        "briefTitle": "A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available",
        "officialTitle": "Phase I Study of Anti-Insulin-Like Growth Factor-I Receptor (IGF-IR) Monoclonal Antibody IMC-A12 Administered Every Other Week in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom No Standard Therapy is Available",
        "lillyAlias": [
            "CP13-0502",
            "I5A-IE-JAEI"
        ]
    },
    "NCT00099619": {
        "briefTitle": "Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy",
        "officialTitle": "Efficacy of Exenatide Compared With Insulin Glargine in Patients With Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy",
        "lillyAlias": []
    },
    "NCT00718419": {
        "briefTitle": "A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma",
        "officialTitle": "An Open Label, Multicenter Phase 2 Study of Single-Agent Enzastaurin HCl in Previously Treated Waldenstrom's Macroglobulinemia or Multiple Myeloma",
        "lillyAlias": [
            "H6Q-MC-S042"
        ]
    },
    "NCT00607919": {
        "briefTitle": "Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia",
        "officialTitle": "A Double-Blind Placebo Controlled Study of Atomoxetine Hydrochloride for the Treatment of ADHD in Children and Adolescents With ADHD and Comorbid Dyslexia",
        "lillyAlias": [
            "B4Z-US-LYEB"
        ]
    },
    "NCT00670319": {
        "briefTitle": "Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis",
        "officialTitle": "Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "H3S-MC-GGGK"
        ]
    },
    "NCT01528124": {
        "briefTitle": "A Study of LY3025876 in Healthy Volunteers",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of LY3025876 in Healthy Subjects",
        "lillyAlias": [
            "I6D-FW-SMRA"
        ]
    },
    "NCT00540124": {
        "briefTitle": "Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Pilot Study to Evaluate the Efficacy and Safety of Tadalafil and Tamsulosin Once-a-Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVHT"
        ]
    },
    "NCT03482024": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function",
        "officialTitle": "Pharmacokinetics of Tirzepatide Following Administration to Subjects With Impaired Renal Function",
        "lillyAlias": [
            "I8F-MC-GPGG"
        ]
    },
    "NCT00542919": {
        "briefTitle": "A Study for Patients With Non-Hodgkin's Lymphomas",
        "officialTitle": "A Multicenter, Open-label, Noncomparative Study of Enzastaurin in Patients With Non-Hodgkin's Lymphomas",
        "lillyAlias": [
            "H6Q-MC-S057"
        ]
    },
    "NCT03499041": {
        "briefTitle": "A Study of LY3314814 in Participants With Liver Impairment",
        "officialTitle": "Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment",
        "lillyAlias": [
            "I8D-MC-AZEJ"
        ]
    },
    "NCT01452919": {
        "briefTitle": "A Physical Dependence Study in Schizophrenia",
        "officialTitle": "A Phase 3, Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of LY2140023 Monohydrate in Patients With DSM-IV-TR Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBDF"
        ]
    },
    "NCT03402919": {
        "briefTitle": "Comprehensive Assessment of Neurodegeneration and Dementia",
        "officialTitle": "The Comprehensive Assessment of Neurodegeneration and Dementia Study",
        "lillyAlias": []
    },
    "NCT00169819": {
        "briefTitle": "EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study",
        "officialTitle": "A Randomized Trial Comparing Same Day Discharge and a Single Bolus of Abciximab to Overnight Hospitalization and Bolus + Perfusion Abciximab After Uncomplicated Trans-Radial Coronary Artery Stenting",
        "lillyAlias": [
            "ISRCTN72335887"
        ]
    },
    "NCT01746017": {
        "briefTitle": "A Study of LY2922470 in Healthy Participants and Participants With Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of LY2922470 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I6K-FW-GLEA"
        ]
    },
    "NCT04238819": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma",
        "officialTitle": "A Phase 1b/2 Study of Abemaciclib in Combination With Irinotecan and Temozolomide (Part A) and Abemaciclib in Combination With Temozolomide (Part B) in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors and Abemaciclib in Combination With Dinutuximab, GM-CSF, Irinotecan, and Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Neuroblastoma (Part C)",
        "lillyAlias": [
            "I3Y-MC-JPCS",
            "2019-002931-27",
            "2023-506778-11-00"
        ]
    },
    "NCT02069041": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer",
        "officialTitle": "Phase 1b Study of 5-FU/FA and Oxaliplatin (FOLFOX4) Plus Ramucirumab (LY3009806) in Patients With Advanced Hepatocellular Carcinoma",
        "lillyAlias": [
            "I4T-CR-JVCQ"
        ]
    },
    "NCT01263119": {
        "briefTitle": "A Study of LY2216684 and Warfarin in Healthy Subjects",
        "officialTitle": "Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCF"
        ]
    },
    "NCT00523419": {
        "briefTitle": "Chemotherapy for Patients With Osteosarcoma",
        "officialTitle": "Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas",
        "lillyAlias": [
            "H3E-EW-S115"
        ]
    },
    "NCT03448419": {
        "briefTitle": "This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms",
        "officialTitle": "A Phase III Randomised, Double-blind Trial to Evaluate the Effect of 12 Weeks Treatment of Once Daily EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Reduced Ejection Fraction (HFrEF) (EMPERIAL-reduced)",
        "lillyAlias": [
            "2017-004073-14"
        ]
    },
    "NCT05372419": {
        "briefTitle": "A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color",
        "officialTitle": "An Open-Label, 24-Week Study to Investigate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color",
        "lillyAlias": [
            "J2T-MC-KGBP"
        ]
    },
    "NCT00965419": {
        "briefTitle": "A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder",
        "officialTitle": "Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "H9P-MC-LNDH"
        ]
    },
    "NCT00190918": {
        "briefTitle": "A Trial for Patients With Gestational Trophoblastic Disease",
        "officialTitle": "A Phase II Trial of Pemetrexed (Alimta) in the Treatment of Recurrent or Persistent Low Risk Gestational Trophoblastic Tumor",
        "lillyAlias": [
            "H3E-US-JMGR"
        ]
    },
    "NCT02119819": {
        "briefTitle": "A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes",
        "officialTitle": "Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "2013-003552-21",
            "I7I-MC-XNAA"
        ]
    },
    "NCT01855919": {
        "briefTitle": "A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain",
        "officialTitle": "Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan",
        "lillyAlias": [
            "F1J-JE-HMGY"
        ]
    },
    "NCT01183013": {
        "briefTitle": "30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks",
        "officialTitle": "A Randomised, Double-blind Parallel Group Study to Compare the Efficacy and Safety of Initial Combination Therapy With Linagliptin 5 mg + Pioglitazone 15 mg, 30 mg, or 45 mg, vs. Monotherapy With Pioglitazone (15 mg, 30 mg, or 45 mg) or Linagliptin 5 mg Once Daily for 30 Weeks, Followed by a Blinded Trial Period on Linagliptin 5 mg + Pioglitazone 30 or 45 mg Versus Pioglitazone Monotherapy 30 or 45 mg or Linagliptin 5 mg for up to 54 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control on Diet and Exercise",
        "lillyAlias": [
            "2008-008127-15"
        ]
    },
    "NCT00609518": {
        "briefTitle": "A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer",
        "officialTitle": "Pemetrexed With Simplified Folate and Dexamethasone Supplementation Versus Pemetrexed With Standard Supplementation as Second-line Chemotherapy for Patients With Non-squamous Non-small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-CR-S111"
        ]
    },
    "NCT02562313": {
        "briefTitle": "A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog\u00ae",
        "officialTitle": "A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog\u00ae",
        "lillyAlias": []
    },
    "NCT02778113": {
        "briefTitle": "A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults",
        "officialTitle": "A Single Site, Randomized, Four-Way, Four-Period PK/PD Crossover Phase 1 Clinical Study in 16 Fasted Healthy Adult Volunteers Receiving 3 Dose Levels of Intranasally Administered Glucagon and One Dose Level of Glucagon Administered by Subcutaneous Injection",
        "lillyAlias": [
            "I8R-MC-IGBD",
            "AMG 101",
            "GUO-P1-557"
        ]
    },
    "NCT02758613": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Healthy Chinese Participants",
        "officialTitle": "A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3009104 in Healthy Chinese Subjects",
        "lillyAlias": [
            "I4V-GH-JAGR"
        ]
    },
    "NCT01469013": {
        "briefTitle": "Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2 Study of Baricitinib (LY3009104) in Japanese Patients With Active Rheumatoid Arthritis on Background Methotrexate Therapy",
        "lillyAlias": [
            "I4V-JE-JADN"
        ]
    },
    "NCT05630196": {
        "briefTitle": "A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3857210 for the Treatment of Chronic Low Back Pain",
        "lillyAlias": [
            "H0P-MC-BP05"
        ]
    },
    "NCT01170663": {
        "briefTitle": "A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma",
        "officialTitle": "A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine",
        "lillyAlias": [
            "I4T-IE-JVBE",
            "CP12-0922",
            "2010-020426-18"
        ]
    },
    "NCT00103935": {
        "briefTitle": "Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine Safety and Pharmacokinetics of Exenatide Long-Acting Release Administered Weekly in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT02693535": {
        "briefTitle": "TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer",
        "officialTitle": "Targeted Agent and Profiling Utilization Registry (TAPUR) Study",
        "lillyAlias": []
    },
    "NCT00190658": {
        "briefTitle": "Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome",
        "officialTitle": "Safety and Efficacy of Humatrope in Pediatric Patients With Genetic Short Stature (SHOX Gene Defect)",
        "lillyAlias": [
            "B9R-MC-GDFN"
        ]
    },
    "NCT01682135": {
        "briefTitle": "A Study in Participants With Advanced Solid Tumors",
        "officialTitle": "Phase I Study of Ramucirumab in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I4T-CR-JVBU"
        ]
    },
    "NCT02260635": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia",
        "officialTitle": "A Double-Blind Efficacy and Safety Study of Evacetrapib Followed by an Open-Label Extension in Japanese Patients With Primary Hypercholesterolemia",
        "lillyAlias": [
            "I1V-JE-EIBI"
        ]
    },
    "NCT02482935": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food",
        "officialTitle": "The Effect of Food on the Pharmacokinetics of the Proposed Commercial Formulation of Abemaciclib in Healthy Subjects",
        "lillyAlias": [
            "I3Y-MC-JPBU"
        ]
    },
    "NCT00051558": {
        "briefTitle": "Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis",
        "officialTitle": "Comparison of the Effects of Teriparatide With Those of Alendronate Sodium on Lumbar Spine Bone Mineral Density in Glucocorticoid-Induced Osteoporosis",
        "lillyAlias": [
            "B3D-US-GHBZ"
        ]
    },
    "NCT03334396": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAHL",
            "2017-000870-12"
        ]
    },
    "NCT00148135": {
        "briefTitle": "Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site",
        "officialTitle": "A Phase II Trial Evaluating the Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site",
        "lillyAlias": []
    },
    "NCT00988858": {
        "briefTitle": "A Study of Advanced or Metastatic Non-small Cell Lung Cancer",
        "officialTitle": "A Phase 2 Study to Evaluate LY2603618 in Combination With Pemetrexed in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",
        "lillyAlias": [
            "I2I-MC-JMMD"
        ]
    },
    "NCT02818335": {
        "briefTitle": "A Study of LY3023414 Formulations and the Effect of Food",
        "officialTitle": "Relative Bioavailability and the Effect of Food on the Bioavailability of LY3023414 in Healthy Subjects",
        "lillyAlias": [
            "I6A-EW-CBBB"
        ]
    },
    "NCT01125358": {
        "briefTitle": "A Study in Schizophrenic Patients",
        "officialTitle": "A Multicenter, Double-Blind, Placebo-Controlled Study of 3 Doses of LY2140023 in Patients With DSM-IV-TR Schizophrenia",
        "lillyAlias": [
            "H8Y-JE-HBDC"
        ]
    },
    "NCT00382135": {
        "briefTitle": "A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg",
        "officialTitle": "An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil",
        "lillyAlias": [
            "H6D-MC-LVFE"
        ]
    },
    "NCT04701658": {
        "briefTitle": "A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)",
        "officialTitle": "A Prospective Cohort Study to Evaluate the Real-world Effectiveness of Bamlanivimab in Participants With Mild-to-moderate COVID-19 at High Risk for Progressing to Severe Illness, With Matched Controls",
        "lillyAlias": [
            "J2X-MC-PYAJ"
        ]
    },
    "NCT00507858": {
        "briefTitle": "Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer",
        "officialTitle": "A Phase I Dose Escalation Study of Pemetrexed in Patients With Advanced Head and Neck Squamous Cell Cancer",
        "lillyAlias": []
    },
    "NCT05362058": {
        "briefTitle": "A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time",
        "officialTitle": "A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Na\u00efve Adults With Type 2 Diabetes",
        "lillyAlias": [
            "I8H-MC-BDCX",
            "2021-005891-21"
        ]
    },
    "NCT00540241": {
        "briefTitle": "Performance Status During Treatment With Pemetrexed in Patients With NSCLC",
        "officialTitle": "Performance Status and Influencing Factors During Second-Line Treatment With Pemetrexed in Patients With Stage III/IVNon Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-SB-B007"
        ]
    },
    "NCT00116519": {
        "briefTitle": "A Study in People With Abnormal Fat Levels in the Blood",
        "officialTitle": "PPAR Alpha: A Phase 2 Dose-Finding and Safety Study for Atherogenic Dyslipidemia by Eli Lilly",
        "lillyAlias": [
            "H8D-MC-EMBB"
        ]
    },
    "NCT06602219": {
        "briefTitle": "A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study of LY4100511 (DC-853) for the Treatment of Adult Participants With Moderate-to Severe Plaque Psoriasis",
        "lillyAlias": [
            "J5C-MC-FOAB"
        ]
    },
    "NCT02304419": {
        "briefTitle": "A Study of Galunisertib on the Immune System in Participants With Cancer",
        "officialTitle": "Phase 1 Study to Determine the Immunomodulatory Activity of LY2157299 Monohydrate in Patients With Solid Tumors",
        "lillyAlias": [
            "H9H-MC-JBAT"
        ]
    },
    "NCT00765817": {
        "briefTitle": "Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications",
        "lillyAlias": []
    },
    "NCT00560417": {
        "briefTitle": "Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide",
        "officialTitle": "A Randomized Trial Comparing Insulin Lispro Protamine Suspension With Insulin Glargine in Subjects With Type 2 Diabetes on Oral Antihyperglycemic Medications and Exenatide",
        "lillyAlias": [
            "F3Z-US-IOPB"
        ]
    },
    "NCT00102219": {
        "briefTitle": "A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer",
        "officialTitle": "A Phase 2 Study of ALIMTA Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer",
        "lillyAlias": [
            "H3E-MC-JMGV"
        ]
    },
    "NCT03740919": {
        "briefTitle": "A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes",
        "lillyAlias": [
            "I8B-MC-ITSB",
            "2018-002371-18"
        ]
    },
    "NCT00190619": {
        "briefTitle": "Efficacy and Safety of Duloxetine",
        "officialTitle": "Efficacy and Safety of Duloxetine Compared With Placebo in Subjects Electing Surgery for Severe Pure Genuine Stress Incontinence",
        "lillyAlias": [
            "F1J-MC-SBAM"
        ]
    },
    "NCT02291341": {
        "briefTitle": "Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition",
        "officialTitle": "Single Dose Crossover Comparative Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg in Healthy Adult Human Subjects Under Fed Conditions",
        "lillyAlias": []
    },
    "NCT01081041": {
        "briefTitle": "A Study in Head and Neck Cancer",
        "officialTitle": "A Randomized, Double-Blind, Phase 2 Safety Study of Cetuximab, Using ImClone Versus Boehringer Ingelheim Manufacturing Processes, in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First-Line Treatment of Patients With Locoregionally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck",
        "lillyAlias": [
            "I4E-MC-JXBD"
        ]
    },
    "NCT05469113": {
        "briefTitle": "A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants",
        "officialTitle": "An Open-Label, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of LOXO-292 on the Single Dose Pharmacokinetics of Repaglinide in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-OX-JZJS",
            "LOXO-RET-18026"
        ]
    },
    "NCT00191113": {
        "briefTitle": "Somatropin Treatment to Final Height in Turner Syndrome",
        "officialTitle": "Humatrope Treatment to Final Height in Turner's Syndrome",
        "lillyAlias": [
            "#817 B9R-CA-GDCT Core study",
            "#4419 GDCT/1 Addenda"
        ]
    },
    "NCT00351936": {
        "briefTitle": "A Placebo-Controlled, Cross-Over Trial of Aripiprazole",
        "officialTitle": "A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia",
        "lillyAlias": []
    },
    "NCT01609218": {
        "briefTitle": "A Study of LY2140023 in Healthy Participants",
        "officialTitle": "A Study to Evaluate the Impact of Activated Charcoal on the Absorption of LY2140023 in Healthy Subjects",
        "lillyAlias": [
            "H8Y-MC-HBCZ"
        ]
    },
    "NCT00176813": {
        "briefTitle": "Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer",
        "officialTitle": "Phase II Study of Gemcitabine, Cisplatin, and Celecoxib in the Treatment of Metastatic Pancreatic Cancer",
        "lillyAlias": [
            "C2442"
        ]
    },
    "NCT05978713": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Healthy Lactating Females",
        "officialTitle": "A Study to Evaluate Tirzepatide Concentrations in Breastmilk Following Administration of Single Dose of Tirzepatide by Subcutaneous Injection in Healthy Lactating Females",
        "lillyAlias": [
            "I8F-MC-GPIN"
        ]
    },
    "NCT02518113": {
        "briefTitle": "A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL",
        "officialTitle": "A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination With Dexamethasone in T-ALL/T-LBL Patients",
        "lillyAlias": [
            "I6F-MC-JJCB",
            "2014-005024-10"
        ]
    },
    "NCT01475136": {
        "briefTitle": "A Study of LY2140023 in Hepatically-Impaired Participants",
        "officialTitle": "A Single Dose Pharmacokinetic Study of LY2140023 in Subjects With Hepatic Impairment",
        "lillyAlias": [
            "H8Y-MC-HBCH",
            "2011-003033-34"
        ]
    },
    "NCT03073213": {
        "briefTitle": "A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris",
        "officialTitle": "A Phase 1, Single- and Multiple-Dose Study to Assess the Safety and Pharmacokinetics of Ixekizumab (LY2439821) (Anti-IL-17 Humanized Antibody) in Chinese Patients With Psoriasis Vulgaris",
        "lillyAlias": [
            "I1F-MC-RHBN"
        ]
    },
    "NCT00191919": {
        "briefTitle": "A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain",
        "officialTitle": "A Ten-Week, Randomized, Double-Blind Study Evaluating the Efficacy of Duloxetine 60mg Once Daily Versus Placebo in Outpatients With Major Depressive Disorder and Pain",
        "lillyAlias": [
            "F1J-BI-HMDH"
        ]
    },
    "NCT04844918": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease",
        "officialTitle": "Efficacy and Safety of Once-Weekly Tirzepatide in Participants With Obesity Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-J)",
        "lillyAlias": [
            "I8F-JE-GPHZ"
        ]
    },
    "NCT00452413": {
        "briefTitle": "A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer",
        "officialTitle": "A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy",
        "lillyAlias": [
            "H6Q-MC-S030"
        ]
    },
    "NCT03343613": {
        "briefTitle": "A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination With Anti- PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors",
        "lillyAlias": [
            "I9L-MC-JZCA",
            "2017-002693-39"
        ]
    },
    "NCT00447213": {
        "briefTitle": "A Study for Patients With Type 1 Diabetes Mellitus",
        "officialTitle": "A Crossover Study to Evaluate the Efficacy and Safety of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "H7U-JE-IDBB"
        ]
    },
    "NCT02836613": {
        "briefTitle": "A Study of Galcanezumab in Healthy Participants.",
        "officialTitle": "Pharmacokinetics and Pharmacodynamics of LY2951742 (Galcanezumab) in Healthy Subjects Following Subcutaneous Administration of LY2951742 (Galcanezumab) Solution in a Prefilled Syringe or an Autoinjector",
        "lillyAlias": [
            "I5Q-MC-CGAQ"
        ]
    },
    "NCT00037713": {
        "briefTitle": "Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG",
        "officialTitle": "The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG",
        "lillyAlias": []
    },
    "NCT06516913": {
        "briefTitle": "A Study of Subcutaneous Injection in Healthy Participants",
        "officialTitle": "A Randomized, Participant-Blinded Study to Investigate the Effects of Subcutaneous Injection Volume, Injection Rate, and Needle Length on Pain in Healthy Participants",
        "lillyAlias": [
            "J3G-MC-S004"
        ]
    },
    "NCT01080313": {
        "briefTitle": "Head and Neck Cancer Registry (LORHAN)",
        "officialTitle": "Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer",
        "lillyAlias": [
            "I4E-US-S003"
        ]
    },
    "NCT06721013": {
        "briefTitle": "A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia",
        "officialTitle": "A Phase 1/2, Dose-finding Study Investigating the Safety and Efficacy of Pirtobrutinib in Adults With Immune Thrombocytopenia",
        "lillyAlias": [
            "J2N-MC-JZNZ"
        ]
    },
    "NCT00494013": {
        "briefTitle": "Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)",
        "officialTitle": "Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IOOY"
        ]
    },
    "NCT05616013": {
        "briefTitle": "Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of Intravenous Bimagrumab, Alone or in Addition to Open Label Subcutaneous Semaglutide, to Investigate the Efficacy and Safety in Overweight or Obese Men and Women",
        "lillyAlias": [
            "J4Z-MC-GIDA",
            "VER201-PH2-031"
        ]
    },
    "NCT00864513": {
        "briefTitle": "Study of Pemetrexed for Second-Line Pancreas Cancer",
        "officialTitle": "A Phase II Study of Pemetrexed as Second-Line Treatment in Patients With Pancreatic Cancer Progressing Despite Therapy With Gemcitabine",
        "lillyAlias": [
            "2007-022"
        ]
    },
    "NCT01970241": {
        "briefTitle": "Inpatient Diabetes on Corticosteroids",
        "officialTitle": "Inpatient Diabetes on Corticosteroids",
        "lillyAlias": []
    },
    "NCT00805441": {
        "briefTitle": "A Study in the Treatment of Alcohol Dependence.",
        "officialTitle": "A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence",
        "lillyAlias": [
            "H8R-MC-HJAQ"
        ]
    },
    "NCT00122824": {
        "briefTitle": "Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder",
        "officialTitle": "Duloxetine Hydrochloride 60 mg or 120 mg Once Daily Compared With Placebo in Patients With Generalized Anxiety Disorder.",
        "lillyAlias": [
            "F1J-MC-HMBR"
        ]
    },
    "NCT00079924": {
        "briefTitle": "Effects of Teriparatide in Postmenopausal Women With Osteoporosis",
        "officialTitle": "Effects of Teriparatide in Postmenopausal Women With Osteoporosis Previously Treated With Alendronate or Raloxifene",
        "lillyAlias": [
            "B3D-MC-GHCM"
        ]
    },
    "NCT00034541": {
        "briefTitle": "Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer",
        "officialTitle": "Phase Ib/IIa Study of an Anti-Epidermal Growth Factor Receptor (EGFr) Antibody Cetuximab in Combination With Carboplatin-Paclitaxel in Patients With Chemotherapy-Naive Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT01326117": {
        "briefTitle": "Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis",
        "officialTitle": "Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis",
        "lillyAlias": []
    },
    "NCT01662817": {
        "briefTitle": "Major Depressive Disorder (MDD)",
        "officialTitle": "Effectiveness of Physicians' Education, Implementation and Follow up of Current Recommendations Regarding Screening for Major Depressive Disorder in High Risk Patients on Improving the Under-Recognition Rates of Depression in Primary Care",
        "lillyAlias": [
            "H6U-XM-S007"
        ]
    },
    "NCT00191841": {
        "briefTitle": "Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy",
        "officialTitle": "Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy in Operable Non Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-VI-S327"
        ]
    },
    "NCT00320541": {
        "briefTitle": "A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer",
        "officialTitle": "A Randomized Phase II Trial of Paclitaxel and Bevacizumab Versus Gemcitabine, Paclitaxel, and Bevacizumab as First Line Treatment for Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-US-S377"
        ]
    },
    "NCT00176241": {
        "briefTitle": "Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer",
        "officialTitle": "A Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent Head & Neck Cancer",
        "lillyAlias": []
    },
    "NCT04033341": {
        "briefTitle": "A Study of LY3214996 in Healthy Participants",
        "officialTitle": "Disposition of [14C]-LY3214996 Following Oral Administration in Healthy Male Subjects",
        "lillyAlias": [
            "I8S-MC-JUAD"
        ]
    },
    "NCT06158113": {
        "briefTitle": "Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study",
        "officialTitle": "Efficacy and Safety of Baricitinib for the Treatment of Oral Lichen Planus: A Proof-of-Concept Study",
        "lillyAlias": []
    },
    "NCT01177813": {
        "briefTitle": "Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 10773 and Sitagliptin Administered Orally Over 24 Weeks, in Drug na\u00efve Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Diet and Exercise",
        "lillyAlias": [
            "2009-016243-20"
        ]
    },
    "NCT03456713": {
        "briefTitle": "A Study of LY3074828 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of 1- and 2-mL Injections of LY3074828 Solution Using Investigational Pre-filled Syringes and Investigational Autoinjectors in Healthy Subjects",
        "lillyAlias": [
            "I6T-MC-AMAQ"
        ]
    },
    "NCT00192036": {
        "briefTitle": "Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer",
        "officialTitle": "Multicenter Phase II Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-BX-JHSQ"
        ]
    },
    "NCT01419236": {
        "briefTitle": "A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency",
        "lillyAlias": [
            "I5E-MC-TSAB"
        ]
    },
    "NCT03292536": {
        "briefTitle": "Merestinib on Bone Metastases in Subjects With Breast Cancer",
        "officialTitle": "An Exploratory Phase 1B Study to Assess the Effects of Merestinib on Bone Metastases in Subjects With Breast Cancer",
        "lillyAlias": []
    },
    "NCT04874636": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain",
        "lillyAlias": [
            "H0P-MC-BP03"
        ]
    },
    "NCT04481113": {
        "briefTitle": "Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer",
        "officialTitle": "A Phase 1 Study of Abemaciclib and Niraparib As Neoadjuvant Therapy in Hormone Receptor Positive (HR+) HER2 Negative (HER2-) Breast Cancer",
        "lillyAlias": [
            "NCI-2020-03813",
            "STUDY00021243"
        ]
    },
    "NCT06292013": {
        "briefTitle": "A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event - ACCLAIM-Lp(a)",
        "lillyAlias": [
            "J3L-MC-EZEF",
            "2023-509190-23"
        ]
    },
    "NCT00415636": {
        "briefTitle": "Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer",
        "officialTitle": "A Phase 1 Dose-Escalation Study to Examine the Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer",
        "lillyAlias": [
            "I2I-MC-JMMB"
        ]
    },
    "NCT00922636": {
        "briefTitle": "A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder",
        "officialTitle": "A Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "H9P-MC-LNBF"
        ]
    },
    "NCT04106219": {
        "briefTitle": "A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma",
        "officialTitle": "A Phase 1 Study of Aurora Kinase A Inhibitor LY3295668 Erbumine as a Single Agent and in Combination in Patients With Relapsed/Refractory Neuroblastoma",
        "lillyAlias": [
            "J1O-MC-JZHD",
            "2019-001042-18",
            "2019-01",
            "ITCC-085"
        ]
    },
    "NCT00216918": {
        "briefTitle": "Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.",
        "officialTitle": "An Open-Label Pilot Study of Atomoxetine Hydrochloride to Evaluate Neuropsychological Function in Children Ages 6 to 10 Years With Attention-Deficit/Hyperactivity Disorder.",
        "lillyAlias": [
            "B4Z-CA-S013"
        ]
    },
    "NCT00636818": {
        "briefTitle": "Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "An Open Study of Atomoxetine (LY139603) in Adult Subjects With Attention-deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-JE-LYEH"
        ]
    },
    "NCT00391118": {
        "briefTitle": "Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo (\"Sugar Pill\")",
        "officialTitle": "A Randomized, Phase 2, Placebo-Controlled, Double-Blinded Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin as First-Line Treatment, Followed by Maintenance Treatment in Advanced Ovarian Cancer",
        "lillyAlias": [
            "H6Q-MC-S019"
        ]
    },
    "NCT00666718": {
        "briefTitle": "A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients",
        "officialTitle": "A Prospective Randomized Trial to Compare Basal Bolus Therapies That Use Either Insulin Lispro Protamine Suspension or Insulin Glargine Together With Lispro Insulin in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "F3Z-EW-IOPJ"
        ]
    },
    "NCT00642018": {
        "briefTitle": "A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer",
        "officialTitle": "A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Hormone Refractory Prostate Cancer",
        "lillyAlias": [
            "H8Z-MC-JACR"
        ]
    },
    "NCT02008318": {
        "briefTitle": "A Study of Galunisertib in Participants With Myelodysplastic Syndromes",
        "officialTitle": "Phase 2/3 Study of Monotherapy LY2157299 Monohydrate in Very Low-, Low-, and Intermediate-Risk Patients With Myelodysplastic Syndromes",
        "lillyAlias": [
            "H9H-MC-JBAV",
            "2013-003235-30"
        ]
    },
    "NCT02543918": {
        "briefTitle": "A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants",
        "officialTitle": "Vaccination Response Following Administration of Ixekizumab to Healthy Subjects",
        "lillyAlias": [
            "I1F-MC-RHCA"
        ]
    },
    "NCT03286218": {
        "briefTitle": "A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users",
        "officialTitle": "A Randomized, Subject- and Investigator-Blind, Placebo and Active-Controlled Study to Assess the Abuse Potential of Lasmiditan",
        "lillyAlias": [
            "H8H-MC-LAHB"
        ]
    },
    "NCT00870155": {
        "briefTitle": "A Study for Patients With Multiple Sclerosis",
        "officialTitle": "An Open Label Follow-On Study to Assess the Ongoing Safety of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis",
        "lillyAlias": [
            "I3E-BM-MSAC",
            "2007-001480-30",
            "MBP8298-SP-02"
        ]
    },
    "NCT04662255": {
        "briefTitle": "Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)",
        "officialTitle": "A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Na\u00efve Mantle Cell Lymphoma (BRUIN MCL-321)",
        "lillyAlias": [
            "J2N-OX-JZNM"
        ]
    },
    "NCT01947855": {
        "briefTitle": "Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomised, Double-blind, Placebo-controlled, Parallel Group, 4-week Study to Evaluate the Efficacy of Empagliflozin (10 mg and 25 mg Administered Orally Once Daily) in Postprandial Glucose and 24-hour Glucose Variability in Japanese Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control",
        "lillyAlias": []
    },
    "NCT01215955": {
        "briefTitle": "Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes",
        "officialTitle": "Two Approaches to Escalate Lispro Therapy in Patients With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on Basal Insulin Therapy and Oral Agents Alone (AUTONOMY)",
        "lillyAlias": [
            "F3Z-MC-IOQC"
        ]
    },
    "NCT01674738": {
        "briefTitle": "TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV",
        "officialTitle": "TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV",
        "lillyAlias": [
            "2011-002145-35"
        ]
    },
    "NCT00191438": {
        "briefTitle": "Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents",
        "officialTitle": "Phase III Study of Docetaxel in Combination With Gemcitabine Versus Docetaxel in Combination With Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-MC-S273"
        ]
    },
    "NCT02779738": {
        "briefTitle": "A Study of Merestinib (LY2801653) in Healthy Participants",
        "officialTitle": "The Effect of Food on the Bioavailability of Merestinib in Healthy Subjects",
        "lillyAlias": [
            "I3O-MC-JSBH"
        ]
    },
    "NCT00977938": {
        "briefTitle": "The Dual Antiplatelet Therapy Study (DAPT Study)",
        "officialTitle": "A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions",
        "lillyAlias": []
    },
    "NCT02576938": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAHG"
        ]
    },
    "NCT05563246": {
        "briefTitle": "A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events",
        "officialTitle": "KRAKEN: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Oral Once-Daily LY3473329 in Adults With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events",
        "lillyAlias": [
            "J2O-MC-EKBC"
        ]
    },
    "NCT02224846": {
        "briefTitle": "A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction",
        "officialTitle": "Postmarketing Surveillance Study: A Randomized, Open-Label, 3-Month Interventional Study of Tadalafil Effectiveness (2.5 mg and 5 mg) and Long-Term Safety Administered Once Daily in Chinese Men With Erectile Dysfunction",
        "lillyAlias": [
            "H6D-GH-B022"
        ]
    },
    "NCT01287546": {
        "briefTitle": "A Study of LY2875358 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2875358 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I4C-MC-JTBA"
        ]
    },
    "NCT01107912": {
        "briefTitle": "Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease",
        "officialTitle": "A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Very Elderly Versus Non-Elderly Aspirin-Treated Subjects With Stable Coronary Artery Disease",
        "lillyAlias": [
            "H7T-MC-TACY"
        ]
    },
    "NCT02453555": {
        "briefTitle": "Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase III, Randomised, Double-blind, Parallel Group, 52 Week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin and Linagliptin Fixed Dose Combination Compared With Linagliptin Plus Placebo in Japanese Type 2 Diabetes Mellitus Patients With Insufficient Glycaemic Control After 16 Weeks Treatment With Once Daily Linagliptin 5 mg.",
        "lillyAlias": []
    },
    "NCT03689855": {
        "briefTitle": "Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC",
        "officialTitle": "Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC (RamAtezo-1)",
        "lillyAlias": []
    },
    "NCT00191555": {
        "briefTitle": "Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment",
        "officialTitle": "Double-Blind Long-term Study Comparing the Efficacy and Safety of Olanzapine Versus Haloperidol in Patients With Schizophrenia Previously Stabilized With Conventional Antipsychotic Treatment",
        "lillyAlias": [
            "F1D-FP-S029"
        ]
    },
    "NCT01247272": {
        "briefTitle": "90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions",
        "officialTitle": "A Relative Bioavailability Study of 90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions",
        "lillyAlias": []
    },
    "NCT01127646": {
        "briefTitle": "A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents",
        "officialTitle": "Assessing the Effect of Missing Doses (Off-Days) of Daily Medication in Patients Stable on Pharmacotherapy for ADHD Receiving Atomoxetine or OROS Methylphenidate: A Parallel Matched Group Clinical Study (On/Off Study)",
        "lillyAlias": [
            "B4Z-EW-LYEN",
            "2009-011426-33"
        ]
    },
    "NCT05714072": {
        "briefTitle": "A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis",
        "officialTitle": "A Phase I Study of Ruxolitinib Plus Abemaciclib for Patients With Primary or Post-polycythemia Vera/Essential Thrombocythemia Myelofibrosis",
        "lillyAlias": []
    },
    "NCT00079872": {
        "briefTitle": "Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer",
        "officialTitle": "A Randomized Phase 2 Trial of ALIMTA Plus a Comparator Versus Leucovorin Modulated Fluorouracil Plus a Comparator in First Line Treatment of Locally Advanced or Metastatic Colorectal Cancer",
        "lillyAlias": [
            "H3E-MC-JMAZ"
        ]
    },
    "NCT04823208": {
        "briefTitle": "A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)",
        "officialTitle": "A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J1I-JE-GZBC"
        ]
    },
    "NCT01874938": {
        "briefTitle": "A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer",
        "officialTitle": "A Non-Randomized, Open-Label, Single-Arm, Phase 2 Study of LY2875358 in Patients With MET Diagnostic Positive, Advanced Gastric Cancer",
        "lillyAlias": [
            "I4C-JE-JTBE"
        ]
    },
    "NCT03018938": {
        "briefTitle": "A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "Comparison Between Basal Insulin Analog and Insulin Analog Mid Mixture AS Starter Insulin for Chinese Patients With Type 2 Diabetes Mellitus (CLASSIC Study)",
        "lillyAlias": [
            "F3Z-GH-IOQR"
        ]
    },
    "NCT00676338": {
        "briefTitle": "Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)",
        "officialTitle": "Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT01205438": {
        "briefTitle": "A Study of LY2127399 in Participants With Systemic Lupus Erythematosus",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients With Systemic Lupus Erythematosus (SLE)",
        "lillyAlias": [
            "H9B-MC-BCDT"
        ]
    },
    "NCT02959190": {
        "briefTitle": "A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine",
        "officialTitle": "A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 (Galcanezumab) in Japanese Patients With Migraine",
        "lillyAlias": [
            "I5Q-JE-CGAP"
        ]
    },
    "NCT01921790": {
        "briefTitle": "Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma",
        "officialTitle": "An Open-Label, Uncontrolled, Single Centered Phase \u2161 Study of Avastin Combined With Gemcitabine, Oxaliplatin, Pegaspargase and Dexamethasone (Avastin+ GemAOD) As First-Line Treatment in Patients With Untreated NK/T Cell Lymphoma",
        "lillyAlias": []
    },
    "NCT06007638": {
        "briefTitle": "A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants",
        "officialTitle": "A Randomised Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3876602 in Healthy Participants",
        "lillyAlias": [
            "J4K-MC-LALA",
            "2023-504838-21-00"
        ]
    },
    "NCT01266590": {
        "briefTitle": "A Study of LY2216684 and Digoxin in Healthy Subjects",
        "officialTitle": "Effect of LY2216684 on the Pharmacokinetics of Digoxin in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCK"
        ]
    },
    "NCT01824290": {
        "briefTitle": "A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)",
        "officialTitle": "A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension",
        "lillyAlias": [
            "H6D-MC-LVHV",
            "2012-002354-23"
        ]
    },
    "NCT01035138": {
        "briefTitle": "A Study of Semagacestat for Alzheimer's Patients",
        "officialTitle": "Open-Label Extension for Alzheimer's Disease Patients Who Complete One of Two Semagacestat Phase 3 Double-Blind Studies (H6L-MC-LFAN or H6L-MC-LFBC)",
        "lillyAlias": [
            "H6L-MC-LFBF"
        ]
    },
    "NCT00255138": {
        "briefTitle": "Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects",
        "officialTitle": "Efficacy of Atomoxetine Therapy Versus Placebo For Ameliorating Cognitive Late Effects Among Survivors of Childhood Cancers",
        "lillyAlias": []
    },
    "NCT02266472": {
        "briefTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and Female",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release (10 mg/1000 mg) Compared With the Free Combination of Empagliflozin and Metformin Extended Release Tablets in Healthy Subjects Following a High-fat, High-caloric Meal (an Open-label, Randomised, Single Dose, Crossover Trial)",
        "lillyAlias": [
            "2014-002360-32"
        ]
    },
    "NCT01158404": {
        "briefTitle": "Notch Inhibitor in Advanced Cancer",
        "officialTitle": "Phase 1 Study of a Notch Inhibitor in Patients With Advanced Cancer",
        "lillyAlias": [
            "I3F-MC-JSRB"
        ]
    },
    "NCT01253304": {
        "briefTitle": "A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment",
        "officialTitle": "A Single Dose Pharmacokinetic Study of LY2189265 in Subjects With Varying Degrees of Hepatic Impairment",
        "lillyAlias": [
            "H9X-EW-GBDO"
        ]
    },
    "NCT00354406": {
        "briefTitle": "Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty",
        "officialTitle": "A Randomized Trial Comparing the Efficacy on Myocardial Infarct Size Reduction of Early vs. Late Abciximab Administration During Primary Percutaneous Coronary Angioplasty",
        "lillyAlias": []
    },
    "NCT00193206": {
        "briefTitle": "Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer",
        "officialTitle": "Phase II Trial of Dose Dense Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer",
        "lillyAlias": []
    },
    "NCT01632306": {
        "briefTitle": "A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer",
        "officialTitle": "Phase I/II Study of LY2090314 and Chemotherapy in Metastatic Pancreatic Cancer Patients With Metastases Amenable to Biopsy",
        "lillyAlias": [
            "I2H-MC-JWYD"
        ]
    },
    "NCT01984606": {
        "briefTitle": "Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase IIIb Randomised, Double-blind, Active-controlled, Parallel Group, Efficacy and Safety Study of Once Daily Oral Administration of Empagliflozin 25 mg Compared to Sitagliptin 100 mg During 52 Weeks in Type 2 Diabetes Mellitus Patients Who Are Treatment-na\u00efve or on Treatment With Metformin With Insufficient Glycaemic Control",
        "lillyAlias": [
            "2013-000060-29"
        ]
    },
    "NCT00409006": {
        "briefTitle": "Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers",
        "officialTitle": "A Phase 2 Trial of Pemetrexed and Cisplatin Followed Sequentially by Gefitinib Versus Pemetrexed and Cisplatin in Asian \"Never Smoker\" Patients With Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-AA-S110"
        ]
    },
    "NCT02561806": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "A 52-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Ustekinumab in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBS",
            "2015-000892-28"
        ]
    },
    "NCT00034606": {
        "briefTitle": "Comparing 3 Schedules of Alimta Plus Gemzar",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-MC-JMEL"
        ]
    },
    "NCT00003906": {
        "briefTitle": "Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women",
        "officialTitle": "Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer",
        "lillyAlias": [
            "CDR0000067081"
        ]
    },
    "NCT01263106": {
        "briefTitle": "A Study of LY2216684 and Theophylline in Healthy Subjects",
        "officialTitle": "Effect of LY2216684 on the Pharmacokinetics of Theophylline in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCE"
        ]
    },
    "NCT00277706": {
        "briefTitle": "Impact of Parathyroid Hormone (PTH) on Osseous Cavity",
        "officialTitle": "Impact of Parathyroid Hormone (1-34) on Osseous Regeneration in the Oral Cavity",
        "lillyAlias": []
    },
    "NCT04844606": {
        "briefTitle": "A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)",
        "officialTitle": "A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the Long-term Efficacy and Safety of Mirikizumab in Children and Adolescents With Moderate-to-severe Ulcerative Colitis or Crohn's Disease",
        "lillyAlias": [
            "I6T-MC-AMAZ",
            "2020-005311-49",
            "ISA-1 UC",
            "ISA-2 CD"
        ]
    },
    "NCT00051506": {
        "briefTitle": "ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-US-JMFW"
        ]
    },
    "NCT00186017": {
        "briefTitle": "Short Term Rescue Study of Olanzapine",
        "officialTitle": "Double-Blind Placebo-Controlled Olanzapine Add-on Therapy in the Treatment of Acute Syndromal and Subsyndromal Exacerbations in Bipolar Disorders",
        "lillyAlias": [
            "F1D-US-X279"
        ]
    },
    "NCT02791334": {
        "briefTitle": "A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of a Novel Anti-PD-L1 Checkpoint Antibody (LY3300054) Administered Alone or in Combination With Other Agents in Advanced Refractory Solid Tumors (Phase 1a/1b Anti-PD-L1 Combinations in Tumors-PACT)",
        "lillyAlias": [
            "I8J-MC-JYCA",
            "2016-000440-33"
        ]
    },
    "NCT01591317": {
        "briefTitle": "Study of Prasugrel in Korean Healthy Male Volunteers",
        "officialTitle": "Single and Multiple Dose Pharmacokinetics and Pharmacodynamics of Prasugrel (LY640315) in Korean Healthy Male Subjects",
        "lillyAlias": [
            "H7T-FW-TACQ"
        ]
    },
    "NCT03443024": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-DM-KGAF",
            "DRM06-AD01"
        ]
    },
    "NCT00481117": {
        "briefTitle": "Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, PK and PD of LY2405319 After Multiple Subcutaneous Injections in Subjects With Type 2 Diabetes",
        "lillyAlias": [
            "I1K-MC-GLUD"
        ]
    },
    "NCT00402116": {
        "briefTitle": "Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients",
        "officialTitle": "Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma",
        "lillyAlias": [
            "H6Q-MC-S008"
        ]
    },
    "NCT02614716": {
        "briefTitle": "A Study of LY3090106 in Participants With Sj\u00f6gren's Syndrome (SS)",
        "officialTitle": "A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3090106 in Subjects With Sj\u00f6gren's Syndrome",
        "lillyAlias": [
            "I6M-MC-SSAD",
            "2015-003523-62"
        ]
    },
    "NCT02020616": {
        "briefTitle": "A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I6I-MC-LMRB"
        ]
    },
    "NCT01602224": {
        "briefTitle": "A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Tabalumab in Combination With Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma",
        "lillyAlias": [
            "H9S-MC-JDCG"
        ]
    },
    "NCT01618916": {
        "briefTitle": "A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol",
        "officialTitle": "A Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3015014 in Japanese and Non-Japanese Subjects With Elevated LDL-C",
        "lillyAlias": [
            "I5S-EW-EFJB"
        ]
    },
    "NCT01215916": {
        "briefTitle": "A Phase 1 Study in Patients With Solid Tumors",
        "officialTitle": "A Phase 1b Study of LY573636-sodium in Combination With Alimta (Pemetrexed) in Patients With Solid Tumors",
        "lillyAlias": [
            "H8K-MC-JZAE"
        ]
    },
    "NCT01448824": {
        "briefTitle": "A Study of LY2484595 on Pharmacokinetics in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Safety and Tolerability of LY2484595 SDSD-PG Tablets and the Effect of CYP3A Inhibition by Ketoconazole on the Pharmacokinetics of LY2484595 in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAL"
        ]
    },
    "NCT05906836": {
        "briefTitle": "A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants",
        "officialTitle": "Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Single Dose Selpercatinib on the Pharmacokinetics of Rosuvastatin in Healthy Participants",
        "lillyAlias": [
            "J2G-MC-JZPB"
        ]
    },
    "NCT05440136": {
        "briefTitle": "A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants",
        "officialTitle": "A Single-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3462817 in Healthy Japanese and Non-Japanese Participants",
        "lillyAlias": [
            "J1A-MC-KDAE"
        ]
    },
    "NCT00176436": {
        "briefTitle": "Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients",
        "officialTitle": "Double-Blind Study of Atomoxetine for Weight Management in Patients Taking Olanzapine or Clozapine",
        "lillyAlias": [
            "F1D-US-X254"
        ]
    },
    "NCT00801736": {
        "briefTitle": "ERCC1 Targeted Trial",
        "officialTitle": "A Multicentre, Randomised, Phase III Trial of Platinum-based Chemotherapy Versus Non-platinum Chemotherapy, After ERCC1 Stratification, in Patients With Advanced/Metastatic Non-small Cell Lung Cancer",
        "lillyAlias": [
            "CRUK-UCL-ET",
            "EUDRACT-2007-007639-17"
        ]
    },
    "NCT06458036": {
        "briefTitle": "Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)",
        "officialTitle": "Selpercatinib to Enhance RAI Avidity in Children, Adolescents, and Young Adults With Newly Diagnosed Differentiated Thyroid Cancers Harboring RET Fusions",
        "lillyAlias": []
    },
    "NCT00088036": {
        "briefTitle": "Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder",
        "officialTitle": "Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Double-Blind Comparison With Placebo",
        "lillyAlias": [
            "F1D-MC-HGKK"
        ]
    },
    "NCT00520936": {
        "briefTitle": "A Study of Pemetrexed in Children With Recurrent Cancer",
        "officialTitle": "A Phase II Study of Pemetrexed in Children With Recurrent Malignancies",
        "lillyAlias": [
            "H3E-MC-JMHW",
            "ADVL0525"
        ]
    },
    "NCT01263236": {
        "briefTitle": "A Study of LY2940094 in Major Depressive Disorder",
        "officialTitle": "A Phase I, Double-Blind, Placebo Controlled, Single and Multiple Oral Dose, Safety, Tolerability, and Pharmacokinetic Study of LY2940094 in Healthy Male Subjects",
        "lillyAlias": [
            "I5J-MC-NOAA"
        ]
    },
    "NCT02008357": {
        "briefTitle": "Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss",
        "officialTitle": "Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)",
        "lillyAlias": [
            "H8A-MC-LZAZ"
        ]
    },
    "NCT05552157": {
        "briefTitle": "A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation",
        "officialTitle": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
        "lillyAlias": [
            "5U01AG059798"
        ]
    },
    "NCT06047548": {
        "briefTitle": "A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities",
        "officialTitle": "A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Once Weekly 5 mg and/or Maximum Tolerated Dose Versus Placebo for Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (SURMOUNT-MAINTAIN)",
        "lillyAlias": [
            "I8F-MC-GPIQ"
        ]
    },
    "NCT01710358": {
        "briefTitle": "A Study in Moderate to Severe Rheumatoid Arthritis",
        "officialTitle": "A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy",
        "lillyAlias": [
            "I4V-MC-JADV"
        ]
    },
    "NCT01991158": {
        "briefTitle": "GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma",
        "officialTitle": "An Open, Single-center, Phase II Clinical Trial for Treatment of Untreated Extranodal NK/T Cell Lymphoma With High Dose of Methotrexate in Combination With Gemcitabine, Pegaspargase and Dexamethasone (GAD-M Regimen)",
        "lillyAlias": []
    },
    "NCT00996658": {
        "briefTitle": "Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone",
        "officialTitle": "A Phase III, Randomised, Double Blind, Placebo Controlled Parallel Group Efficacy and Safety Study of Linagliptin 5 mg Administered Orally Once Daily Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite a Therapy of Metformin in Combination With Pioglitazone",
        "lillyAlias": [
            "2009-013289-20"
        ]
    },
    "NCT02414958": {
        "briefTitle": "Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)",
        "officialTitle": "A Phase III, Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy, Safety and Tolerability Trial of Once Daily, Oral Doses of Empagliflozin as Adjunctive to inSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)",
        "lillyAlias": [
            "2014-001922-14"
        ]
    },
    "NCT02178358": {
        "briefTitle": "A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma",
        "officialTitle": "A Randomized Phase 2 Study of LY2157299 Versus LY2157299 - Sorafenib Combination Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma",
        "lillyAlias": [
            "H9H-MC-JBAS"
        ]
    },
    "NCT03861039": {
        "briefTitle": "A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Long-Term Safety Study of Tirzepatide in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus (SURPASS J-combo)",
        "lillyAlias": [
            "I8F-JE-GPGP"
        ]
    },
    "NCT00577863": {
        "briefTitle": "Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy",
        "officialTitle": "B3D-MC-GHDF: Community Experience of Subjects With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy",
        "lillyAlias": [
            "B3D-MC-GHDF"
        ]
    },
    "NCT00044863": {
        "briefTitle": "Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma",
        "officialTitle": "A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma",
        "lillyAlias": []
    },
    "NCT04146363": {
        "briefTitle": "Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)",
        "officialTitle": "A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis",
        "lillyAlias": [
            "2019-002932-10",
            "J2T-DM-KGAB",
            "DRM06-AD04"
        ]
    },
    "NCT05620563": {
        "briefTitle": "A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3857210 for the Treatment of Osteoarthritis Pain",
        "lillyAlias": [
            "H0P-MC-OA05"
        ]
    },
    "NCT01606436": {
        "briefTitle": "A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia",
        "officialTitle": "A Placebo- and Positive-Controlled Study of the Electrophysiological Effects on the QT Interval After a Supratherapeutic Dose of LY2140023 in Subjects With Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBCG"
        ]
    },
    "NCT03942042": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis",
        "officialTitle": "A Multicenter, Open-Label, Post Marketing Clinical Trial to Evaluate the Efficacy And Safety Of Ixekizumab in Patients With Generalized Pustular Psoriasis and Erythrodermic Psoriasis",
        "lillyAlias": [
            "I1F-JE-RHCV"
        ]
    },
    "NCT01237899": {
        "briefTitle": "Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance",
        "officialTitle": "Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance After Multiple Oral Dosing of LY2623091 in Healthy Volunteers",
        "lillyAlias": [
            "I4M-MC-MRAB"
        ]
    },
    "NCT00627042": {
        "briefTitle": "Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy",
        "officialTitle": "An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B as First Line Monotherapy in Patients With Unresectable Hepatocellular Cancer",
        "lillyAlias": [
            "CP12-0710",
            "I4T-IE-JVBQ"
        ]
    },
    "NCT00672399": {
        "briefTitle": "Electrophysiological Effects of a Single 10 \u03bcg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects",
        "officialTitle": "A Placebo- and Positive-Controlled Study of the Electrophysiological Effects of a Single 10 \u03bcg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects",
        "lillyAlias": []
    },
    "NCT05887999": {
        "briefTitle": "A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Phase 1, Randomized, Placebo-Controlled, 2-Period, Cross-over, Double- Blind, Single-Dose Study to Evaluate the Effects of LY3532226 on Insulin- Induced Hypoglycemia in Participants With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "J2V-MC-GZLC"
        ]
    },
    "NCT05222399": {
        "briefTitle": "A Study of LY3871801 in Healthy Participants",
        "officialTitle": "Pharmacokinetics of LY3871801 Following Oral Administration of a Crystalline Freebase Tablet and a Solid Dispersion Oral Suspension",
        "lillyAlias": [
            "J3P-MC-FTAB"
        ]
    },
    "NCT03955042": {
        "briefTitle": "Pemetrexed for the Treatment of Chordoma",
        "officialTitle": "Pilot Study of Pemetrexed for the Treatment of Chordoma",
        "lillyAlias": [
            "H3E-US-X091"
        ]
    },
    "NCT00489242": {
        "briefTitle": "Prediction of CK-MB Release During Otherwise Successful Stenting Procedure",
        "officialTitle": "PREDICT Trial: Prediction of CK-MB Release During Otherwise Successful Stenting Procedure Correlating With Indicators of Microvascular Obstruction",
        "lillyAlias": [
            "GCO #: 02-1162"
        ]
    },
    "NCT00191399": {
        "briefTitle": "Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response",
        "officialTitle": "Bipolar Depression Assessment Study on Tx Response",
        "lillyAlias": [
            "F1D-SU-HGMA"
        ]
    },
    "NCT00882999": {
        "briefTitle": "A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)",
        "officialTitle": "Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects With Relapsing-Remitting Multiple Sclerosis",
        "lillyAlias": [
            "H9B-MC-BCDJ"
        ]
    },
    "NCT01451606": {
        "briefTitle": "Duloxetine for the Treatment of Chronic Pelvic Pain",
        "officialTitle": "Evaluating Duloxetine's Analgesic Effectiveness in Chronic Pelvic Pain",
        "lillyAlias": []
    },
    "NCT00490399": {
        "briefTitle": "Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas",
        "officialTitle": "A Phase II Trial of GEMZAR Combined With Cisplatin in Patients With Inoperable Biliary Tract Carcinomas",
        "lillyAlias": [
            "B9E-KL-S292"
        ]
    },
    "NCT00296699": {
        "briefTitle": "A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression",
        "officialTitle": "A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression",
        "lillyAlias": []
    },
    "NCT00547599": {
        "briefTitle": "Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects",
        "officialTitle": "Does Presence of Distress Due to Erectile Dysfunction Affect the Effect of Tadalafil on Sexual Life and Life Satisfaction?",
        "lillyAlias": [
            "H6D-SO-LVFR"
        ]
    },
    "NCT00316199": {
        "briefTitle": "Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer",
        "officialTitle": "Phase II Study of Gemcitabine-Paclitaxel 3-Weekly Schedule as First-Line Treatment in Metastatic Breast Cancer After Anthracycline Failure",
        "lillyAlias": [
            "B9E-MC-JHST"
        ]
    },
    "NCT01324999": {
        "briefTitle": "Tadalafil for Sarcoidosis Associated Pulmonary Hypertension",
        "officialTitle": "Tadalafil for Sarcoidosis Associated Pulmonary Hypertension",
        "lillyAlias": []
    },
    "NCT00191542": {
        "briefTitle": "Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents",
        "officialTitle": "A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and Adolescents",
        "lillyAlias": [
            "B4Z-SO-LY15"
        ]
    },
    "NCT00190606": {
        "briefTitle": "Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence",
        "officialTitle": "Efficacy and Safety of Duloxetine Compared With Placebo,Pelvic Floor Muscle Training, and Combined Duloxetine/Pelvic Floor Muscle Training in Subjects With Moderate to Sever Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBAF"
        ]
    },
    "NCT01751399": {
        "briefTitle": "A Single Dose Study of LY2605541 in Participants With Liver Impairment",
        "officialTitle": "A Single Dose Pharmacokinetic Study of LY2605541 in Subjects With Hepatic Impairment",
        "lillyAlias": [
            "I2R-MC-BIDA"
        ]
    },
    "NCT01924299": {
        "briefTitle": "A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants",
        "officialTitle": "The Effect of Ketoconazole or Fluconazole on the Pharmacokinetics of Baricitinib in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGJ"
        ]
    },
    "NCT00455442": {
        "briefTitle": "A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain",
        "officialTitle": "A Two-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain in Healthy Male Volunteers",
        "lillyAlias": []
    },
    "NCT03115099": {
        "briefTitle": "A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes",
        "officialTitle": "A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3325656 After Single Dose in Healthy Subjects and Patients With Type 2 Diabetes",
        "lillyAlias": [
            "I8U-MC-DMBA"
        ]
    },
    "NCT02489942": {
        "briefTitle": "Long Term Daily Use of JARDIANCE\u00ae Tablets in Japanese Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "Post Marketing Surveillance in Japan on Long Term Drug Use of JARDIANCE\u00ae Tablets in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01215942": {
        "briefTitle": "An Open Label Study for Participants With Rheumatoid Arthritis",
        "officialTitle": "A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)",
        "lillyAlias": [
            "H9B-MC-BCDP"
        ]
    },
    "NCT00503399": {
        "briefTitle": "Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis",
        "officialTitle": "Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine vBMD in Glucocorticoid-Induced Osteoporosis in Men",
        "lillyAlias": [
            "B3D-EW-GHDH"
        ]
    },
    "NCT01178099": {
        "briefTitle": "An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults",
        "officialTitle": "A Pharmacokinetic and Pharmacodynamic Assessment of Prasugrel in Healthy Adults and Adults With Sickle Cell Disease",
        "lillyAlias": [
            "H7T-MC-TAEJ"
        ]
    },
    "NCT00910299": {
        "briefTitle": "Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)",
        "officialTitle": "Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent",
        "lillyAlias": [
            "H7T-MC-TACW"
        ]
    },
    "NCT01088399": {
        "briefTitle": "A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults",
        "officialTitle": "The Global Hypopituitary Control and Complications Study",
        "lillyAlias": [
            "B9R-MC-GDGA"
        ]
    },
    "NCT00381342": {
        "briefTitle": "Safety and Efficacy of Exenatide as Monotherapy",
        "officialTitle": "Safety and Efficacy of Exenatide as Monotherapy in Drug Naive Patients With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT02597049": {
        "briefTitle": "A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-MC-GBGE",
            "2015-002095-24"
        ]
    },
    "NCT00887549": {
        "briefTitle": "A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer",
        "officialTitle": "An Exploratory, Prospective Phase II Study to Investigate Progression-Free Survival, Response and Overall Survival Seen With Pemetrexed/Cisplatin and the Role of Thymidylate Synthase Expression",
        "lillyAlias": [
            "H3E-BP-JMIK"
        ]
    },
    "NCT00191906": {
        "briefTitle": "Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)",
        "officialTitle": "A Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder.",
        "lillyAlias": [
            "B4Z-MC-LYCK"
        ]
    },
    "NCT04682106": {
        "briefTitle": "A Study of LY3493269 in Healthy Participants",
        "officialTitle": "A Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of an LY3493269 Formulation in Healthy Participants",
        "lillyAlias": [
            "J1X-MC-GZHF"
        ]
    },
    "NCT04106206": {
        "briefTitle": "A Safety Study of LY3372689 in Healthy Participants",
        "officialTitle": "Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3372689",
        "lillyAlias": [
            "I9X-MC-MTAC"
        ]
    },
    "NCT00190736": {
        "briefTitle": "Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)",
        "officialTitle": "Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months); With a Brief Evaluation of Executive Cognition",
        "lillyAlias": [
            "B4Z-US-LYCU"
        ]
    },
    "NCT03570749": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata",
        "lillyAlias": [
            "I4V-MC-JAHO"
        ]
    },
    "NCT01778049": {
        "briefTitle": "Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes",
        "officialTitle": "A Phase III, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Linagliptin 5 mg Compared to Placebo, Administered as Oral Fixed Dose Combination With Empagliflozin 10 mg or 25 mg for 24 Weeks, in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16 Weeks of Treatment With Empagliflozin 10 mg or 25 mg on Metformin Background Therapy",
        "lillyAlias": [
            "2012-002271-34"
        ]
    },
    "NCT05706506": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)",
        "officialTitle": "An Open-Label, Single-Arm, Phase 4 Study to Assess Glycemic Control When Adults With Type 2 Diabetes Switch From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)",
        "lillyAlias": [
            "I8F-MC-GPIL",
            "2022-002708-18"
        ]
    },
    "NCT00485849": {
        "briefTitle": "A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD",
        "officialTitle": "An Open Label Pilot Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behavior Problems in Children and Adolescents With Autistic Spectrum Disorders",
        "lillyAlias": [
            "B4Z-UT-S003"
        ]
    },
    "NCT06672549": {
        "briefTitle": "A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)",
        "officialTitle": "A Master Protocol for a Randomized, Controlled, Clinical Platform Trial to Investigate the Efficacy and Safety of Interventions for Chronic Weight Management in Pediatric Participants With Obesity or Overweight",
        "lillyAlias": [
            "J4M-MC-PWMP"
        ]
    },
    "NCT00767806": {
        "briefTitle": "A Study for Patient With Chronic Low Back Pain",
        "officialTitle": "Effect of Duloxetine 60 mg Once Daily Versus Placebo in Patients With Chronic Low Back Pain",
        "lillyAlias": [
            "F1J-MC-HMGC"
        ]
    },
    "NCT01640249": {
        "briefTitle": "A Study of LY3006072 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3006072 in Healthy Subjects",
        "lillyAlias": [
            "I6B-MC-HZBA"
        ]
    },
    "NCT06181006": {
        "briefTitle": "A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants",
        "officialTitle": "A Phase I, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LOXO-305 in Healthy Adult Subjects",
        "lillyAlias": [
            "J2N-OX-JZNS"
        ]
    },
    "NCT04050670": {
        "briefTitle": "A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes",
        "officialTitle": "Effect of Injection Site on the Relative Bioavailability of a Single Dose of Tirzepatide in Subjects With Low and High Body Mass Indices",
        "lillyAlias": [
            "I8F-MC-GPHI"
        ]
    },
    "NCT01087970": {
        "briefTitle": "A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer",
        "officialTitle": "Phase 2 Study of Pemetrexed in Combination With Carboplatin or Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck",
        "lillyAlias": [
            "H3E-MC-S132"
        ]
    },
    "NCT03882970": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes",
        "officialTitle": "A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "I8F-MC-GPGH",
            "2018-003422-84"
        ]
    },
    "NCT06566170": {
        "briefTitle": "A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease",
        "officialTitle": "Long-Term Real-World Comparative Effectiveness of Donanemab Plus Usual Care Versus Usual Care Alone in US Patients With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-REAL US)",
        "lillyAlias": [
            "I5T-MC-AACS"
        ]
    },
    "NCT01341470": {
        "briefTitle": "A Study of LY2495655 in Healthy Subjects",
        "officialTitle": "A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2495655 in Japanese Subjects",
        "lillyAlias": [
            "I1Q-JE-JDDH"
        ]
    },
    "NCT05067270": {
        "briefTitle": "A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Study to Investigate Local Infusion Site Pain After Infusion of Excipients Across Infusion Sites and Infusion Depths",
        "lillyAlias": [
            "I8B-MC-ITTC",
            "2021-001987-18"
        ]
    },
    "NCT03819270": {
        "briefTitle": "A Safety Study of LY3372689 Given By Mouth to Healthy Participants",
        "officialTitle": "Single-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3372689",
        "lillyAlias": [
            "I9X-MC-MTAA"
        ]
    },
    "NCT01931475": {
        "briefTitle": "A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China",
        "officialTitle": "Effect of Duloxetine 60mg Once Daily in Patients With Chronic Pain Due to Osteoarthritis in China",
        "lillyAlias": [
            "F1J-MC-HMGS"
        ]
    },
    "NCT03559270": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis",
        "officialTitle": "A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAIX"
        ]
    },
    "NCT00497770": {
        "briefTitle": "An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed",
        "officialTitle": "Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study",
        "lillyAlias": [
            "H3E-US-B001"
        ]
    },
    "NCT00003670": {
        "briefTitle": "Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer",
        "officialTitle": "Phase II Study of LY353381-HC1 Administered to Women With Refractory Ovarian Cancer",
        "lillyAlias": [
            "LILLY-H4Z-MC-JWWJ",
            "MDA-DM-98225",
            "CDR0000066767"
        ]
    },
    "NCT01063075": {
        "briefTitle": "A Study in Advanced Solid Tumors",
        "officialTitle": "Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Carboplatin in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I4E-MC-JXBB"
        ]
    },
    "NCT02490670": {
        "briefTitle": "A Study of Cephalexin Liquid in Healthy Participants",
        "officialTitle": "A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Suspension With 250 mg/5 ml of Cephalexin (Keflex\u00ae Liquido Made in Mexico by Eli Lilly y compa\u00f1\u00eda De m\u00e9xico, s.a. De cv. Vs. Keflex\u00ae Liquido Made by Antibioticos do Brasil Ltda for Eli Lilly y compa\u00f1\u00eda de M\u00e9xico, s.a. De c.v.) in Fasting Healthy Volunteers",
        "lillyAlias": [
            "A3Q-ME-AFBS"
        ]
    },
    "NCT00804570": {
        "briefTitle": "A Study for the Treatment of Alcohol Dependence",
        "officialTitle": "A Phase 2 Study of LY2196044 Compared With Placebo in the Treatment of Alcohol Dependence",
        "lillyAlias": [
            "H9T-MC-NABJ"
        ]
    },
    "NCT03076970": {
        "briefTitle": "Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants",
        "officialTitle": "A Randomized, Double-Blind, Three Period, Cross-Over Study to Evaluate the Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan (Imitrex) in Healthy Male and Female Subjects",
        "lillyAlias": [
            "COL MIG-118",
            "H8H-CD-LAHI"
        ]
    },
    "NCT00870870": {
        "briefTitle": "A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before",
        "officialTitle": "Randomized, Open Label, Stratified Phase 2 Trial of Gemcitabine, Carboplatin, and Cetuximab With Vs. Without IMC-A12 in Chemotherapy-Naive Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "CP02-0860",
            "CP13-0811",
            "I5A-IE-JAEF"
        ]
    },
    "NCT00489775": {
        "briefTitle": "Duloxetine Versus Paroxetine for Major Depression",
        "officialTitle": "Duloxetine Versus Paroxetine in the Acute Treatment of Major Depression",
        "lillyAlias": [
            "F1J-AA-HMCV"
        ]
    },
    "NCT00095199": {
        "briefTitle": "Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer",
        "officialTitle": "Randomized Phase III Study of Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer After Platinum-Based Therapy",
        "lillyAlias": [
            "I4E-MC-JXBC",
            "CP02-0452"
        ]
    },
    "NCT05487599": {
        "briefTitle": "A Clinical Trial of PR001 (LY3884961) in Patients with Peripheral Manifestations of Gaucher Disease (PROCEED)",
        "officialTitle": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients with Peripheral Manifestations of Gaucher Disease (PROCEED)",
        "lillyAlias": []
    },
    "NCT00216099": {
        "briefTitle": "Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer",
        "officialTitle": "A Phase II Study of Pemetrexed (Alimta) as Second-Line Therapy for Hormone Refractory Prostate Cancer: Hoosier Oncology Group GU03-67",
        "lillyAlias": []
    },
    "NCT03341299": {
        "briefTitle": "A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog\u00ae in Patients With T1DM",
        "lillyAlias": [
            "I8B-MC-ITRV",
            "2017-001500-30"
        ]
    },
    "NCT02783599": {
        "briefTitle": "A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma",
        "officialTitle": "A Phase 1b Trial to Assess the Modulation of Biological Markers in Patients With Potentially Resectable Soft Tissue Sarcoma Treated With Olaratumab Monotherapy Followed by Olaratumab Plus Doxorubicin Combination Therapy",
        "lillyAlias": [
            "I5B-MC-JGDM",
            "2015-005018-31"
        ]
    },
    "NCT04923542": {
        "briefTitle": "Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases",
        "officialTitle": "Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases",
        "lillyAlias": []
    },
    "NCT00050206": {
        "briefTitle": "Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder",
        "officialTitle": "Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder",
        "lillyAlias": [
            "F1D-MC-HGIU"
        ]
    },
    "NCT03382899": {
        "briefTitle": "Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)",
        "lillyAlias": [
            "J1L-AM-JZGC",
            "AM0010-201"
        ]
    },
    "NCT01370499": {
        "briefTitle": "A Study of LY2216684 in Participants With Major Depression Disorder",
        "officialTitle": "Long-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Adult Patients With Major Depressive Disorder Who Were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment",
        "lillyAlias": [
            "H9P-JE-LNDJ"
        ]
    },
    "NCT01107899": {
        "briefTitle": "Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes",
        "officialTitle": "Recovery of Platelet Function After a Loading Dose of Prasugrel or Clopidogrel in Aspirin-Treated Subjects Presenting With Symptoms of Acute Coronary Syndromes",
        "lillyAlias": [
            "H7T-MC-TACM"
        ]
    },
    "NCT03940742": {
        "briefTitle": "A Study of Tirzepatide in Participants With Impaired Liver Function",
        "officialTitle": "A Single Dose Pharmacokinetic Study of Tirzepatide in Subjects With Varying Degrees of Hepatic Impairment",
        "lillyAlias": [
            "I8F-MC-GPGQ"
        ]
    },
    "NCT00236899": {
        "briefTitle": "Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC",
        "officialTitle": "A Randomized Phase III Trial of Gemcitabine and Docetaxel Versus Gemcitabine and Paclitaxel in Patients With Metastatic Breast Cancer: A Comparison of Different Schedules",
        "lillyAlias": [
            "B9E-IT-S376"
        ]
    },
    "NCT03506399": {
        "briefTitle": "A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive",
        "officialTitle": "Effect of Lanabecestat on the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel in Healthy Female Subjects",
        "lillyAlias": [
            "I8D-MC-AZEK"
        ]
    },
    "NCT04623242": {
        "briefTitle": "Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.",
        "officialTitle": "A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease",
        "lillyAlias": [
            "The Alzheimer's Association",
            "U01AG042791",
            "2013-000307-17",
            "R01AG046179",
            "REec-2014-0817",
            "The Alzheimer's Association",
            "GHR Foundation",
            "Alzheimer's Association"
        ]
    },
    "NCT00188942": {
        "briefTitle": "A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder",
        "officialTitle": "Neural Correlates of Emotional Processing in Depressed and Remitted Bipolar and Unipolar Depressed Subjects: An fMRI Investigation",
        "lillyAlias": [
            "CTA Control #095694"
        ]
    },
    "NCT00192049": {
        "briefTitle": "A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer",
        "officialTitle": "A Randomized Phase II Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer",
        "lillyAlias": [
            "B9E-MC-S344"
        ]
    },
    "NCT01056549": {
        "briefTitle": "Exenatide (Byetta \u00ae) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans",
        "officialTitle": "Exenatide (Byetta \u00ae) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans.",
        "lillyAlias": []
    },
    "NCT03448406": {
        "briefTitle": "This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.",
        "officialTitle": "A Phase III Randomised, Double-blind Trial to Evaluate the Effect of 12 Weeks Treatment of Once Daily EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Preserved Ejection Fraction (HFpEF) (EMPERIAL - Preserved)",
        "lillyAlias": [
            "2017-004072-59"
        ]
    },
    "NCT00368849": {
        "briefTitle": "Atomoxetine and Huntington's Disease",
        "officialTitle": "Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study",
        "lillyAlias": []
    },
    "NCT00728949": {
        "briefTitle": "A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer",
        "officialTitle": "Phase 2 Randomized, Multicenter Study of IMC-A12 as a Single Agent or in Combination With Antiestrogens in Postmenopausal Women With Hormone Receptor-Positive Advanced or Metastatic Breast Cancer After Progression on Antiestrogen Therapy",
        "lillyAlias": [
            "CP13-0604",
            "I5A-IE-JAEK"
        ]
    },
    "NCT01968070": {
        "briefTitle": "A Study of LY3127760 in Healthy Participants",
        "officialTitle": "A Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of LY3127760 in Healthy Subjects",
        "lillyAlias": [
            "I7A-MC-EACA"
        ]
    },
    "NCT00827242": {
        "briefTitle": "Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multinational Study to Evaluate the Efficacy and Safety of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVHJ"
        ]
    },
    "NCT00512070": {
        "briefTitle": "Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine",
        "officialTitle": "Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality",
        "lillyAlias": []
    },
    "NCT00190970": {
        "briefTitle": "The Effect of Ruboxistaurin on Small Fiber Function",
        "officialTitle": "The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.",
        "lillyAlias": [
            "B7A-MC-MBDO"
        ]
    },
    "NCT02857270": {
        "briefTitle": "A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer",
        "officialTitle": "A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination With Other Agents in Advanced Cancer",
        "lillyAlias": [
            "I8S-MC-JUAB",
            "2016-001907-21"
        ]
    },
    "NCT00063570": {
        "briefTitle": "Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy",
        "officialTitle": "Phase II Trial of Alimta (Pemetrexed) and Gemzar (Gemcitabine) in Metastatic Breast Cancer Patients Who Have Received Prior Taxane Therapy",
        "lillyAlias": [
            "H3E-US-JMEO"
        ]
    },
    "NCT06568042": {
        "briefTitle": "Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study Evaluating LY3848575 in Chronic Neuropathic Pain Associated With Distal Sensory Polyneuropathy",
        "lillyAlias": [
            "J4F-MC-CYAB",
            "2024-513435-24-00"
        ]
    },
    "NCT01576549": {
        "briefTitle": "A Study of LY2127399 in Rheumatoid Arthritis",
        "officialTitle": "An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies",
        "lillyAlias": [
            "H9B-MC-BCEE"
        ]
    },
    "NCT06606106": {
        "briefTitle": "A Study of LY3537031 in Overweight, Obese, and Healthy Participants",
        "officialTitle": "A Multiple-Ascending Dose Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of LY3537031 in Overweight and Obese Participants and Healthy Volunteers",
        "lillyAlias": [
            "J2S-MC-GZMD"
        ]
    },
    "NCT06413706": {
        "briefTitle": "A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy",
        "officialTitle": "A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Temozolomide Compared to Temozolomide Monotherapy in Children and Young Adults With Newly Diagnosed High-Grade Glioma Following Radiotherapy",
        "lillyAlias": [
            "I3Y-MC-JPEH",
            "2022-502269-13-00",
            "U1111-1289-0405"
        ]
    },
    "NCT00094549": {
        "briefTitle": "Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder",
        "officialTitle": "Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder",
        "lillyAlias": [
            "F1D-MC-HGKQ"
        ]
    },
    "NCT03692949": {
        "briefTitle": "A Study of LY3451838 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetics Study of LY3451838 in Healthy Subjects",
        "lillyAlias": [
            "J1H-MC-LAJA"
        ]
    },
    "NCT02555449": {
        "briefTitle": "A Study of [\u00b9\u2074C]-LY3202626 in Healthy Male Participants",
        "officialTitle": "Disposition of [\u00b9\u2074C]-LY3202626 Following Oral Administration in Healthy Male Subjects",
        "lillyAlias": [
            "I7X-EW-LLCC"
        ]
    },
    "NCT01137006": {
        "briefTitle": "An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma",
        "officialTitle": "An Open-Label, Dose-Escalation Phase 1/1b Study of the Anti-gp75 Monoclonal Antibody IMC-20D7S In Patients With Malignant Melanoma Who Have Progressed After or During at Least One Treatment With Standard Cytotoxic Treatment or/and Immunotherapy Therapy or For Whom Standard Therapy is Not Indicated",
        "lillyAlias": [
            "CP22-0901",
            "I4Z-IE-JDEA"
        ]
    },
    "NCT02897349": {
        "briefTitle": "Linagliptin Add-on to Insulin Background Therapy",
        "officialTitle": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Linagliptin, Administered Orally Once Daily, in Combination With Insulin Therapy for 24 Weeks in Chinese Type 2 Diabetes Mellitus Patients With Insufficient Glycaemic Control",
        "lillyAlias": []
    },
    "NCT00290706": {
        "briefTitle": "A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma",
        "officialTitle": "A Phase I/II Trial of Combination Bortezomib (VELCADE) and Gemcitabine Therapy for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma",
        "lillyAlias": [
            "NU 04H4",
            "VEL-03-082",
            "STU00007425"
        ]
    },
    "NCT00190749": {
        "briefTitle": "Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder",
        "officialTitle": "Insulin Sensitivity in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Risperidone",
        "lillyAlias": [
            "F1D-MC-S014"
        ]
    },
    "NCT01515306": {
        "briefTitle": "A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors",
        "officialTitle": "A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Paclitaxel in Patients With Advanced Malignant Solid Tumors",
        "lillyAlias": [
            "I4T-IE-JVCA",
            "CP12-1032"
        ]
    },
    "NCT01969149": {
        "briefTitle": "Exenatide for Stress Hyperglycemia",
        "officialTitle": "Intravenous Exenatide (Byetta\u00ae) Versus Insulin for Perioperative Glycemic Control in Cardiac Surgery: the Open-labeled Randomized Phase II/III ExStress Study",
        "lillyAlias": []
    },
    "NCT03363906": {
        "briefTitle": "A Study of Dulaglutide in Healthy Participants",
        "officialTitle": "Relative Bioavailability of an Investigational Single Dose of Dulaglutide After Subcutaneous Administration by a Single Dose Pen Compared to a Prefilled Syringe in Healthy Subjects",
        "lillyAlias": [
            "H9X-MC-GBGM"
        ]
    },
    "NCT01214642": {
        "briefTitle": "A Dose-Escalation Study for Patients With Advanced Cancer",
        "officialTitle": "A Phase 1 Dose-Escalation Study of LY2523355 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I1Y-MC-JFBB"
        ]
    },
    "NCT04270370": {
        "briefTitle": "A Study of LY3478045 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Single-and Multiple Ascending Doses of LY3478045in Healthy Subjects",
        "lillyAlias": [
            "J2M-MC-GZKA"
        ]
    },
    "NCT02981342": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma",
        "officialTitle": "An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma",
        "lillyAlias": [
            "I3Y-MC-JPCJ",
            "2016-002218-36"
        ]
    },
    "NCT05565742": {
        "briefTitle": "A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults With Elevated Lipoprotein(a)",
        "lillyAlias": [
            "J3L-MC-EZEB"
        ]
    },
    "NCT05080218": {
        "briefTitle": "COVID-19 VaccinE Response in Rheumatology Patients",
        "officialTitle": "The SARS-CoV-2 Vaccine Response and Safety in Rheumatology Patients and the Influence of Temporary Interruptions in Immunomodulatory Therapy",
        "lillyAlias": []
    },
    "NCT01286818": {
        "briefTitle": "A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)",
        "officialTitle": "A Phase 1b Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) Drug Product in Japanese Subjects With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine",
        "lillyAlias": [
            "CP12-1029",
            "14T-IE-JVBY"
        ]
    },
    "NCT00543218": {
        "briefTitle": "PTH Comparison in Post Menopausal Women",
        "officialTitle": "Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-TW-GHCB"
        ]
    },
    "NCT01445119": {
        "briefTitle": "A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas",
        "officialTitle": "A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas",
        "lillyAlias": [
            "07-C-0053"
        ]
    },
    "NCT02906618": {
        "briefTitle": "Study of LY3039478 in Healthy Participants",
        "officialTitle": "An Absolute Bioavailability Study of LY3039478 in Healthy Subjects Using the Intravenous Tracer Method",
        "lillyAlias": [
            "I6F-MC-JJCG",
            "2016-001073-33"
        ]
    },
    "NCT06515418": {
        "briefTitle": "Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Proof-of-Concept Study to Investigate Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over (STRIDES)",
        "lillyAlias": []
    },
    "NCT01026818": {
        "briefTitle": "A Study of Tadalafil After Radical Prostatectomy",
        "officialTitle": "A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect on Unassisted Erectile Function of the Early Use of Tadalafil 5 mg Once a Day and Tadalafil 20 mg On Demand Treatment for 9 Months in Subjects Undergoing Bilateral Nerve-Sparing Radical Prostatectomy",
        "lillyAlias": [
            "H6D-EW-LVIK"
        ]
    },
    "NCT03407118": {
        "briefTitle": "A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro (Humalog) Following Single Dose Administration in Japanese Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I8B-MC-ITRZ"
        ]
    },
    "NCT01193218": {
        "briefTitle": "Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Double-blind, Randomised, Parallel Group Efficacy and Safety Study of BI 10773 (5 mg, 10 mg, 25 mg, and 50 mg) Compared to Placebo When Administered Orally Once Daily Over 12 Weeks, as Monotherapy, in Patients With Type 2 Diabetes and Insufficient Glycaemic Control Despite Diet and Exercise, Followed by a 40 Week Randomised Extension Study to Assess Long Term Safety of BI 10773 (10 mg and 25 mg)",
        "lillyAlias": []
    },
    "NCT02217618": {
        "briefTitle": "A Study of LY2409021 in Healthy Participants",
        "officialTitle": "A Single Dose Pharmacokinetic Study of LY2409021 Tablet Administered in Healthy Subjects",
        "lillyAlias": [
            "I1R-MC-GLDL"
        ]
    },
    "NCT03574818": {
        "briefTitle": "Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001",
        "officialTitle": "A Feasibility and Biomarker Study to Evaluate Necitumumab in the Neoadjuvant Setting With Gemcitabine and Cisplatin in Surgically Resectable Squamous Lung Cancer",
        "lillyAlias": []
    },
    "NCT00380718": {
        "briefTitle": "Chemotherapy for Patients With Non-Small Cell Lung Cancer",
        "officialTitle": "Open-Label Single-Arm Phase IV Study of Pemetrexed in Taiwanese Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy",
        "lillyAlias": [
            "H3E-MC-JMIC"
        ]
    },
    "NCT00870818": {
        "briefTitle": "Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)",
        "officialTitle": "An Extension of Study CP-MGA031-01 to Evaluate the Long-Term Efficacy and Safety of Teplizumab (MGA031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Patients With Recent-Onset Type 1 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01236118": {
        "briefTitle": "A Study of LY2439821 in Rheumatoid Arthritis",
        "officialTitle": "An Open-Label Extension Study to Evaluate Safety and Tolerability of Multiple Subcutaneous Doses of LY2439821 in Japanese Patients With Rheumatoid Arthritis on Concomitant Methotrexate",
        "lillyAlias": [
            "I1F-JE-RHAM"
        ]
    },
    "NCT00125918": {
        "briefTitle": "PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension",
        "officialTitle": "PHIRST-1: Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment in Patients With Pulmonary Arterial Hypertension",
        "lillyAlias": [
            "H6D-MC-LVGY"
        ]
    },
    "NCT00843518": {
        "briefTitle": "Treatment for Aggression and Agitation in Patients With Alzheimer's Disease",
        "officialTitle": "Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease",
        "lillyAlias": [
            "H6N-MC-LEAQ"
        ]
    },
    "NCT00279214": {
        "briefTitle": "Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock",
        "officialTitle": "An Evaluation of Vasopressor Requirement, Hemodynamic Response and Measures of Tissue Perfusion With the Administration of Drotrecogin Alfa (Activated) as Part of Physician-Directed Therapy in Patients With Septic Shock",
        "lillyAlias": [
            "F1K-US-EVDA"
        ]
    },
    "NCT02230995": {
        "briefTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release (25 mg/1000 mg) Compared With the Free Combination of Empagliflozin and Metformin Extended Release Tablets in Healthy Subjects Following a High-fat, High-caloric Meal (an Open-label, Randomised, Single Dose, Crossover Trial)",
        "lillyAlias": [
            "2014-002016-17"
        ]
    },
    "NCT03891784": {
        "briefTitle": "Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors",
        "officialTitle": "A Phase 2 Trial of the CDK4/6 Inhibitor Abemaciclib in Patients With Advanced and Refractory Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)",
        "lillyAlias": [
            "NCI-2019-01490",
            "9959"
        ]
    },
    "NCT03495102": {
        "briefTitle": "A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes",
        "officialTitle": "A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-MC-GBGL",
            "2017-003490-33"
        ]
    },
    "NCT05338502": {
        "briefTitle": "Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants",
        "officialTitle": "An Open-Label, 3-Period, Fixed Sequence Study to Evaluate the Effect of an H2 Antagonist and a Proton Pump Inhibitor on the Single Dose Pharmacokinetics of LOXO-292 in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-OX-JZJL",
            "LOXO-RET-19075"
        ]
    },
    "NCT04768855": {
        "briefTitle": "A Study of LY3540378 in Healthy Participants",
        "officialTitle": "A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3540378 in Healthy Participants",
        "lillyAlias": [
            "J3E-MC-EZDA"
        ]
    },
    "NCT00292955": {
        "briefTitle": "Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma",
        "officialTitle": "An Exploratory Pharmacogenomic Study of Neoadjuvant Cetuximab Followed by Cisplatin, Radiotherapy, and Cetuximab in Women With Newly Diagnosed Locally Advanced or Metastatic Cervical Carcinoma",
        "lillyAlias": [
            "CA225243",
            "HRPO #05-0702"
        ]
    },
    "NCT00149214": {
        "briefTitle": "Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens",
        "officialTitle": "A Randomized Phase 2 Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel, Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel, as Neoadjuvant Treatment for Early Breast Cancer",
        "lillyAlias": [
            "H3E-MC-S080"
        ]
    },
    "NCT00190814": {
        "briefTitle": "Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.",
        "officialTitle": "Efficacy and Safety of Duloxetine Compared With Placebo in Women With Symptoms of Mixed Urinary Incontinence.",
        "lillyAlias": [
            "F1J-MC-SBBO"
        ]
    },
    "NCT02387814": {
        "briefTitle": "A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment",
        "officialTitle": "A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment",
        "lillyAlias": [
            "I3Y-MC-JPBV"
        ]
    },
    "NCT01913314": {
        "briefTitle": "A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants",
        "officialTitle": "Disposition of [^14C]-LY2835219 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I3Y-MC-JPBD"
        ]
    },
    "NCT01697514": {
        "briefTitle": "A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma",
        "officialTitle": "A Phase 1 Trial of LY2940680 in Pediatric Patients With Recurrent or Refractory Rhabdomyosarcoma or Medulloblastoma",
        "lillyAlias": [
            "I4J-MC-HHBD"
        ]
    },
    "NCT00192114": {
        "briefTitle": "Enzastaurin for Patients With Metastatic Colorectal Cancer",
        "officialTitle": "A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer",
        "lillyAlias": [
            "H6Q-MC-JCAR"
        ]
    },
    "NCT05327595": {
        "briefTitle": "A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)",
        "officialTitle": "A Randomized, Double-Blind, Multiple-Ascending Dose, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3549492 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J3H-MC-GZNB",
            "2021-002220-20"
        ]
    },
    "NCT01634555": {
        "briefTitle": "A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI",
        "officialTitle": "A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Irinotecan and Its Metabolite SN-38 When Coadministered With Folinic Acid and 5 Fluorouracil in Patients With Advanced Malignant Solid Tumors",
        "lillyAlias": [
            "CP12-1033",
            "I4T-IE-JVCB"
        ]
    },
    "NCT01577355": {
        "briefTitle": "A Study of LY2784544 in Healthy Male Subjects",
        "officialTitle": "Disposition of [14C]-LY2784544 Following Oral Administration in Healthy Male Subjects",
        "lillyAlias": [
            "I3X-MC-JHTD"
        ]
    },
    "NCT00604214": {
        "briefTitle": "Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock",
        "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of Drotrecogin Alfa (Activated) Administered as a Continuous 96-hr Infusion to Adult Patients With Septic Shock",
        "lillyAlias": [
            "F1K-MC-EVDP"
        ]
    },
    "NCT01408095": {
        "briefTitle": "A Study in Patients With Type 2 Diabetes",
        "officialTitle": "A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2608204 Given as Monotherapy or in Combination With Metformin in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I3P-MC-GKBC"
        ]
    },
    "NCT01849055": {
        "briefTitle": "A Multiple Dose Study of LY3023703 in Healthy Participants",
        "officialTitle": "A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3023703 in Healthy Subjects",
        "lillyAlias": [
            "I6H-MC-MCBB"
        ]
    },
    "NCT04352114": {
        "briefTitle": "A Study of LY3461767 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3461767 in Healthy Participants",
        "lillyAlias": [
            "J2L-MC-EZBA"
        ]
    },
    "NCT06194214": {
        "briefTitle": "A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants",
        "officialTitle": "A Phase I, Open-label, Fixed-sequence, Drug Interaction Study to Investigate the Effect of Single and Multiple Oral Doses of LOXO-305 on the Pharmacokinetics of Multiple Oral Doses of Digoxin (P-Glycoprotein Substrate) in Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZNT"
        ]
    },
    "NCT00531895": {
        "briefTitle": "An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache",
        "officialTitle": "An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache",
        "lillyAlias": []
    },
    "NCT06503679": {
        "briefTitle": "A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants",
        "officialTitle": "A Phase 1, Single-center, Open-label, Fixed-sequence, Crossover Study to Evaluate the Effect of LY4100511 (DC-853) on the Single-dose Pharmacokinetics of Midazolam, Repaglinide, Digoxin, and Rosuvastatin in Healthy Participants",
        "lillyAlias": [
            "J5C-MC-FOAF, DC-853104"
        ]
    },
    "NCT00400803": {
        "briefTitle": "Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer",
        "officialTitle": "Phase II Study of Biweekly Carboplatin and Gemcitabine With Bevacizumab as 1st Line Treatment in Patients With Advanced, Inoperable Stage IIIb/IV NSCLC",
        "lillyAlias": [
            "HHH2L06",
            "AVF3982s",
            "B9E-US-X463"
        ]
    },
    "NCT02575703": {
        "briefTitle": "A Study of [\u00b9\u2074C]-LY3023414 in Healthy Participants",
        "officialTitle": "Disposition of [\u00b9\u2074C]-LY3023414 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I6A-EW-CBBC"
        ]
    },
    "NCT01198002": {
        "briefTitle": "A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)",
        "lillyAlias": [
            "H9B-MC-BCDM",
            "CTRI/2011/07/001870"
        ]
    },
    "NCT00191802": {
        "briefTitle": "Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients",
        "officialTitle": "Compliance With and Acceptance of Teriparatide Pen Injection in Severely Osteoporotic Patients [CATS]",
        "lillyAlias": [
            "B3D-CA-GHCP"
        ]
    },
    "NCT03837821": {
        "briefTitle": "(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer",
        "officialTitle": "A Window-of-opportunity Trial of Abemaciclib Followed by Radical Cystectomy in Patients With Platinum-ineligible Urothelial Carcinoma to Evaluate CDK4/6-dependent Phosphorylation of Pocket Proteins and Clonal Evolution Dynamics",
        "lillyAlias": []
    },
    "NCT00408421": {
        "briefTitle": "Duloxetine Versus Placebo for Osteoarthritis Knee Pain",
        "officialTitle": "Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain",
        "lillyAlias": [
            "F1J-MC-HMEP"
        ]
    },
    "NCT02760602": {
        "briefTitle": "A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease",
        "officialTitle": "A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease",
        "lillyAlias": [
            "H8A-MC-LZBE",
            "2016-000108-27"
        ]
    },
    "NCT00362102": {
        "briefTitle": "A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma",
        "officialTitle": "A Multi-center, Open Label, Non-randomized, Phase II Study to Assess the Activity and Safety of Cetuximab Plus Irinotecan in Subjects With EGFR-detectable Metastatic Colorectal Carcinoma",
        "lillyAlias": []
    },
    "NCT05403502": {
        "briefTitle": "Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes",
        "officialTitle": "Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes",
        "lillyAlias": []
    },
    "NCT00533702": {
        "briefTitle": "A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma",
        "officialTitle": "Phase II Randomized, Open-Label Study of IMC-1121B With or Without Dacarbazine in Patients With Metastatic Malignant Melanoma",
        "lillyAlias": [
            "CP12-0604",
            "I4T-IE-JVBO"
        ]
    },
    "NCT00290121": {
        "briefTitle": "Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics",
        "officialTitle": "Cerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT)",
        "lillyAlias": []
    },
    "NCT02242903": {
        "briefTitle": "A Study of LY3079514 in Healthy Participants",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3079514 in Healthy Subjects",
        "lillyAlias": [
            "I7B-MC-DPAA"
        ]
    },
    "NCT05468164": {
        "briefTitle": "A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants",
        "officialTitle": "An Open-Label, Randomized, Crossover Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Single-Dose Pharmacokinetics of LOXO-292 in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-MC-JZJQ",
            "LOXO-RET-18015"
        ]
    },
    "NCT05262764": {
        "briefTitle": "Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF)",
        "officialTitle": "Post Marketing Surveillance on Long Term Drug Use of JARDIANCE\u00ae Tablets in Patients With Chronic Heart Failure in Japan",
        "lillyAlias": []
    },
    "NCT03339843": {
        "briefTitle": "Multiorgan Metabolic Imaging Response Assessment of Abemaciclib",
        "officialTitle": "Multiorgan Metabolic Imaging Response Assessment of Abemaciclib",
        "lillyAlias": []
    },
    "NCT04498390": {
        "briefTitle": "A Safety Study of LY3493269 in Healthy Participants",
        "officialTitle": "A Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3493269 in Healthy Participants",
        "lillyAlias": [
            "J1X-MC-GZHB"
        ]
    },
    "NCT01719003": {
        "briefTitle": "Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes",
        "officialTitle": "A 24-week Phase III Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Twice Daily Oral Administration of Empagliflozin + Metformin Compared With the Individual Components of Empagliflozin or Metformin in Drug Naive Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "2010-021375-92"
        ]
    },
    "NCT01821703": {
        "briefTitle": "A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants",
        "officialTitle": "A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3045697 After Multiple Oral Dosing in Healthy Subjects",
        "lillyAlias": [
            "I6S-MC-ASEB",
            "2013-000475-32"
        ]
    },
    "NCT02452008": {
        "briefTitle": "Study of TGF-\u03b2 Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer",
        "officialTitle": "Overcoming Drug Resistance in Metastatic Castration-resistant Prostate Cancer With Novel Combination of TGF-\u03b2 Receptor Inhibitor LY2157299 and Enzalutamide: a Randomized Multi-site Phase II Study",
        "lillyAlias": [
            "IRB00065746"
        ]
    },
    "NCT03338023": {
        "briefTitle": "A Study of LY2963016 Compared to Lantus\u00ae in Adult Chinese Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog, LY2963016, to Lantus\u00ae in Combination With Mealtime Insulin Lispro in Adult Chinese Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I4L-GH-ABES"
        ]
    },
    "NCT02106923": {
        "briefTitle": "Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets",
        "officialTitle": "Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (10 mg/1000 mg and 5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)",
        "lillyAlias": []
    },
    "NCT00044408": {
        "briefTitle": "Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes",
        "officialTitle": "LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes",
        "lillyAlias": [
            "B7A-MC-MBCW"
        ]
    },
    "NCT00543023": {
        "briefTitle": "A Study of the Treatment of Postmenopausal Women With Osteoporosis",
        "officialTitle": "Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-AA-GHCF"
        ]
    },
    "NCT00622323": {
        "briefTitle": "Post Marketing Surveillance Study of Byetta \u2122 (Exenatide) Use Among Filipino Patients",
        "officialTitle": "Post Marketing Surveillance Study of Byetta \u2122 (Exenatide) Use Among Filipino Patients",
        "lillyAlias": [
            "H8O-PH-B006"
        ]
    },
    "NCT01183650": {
        "briefTitle": "A Study of Tadalafil in Benign Prostatic Hyperplasia",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics of Tadalafil Administered Once Daily in Japanese and Non-Japanese Subjects With Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVIY"
        ]
    },
    "NCT01055808": {
        "briefTitle": "Observational Study in Japanese Type 2 Diabetes Patients",
        "officialTitle": "A Prospective, Non-safety Observational Study in Japanese Type 2 Diabetes Patients(INSIGHTS)",
        "lillyAlias": [
            "F3Z-JE-PV06"
        ]
    },
    "NCT03611608": {
        "briefTitle": "A Study of LY3316531 in Healthy Participants",
        "officialTitle": "A Phase 1 Randomized, Placebo-Controlled Study to Determine the Effect of LY3316531 on Capsaicin-Induced Dermal Blood Flow in Healthy Male Subjects",
        "lillyAlias": [
            "I9H-MC-FFAB",
            "2018-000710-38"
        ]
    },
    "NCT00414323": {
        "briefTitle": "Evaluation of the Effects of Duloxetine on Norepinephrine",
        "officialTitle": "Evaluation of the Effects of Duloxetine on Norepinephrine Transporter Inhibition in Healthy Subjects",
        "lillyAlias": [
            "F1J-MC-HMEU"
        ]
    },
    "NCT00308750": {
        "briefTitle": "First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomized, Open-label Phase II Study of Pemetrexed (Alimta) Plus Carboplatin With or Without Enzastaurin Hydrochloride, or Docetaxel Plus Carboplatin as First Line Treatment in Patients With Advanced Stage Non-small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "H6Q-US-S004"
        ]
    },
    "NCT01488708": {
        "briefTitle": "On Open-Label Study in Participants With Systemic Lupus Erythematosus",
        "officialTitle": "A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutaneous LY2127399 in Participants With Systemic Lupus Erythematosus (SLE) (Illuminate-X)",
        "lillyAlias": [
            "H9B-MC-BCDX"
        ]
    },
    "NCT04476108": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "H0P-MC-NP01"
        ]
    },
    "NCT05486208": {
        "briefTitle": "A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis",
        "officialTitle": "A Phase 1, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending Dose Study of LY3844583 in Healthy Participants, and Multiple-Dose Study of LY3844583 in Healthy Participants and Patients With Atopic Dermatitis",
        "lillyAlias": [
            "J3V-MC-KKAA"
        ]
    },
    "NCT01606423": {
        "briefTitle": "The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants",
        "officialTitle": "The Effect of LY2409021 on Blood Glucose Concentrations During Hyperglucagonaemia in Healthy Male Subjects",
        "lillyAlias": [
            "I1R-FW-GLBC"
        ]
    },
    "NCT06049108": {
        "briefTitle": "A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants",
        "officialTitle": "A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-LY3871801 in Healthy Male Participants",
        "lillyAlias": [
            "J3P-MC-FTAE"
        ]
    },
    "NCT03573323": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHCR"
        ]
    },
    "NCT04049123": {
        "briefTitle": "A Study of LY900014 in Healthy Chinese Participants",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Following Single Dose Administration in Healthy Chinese Subjects",
        "lillyAlias": [
            "I8B-MC-ITRY"
        ]
    },
    "NCT04451408": {
        "briefTitle": "A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants",
        "officialTitle": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Participants With Alzheimer's Disease and Healthy Participants",
        "lillyAlias": [
            "J1G-MC-LAKB"
        ]
    },
    "NCT01167023": {
        "briefTitle": "Prasugrel Versus Placebo in Adult Sickle Cell Disease",
        "officialTitle": "A Double-Blind, Randomized, Multicenter Study of Prasugrel Compared to Placebo in Adult Patients With Sickle Cell Disease",
        "lillyAlias": [
            "H7T-MC-TAEK"
        ]
    },
    "NCT00485550": {
        "briefTitle": "Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy",
        "officialTitle": "A Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride Augmented With Either Extended-Release Methylphenidate Hydrochloride (Concerta-TM) or Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Not Responded to Stimulant Mono Therapy",
        "lillyAlias": [
            "B4Z-MC-LYBU"
        ]
    },
    "NCT00251550": {
        "briefTitle": "Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma",
        "officialTitle": "Phase I/II Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma",
        "lillyAlias": [
            "H3E-JE-ME01"
        ]
    },
    "NCT00055250": {
        "briefTitle": "A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer",
        "officialTitle": "A Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of Gemcitabine Plus LY293111 Compared to Gemcitabine Plus Placebo in Patients With Locally Advanced or Metastatic Pancreatic Cancer",
        "lillyAlias": [
            "H6H-MC-JEAL"
        ]
    },
    "NCT01928823": {
        "briefTitle": "Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia",
        "officialTitle": "Augmentation of Exposure Therapy With D-Cycloserine in Patients With Agoraphobia With or Without Panic Disorder",
        "lillyAlias": []
    },
    "NCT00702650": {
        "briefTitle": "A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations",
        "officialTitle": "A Phase III Open-label Titration Trial to Evaluate the Effectiveness and Safety of Different Doses of a Dermal Application of Testosterone MD-Lotion\u00ae (Cutaneous Solution) in Hypogonadal Men",
        "lillyAlias": [
            "MTE08",
            "I5E-MC-TSAH"
        ]
    },
    "NCT06339008": {
        "briefTitle": "A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis",
        "lillyAlias": [
            "J2T-MC-KGBT",
            "2023-508817-18-00"
        ]
    },
    "NCT00192023": {
        "briefTitle": "An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).",
        "officialTitle": "An Italian Randomised, Double-blind Placebo Controlled Study of the Efficacy of Atomoxetine Hydrochloride in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder",
        "lillyAlias": [
            "B4Z-IT-LYCY"
        ]
    },
    "NCT04537923": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin",
        "officialTitle": "A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)",
        "lillyAlias": [
            "I8F-MC-GPHD",
            "2020-000284-23"
        ]
    },
    "NCT01247350": {
        "briefTitle": "A Study of LY3009104(Baricitinib) for Healthy Subjects",
        "officialTitle": "A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3009104 in Japanese Healthy Subjects",
        "lillyAlias": [
            "I4V-JE-JADM"
        ]
    },
    "NCT00280150": {
        "briefTitle": "Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer",
        "officialTitle": "Phase I/II Trial of Induction Carboplatin/Paclitaxel With Bevacizumab Followed by Concurrent Thoracic Conformal Radiation Therapy With Carboplatin/Paclitaxel, Bevacizumab and Erlotinib in Stage IIIA/B Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "UNC IRB 05-2091"
        ]
    },
    "NCT02568423": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Healthy Participants",
        "officialTitle": "A Single-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of LY3074828 in Japanese and Caucasian Healthy Subjects",
        "lillyAlias": [
            "I6T-JE-AMAD"
        ]
    },
    "NCT01600950": {
        "briefTitle": "A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "Pharmacodynamics of LY2963016 Compared to LANTUS\u00ae in Subjects With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I4L-MC-ABEE"
        ]
    },
    "NCT02513550": {
        "briefTitle": "A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Dosing Regimens in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBP",
            "2015-000190-12"
        ]
    },
    "NCT00193050": {
        "briefTitle": "Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer",
        "officialTitle": "Phase II Trial of Induction Chemotherapy With Weekly Gemcitabine, Epirubicin, Docetaxel as Primary Treatment of Locally Advanced or Inflammatory Breast Cancer Patients",
        "lillyAlias": []
    },
    "NCT00091650": {
        "briefTitle": "Olanzapine in Patients With Borderline Personality Disorder",
        "officialTitle": "Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Flexible Dose Double-Blind Comparison With Placebo",
        "lillyAlias": [
            "F1D-MC-HGKL"
        ]
    },
    "NCT04518410": {
        "briefTitle": "ACTIV-2: A Study for Outpatients With COVID-19",
        "officialTitle": "Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)",
        "lillyAlias": [
            "38742"
        ]
    },
    "NCT00067912": {
        "briefTitle": "Duloxetine vs. Active Comparator for the Treatment of Depression",
        "officialTitle": "Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMCQ"
        ]
    },
    "NCT00510146": {
        "briefTitle": "Olanzapine Treatment of Patients With Bipolar I Disorder",
        "officialTitle": "Efficacy and Safety of Olanzapine in the Treatment of Patients With Bipolar I Disorder, Depressed: A Randomized, Double-Blind Comparison With Placebo",
        "lillyAlias": [
            "F1D-MC-HGMP"
        ]
    },
    "NCT00857246": {
        "briefTitle": "Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer",
        "officialTitle": "Neoadjuvant Therapy of Gastric Cancer With Irinotecan, Cisplatin and Cetuximab Followed by Surgical Resection and Adjuvant Chemoradiation",
        "lillyAlias": [
            "BMS #CA225112"
        ]
    },
    "NCT06797310": {
        "briefTitle": "Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study",
        "officialTitle": "Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study",
        "lillyAlias": []
    },
    "NCT03153410": {
        "briefTitle": "Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas",
        "officialTitle": "A Pilot Study of a GVAX Pancreas Vaccine (With Cyclophosphamide) in Combination With a PD-1 Blockade Antibody (Pembrolizumab) and a Macrophage Targeting Agent (CSF1R Inhibitor) for the Treatment of Patients With Borderline Resectable Adenocarcinoma of the Pancreas",
        "lillyAlias": [
            "IRB00130267"
        ]
    },
    "NCT01426412": {
        "briefTitle": "A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3015014 in Subjects With Elevated LDL-C",
        "lillyAlias": [
            "I5S-EW-EFJA"
        ]
    },
    "NCT00437112": {
        "briefTitle": "Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents",
        "lillyAlias": [
            "H7U-MC-IDAZ"
        ]
    },
    "NCT03616912": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus",
        "lillyAlias": [
            "I4V-MC-JAHZ",
            "2017-005026-37"
        ]
    },
    "NCT03849612": {
        "briefTitle": "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "An Early Feasibility Study to Evaluate Basal Initialization Parameters in an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IORB"
        ]
    },
    "NCT02307812": {
        "briefTitle": "Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France",
        "officialTitle": "Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France",
        "lillyAlias": [
            "I4T-FR-JVCS"
        ]
    },
    "NCT05556512": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity",
        "officialTitle": "A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity",
        "lillyAlias": [
            "I8F-MC-GPIJ",
            "2022-501744-15-00"
        ]
    },
    "NCT02082210": {
        "briefTitle": "A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1b/2 Study of Ramucirumab in Combination With LY2875358 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I4C-MC-JTBF"
        ]
    },
    "NCT03594110": {
        "briefTitle": "EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)",
        "officialTitle": "A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease",
        "lillyAlias": [
            "2017-002971-24"
        ]
    },
    "NCT04545710": {
        "briefTitle": "Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance",
        "officialTitle": "A Phase II Trial of Osimertinib and Abemaciclib With a Focus on Non-Small Cell Lung Cancer Patients With EGFR Activating Mutations With Osimertinib Resistance",
        "lillyAlias": []
    },
    "NCT02821910": {
        "briefTitle": "Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets",
        "officialTitle": "Relative Bioavailability of Two FDC Tablet Strengths of Empagliflozin/Linagliptin/Metformin Extended Release Compared to the Free Combination of Empagliflozin, Linagliptin and Metformin Extended Release Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Study)",
        "lillyAlias": [
            "2015-005082-23"
        ]
    },
    "NCT00640510": {
        "briefTitle": "A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia",
        "officialTitle": "A Placebo-Controlled, Double-Blind Confirmatory Study of Rapid-Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-JE-RA03"
        ]
    },
    "NCT05691712": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes",
        "officialTitle": "A Randomized, Phase 3, Double Blind Trial Comparing the Effect of the Addition of Tirzepatide Versus the Addition of Placebo to Titrated Basal Insulin on Glycemic Control in Chinese Participants With Type 2 Diabetes",
        "lillyAlias": [
            "I8F-MC-GPIM"
        ]
    },
    "NCT00065312": {
        "briefTitle": "An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes",
        "officialTitle": null,
        "lillyAlias": [
            "H7R-MC-GCBD"
        ]
    },
    "NCT00337012": {
        "briefTitle": "The Effect of Duloxetine on Interoceptive Awareness",
        "officialTitle": "The Effect of Duloxetine on Interoceptive Awareness, Thermal Heat Pain Perception, and Bodily Symptoms in Major Depressive: a Pilot Study With fMRI.",
        "lillyAlias": []
    },
    "NCT00428610": {
        "briefTitle": "A Study of Chemotherapy Treatment for Patients With Ovarian Cancer",
        "officialTitle": "A Phase 2 Study of LY573636-Sodium as Treatment for Patients With Platinum-Resistant Ovarian Cancer",
        "lillyAlias": [
            "H8K-MC-JZAG"
        ]
    },
    "NCT01214655": {
        "briefTitle": "A Study for Patients With Acute Leukemia",
        "officialTitle": "Phase 1 Study of LY2523355 in Patients With Acute Leukemia",
        "lillyAlias": [
            "I1Y-MC-JFBC"
        ]
    },
    "NCT02342314": {
        "briefTitle": "A Study of LY3143753 and LY3185643 in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3143753 and LY3185643 in Healthy Subjects",
        "lillyAlias": [
            "I7U-MC-GAHA"
        ]
    },
    "NCT01816295": {
        "briefTitle": "A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Parallel Study With an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men",
        "lillyAlias": [
            "I5E-MC-TSAT",
            "2012-004866-16"
        ]
    },
    "NCT02784795": {
        "briefTitle": "A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors",
        "officialTitle": "A Phase 1b Study of LY3039478 in Combination With Other Anticancer Agents in Patients With Advanced or Metastatic Solid Tumors",
        "lillyAlias": [
            "I6F-MC-JJCD",
            "2015-004421-14"
        ]
    },
    "NCT00415155": {
        "briefTitle": "A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma",
        "officialTitle": "An Open Label, Single Arm, Phase 1b/2 Study With Pharmacokinetic Sampling to Evaluate LY2181308 in Patients With Advanced Hepatocellular Carcinoma",
        "lillyAlias": [
            "H8Z-MC-JACS"
        ]
    },
    "NCT03988114": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer",
        "officialTitle": "A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors",
        "lillyAlias": [
            "I3Y-MC-JPCX",
            "2019-001781-16"
        ]
    },
    "NCT06565195": {
        "briefTitle": "A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease",
        "officialTitle": "A Randomized, Double-blind (Sponsor-unblinded), Placebo-controlled, Single-ascending-dose Study in Healthy Volunteers and a Double-blind (Sponsor-unblinded), Placebo-controlled, Multiple-ascending-dose Study in Patients With Parkinson's Disease to Evaluate the Safety, Tolerability, and PK/PD of LY3962681",
        "lillyAlias": []
    },
    "NCT05254795": {
        "briefTitle": "Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care",
        "officialTitle": "Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care",
        "lillyAlias": []
    },
    "NCT05176314": {
        "briefTitle": "A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants",
        "officialTitle": "A Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Single and Multiple Doses of Pirtobrutinib on the Pharmacokinetics of Rosuvastatin in Healthy Participants",
        "lillyAlias": [
            "J2N-MC-JZNW"
        ]
    },
    "NCT00482014": {
        "briefTitle": "A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer",
        "officialTitle": "Phase 1/2 Study of Pemetrexed (Alimta) Plus Carboplatin, or Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Every-21-Day Pemetrexed Consolidation in Patients With Favorable-Prognosis Inoperable Stage IIIA/B Non-Small-Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "H3E-US-S047"
        ]
    },
    "NCT02708095": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)",
        "lillyAlias": [
            "I4V-MC-JAHH",
            "2015-004404-35"
        ]
    },
    "NCT01438814": {
        "briefTitle": "Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control",
        "officialTitle": "A Randomised, Double-blind, Double-dummy, Active-comparator Controlled Study Investigating the Efficacy and Safety of Linagliptin Co-administered With Metformin QD at Evening Time Versus Metformin BID Over 14 Weeks in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control",
        "lillyAlias": [
            "2011-002276-16"
        ]
    },
    "NCT00207155": {
        "briefTitle": "An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer",
        "officialTitle": "An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer",
        "lillyAlias": []
    },
    "NCT00428714": {
        "briefTitle": "Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy",
        "officialTitle": "Phase 2 Trial Oral Enzastaurin in Prostate Cancer Patients Who Have Rising PSA (1) During Hormonal Manipulation and (2) After First-Line Cytotoxic Chemotherapy",
        "lillyAlias": [
            "H6Q-MC-S024"
        ]
    },
    "NCT04840914": {
        "briefTitle": "A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction",
        "officialTitle": "A Single-Dose Study Evaluating Different Dose Levels and Subcutaneous Infusion Durations on Safety, Pharmacokinetics, and Pharmacodynamics of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction",
        "lillyAlias": [
            "J2L-MC-EZBB"
        ]
    },
    "NCT03643510": {
        "briefTitle": "Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer",
        "officialTitle": "Phase II Study of Fulvestrant in Combination With Abemaciclib in Hormone Receptor Positive Adenocarcinoma of Endometrium",
        "lillyAlias": []
    },
    "NCT03338010": {
        "briefTitle": "A Study of LY2963016 Compared to Lantus\u00ae in Adult Chinese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus\u00ae in Adult Chinese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I4L-GH-ABET"
        ]
    },
    "NCT01358981": {
        "briefTitle": "A Study of LY2881835 in Healthy People and People With Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Oral Doses of LY2881835 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I4P-FW-GPFA"
        ]
    },
    "NCT00128310": {
        "briefTitle": "Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients",
        "officialTitle": "Randomized Phase III Trial Comparing Vinorelbine vs. Gemcitabine Plus Vinorelbine in Patients With Advanced Breast Cancer, Previously Treated With Anthracyclines and Taxanes",
        "lillyAlias": []
    },
    "NCT00082381": {
        "briefTitle": "Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin",
        "officialTitle": "Effect of AC2993 (Synthetic Exendin-4) Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin",
        "lillyAlias": []
    },
    "NCT00520481": {
        "briefTitle": "Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer",
        "officialTitle": "Phase 2 Single Arm, Open-Label Study of IMC-A12 in Asymptomatic, Chemotherapy-Na\u00efve Patients With Metastatic Androgen-Independent Prostate Cancer",
        "lillyAlias": [
            "CP13-0603",
            "I5A-IE-JAEJ"
        ]
    },
    "NCT01872910": {
        "briefTitle": "A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal",
        "officialTitle": "Evaluation of the Acute Analgesic Efficacy of a Single Dose of LY3023703 in Patients With Postsurgical Dental Pain: A Parallel, Double-Blind, Randomized, Placebo and Positive Control Study",
        "lillyAlias": [
            "I6H-MC-MCBC"
        ]
    },
    "NCT00193310": {
        "briefTitle": "Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer",
        "officialTitle": "Preoperative (Neoadjuvant) or Postoperative (Adjuvant) Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT00191412": {
        "briefTitle": "A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver",
        "officialTitle": "Phase II Study of Single-Agent Alimta in the Treatment of Patients With Advanced and Metastatic Hepatoma",
        "lillyAlias": [
            "H3E-US-S055"
        ]
    },
    "NCT00546910": {
        "briefTitle": "Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "A Randomized, Double Blind Comparison of the Effects of Atomoxetine Versus Placebo on Neuropsychological Outcomes Across the Day in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) by Use of a Computer Based Continuous Performance Test (cb CPT)",
        "lillyAlias": [
            "B4Z-SB-LYDV"
        ]
    },
    "NCT03670810": {
        "briefTitle": "A Study of Lasmiditan (LY573144) Over Four Migraine Attacks",
        "officialTitle": "Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks",
        "lillyAlias": [
            "H8H-MC-LAIJ",
            "2018-001661-17"
        ]
    },
    "NCT03188510": {
        "briefTitle": "A Study of Two Different Formulations of LY3074828 in Healthy Participants",
        "officialTitle": "Relative Bioavailability of LY3074828 Solution Formulation in Pre-Filled Syringes Compared to Lyophilized Formulation After Single Subcutaneous Administration",
        "lillyAlias": [
            "I6T-MC-AMAE"
        ]
    },
    "NCT00557310": {
        "briefTitle": "A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide",
        "officialTitle": "The Effects of Teriparatide on Bone Microarchitecture as Determined by High Resolution Magnetic Resonance Imaging and Digital Topological Analysis",
        "lillyAlias": [
            "B3D-US-GHDJ"
        ]
    },
    "NCT03724981": {
        "briefTitle": "A Study Comparing the Dulaglutide Pen and the Semaglutide Pen",
        "officialTitle": "Crossover Study Comparing the Dulaglutide (Trulicity) Pen and the Semaglutide (Ozempic) Pen",
        "lillyAlias": [
            "H9X-MC-B021"
        ]
    },
    "NCT01368081": {
        "briefTitle": "Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "A 52-week, Randomised, Multi-centre, Parallel Group Study to Investigate the Safety and Efficacy of BI 10773 (10 mg or 25 mg Administered Orally Once Daily) as add-on Therapy to an Oral Antidiabetic Drug (Sulfonylurea, Biguanide, Thiazolidinedione, Alpha Glucosidase Inhibitor, DPP-IV Inhibitor, or Glinide) in Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control",
        "lillyAlias": []
    },
    "NCT00162110": {
        "briefTitle": "A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces",
        "officialTitle": "A Phase II Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces",
        "lillyAlias": []
    },
    "NCT02944110": {
        "briefTitle": "Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism",
        "officialTitle": "Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism",
        "lillyAlias": []
    },
    "NCT00538681": {
        "briefTitle": "Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo",
        "officialTitle": "Randomized, Double-Blind, Placebo Controlled, Phase 2 Study of Pemetrexed and Cisplatin Plus Enzastaurin Versus Pemetrexed and Cisplatin Plus Placebo in Chemonaive Patients With Advanced, Unresectable, or Metastatic (Stage IIIB or IV) Nonsquamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H6Q-MC-S021"
        ]
    },
    "NCT00440895": {
        "briefTitle": "A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI",
        "officialTitle": "A Randomized Trial of Early Discharge After Trans-Radial Stenting of Coronary Arteries in Acute Myocardial Infarction and RESCUE-PCI: The EASY-RESCUE Pilot Study",
        "lillyAlias": []
    },
    "NCT00517595": {
        "briefTitle": "Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC",
        "officialTitle": "A Phase II Study of Pemetrexed and Gemcitabine Plus Bevacizumab as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT00169195": {
        "briefTitle": "Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma",
        "officialTitle": "Gemcitabine-oxaliplatin Plus Rituximab (R-GEMOX) in Refractory/Relapsed Patients With CD 20 Positive Diffuse Large B-cell Lymphoma, Non Eligible for High-dose Chemotherapy Followed by Autotransplantation",
        "lillyAlias": []
    },
    "NCT00071695": {
        "briefTitle": "Duloxetine vs. Active Comparator in the Treatment of Patients With Depression",
        "officialTitle": "Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMBU"
        ]
    },
    "NCT04975295": {
        "briefTitle": "A Study of LY3361237 in Participants With Psoriasis",
        "officialTitle": "A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3361237 in Participants With Psoriasis",
        "lillyAlias": [
            "I9S-MC-BTAC",
            "2019-003187-40"
        ]
    },
    "NCT04760314": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab When Used in Combination With Topical Corticosteroid Treatment in Japanese Patients With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-JE-KGAL"
        ]
    },
    "NCT01029795": {
        "briefTitle": "A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus",
        "officialTitle": "A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2599506 Given as Monotherapy or in Combination With Metformin in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I2Q-MC-GMAJ"
        ]
    },
    "NCT05734495": {
        "briefTitle": "Pirtobrutinib and Venetoclax in Waldenstr\u00f6m Macroglobulinemia",
        "officialTitle": "A Phase II Study Evaluating Venetoclax and Pirtobrutinib in Previously Treated Waldenstr\u00f6m Macroglobulinemia",
        "lillyAlias": []
    },
    "NCT00547495": {
        "briefTitle": "Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Tadalafil Administered \"On Demand\" to Patients With Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVDI"
        ]
    },
    "NCT00394095": {
        "briefTitle": "Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine",
        "officialTitle": "A Double-Blind, Randomized, Placebo-Controlled, Pilot Study of Topiramate vs. Placebo in Combination With Olanzapine for the Prevention of Weight Gain in Manic or Mixed Youth With Bipolar Disorder",
        "lillyAlias": []
    },
    "NCT02942914": {
        "briefTitle": "A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes",
        "officialTitle": "A First-in-Human, Ascending-Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single, Subcutaneous Dose of LY3209590",
        "lillyAlias": [
            "I8H-MC-BDCA",
            "2016-001048-20"
        ]
    },
    "NCT06696014": {
        "briefTitle": "Mirikizumab Real World Protocol",
        "officialTitle": "MIrikizumab in UC - a Real-woRld prOspective multicenteR Registry",
        "lillyAlias": []
    },
    "NCT03616795": {
        "briefTitle": "Study of LY3154207 in Healthy Participants",
        "officialTitle": "Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects",
        "lillyAlias": [
            "I7S-MC-HBEE"
        ]
    },
    "NCT04391595": {
        "briefTitle": "LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients",
        "officialTitle": "A Phase 0/2 Study of LY3214996 (ERK Inhibitor) in Combination With Abemaciclib (CDK4 and 6 Inhibitor) in Recurrent Glioblastoma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration",
        "lillyAlias": []
    },
    "NCT00044395": {
        "briefTitle": "Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes",
        "officialTitle": "LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes",
        "lillyAlias": [
            "B7A-MC-MBBP"
        ]
    },
    "NCT02349295": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis",
        "lillyAlias": [
            "I1F-MC-RHBE",
            "2011-002328-42"
        ]
    },
    "NCT01049412": {
        "briefTitle": "A Study for Patients With Type 1 Diabetes",
        "officialTitle": "A Phase 2 Study of LY2605541 Compared With Insulin Glargine in the Treatment of Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIAD"
        ]
    },
    "NCT05436912": {
        "briefTitle": "A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy Participants",
        "officialTitle": "Open-label, Nonrandomized, Single-dose, Parallel-group, Safety, Tolerance, and Pharmacokinetic Study of LOXO-292 Administered to Fasted Hepatically Impaired Male and Female Subjects and Fasted Matched-control Healthy Subjects",
        "lillyAlias": [
            "J2G-OX-JZJD",
            "LOXO-RET-18022"
        ]
    },
    "NCT00082212": {
        "briefTitle": "A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma",
        "officialTitle": "A Phase II Trial of Single-agent Cetuximab Dose Escalated to Rash in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma",
        "lillyAlias": []
    },
    "NCT00985712": {
        "briefTitle": "A Study on the Effect of 2 Pen Devices on HbA1c",
        "officialTitle": "A Randomized, Open-label Study on the Effects of Insulin Pen Devices on Glycemic Control in Children, Adolescents and Adults With Type 1 Diabetes: Novel Pen With Memory Function (HumaPen Memoir) vs. Conventional Pen Without Memory Function (HumaPen Luxura)",
        "lillyAlias": [
            "H9D-SB-ITAE"
        ]
    },
    "NCT02688712": {
        "briefTitle": "ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer",
        "officialTitle": "Phase II Study of TGF\u03b2 Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma",
        "lillyAlias": []
    },
    "NCT06395012": {
        "briefTitle": "A First-In-Human Study of LY3985297 in Healthy Participants",
        "officialTitle": "A Phase 1, Randomized, Placebo-controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3985297 in Healthy Participants",
        "lillyAlias": [
            "J4S-MC-KSAA"
        ]
    },
    "NCT04641312": {
        "briefTitle": "A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes",
        "officialTitle": "A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3457263 in Healthy Participants and in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "2020-001828-34",
            "J1R-MC-GZFA"
        ]
    },
    "NCT01474512": {
        "briefTitle": "A Phase 3 Study in Participants With Moderate to Severe Psoriasis",
        "officialTitle": "A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period and a Long- Term Extension Period to Evaluate the Efficacy and Safety of LY2439821 in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHAZ"
        ]
    },
    "NCT06102512": {
        "briefTitle": "A Study of [14C]-LOXO-783 in Healthy Adult Participants",
        "officialTitle": "A Phase 1, Open-label Two-part Study of the Absorption, Metabolism, Excretion, and the Absolute Bioavailability of [14C]-LOXO-783 in Healthy Adult Subjects",
        "lillyAlias": [
            "J4C-OX-JZUE"
        ]
    },
    "NCT03735446": {
        "briefTitle": "Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial",
        "officialTitle": "Prexasertib in Combination With Mitoxantrone, Etoposide and Cytarabine (MEC) in Relapsed/Refractory Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) - a Phase I Trial",
        "lillyAlias": []
    },
    "NCT01136746": {
        "briefTitle": "Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin",
        "officialTitle": "Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial",
        "lillyAlias": [
            "F3Z-US-IOPZ"
        ]
    },
    "NCT02123446": {
        "briefTitle": "A Study of Cephalexin Capsules in Healthy Participants",
        "officialTitle": "A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Capsules With 250 mg of Cephalexin (Keflex\u00ae Made in Mexico by Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V. vs. Keflex\u00ae Made in Italy by Facta Farmaceutici S.p.A. for Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V.) in Fasting Healthy Volunteers",
        "lillyAlias": [
            "A3Q-ME-AFBP"
        ]
    },
    "NCT01724112": {
        "briefTitle": "Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)",
        "officialTitle": "8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)",
        "lillyAlias": [
            "I5J-MC-NOAC"
        ]
    },
    "NCT01808612": {
        "briefTitle": "A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing",
        "officialTitle": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Parallel-Design Study to Evaluate the Short-Term, Fixed Dose Efficacy and Safety of LY110140 Once Daily Dosing in Japanese Patients With Major Depressive Disorder",
        "lillyAlias": [
            "B1Y-JE-HCLV"
        ]
    },
    "NCT02441946": {
        "briefTitle": "A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer",
        "officialTitle": "neoMONARCH: A Phase 2 Neoadjuvant Trial Comparing the Biological Effects of 2 Weeks of Abemaciclib (LY2835219) in Combination With Anastrozole to Those of Abemaciclib Monotherapy and Anastrozole Monotherapy and Evaluating the Clinical Activity and Safety of a Subsequent 14 Weeks of Therapy With Abemaciclib in Combination With Anastrozole in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPBY",
            "2014-005486-75"
        ]
    },
    "NCT03341312": {
        "briefTitle": "A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog\u00ae in Patients With T2DM",
        "lillyAlias": [
            "I8B-MC-ITRW",
            "2017-001501-33"
        ]
    },
    "NCT03502746": {
        "briefTitle": "Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma",
        "officialTitle": "Phase II Study of Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma:Hoosier Cancer Research Network LUN15-299",
        "lillyAlias": []
    },
    "NCT00149110": {
        "briefTitle": "Chronos: the Use of Chronobiological Treatment in Depression",
        "officialTitle": "\"The CHRONOS Study: Can the Sleep-deprivation Induced Antidepressive Effect in Patients With Major Depression be Sustained by Correction of Diurnal Rhythms, Long Term Light Treatment and Duloxetine Treatment?\"",
        "lillyAlias": []
    },
    "NCT01018810": {
        "briefTitle": "A Study for Adults With Plaque Psoriasis",
        "officialTitle": "LY2525623 (IL-23 Antibody) Multiple-Dose Study in Adults With Plaque Psoriasis",
        "lillyAlias": [
            "I1X-MC-BDAD"
        ]
    },
    "NCT01173081": {
        "briefTitle": "The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures",
        "officialTitle": "The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures",
        "lillyAlias": []
    },
    "NCT04498910": {
        "briefTitle": "A Study of LY3451838 in Participants With Migraine",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3451838 in Adults With Treatment-Resistant Migraine",
        "lillyAlias": [
            "J1H-MC-LAJB"
        ]
    },
    "NCT00190710": {
        "briefTitle": "A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer",
        "officialTitle": "A Randomized Phase III Trial of Paraplatin (Carboplatin) + Gemzar Versus Gemzar Alone in Patients With Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-US-S358"
        ]
    },
    "NCT00088010": {
        "briefTitle": "Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer",
        "officialTitle": "Effects of Arzoxifene on Vertebral Fracture Incidence and on Invasive Breast Cancer Incidence in Postmenopausal Women With Osteoporosis or With Low Bone Density.",
        "lillyAlias": [
            "H4Z-MC-GJAD"
        ]
    },
    "NCT02750410": {
        "briefTitle": "A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 4 Study of Efficacy and Safety of Dulaglutide When Added to Insulin Treatment With or Without Oral Antidiabetic Medication in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "H9X-JE-GBGF"
        ]
    },
    "NCT01204710": {
        "briefTitle": "A Study of Olaratumab (IMC-3G3) in Prostate Cancer",
        "officialTitle": "A Randomized Phase 2 Study of Human Anti-PDGFR\u03b1 Monoclonal Antibody IMC-3G3 Plus Mitoxantrone Plus Prednisone or Mitoxantrone Plus Prednisone in Metastatic Castration-Refractory Prostate Cancer Following Disease Progression or Intolerance on Docetaxel-based Chemotherapy",
        "lillyAlias": [
            "I5B-IE-JGDD",
            "CP15-0805",
            "2009-018015-11"
        ]
    },
    "NCT01468181": {
        "briefTitle": "A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A 52-Week, Open-Label, Long-Term Safety Study of LY2189265 in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-JE-GBDQ"
        ]
    },
    "NCT03997981": {
        "briefTitle": "Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)",
        "officialTitle": "Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)",
        "lillyAlias": [
            "H7I-MC-S028",
            "10001"
        ]
    },
    "NCT02622581": {
        "briefTitle": "Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients",
        "officialTitle": "Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients",
        "lillyAlias": []
    },
    "NCT05608252": {
        "briefTitle": "VS-6766+Abema+Fulv in Met HR+/HER- BC",
        "officialTitle": "A Single Arm Phase 1/2 Trial of Abemaciclib + VS-6766 + Fulvestrant in Metastatic HR+/HER2- Breast Cancer",
        "lillyAlias": []
    },
    "NCT05615532": {
        "briefTitle": "A Relative Bioavailability Study of LY3209590 in Healthy Participants",
        "officialTitle": "Effect of Injection Site on the Relative Bioavailability of Single Dose of LY3209590 and Evaluation of Absolute Bioavailability of LY3209590 in Healthy Participants",
        "lillyAlias": [
            "I8H-MC-BDDD"
        ]
    },
    "NCT00970632": {
        "briefTitle": "A Study of Tadalafil in Men With Benign Prostatic Hyperplasia",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Global Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once Daily Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVID"
        ]
    },
    "NCT03267732": {
        "briefTitle": "A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)",
        "officialTitle": "A Phase 1 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of AM0010 in Healthy Adult Subjects",
        "lillyAlias": [
            "J1L-AM-JZGE",
            "AM0010-801"
        ]
    },
    "NCT00191932": {
        "briefTitle": "Switching to Duloxetine From Other Antidepressants",
        "officialTitle": "Switching to Duloxetine From Other Antidepressants: A Regional Multicentre Trial Comparing Two Switching Techniques",
        "lillyAlias": [
            "F1J-MC-HMDG"
        ]
    },
    "NCT00311532": {
        "briefTitle": "Observational Study of Pergolide Mesylate and Cardiac Valvulopathy",
        "officialTitle": "Observational Study to Determine the Incidence of New-Onset Valvulopathy in Patients Treated With Pergolide as Second-Line Therapy for Parkinson's Disease",
        "lillyAlias": [
            "B4G-MC-B001"
        ]
    },
    "NCT05882032": {
        "briefTitle": "A Study of LY3502970 in Participants With Impaired and Normal Liver Function",
        "officialTitle": "A Phase 1, Multicenter, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Hepatic Function and Participants With Mild, Moderate, or Severe Hepatic Impairment",
        "lillyAlias": [
            "J2A-MC-GZPB"
        ]
    },
    "NCT03252015": {
        "briefTitle": "A Study of Multiple Doses of Lasmiditan in Healthy Participants",
        "officialTitle": "Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Drug-Drug Interaction Study of Lasmiditan",
        "lillyAlias": [
            "H8H-MC-LAHE"
        ]
    },
    "NCT02623452": {
        "briefTitle": "A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel Insulin Lispro Formulation in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy",
        "lillyAlias": [
            "F3Z-FW-ITCB",
            "2015-003351-21"
        ]
    },
    "NCT00510952": {
        "briefTitle": "Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)",
        "officialTitle": "The PERSISTENT Trial: A Prospective Randomized Trial Comparing Insulin Lispro Protamine Suspension to Insulin Glargine in Patients With Type 2 Diabetes on Anti-hyperglycemic Medications",
        "lillyAlias": [
            "F3Z-MC-IOPE"
        ]
    },
    "NCT05024032": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)",
        "officialTitle": "Efficacy and Safety of Tirzepatide Once Weekly in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-CN)",
        "lillyAlias": [
            "I8F-MC-GPIA"
        ]
    },
    "NCT00839332": {
        "briefTitle": "A Study for Participants With Pancreatic Cancer",
        "officialTitle": "A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination With Gemcitabine in Patients With Pancreatic Cancer",
        "lillyAlias": [
            "I2I-MC-JMMC"
        ]
    },
    "NCT01810432": {
        "briefTitle": "Study of Food on Evacetrapib (LY2484595) in Healthy Participants",
        "officialTitle": "Effect of Food on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAX"
        ]
    },
    "NCT00122837": {
        "briefTitle": "A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder",
        "officialTitle": "A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder",
        "lillyAlias": [
            "F1J-MC-HMDW"
        ]
    },
    "NCT00497315": {
        "briefTitle": "Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomized Multicenter Phase II Study Of Induction Therapy With Pemetrexed And Cisplatin Followed By Chemoradiation With Pemetrexed Versus Chemoradiation With Pemetrexed Followed By Consolidation Therapy With Pemetrexed And Cisplatin In Patients With Stage III Non-Small Cell Lung Cancer: Paccora Trial",
        "lillyAlias": [
            "Eudra CT 2005-004030-40"
        ]
    },
    "NCT02245737": {
        "briefTitle": "An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease",
        "officialTitle": "A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)",
        "lillyAlias": [
            "I8D-MC-AZES",
            "2014-002601-38",
            "D5010C00009"
        ]
    },
    "NCT05113537": {
        "briefTitle": "Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer",
        "officialTitle": "Phase I/II Study of CDK4/6 Inhibition With Abemaciclib to Upregulate PSMA Expression Prior to 177Lu-PSMA-617 Treatment in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Chemotherapy",
        "lillyAlias": [
            "NCI-2021-11123"
        ]
    },
    "NCT00512499": {
        "briefTitle": "Strategies to Treat Osteoporosis Following a Fragility Fracture",
        "officialTitle": "Osteoporosis and Peripheral Fractures: Treatment and Investigation Multidisciplinary at the chUS",
        "lillyAlias": []
    },
    "NCT00767299": {
        "briefTitle": "A Study of Arzoxifene to Treat Korean Women With Osteoporosis",
        "officialTitle": "Effects of Arzoxifene on Bone Mineral Density in Korean Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "H4Z-MC-GJAV"
        ]
    },
    "NCT00101842": {
        "briefTitle": "Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer",
        "officialTitle": "Phase I/II Study of Gemzar and Platinol Followed by Alimta and Gemzar in Patients With Advanced or Metastatic Bladder Cancer",
        "lillyAlias": [
            "H3E-US-S066"
        ]
    },
    "NCT01460342": {
        "briefTitle": "Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Study to Evaluate the Efficacy and Safety of Tadalafil Once-a-day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-JE-LVJF"
        ]
    },
    "NCT00110370": {
        "briefTitle": "Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes",
        "officialTitle": "A Comparison of Prandial Insulin Lispro Mixtures Therapy to Glargine Basal-Bolus Therapy With Insulin Lispro on the Overall Glycemic Control of Patients With Type 2 Diabetes Previously Treated With Oral Agents Combined With Insulin Glargine",
        "lillyAlias": [
            "F3Z-US-IOOQ"
        ]
    },
    "NCT00500370": {
        "briefTitle": "A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients",
        "officialTitle": "A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients",
        "lillyAlias": []
    },
    "NCT01637142": {
        "briefTitle": "A Study of LY2140023 in Healthy Participants",
        "officialTitle": "An Absolute Bioavailability Study of LY2140023 and LY404039 in Healthy Subjects Using the Intravenous Tracer Method",
        "lillyAlias": [
            "H8Y-MC-HBCU"
        ]
    },
    "NCT02109042": {
        "briefTitle": "A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants",
        "officialTitle": "A Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Blosozumab Proposed Phase 3 Formulation in Postmenopausal Women",
        "lillyAlias": [
            "I2M-MC-GSDM"
        ]
    },
    "NCT00489359": {
        "briefTitle": "Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer",
        "officialTitle": "A Phase 1 and 2 Clinical Trial of ALIMTA\u00ae (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer",
        "lillyAlias": [
            "H3E-MC-JMHH"
        ]
    },
    "NCT01060059": {
        "briefTitle": "Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes",
        "officialTitle": "EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients With Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment",
        "lillyAlias": []
    },
    "NCT03662100": {
        "briefTitle": "A Study of Two Formulations of LY3074828 in Healthy Participants",
        "officialTitle": "A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 2-mL Autoinjector in Healthy Subjects",
        "lillyAlias": [
            "I6T-MC-AMAR"
        ]
    },
    "NCT02683200": {
        "briefTitle": "MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer",
        "officialTitle": "Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma Utilizing an MRI-Guided Tri-60Co Teletherapy System",
        "lillyAlias": [
            "NCI-2015-01665"
        ]
    },
    "NCT01524770": {
        "briefTitle": "A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe",
        "officialTitle": "Comparative Pharmacokinetics of Dulaglutide After Administration Via an Auto-injector and a Manual Syringe in Healthy Subjects",
        "lillyAlias": [
            "H9X-MC-GBDT"
        ]
    },
    "NCT00966875": {
        "briefTitle": "A Study in Patients With Rheumatoid Arthritis",
        "officialTitle": "A Phase 2 Dose-Ranging Study of Multiple Subcutaneous Doses of LY2439821 (an Anti-IL-17 Antibody) in Patients With Active Rheumatoid Arthritis on Concomitant DMARD Therapy",
        "lillyAlias": [
            "I1F-MC-RHAK"
        ]
    },
    "NCT06594159": {
        "briefTitle": "A Study of LY4065967 in Healthy Japanese Participants",
        "officialTitle": "A Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of LY4065967, to Evaluate the Effect of LY4065967 on the Pharmacokinetics of Rosuvastatin, and to Assess Regional Absorption of LY4065967 in Healthy Japanese Participants",
        "lillyAlias": [
            "J4X-JE-LWCA"
        ]
    },
    "NCT01398475": {
        "briefTitle": "A Relative Bioavailability and Food Effect Study of New Formulations",
        "officialTitle": "Relative Bioavailability of the LY3009104 Free Base Test Formulation Compared to the Reference Phosphate Salt Formulation and the Effect of Food on the Bioavailability of the Test Formulation in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JADH"
        ]
    },
    "NCT00147875": {
        "briefTitle": "Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma",
        "officialTitle": "PVAG - Phase I/II Dose Finding Trial in Elderly Patients (> 60 Years) With Advanced Stages Hodgkin's Lymphoma",
        "lillyAlias": []
    },
    "NCT01139775": {
        "briefTitle": "A Study in Non Small Cell Lung Cancer",
        "officialTitle": "A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination With Pemetrexed and Cisplatin in Patients With Stage IV Non-small Cell Lung Cancer",
        "lillyAlias": [
            "I2I-MC-JMMG"
        ]
    },
    "NCT03899259": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata",
        "lillyAlias": [
            "I4V-MC-JAIR"
        ]
    },
    "NCT00069875": {
        "briefTitle": "A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer",
        "officialTitle": "Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study of Gemcitabine-Cisplatin Combined With Two Different Doses of LY293111 or Placebo in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H6H-MC-JEAM"
        ]
    },
    "NCT00192075": {
        "briefTitle": "A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer",
        "officialTitle": "A Multicenter, Randomized Phase II Trial of Avastin Plus Gemcitabine Plus 5FU/Folinic Acid (A + FFG) vs. Avastin Plus Oxaliplatin Plus 5FU/Folinic Acid (A + FOLFOX 4) as Therapy for Patients With Metastatic Colorectal Cancer",
        "lillyAlias": [
            "B9E-US-S337"
        ]
    },
    "NCT01650259": {
        "briefTitle": "Long-term Daily Use of Trazenta\u00ae Tablets in Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "Post Marketing Surveillance on Long Term Drug Use of Trazenta\u00ae Tablets in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT05602675": {
        "briefTitle": "A Drug Interaction Study of LY3871801 in Healthy Participants",
        "officialTitle": "Evaluation of the Effect of LY3871801 on the Pharmacokinetics of CYP450 Substrates and an OAT1/3 Substrate in Healthy Participants",
        "lillyAlias": [
            "J3P-MC-FTAD"
        ]
    },
    "NCT00793975": {
        "briefTitle": "Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy",
        "officialTitle": "Phase I Study of Weekly Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Monoclonal Antibody IMC-1121B in Patients With Advanced Solid Tumors Who Have Not Responded to Standard Therapy",
        "lillyAlias": [
            "CP12-0401",
            "I4T-IE-JVBM"
        ]
    },
    "NCT00630149": {
        "briefTitle": "Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy",
        "officialTitle": "Open-Label Single-Arm Phase 2 Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Who Have Had Prior Platinum Based Chemotherapy",
        "lillyAlias": []
    },
    "NCT00355849": {
        "briefTitle": "Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine",
        "lillyAlias": [
            "H7U-MC-IDBA"
        ]
    },
    "NCT04396236": {
        "briefTitle": "A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine",
        "officialTitle": "Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1",
        "lillyAlias": [
            "H8H-MC-LAHV",
            "2019-004378-24"
        ]
    },
    "NCT02595736": {
        "briefTitle": "A Study of LY3200327 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3200327 in Healthy Subjects",
        "lillyAlias": [
            "I8C-MC-GSFA"
        ]
    },
    "NCT03019549": {
        "briefTitle": "A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin",
        "officialTitle": "Effect of LY3314814 on the Pharmacokinetics of Rosuvastatin in Caucasian Healthy Subjects",
        "lillyAlias": [
            "I8D-MC-AZEB"
        ]
    },
    "NCT00286949": {
        "briefTitle": "Treatment of Executive Dysfunction in Parkinson's Disease",
        "officialTitle": "Atomoxetine for the Treatment of Executive Dysfunction in Patients With Parkinson's Disease: A Pilot Open-label Study",
        "lillyAlias": [
            "B4Z-US-X029"
        ]
    },
    "NCT04145349": {
        "briefTitle": "CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor",
        "officialTitle": "A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor",
        "lillyAlias": [
            "J1S-MC-JV01",
            "2018-004242-42"
        ]
    },
    "NCT00088049": {
        "briefTitle": "Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia",
        "officialTitle": "A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia",
        "lillyAlias": [
            "F1D-MC-HGLB"
        ]
    },
    "NCT02009449": {
        "briefTitle": "A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, Preliminary Clinical Activity and Pharmacokinetics of AM0010 in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "J1L-AM-JZGA",
            "AM0010-001"
        ]
    },
    "NCT01876849": {
        "briefTitle": "An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00071136": {
        "briefTitle": "Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "Phase 1/2 Dose-Escalating Study of Biweekly Alimta and Gemcitabine in Patients With Advanced Cancer",
        "lillyAlias": [
            "H3E-US-JMGC"
        ]
    },
    "NCT03958136": {
        "briefTitle": "Clinico-biological Data Collection Study of Metastatic Breast Cancer",
        "officialTitle": "Prediction in Silico of Overall Survival in a Pilot Prospective Cohort Study of Metastatic Breast Cancer Patients",
        "lillyAlias": []
    },
    "NCT02317575": {
        "briefTitle": "A Study of LY900014 Formulations in Healthy Participants",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics and Glucodynamics of Multiple Insulin Lispro (LY900014) Formulations",
        "lillyAlias": [
            "I8B-FW-ITRA"
        ]
    },
    "NCT00185575": {
        "briefTitle": "Duloxetine for the Treatment of Dysthymia",
        "officialTitle": "Duloxetine for the Treatment of Dysthymia",
        "lillyAlias": []
    },
    "NCT00948675": {
        "briefTitle": "Study of Participants With Advanced Non-Small Cell Lung Cancer",
        "officialTitle": "A Study of Pemetrexed Plus Carboplatin Followed by Maintenance Pemetrexed vs Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced NCSLC of Nonsquamous Histology",
        "lillyAlias": [
            "H3E-US-S130"
        ]
    },
    "NCT05592275": {
        "briefTitle": "A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)",
        "lillyAlias": [
            "J3E-MC-EZDB",
            "2023-505902-40-00"
        ]
    },
    "NCT06252675": {
        "briefTitle": "Glofitamab with Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma",
        "officialTitle": "A Multicenter Phase 2 Study of Glofitamab with Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma",
        "lillyAlias": [
            "NCI-2024-00054"
        ]
    },
    "NCT00190775": {
        "briefTitle": "A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder: With a Secondary Examination of Impact of Treatment on Family Functioning",
        "lillyAlias": [
            "B4Z-US-LYCW"
        ]
    },
    "NCT03019536": {
        "briefTitle": "A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease",
        "officialTitle": "Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease",
        "lillyAlias": [
            "I8G-MC-LMDD",
            "2016-002102-39"
        ]
    },
    "NCT03465436": {
        "briefTitle": "A Study of Lasmiditan on the Heart in Healthy Participants",
        "officialTitle": "A Randomized, Double-blind, Placebo-controlled, 4-way Crossover Study to Compare the Effects on the Cardiac De- and Repolarization Duration as Well as Other Cardiac Safety Parameters of Two Doses of Oral Lasmiditan (100 mg and 400 mg) With Those of Moxifloxacin (400 mg) and Placebo in Healthy Subjects",
        "lillyAlias": [
            "H8H-CD-LAHP",
            "COL-MIG-105",
            "2011-003229-88"
        ]
    },
    "NCT02265536": {
        "briefTitle": "A Study of LY3022855 In Participants With Breast or Prostate Cancer",
        "officialTitle": "Phase 1 Study to Identify the Immunomodulatory Activity of LY3022855 (IMC-CS4) in Patients With Advanced, Refractory Breast or Prostate Cancer",
        "lillyAlias": [
            "I5F-MC-JSCB"
        ]
    },
    "NCT02079636": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)",
        "officialTitle": "A Phase 1b Study of LY2835219 in Combination With Multiple Single Agent Options for Patients With Stage IV NSCLC",
        "lillyAlias": [
            "I3Y-MC-JPBJ",
            "2013-004648-41",
            "KEYNOTE-238"
        ]
    },
    "NCT01792518": {
        "briefTitle": "MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin",
        "officialTitle": "A Phase IIIb, Multicenter, Multinational, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Glycemic and Renal Efficacy of Once Daily Administration of Linagliptin 5 mg for 24 Weeks in Type 2 Diabetes Patients, With Micro- or Macroalbuminuria (30-3000mg/g Creatinine) on Top of Current Treatment With Angiotensin ConvEnzyme Inhibitor or Angiotensin Receptor Blocker - MARLINA (Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin)",
        "lillyAlias": [
            "2012-002603-17"
        ]
    },
    "NCT00969618": {
        "briefTitle": "A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder",
        "officialTitle": "Long-Term, Open-Label Safety and Efficacy Study of Atomoxetine Hydrochloride in Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "lillyAlias": [
            "B4Z-JE-LYEK"
        ]
    },
    "NCT00162318": {
        "briefTitle": "A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "officialTitle": "A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT02597036": {
        "briefTitle": "A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1 Study of LY3127804 as Monotherapy and in Combination With Ramucirumab in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I7W-MC-JQBA",
            "2015-001204-64"
        ]
    },
    "NCT04305236": {
        "briefTitle": "Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer",
        "officialTitle": "A Phase II Open Label Trial of Neo-Adjuvant Abemaciclib With Fulvestrant in Patients Who Develop Localized Recurrence While on Adjuvant Endocrine Therapy With Molecular Evidence of Endocrine Resistance",
        "lillyAlias": [
            "2020-5660"
        ]
    },
    "NCT01375075": {
        "briefTitle": "A Study of LY2484595 in Japanese Subjects",
        "officialTitle": "A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects",
        "lillyAlias": [
            "I1V-JE-EIAE"
        ]
    },
    "NCT01836575": {
        "briefTitle": "Alimta\u00ae Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2",
        "officialTitle": "Phase III Trial of Single-Agent Pemetrexed (Alimta\u00ae) Versus the Combination of Carboplatin and Pemetrexed in Patients With Advanced Non-small-cell Lung Cancer and Performance Status of 2",
        "lillyAlias": [
            "H3E - US -I023",
            "INCA-Lung001"
        ]
    },
    "NCT00206375": {
        "briefTitle": "Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism",
        "officialTitle": "Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism",
        "lillyAlias": []
    },
    "NCT00784875": {
        "briefTitle": "An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study of the Safety and Efficacy of LY2624803 in Outpatients With Insomnia",
        "lillyAlias": [
            "I2K-MC-ZZAD"
        ]
    },
    "NCT00279175": {
        "briefTitle": "REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)",
        "officialTitle": "Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Myocardial Infarction (REPAIR - AMI)",
        "lillyAlias": [
            "Paul-Ehrlich-Institute 1034/01",
            "EudraCT 2006-000250-43"
        ]
    },
    "NCT00485875": {
        "briefTitle": "Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD",
        "officialTitle": "An Open-Label, Multicenter, Pilot Study of the Safety and Efficacy of Transitioning From a Stimulant Medication to Atomoxetine in Pediatric and Adolescent Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "lillyAlias": [
            "B4Z-MC-LYCI"
        ]
    },
    "NCT00491075": {
        "briefTitle": "Pemetrexed Plus Gemcitabine in Renal Cell Cancer",
        "officialTitle": "Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Advanced Non-Clear Cell Renal Cell Cancer",
        "lillyAlias": []
    },
    "NCT00552175": {
        "briefTitle": "A Study for the Treatment of Diabetic Peripheral Neuropathic Pain",
        "officialTitle": "A Superiority Study of LY248686 Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "0715N0831",
            "F1J-JE-HMFX"
        ]
    },
    "NCT00042575": {
        "briefTitle": "Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression",
        "officialTitle": "Protocol F1J-US-HMBY Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression",
        "lillyAlias": [
            "F1J-US-HMBY"
        ]
    },
    "NCT01105975": {
        "briefTitle": "A Study of LY2484595 in Patients With High LDL-C or Low HDL-C",
        "officialTitle": "A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination With Atorvastatin, Simvastatin, and Rosuvastatin in Patients With Hypercholesterolemia or Low HDL-C",
        "lillyAlias": [
            "I1V-MC-EIAF"
        ]
    },
    "NCT00337259": {
        "briefTitle": "Gemcitabine for Marginal Zone Lymphoma",
        "officialTitle": "Phase II Study of Gemcitabine in Patients With Advanced Stage Marginal Zone B-cell Lymphoma",
        "lillyAlias": []
    },
    "NCT05559359": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-MC-KGBI",
            "DRM06-AD13",
            "2021-005232-29",
            "2022-501476-25-00"
        ]
    },
    "NCT04768842": {
        "briefTitle": "A Study of Two Different Formulations of LY3209590 in Healthy Participants",
        "officialTitle": "Comparative Pharmacokinetics of LY3209590 After Administration of a Lyophilized Formulation and a Solution Formulation in Healthy Participants",
        "lillyAlias": [
            "I8H-MC-BDCJ",
            "2020-003738-19"
        ]
    },
    "NCT00490659": {
        "briefTitle": "Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes",
        "officialTitle": "A Phase II Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (-With Weekly Low-Dose Gemcitabine) in the Treatment of Nodes Positive NSCLC Patients",
        "lillyAlias": [
            "B9E-MC-S339"
        ]
    },
    "NCT02703350": {
        "briefTitle": "A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy",
        "lillyAlias": [
            "I8B-FW-ITRG",
            "2015-004737-27"
        ]
    },
    "NCT04250350": {
        "briefTitle": "Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-DM-KGAE",
            "DRM06-AD17",
            "2019-004301-28"
        ]
    },
    "NCT00190723": {
        "briefTitle": "A Study of LY317615 in Patients With Brain Tumors",
        "officialTitle": "A Phase II Trial of LY317615 in Patients With Recurrent High-Grade Gliomas",
        "lillyAlias": [
            "H6Q-MC-JCAJ"
        ]
    },
    "NCT00122850": {
        "briefTitle": "A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder",
        "officialTitle": "A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder.",
        "lillyAlias": [
            "F1J-MC-HMDU"
        ]
    },
    "NCT00241423": {
        "briefTitle": "Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes",
        "officialTitle": "Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes Using Metformin or Metformin Plus a Thiazolidinedione",
        "lillyAlias": []
    },
    "NCT01771250": {
        "briefTitle": "A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes",
        "officialTitle": "Assessment of the Effects of LY2605541 on Triglyceride Metabolism, Compared to Insulin Glargine, in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIDN"
        ]
    },
    "NCT00374855": {
        "briefTitle": "A Study in People With Mild Hypertension",
        "officialTitle": "Protocol H8D-MC-EMBH PPAR Alpha (LY518674): a Phase 2 Dose-Response Study to Evaluate the Blood Pressure-Lowering Effect in Essential Hypertension",
        "lillyAlias": [
            "H8D-MC-EMBH"
        ]
    },
    "NCT01306214": {
        "briefTitle": "Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase III, Randomized, Double-blind, Placebo-controlled, Parallel Group Safety and Efficacy Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) During 52 Weeks in Patients With Type 2 Diabetes Mellitus and Insufficient Glycemic Control on MDI Insulin Regimen Alone or With Metformin",
        "lillyAlias": [
            "2010-019968-37"
        ]
    },
    "NCT02864914": {
        "briefTitle": "Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors",
        "officialTitle": "Post-authorisation Safety Study in Patients With Type 2 Diabetes Mellitus to Assess the Risk of Acute Liver Injury, Acute Kidney Injury and Chronic Kidney Disease, Severe Complications of Urinary Tract Infection, Genital Infections, and Diabetic Ketoacidosis Among Patients Treated With Empagliflozin Compared to Patients Treated With DPP-4 Inhibitors",
        "lillyAlias": []
    },
    "NCT00097214": {
        "briefTitle": "Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Phase II Trial of Carboplatin Plus Cetuximab for the Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT01263223": {
        "briefTitle": "A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors",
        "officialTitle": "Effect of LY2216684 on Ambulatory Heart Rate and Blood Pressure in Patients With Major Depressive Disorder Who Are Being Treated With Selective Serotonin Reuptake Inhibitors",
        "lillyAlias": [
            "H9P-EW-LNCP"
        ]
    },
    "NCT00451555": {
        "briefTitle": "Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer",
        "officialTitle": "A Randomized, Double-Blind, Phase II Trial of Fulvestrant Plus Enzastaurin Versus Fulvestrant Plus Placebo in Aromatase Inhibitor-Resistant Metastatic Breast Cancer",
        "lillyAlias": [
            "H6Q-MC-S023"
        ]
    },
    "NCT00485823": {
        "briefTitle": "Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia",
        "officialTitle": "The Assessment of a Weight Management Program for Treatment-Emergent Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, and Schizoaffective Disorder During Olanzapine Therapy",
        "lillyAlias": [
            "F1D-KL-S031"
        ]
    },
    "NCT03495323": {
        "briefTitle": "A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors",
        "officialTitle": "A Phase I Combination Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors",
        "lillyAlias": []
    },
    "NCT01077323": {
        "briefTitle": "A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents",
        "officialTitle": "A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Byetta (Exenatide) and Other Antidiabetic Agents",
        "lillyAlias": []
    },
    "NCT00934908": {
        "briefTitle": "Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine",
        "officialTitle": "Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine",
        "lillyAlias": []
    },
    "NCT03527108": {
        "briefTitle": "Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC",
        "officialTitle": "A Phase 2 Study of Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic Non-Small Cell Lung Carcinoma",
        "lillyAlias": [
            "TH-189"
        ]
    },
    "NCT02672423": {
        "briefTitle": "A Study of Abemaciclib in Healthy Participants",
        "officialTitle": "A Bioequivalence Study Comparing Abemaciclib Capsule and Tablet Formulations and Effect of Food on Abemaciclib Tablet Pharmacokinetics in Healthy Subjects",
        "lillyAlias": [
            "I3Y-MC-JPCC"
        ]
    },
    "NCT00191308": {
        "briefTitle": "Molecular Profiling in Lung Cancer Patients",
        "officialTitle": "Molecular Profiling and Safety Study of Operable Lung Cancer Patients Treated With Alimta Combined With Cisplatin as Neoadjuvant Chemotherapy",
        "lillyAlias": [
            "H3E-PL-S051"
        ]
    },
    "NCT01965808": {
        "briefTitle": "A Study of LY2157299 in Healthy Participants",
        "officialTitle": "Effect of Food on the Pharmacokinetics of LY2157299 Monohydrate in Healthy Subjects",
        "lillyAlias": [
            "H9H-MC-JBAU"
        ]
    },
    "NCT01594723": {
        "briefTitle": "A Study of LY2784544 in Participants With Myeloproliferative Neoplasms",
        "officialTitle": "A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms",
        "lillyAlias": [
            "I3X-MC-JHTB"
        ]
    },
    "NCT01981408": {
        "briefTitle": "A Study of LY2801653 in Healthy Participants",
        "officialTitle": "Disposition of [^14C]-LY2801653 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I3O-EW-JSBC"
        ]
    },
    "NCT04975308": {
        "briefTitle": "A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer",
        "officialTitle": "EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy",
        "lillyAlias": [
            "J2J-OX-JZLC",
            "2021-000079-35"
        ]
    },
    "NCT00491114": {
        "briefTitle": "Intravesical Chemotherapy Treatment of Superficial Bladder Cancer",
        "officialTitle": "Intravesical Gemcitabine Therapy in Intermediate Risk Superficial Bladder Cancer: A Phase II Study With the Marker Lesion",
        "lillyAlias": [
            "B9E-MC-S340"
        ]
    },
    "NCT04749914": {
        "briefTitle": "A Study of Lasmiditan in Healthy Volunteers",
        "officialTitle": "An Open-Label, 2-Part Study to Investigate the Effect of Lasmiditan on the Pharmacokinetics of Dabigatran and Rosuvastatin in Healthy Volunteers",
        "lillyAlias": [
            "H8H-MC-LAIO"
        ]
    },
    "NCT06153355": {
        "briefTitle": "A First-In-Human Study of LY3839840 in Healthy Participants",
        "officialTitle": "Single- and Multiple-Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of LY3839840 Following Oral Dosing in Healthy Participants",
        "lillyAlias": [
            "J4U-MC-KTAA"
        ]
    },
    "NCT01784614": {
        "briefTitle": "A Study of LY2624803 in Japanese Participants With Transient Insomnia",
        "officialTitle": "Pharmacodynamics and Pharmacokinetics of Single Doses of LY2624803 in a 5-hour Phase Advance Model of Transient Insomnia in Healthy Japanese Subjects",
        "lillyAlias": [
            "I2K-JE-ZZAW"
        ]
    },
    "NCT01005355": {
        "briefTitle": "Study of IMC-1121B in Patients With Advanced Solid Tumors",
        "officialTitle": "Phase 1 Study of IMC-1121B in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "CP12-0816",
            "I4T-IE-JVBI"
        ]
    },
    "NCT02584855": {
        "briefTitle": "A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis",
        "officialTitle": "A Phase 3, Multicenter Study With a 36-Week Open-Label Period Followed by a Randomized Double-Blind Withdrawal Period From Week 36 to Week 104 to Evaluate the Long-Term Efficacy and Safety of Ixekizumab (LY2439821) 80 mg Every 2 Weeks in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis",
        "lillyAlias": [
            "I1F-MC-RHBF",
            "2015-002433-22"
        ]
    },
    "NCT04957914": {
        "briefTitle": "A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "Effects of LY3209590 on Frequency and Severity of Hypoglycaemia Under Conditions of Increased Hypoglycaemic Risk Compared to Insulin Glargine in Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-MC-BDCI",
            "2019-003537-42"
        ]
    },
    "NCT00193414": {
        "briefTitle": "Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer",
        "officialTitle": "Phase II Study of First-Line Therapy With Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-US-X011"
        ]
    },
    "NCT01604408": {
        "briefTitle": "A Study in Older Participants Who Have Fallen and Have Muscle Weakness",
        "officialTitle": "A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness",
        "lillyAlias": [
            "I1Q-MC-JDDJ"
        ]
    },
    "NCT00548808": {
        "briefTitle": "A Study for Type 2 Diabetic Patients",
        "officialTitle": "Comparison of Insulin Lispro Low Mixture With Insulin Glargine When Initiating and Intensifying Insulin Therapy As Required in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Oral Antihyperglycemic Medication",
        "lillyAlias": [
            "F3Z-CR-IOPH"
        ]
    },
    "NCT01184508": {
        "briefTitle": "A Study in Migraine Prevention",
        "officialTitle": "A Randomized, Double-Blind, Placebo Controlled Proof of Concept Study of LY2300559 in Patients With Migraine",
        "lillyAlias": [
            "I1N-MC-CDBE"
        ]
    },
    "NCT00071708": {
        "briefTitle": "Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial",
        "officialTitle": "Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial",
        "lillyAlias": [
            "F1J-MC-HMCN"
        ]
    },
    "NCT00520923": {
        "briefTitle": "A Study for Patients With Schizophrenia",
        "officialTitle": "A Multi-Center, Inpatient, Phase 2, Double-blind, Placebo-Controlled Dose Ranging Study of LY2140023 in Patients With DSM-IV Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBBI"
        ]
    },
    "NCT00547508": {
        "briefTitle": "To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking",
        "officialTitle": "A Randomized, Double-Blind, Parallel, Placebo-Controlled Study in Men With Erectile Dysfunction to Evaluate the Efficacy and Safety of Tadalafil When Sexual Attempts Occur at Specific Time Points After Dosing",
        "lillyAlias": [
            "H6D-MC-LVFD"
        ]
    },
    "NCT05380323": {
        "briefTitle": "A Study of LY3541105 in Healthy and Overweight Participants",
        "officialTitle": "A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and PK of LY3541105 Following Single Doses in Healthy/Overweight Participants and Multiple Doses in Overweight Participants",
        "lillyAlias": [
            "J3S-MC-YEAA"
        ]
    },
    "NCT06683508": {
        "briefTitle": "A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight",
        "officialTitle": "A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3549492 Once Daily Compared With Placebo in Adult Participants With Obesity or Overweight",
        "lillyAlias": [
            "W8M-MC-GN01",
            "W8M-MC-CWMM"
        ]
    },
    "NCT06230523": {
        "briefTitle": "A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight",
        "officialTitle": "A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight",
        "lillyAlias": [
            "W8M-MC-LAA1",
            "CWMM Master Protocol"
        ]
    },
    "NCT00833638": {
        "briefTitle": "A Study in Erectile Dysfunction",
        "officialTitle": "Tadalafil 2.5 mg and 5 mg Once a Day Compared to Placebo in Day of Onset of Efficacy",
        "lillyAlias": [
            "H6D-US-LVHZ"
        ]
    },
    "NCT02914379": {
        "briefTitle": "A Study of LY3337641 in Healthy Male Participants",
        "officialTitle": "Disposition of [\u00b9\u2074C]-LY3337641 Following Oral Administration in Healthy Male Subjects",
        "lillyAlias": [
            "I8K-MC-JPDE"
        ]
    },
    "NCT00190879": {
        "briefTitle": "Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder",
        "officialTitle": "Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder",
        "lillyAlias": [
            "B4Z-US-LYDQ"
        ]
    },
    "NCT01364584": {
        "briefTitle": "Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes",
        "officialTitle": "Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT00359879": {
        "briefTitle": "Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes",
        "officialTitle": "Safety and Efficacy of Exenatide Taken Before Lunch and Before Dinner Compared With Before Breakfast and Before Dinner in Patients With Type 2 Diabetes Using Oral Antidiabetic Therapy",
        "lillyAlias": []
    },
    "NCT03421379": {
        "briefTitle": "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus",
        "officialTitle": "A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients With Diabetes Mellitus",
        "lillyAlias": [
            "I8R-JE-IGBJ"
        ]
    },
    "NCT04484779": {
        "briefTitle": "A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes",
        "officialTitle": "User Experience and Daily Use Patterns With the Integrated Insulin Management (IIM) System",
        "lillyAlias": [
            "F3Z-MC-IOQY"
        ]
    },
    "NCT00791479": {
        "briefTitle": "Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes",
        "officialTitle": "Assessment of Dose-Dependent Effects of LY2189265 on Glycemic Control in Patients With Type 2 Diabetes Treated Only With Lifestyle Interventions",
        "lillyAlias": [
            "H9X-MC-GBCK",
            "CTRI/2009/091/000105"
        ]
    },
    "NCT05974579": {
        "briefTitle": "Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated with Amyotrophic Lateral Sclerosis",
        "officialTitle": "A Single Center, Open Label Study to Evaluate Biodistribution, Pharmacokinetics and Safety of [89Zr]Zr-DFO-AP-101 PET (Positron Emission Tomography) in Healthy Volunteers and Amyotrophic Lateral Sclerosis (ALS) Patients",
        "lillyAlias": [
            "2024-5148"
        ]
    },
    "NCT06238479": {
        "briefTitle": "A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors",
        "officialTitle": "A Phase 1 Trial Investigating LY4101174, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Recurrent, Advanced or Metastatic Solid Tumors",
        "lillyAlias": [
            "J5A-OX-JZWA",
            "2023-509867-26-00"
        ]
    },
    "NCT00042679": {
        "briefTitle": "A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.",
        "officialTitle": "A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.",
        "lillyAlias": [
            "H7X-MC-JVAB"
        ]
    },
    "NCT06594679": {
        "briefTitle": "A Study of Niraparib in Combination with Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)",
        "officialTitle": "A Study of Niraparib in Combination with Abemaciclib for Late Line Treatment of Ovarian Cancer: a Single Center, Open Label, Single Arm, Phase Ib/II Trial NICHOL TRIAL",
        "lillyAlias": []
    },
    "NCT04666038": {
        "briefTitle": "Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)",
        "officialTitle": "A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)",
        "lillyAlias": [
            "J2N-OX-JZNN"
        ]
    },
    "NCT01474538": {
        "briefTitle": "Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy",
        "officialTitle": "A Randomized, Double-Blind, Crossover Trial Comparing the Safety and Efficacy of Insulin Lispro With the Safety and Efficacy of Insulin Aspart in Subjects With Type 2 Diabetes on CSII Therapy",
        "lillyAlias": [
            "F3Z-MC-IOQH"
        ]
    },
    "NCT04627038": {
        "briefTitle": "Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis",
        "officialTitle": "Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain",
        "lillyAlias": [
            "H0P-MC-OA03"
        ]
    },
    "NCT02903238": {
        "briefTitle": "Brain Morphometry in OA Patients Treated With Duloxetine",
        "officialTitle": "Brain Morphometric Study in Knee Osteoarthritis Patients Treated With Duloxetine",
        "lillyAlias": []
    },
    "NCT03933943": {
        "briefTitle": "A Study of LY3361237 in Participants With Systemic Lupus Erythematosus",
        "officialTitle": "A Phase 1, Randomized, Placebo-Controlled, Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3361237 in Patients With Systemic Lupus Erythematosus",
        "lillyAlias": [
            "I9S-MC-BTAB"
        ]
    },
    "NCT03031938": {
        "briefTitle": "Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies",
        "officialTitle": "A PROTOCOL TO MONITOR FROM BIRTH TO AGE 15 MONTHS THE NEUROLOGICAL DEVELOPMENT OF INFANTS WITH EXPOSURE IN-UTERO IN TANEZUMAB CLINICAL STUDIES AT ALL INVESTIGATIONAL SITES",
        "lillyAlias": [
            "2013-002548-10",
            "INFANT SAFETY FOLLOW-UP #2",
            "NEONATAL MONITORING STUDY #2"
        ]
    },
    "NCT00638638": {
        "briefTitle": "Myocardial Infarction With ST-Elevation",
        "officialTitle": "Myocardial Infarction With ST-elevation Treated by Primary Percutaneous Intervention Facilitated by Early Reopro Administration in Alsace.",
        "lillyAlias": []
    },
    "NCT00191750": {
        "briefTitle": "A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned",
        "officialTitle": "Phase II Trial of ALIMTA in Relapsed Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-US-S069"
        ]
    },
    "NCT00882050": {
        "briefTitle": "Intravenous Exenatide (Byetta) During Surgery",
        "officialTitle": "Intravenous Exenatide (Byetta) for the Treatment of Perioperative Hyperglycemia: Rollover Phase I/II Trial",
        "lillyAlias": []
    },
    "NCT03470350": {
        "briefTitle": "Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer",
        "officialTitle": "MoTriColor: Phase I/II Study With Galunisertib (LY2157299) Combined With Capecitabine in Patients With Advanced Chemotherapy Resistant Colorectal Cancer and an Activated TGF-beta Signature",
        "lillyAlias": [
            "2016-002349-50"
        ]
    },
    "NCT01004250": {
        "briefTitle": "A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer",
        "officialTitle": "A Single-Arm, Phase 2 Trial of Pemetrexed, Cisplatin,and Bevacizumab as Induction, Followed by Pemetrexed and Bevacizumab as Maintenance, in First-Line Treatment of Nonsquamous Advanced NSCLC",
        "lillyAlias": [
            "H3E-EW-S125"
        ]
    },
    "NCT04081350": {
        "briefTitle": "A Study of LY3471851 in Participants With Eczema",
        "officialTitle": "A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis",
        "lillyAlias": [
            "J1P-MC-KFAD"
        ]
    },
    "NCT02588950": {
        "briefTitle": "A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes",
        "officialTitle": "Comparative Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered Subcutaneously as a Bolus Via Syringe Versus Continuous Subcutaneous Insulin Infusion and Characterization of TID and BID Dosing at Steady State in High-Dose Insulin-Treated Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "B5K-EW-IBHG"
        ]
    },
    "NCT02148250": {
        "briefTitle": "PK/PD Study of U-500 Regular Insulin",
        "officialTitle": "Duration of Action and Peak Effect of High Dose of U-500 Regular Insulin In Severly Insulin Resistant Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT05580250": {
        "briefTitle": "A Study of LY3526318 in Healthy Male Japanese Participants",
        "officialTitle": "A Phase I, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of LY3526318, and to Investigate the Effect of LY3526318 on Metformin and Simvastatin Pharmacokinetics in Healthy Male Japanese Participants",
        "lillyAlias": [
            "J2D-JE-CVAD"
        ]
    },
    "NCT04156750": {
        "briefTitle": "A Study of LY3556050 in Healthy Participants",
        "officialTitle": "Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3556050 in Healthy Subjects",
        "lillyAlias": [
            "J2P-MC-LXBA"
        ]
    },
    "NCT00420095": {
        "briefTitle": "A Study for Patients With Diabetes Mellitus (IOPA)",
        "officialTitle": "Comparison of HbA1c in Type 1 or Type 2 Diabetic Patients Using Insulin Treated Twice Daily With Either Insulin Lispro Low Mixture or Human Insulin Mix 30/70",
        "lillyAlias": [
            "F3Z-GH-IOPA"
        ]
    },
    "NCT06023095": {
        "briefTitle": "A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities",
        "officialTitle": "A Multiple Dose Titration Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3502970 in Chinese Participants Who Have Obesity or Are Overweight With Weight-related Comorbidities",
        "lillyAlias": [
            "J2A-GH-GZGX"
        ]
    },
    "NCT06173895": {
        "briefTitle": "A Relative Bioavailability Study of LY3454738 in Healthy Participants",
        "officialTitle": "A Phase 1, Open-Label Study to Determine the Relative Bioavailability of LY3454738 in Healthy Participants",
        "lillyAlias": [
            "J1B-MC-FRCJ"
        ]
    },
    "NCT00191295": {
        "briefTitle": "Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Comparison of Fixed-Dose Ranges of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-JE-LYBC"
        ]
    },
    "NCT01774981": {
        "briefTitle": "Study of LY3016859 in Participants With Diabetic Nephropathy",
        "officialTitle": "Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients",
        "lillyAlias": [
            "I5V-MC-TGAB",
            "2012-004496-40"
        ]
    },
    "NCT00790790": {
        "briefTitle": "A Study in the Treatment of Osteoarthritis Knee Pain",
        "officialTitle": "A Phase 2 Study of the Effects of LY545694, an iGluR5 Antagonist, in the Treatment of Subjects With Osteoarthritis Knee Pain",
        "lillyAlias": [
            "H8C-MC-LQBG(a)"
        ]
    },
    "NCT05734690": {
        "briefTitle": "COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure",
        "officialTitle": "COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure",
        "lillyAlias": []
    },
    "NCT01289990": {
        "briefTitle": "Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III Double-blind, Extension, Placebo-controlled Parallel Group Safety and Efficacy Trial of BI 10773 (10 and 25mg Once Daily) and Sitagliptin (100mg Once Daily) Given for Minimum 76 Weeks (Incl. 24 Weeks of Preceding Trial) as Monotherapy or With Different Back-ground Therapies in Patients With Type 2 Diabetes Mellitus Previously Completing Trial 1245.19, 1245.20 or 1245.23",
        "lillyAlias": [
            "2010-022718-17"
        ]
    },
    "NCT01152190": {
        "briefTitle": "A Study in Benign Prostatic Hyperplasia",
        "officialTitle": "A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVIR"
        ]
    },
    "NCT06297590": {
        "briefTitle": "A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease",
        "officialTitle": "A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3954068 in Patients With Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "J4T-MC-OLAA",
            "2024-510604-37-00",
            "U1111-1302-6222"
        ]
    },
    "NCT01790438": {
        "briefTitle": "A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes",
        "officialTitle": "A Comparison of LY2605541 Versus Human Insulin NPH as Basal Insulin Treatment in Insulin-Na\u00efve Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With 2 or More Oral Antihyperglycemic Medications: An Open-Label, Randomized Study",
        "lillyAlias": [
            "I2R-MC-BIAK",
            "2012-003941-13"
        ]
    },
    "NCT06192108": {
        "briefTitle": "A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin",
        "officialTitle": "A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral Orforglipron Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-2)",
        "lillyAlias": [
            "J2A-MC-GZGV",
            "2023-507206-13-00",
            "U1111-1296-1507"
        ]
    },
    "NCT05841238": {
        "briefTitle": "A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants",
        "officialTitle": "A Multiple Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tablet and Capsule Formulations of LY3502970 in Healthy Overweight and Obese Participants",
        "lillyAlias": [
            "J2A-MC-GZGN"
        ]
    },
    "NCT04623138": {
        "briefTitle": "A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections",
        "officialTitle": "A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and SARS-CoV-2 Infection",
        "lillyAlias": []
    },
    "NCT05289908": {
        "briefTitle": "Intrathecal Pemetrexed for Leptomeningeal Metastasis",
        "officialTitle": "Phase I/II Clinical Trial of Intrathecal Pemetrexed As First Line Intrathecal Chemotherapy in Patients with Leptomeningeal Metastasis",
        "lillyAlias": []
    },
    "NCT00785538": {
        "briefTitle": "A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available",
        "officialTitle": "Phase I Study of Anti-Insulin-Like Growth Factor-I Receptor (IGF-IR) Monoclonal Antibody IMC-A12 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom No Standard Therapy is Available",
        "lillyAlias": [
            "CP13-0501",
            "I5A-IE-JAEH"
        ]
    },
    "NCT00586508": {
        "briefTitle": "Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas",
        "officialTitle": "A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas",
        "lillyAlias": [
            "H6Q-MC-S033"
        ]
    },
    "NCT01159938": {
        "briefTitle": "A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes",
        "officialTitle": "The Effect of Postprandial Hyperglycemia on the Arterial Stiffness in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "F3Z-EW-IOPT"
        ]
    },
    "NCT00191100": {
        "briefTitle": "Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix",
        "officialTitle": "Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA",
        "lillyAlias": [
            "B9E-MC-JHQS"
        ]
    },
    "NCT04158752": {
        "briefTitle": "Anti-CGRP for Inflamation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia",
        "officialTitle": "Anti-CGRP Neutralizing Antibody for Modulation of Neurogenic Inflammation in Trigeminal and Glossopharyngeal Pain Associated With Small Fiber Neuropathy/Fibromyalgia",
        "lillyAlias": []
    },
    "NCT01711359": {
        "briefTitle": "A Study in Participants With Moderate to Severe Rheumatoid Arthritis",
        "officialTitle": "A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs",
        "lillyAlias": [
            "I4V-MC-JADZ"
        ]
    },
    "NCT01869959": {
        "briefTitle": "A Study of LY2405319 in Participants With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2405319 With 28 Days of Subcutaneous Injections in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1K-MC-GLUG"
        ]
    },
    "NCT00686959": {
        "briefTitle": "Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer",
        "officialTitle": "Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology",
        "lillyAlias": [
            "H3E-MC-JMIG"
        ]
    },
    "NCT00202800": {
        "briefTitle": "Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer",
        "officialTitle": "Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer",
        "lillyAlias": []
    },
    "NCT04158700": {
        "briefTitle": "A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer",
        "officialTitle": "Phase 1b/2 Study of LY3200882 and Pembrolizumab in Patients With Advanced Cancer",
        "lillyAlias": [
            "I8X-MC-JECD",
            "2019-001156-18",
            "KEYNOTE-961"
        ]
    },
    "NCT01558700": {
        "briefTitle": "Duloxetine in Osteoarthritis (OA) Pain",
        "officialTitle": "Brain Morphometries in OA Patients Treated With Duloxetine",
        "lillyAlias": []
    },
    "NCT01644500": {
        "briefTitle": "A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus",
        "officialTitle": "The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Monotherapy Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-JE-GBCG"
        ]
    },
    "NCT05496959": {
        "briefTitle": "177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study",
        "officialTitle": "177-Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (Lunar)",
        "lillyAlias": [
            "NCI-2022-05748"
        ]
    },
    "NCT02973100": {
        "briefTitle": "A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy",
        "officialTitle": "A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy",
        "lillyAlias": [
            "H9X-MC-GBGJ",
            "2016-002494-34"
        ]
    },
    "NCT05980000": {
        "briefTitle": "Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma",
        "officialTitle": "Open-Label, Randomized Phase 2 Trial of Ramucirumab in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-Line Treatment of PD-L1 Positive, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC)",
        "lillyAlias": []
    },
    "NCT02778100": {
        "briefTitle": "A Study of Nasal Glucagon in Participants With a Common Cold",
        "officialTitle": "A Phase 1 Study to Evaluate the Effects of Common Cold and of Concomitant Administration of Nasal Decongestant on the Pharmacokinetics and Pharmacodynamics of a Novel Glucagon Formulation in Otherwise Healthy Subjects",
        "lillyAlias": [
            "GUO-P2-628",
            "AMG 104",
            "I8R-MC-IGBE"
        ]
    },
    "NCT02792400": {
        "briefTitle": "The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors",
        "officialTitle": "The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors",
        "lillyAlias": []
    },
    "NCT01624259": {
        "briefTitle": "A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes",
        "officialTitle": "A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)",
        "lillyAlias": [
            "H9X-MC-GBDE",
            "2011-003810-18"
        ]
    },
    "NCT00718159": {
        "briefTitle": "Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia",
        "officialTitle": "Phase 1 Study of LY573636-sodium in Patients With Essential Thrombocythemia and Acute Myeloid Leukemia",
        "lillyAlias": [
            "H8K-MC-JZAJ"
        ]
    },
    "NCT03428100": {
        "briefTitle": "A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable",
        "officialTitle": "A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine",
        "lillyAlias": [
            "I4V-MC-JAIN",
            "2017-004574-34"
        ]
    },
    "NCT02624700": {
        "briefTitle": "2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer",
        "officialTitle": "Phase 2 Study of Pemetrexed and Sorafenib for Treatment of Recurrent or Metastatic Triple Negative Breast Cancer",
        "lillyAlias": [
            "HM20005967",
            "NCI-2015-02190"
        ]
    },
    "NCT05708859": {
        "briefTitle": "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT",
        "officialTitle": "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT",
        "lillyAlias": []
    },
    "NCT02300259": {
        "briefTitle": "A Study of LY2623091 in Healthy Participants",
        "officialTitle": "A Study to Determine the Effect of CYP3A Inhibition on the Pharmacokinetics of LY2623091 and the Effect of LY2623091 on the Pharmacokinetics of CYP3A Substrates in Healthy Subjects",
        "lillyAlias": [
            "I7T-MC-RMAG"
        ]
    },
    "NCT03129100": {
        "briefTitle": "A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis",
        "officialTitle": "A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis",
        "lillyAlias": [
            "I1F-MC-RHBY",
            "2016-002634-69"
        ]
    },
    "NCT01900652": {
        "briefTitle": "A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants",
        "officialTitle": "A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients With Acquired Resistance to Erlotinib",
        "lillyAlias": [
            "I4C-MC-JTBC"
        ]
    },
    "NCT01421459": {
        "briefTitle": "A Study in Adults With Type 2 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus in Adult Patients With Type 2 Diabetes Mellitus: The ELEMENT 2 Study",
        "lillyAlias": [
            "I4L-MC-ABEC",
            "2011-000828-15"
        ]
    },
    "NCT00006459": {
        "briefTitle": "Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer",
        "officialTitle": "Phase III Study of Gemcitabine Plus Paclitaxel Versus Paclitaxel in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer",
        "lillyAlias": [
            "LILLY-B9E-MC-JHQG",
            "CDR0000068216"
        ]
    },
    "NCT04145700": {
        "briefTitle": "CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma",
        "officialTitle": "A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma",
        "lillyAlias": [
            "J1S-MC-JV02",
            "2018-004243-23"
        ]
    },
    "NCT03936959": {
        "briefTitle": "A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY3434172, a Bispecific Antibody Monotherapy in Advanced Solid Tumors",
        "lillyAlias": [
            "J1E-MC-JZEA",
            "2018-003871-37"
        ]
    },
    "NCT00683475": {
        "briefTitle": "A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer",
        "officialTitle": "A Phase 2, Multicenter, Randomized Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer (AIPC) Following Disease Progression on Docetaxel-Based Chemotherapy",
        "lillyAlias": [
            "CP18-0601",
            "I4T-IE-JVBS"
        ]
    },
    "NCT04235959": {
        "briefTitle": "A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Multiple Dose Titration Study in Chinese Patients With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Tirzepatide",
        "lillyAlias": [
            "I8F-MC-GPHT"
        ]
    },
    "NCT00191659": {
        "briefTitle": "Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents",
        "officialTitle": "A Randomised, Controlled, Open-Label Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents",
        "lillyAlias": [
            "B4Z-BP-LYBS"
        ]
    },
    "NCT00485459": {
        "briefTitle": "Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD",
        "officialTitle": "Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-TW-S010"
        ]
    },
    "NCT06370715": {
        "briefTitle": "A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India",
        "officialTitle": "A 26- Week, Multicenter, Open-Label, Single-Arm, Phase 4 Study to Assess The Safety of Lyumjev in Adult Patients With Type 2 Diabetes Mellitus in India",
        "lillyAlias": [
            "I8B-MC-ITTA"
        ]
    },
    "NCT00414115": {
        "briefTitle": "National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children",
        "officialTitle": "Canadian Pharmacogenomics Network for Drug Safety",
        "lillyAlias": [
            "CW Health Centre of BC",
            "W04-0138"
        ]
    },
    "NCT05662332": {
        "briefTitle": "A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)",
        "officialTitle": "A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 Administered Weekly Using a Fixed Dose Escalation Compared to Insulin Glargine in Insulin-Na\u00efve Adults With Type 2 Diabetes",
        "lillyAlias": [
            "I8H-MC-BDCW"
        ]
    },
    "NCT00667732": {
        "briefTitle": "How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics",
        "officialTitle": "Metformin, Exenatide, and Glargine Insulin in Combination for Treatment of Patients With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT02102932": {
        "briefTitle": "Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers",
        "officialTitle": "Relative Bioavailability of Empagliflozin (12.5 or 5 mg)/Metformin (850 mg or 500 mg) Fixed Dose Combination Tablets Compared to Single Tablets Administered Together to Healthy Chinese Male and Female Volunteers in an Open-label, Randomised, Single-dose, Two-way Crossover Study",
        "lillyAlias": []
    },
    "NCT00761332": {
        "briefTitle": "Back Pain in Patients With Severe Osteoporosis",
        "officialTitle": "An Observational Study to Assess Back Pain in Patients With Severe Osteoporosis Treated With Teriparatide Versus Antiresorptives",
        "lillyAlias": [
            "B3D-CR-B013"
        ]
    },
    "NCT04250337": {
        "briefTitle": "Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis",
        "lillyAlias": [
            "2019-004300-34",
            "J2T-DM-KGAD",
            "DRM06-AD06"
        ]
    },
    "NCT01977300": {
        "briefTitle": "Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode",
        "officialTitle": "Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode",
        "lillyAlias": [
            "V02-0130"
        ]
    },
    "NCT00287352": {
        "briefTitle": "Study of Amantadine for Weight Stabilization During Olanzapine Treatment",
        "officialTitle": "Double Blind Placebo Controlled Investigation of Amantadine for Retarding Weight Gain in First Episode Adlt Psychotic Subjects Beginning Therapy With Olanzapine.",
        "lillyAlias": [
            "GCRC 2235"
        ]
    },
    "NCT00761852": {
        "briefTitle": "Signaling Mechanisms and Vascular Function in Diabetes Mellitus",
        "officialTitle": "Signaling Mechanisms and Vascular Function in Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00046137": {
        "briefTitle": "Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis",
        "officialTitle": null,
        "lillyAlias": [
            "B3D-MC-GHCD"
        ]
    },
    "NCT02703337": {
        "briefTitle": "A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 2 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy",
        "lillyAlias": [
            "I8B-FW-ITRH",
            "2015-004704-39"
        ]
    },
    "NCT00835185": {
        "briefTitle": "Study of IMC-11F8 in Participants With Colorectal Cancer",
        "officialTitle": "Open Label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of IMC-11F8 in Combination With 5-FU/FA and Oxaliplatin (mFOLFOX-6) in Patients With Treatment-na\u00efve, Locally-advanced or Metastatic Colorectal Cancer",
        "lillyAlias": [
            "2006-003147-23",
            "CP11-0602",
            "I4X-IE-JFCD"
        ]
    },
    "NCT01006252": {
        "briefTitle": "A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma",
        "officialTitle": "A Randomized Phase 3 Study of Tasisulam-sodium Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle Versus Paclitaxel as Second-line Treatment in Patients With Metastatic Melanoma",
        "lillyAlias": [
            "H8K-MC-JZAO"
        ]
    },
    "NCT01897532": {
        "briefTitle": "Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)",
        "officialTitle": "CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk",
        "lillyAlias": [
            "2011-004148-23"
        ]
    },
    "NCT01227252": {
        "briefTitle": "A Safety Study of LY2886721 Multiple Doses in Healthy Subjects",
        "officialTitle": "Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects",
        "lillyAlias": [
            "I4O-MC-BACB"
        ]
    },
    "NCT00191152": {
        "briefTitle": "A Phase III Trial For Patients With Metastatic Breast Cancer",
        "officialTitle": "Randomized Trial of Gemcitabine Plus Docetaxel vs. Docetaxel Plus Capecitabine in Metastatic Breast Cancer in 1st and 2nd",
        "lillyAlias": [
            "B9E-US-S188"
        ]
    },
    "NCT01394952": {
        "briefTitle": "Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)",
        "officialTitle": "The Effect of Dulaglutide on Major Cardiovascular Events in Patients With Type 2 Diabetes: Researching Cardiovascular Events With a Weekly INcretin in Diabetes (REWIND)",
        "lillyAlias": [
            "H9X-MC-GBDJ"
        ]
    },
    "NCT01794000": {
        "briefTitle": "A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)",
        "officialTitle": "A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease.",
        "lillyAlias": [
            "H7T-MC-TADO",
            "2012-003837-41"
        ]
    },
    "NCT02377752": {
        "briefTitle": "A Study of Olaratumab in Japanese Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of Olaratumab in Japanese Patients With Advanced Soft Tissue Sarcoma or Advanced Solid Tumors",
        "lillyAlias": [
            "I5B-JE-JGDK"
        ]
    },
    "NCT00547352": {
        "briefTitle": "Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection",
        "officialTitle": "Switching From Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Assessment of Treatment Preference",
        "lillyAlias": [
            "H6D-KL-S002"
        ]
    },
    "NCT01209832": {
        "briefTitle": "A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients",
        "officialTitle": "The Effect of Tasisulam on CYP3A-mediated Metabolism of Midazolam: A Pharmacokinetic Interaction Study in Cancer Patients With Advanced and/or Metastatic Tumors or Lymphoma",
        "lillyAlias": [
            "H8K-MC-JZAP",
            "2010-020090-16"
        ]
    },
    "NCT00935532": {
        "briefTitle": "Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus",
        "officialTitle": "Parallel Group Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus Treated With Oral Antidiabetic(s)",
        "lillyAlias": []
    },
    "NCT04088032": {
        "briefTitle": "Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer",
        "officialTitle": "A Pilot Neoadjuvant Clinical Trial of Combination Therapy With Abemaciclib, Durvalumab (MEDI4736), and an Aromatase Inhibitor in Locally Advanced Hormone Receptor Positive Breast Cancer",
        "lillyAlias": []
    },
    "NCT01232452": {
        "briefTitle": "A Study in Non-Small Cell Lung Cancer",
        "officialTitle": "An Open-label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Cisplatin and Pemetrexed With or Without Cixutumumab as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Carcinoma",
        "lillyAlias": [
            "I5A-MC-JAEM"
        ]
    },
    "NCT01490632": {
        "briefTitle": "A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of Baricitinib in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I4V-MC-JADP"
        ]
    },
    "NCT06037252": {
        "briefTitle": "A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity",
        "officialTitle": "A Phase 2, Randomized, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Investigational Tirzepatide Doses in Participants With Type 2 Diabetes and Obesity",
        "lillyAlias": [
            "I8F-MC-GPIT",
            "2023-504561-24-00"
        ]
    },
    "NCT02757352": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis",
        "officialTitle": "A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis",
        "lillyAlias": [
            "I1F-MC-RHBX",
            "2015-003938-27"
        ]
    },
    "NCT01007032": {
        "briefTitle": "A Study of IMC-A12 in Advanced Solid Tumors",
        "officialTitle": "A Phase 1 Study Evaluating the Safety and Pharmacokinetic Profiles of IMC-A12 Administered Every 2 Weeks or Every 3 Weeks to Japanese Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "21-1258",
            "CP13-0813",
            "I5A-IE-JAEA"
        ]
    },
    "NCT00391209": {
        "briefTitle": "Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H7U-MC-IDAY"
        ]
    },
    "NCT03056456": {
        "briefTitle": "A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump",
        "officialTitle": "A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy",
        "lillyAlias": [
            "I8B-MC-ITSC",
            "2016-004093-18"
        ]
    },
    "NCT03305809": {
        "briefTitle": "A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)",
        "officialTitle": "Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)",
        "lillyAlias": [
            "I7S-MC-HBEH"
        ]
    },
    "NCT02144285": {
        "briefTitle": "A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Healthy Subjects and Patients With Chronic Kidney Disease Treated With Hemodialysis",
        "lillyAlias": [
            "I7C-MC-FEAA"
        ]
    },
    "NCT05444556": {
        "briefTitle": "A Study of Imlunestrant (LY3484356) in Female Healthy Participants",
        "officialTitle": "The Effect of Imlunestrant on CYP2C8, CYP2C19, CYP2D6, P-gp, and BCRP Activity and the Effect of P-gp Inhibition on Imlunestrant Pharmacokinetics in Healthy Women of Non-childbearing Potential",
        "lillyAlias": [
            "J2J-MC-JZLI"
        ]
    },
    "NCT01753856": {
        "briefTitle": "Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis",
        "officialTitle": "Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-US-GHDV"
        ]
    },
    "NCT00456885": {
        "briefTitle": "The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women",
        "officialTitle": "The Effect of Exenatide on Body Weight, Energy Expenditure and Hunger in Obese Women Without Diabetes Mellitus",
        "lillyAlias": [
            "BFA912"
        ]
    },
    "NCT01836185": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment",
        "officialTitle": "Pharmacokinetics of Evacetrapib (LY2484595) in Subjects With Hepatic Impairment",
        "lillyAlias": [
            "I1V-MC-EIAS"
        ]
    },
    "NCT06143956": {
        "briefTitle": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight",
        "officialTitle": "A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants With Obesity or Overweight",
        "lillyAlias": [
            "W8M-MC-CWMM"
        ]
    },
    "NCT02370485": {
        "briefTitle": "A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children",
        "officialTitle": "Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects",
        "lillyAlias": [
            "I3O-EW-JSBD"
        ]
    },
    "NCT01089556": {
        "briefTitle": "A Study in Painful Diabetic Neuropathy",
        "officialTitle": "Use of Duloxetine or Pregabalin in Monotherapy Versus Combination Therapy of Both Drugs in Patients With Painful Diabetic Neuropathy \"The COMBO - DN (COmbination vs Monotherapy of pregaBalin and dulOxetine in Diabetic Neuropathy) Study\"",
        "lillyAlias": [
            "F1J-EW-HMGQ"
        ]
    },
    "NCT05826756": {
        "briefTitle": "Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting",
        "officialTitle": "Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting",
        "lillyAlias": []
    },
    "NCT00191256": {
        "briefTitle": "Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer",
        "officialTitle": "Randomized Phase II Trial to Outline the Efficacy of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/Paclitaxel) When Used as Preoperative Chemotherapy In Patients With Stage I and II NSCLC",
        "lillyAlias": [
            "B9E-US-S235"
        ]
    },
    "NCT05462756": {
        "briefTitle": "A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections",
        "officialTitle": "A Phase 3, Parallel-Design, Open-Label, Randomized Controlled Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Glargine in Adults With Type 2 Diabetes on Multiple Daily Injections",
        "lillyAlias": [
            "I8H-MC-BDCV",
            "2021-005878-25"
        ]
    },
    "NCT00641056": {
        "briefTitle": "Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)",
        "officialTitle": "Efficacy of Once-Weekly Exenatide Long-Acting Release and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea",
        "lillyAlias": []
    },
    "NCT02443337": {
        "briefTitle": "A Study of LY3023414 and Necitumumab in Squamous Lung Cancer",
        "officialTitle": "A Phase II Study of the Combination of LY3023414 and Necitumumab After First-Line Chemotherapy for Metastatic Squamous Non-small Cell Carcinoma of the Lung",
        "lillyAlias": [
            "I6A-MC-CBBE"
        ]
    },
    "NCT02581215": {
        "briefTitle": "Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer",
        "officialTitle": "Phase II Randomized, Double-Blind Study of mFOLFIRINOX Plus Ramucirumab Versus mFOLFIRINOX Plus Placebo in Advanced Pancreatic Cancer Patients: Hoosier Cancer Research Network GI14-198",
        "lillyAlias": []
    },
    "NCT00954915": {
        "briefTitle": "Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis",
        "officialTitle": "A Phase 2a, Open Label, Multiple-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Teplizumab in Adults With Moderate or More Severe Psoriasis",
        "lillyAlias": []
    },
    "NCT00568737": {
        "briefTitle": "The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death",
        "officialTitle": "Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Early Stage Severe Sepsis",
        "lillyAlias": [
            "F1K-MC-EVCM"
        ]
    },
    "NCT00765115": {
        "briefTitle": "A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.",
        "officialTitle": "Assessment of LY450139-Mediated Inhibition of Amyloid Beta Formation Determined by 13C6-Leucine In Healthy Subjects",
        "lillyAlias": [
            "H6L-MC-LFAM"
        ]
    },
    "NCT00363415": {
        "briefTitle": "Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 3 Trial of Alimta (Pemetrexed) and Carboplatin Versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-MC-JMHO"
        ]
    },
    "NCT02108015": {
        "briefTitle": "Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8",
        "officialTitle": "Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8",
        "lillyAlias": [
            "14-M-0068"
        ]
    },
    "NCT00099515": {
        "briefTitle": "Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)",
        "officialTitle": "Standard Training Versus Intensive Training for HIIP Delivery System Usage in Insulin-Na\u00efve Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H7U-MC-IDAP"
        ]
    },
    "NCT00320515": {
        "briefTitle": "Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer",
        "officialTitle": "Phase 1/2 Study of Pemetrexed Plus Cisplatin in Unresectable, Advanced Gastric Carcinoma.",
        "lillyAlias": [
            "H3E-AA-S038"
        ]
    },
    "NCT06641037": {
        "briefTitle": "A Study of LY3866288 in Healthy Participants",
        "officialTitle": "A Phase 1, Open-label, Randomized, Crossover Study to Assess the Effect of Food on the Pharmacokinetics of LY3866288 in Healthy Participants",
        "lillyAlias": [
            "J4G-OX-JZVC"
        ]
    },
    "NCT00295815": {
        "briefTitle": "Enzastaurin Versus Lomustine in Glioblastoma",
        "officialTitle": "Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma",
        "lillyAlias": [
            "H6Q-MC-JCBF"
        ]
    },
    "NCT01354015": {
        "briefTitle": "Diabetes Remote Care Management System",
        "officialTitle": "Diabetes Remote Care Management System",
        "lillyAlias": []
    },
    "NCT05338515": {
        "briefTitle": "A Study of Selpercatinib (LY3527723) in Healthy Participants",
        "officialTitle": "A Phase I, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LOXO-292 in Healthy Adult Subjects",
        "lillyAlias": [
            "J2G-OX-JZJF",
            "LOXO-RET-18057"
        ]
    },
    "NCT06007937": {
        "briefTitle": "A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer",
        "officialTitle": "A Phase 1/2 Study of Combination Lorlatinib and Ramucirumab in Patients With Advanced ALK-rearranged Lung Cancers",
        "lillyAlias": []
    },
    "NCT00503685": {
        "briefTitle": "Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy",
        "officialTitle": "A Randomized Phase 2 Clinical Trial of IMC-A12, as a Single Agent or in Combination With Cetuximab, in Patients With Metastatic Colorectal Cancer With Disease Progression on Prior Anti-EGFR Therapy",
        "lillyAlias": [
            "CP02-0657",
            "CP13-0605",
            "I5A-IE-JAEL"
        ]
    },
    "NCT05459285": {
        "briefTitle": "A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY\u00ae in Healthy Chinese Subjects",
        "officialTitle": "Pharmacokinetics, Safety and Immunogenicity of 14028 Injection Versus Dulaglutide Injection in Healthy Subjects: a Phase I \uff0cSingle-center, Randomized, Open-label, Single-dose, Parallel-controlled Clinical Study",
        "lillyAlias": []
    },
    "NCT02084056": {
        "briefTitle": "Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release (2.5 mg/1000 mg) Compared With the Free Combination of Linagliptin and Metformin Extended Release Tablets in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Trial)",
        "lillyAlias": [
            "2013-005144-28"
        ]
    },
    "NCT05617885": {
        "briefTitle": "Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer",
        "officialTitle": "A Phase 1/2 Study of Darolutamide and Abemaciclib in High-Risk Prostate Cancer",
        "lillyAlias": []
    },
    "NCT00517985": {
        "briefTitle": "Duloxetine for Perimenopausal Depression",
        "officialTitle": "Duloxetine for Perimenopausal Depression",
        "lillyAlias": []
    },
    "NCT01119456": {
        "briefTitle": "A Study of IMC-RON8 in Advanced Solid Tumors",
        "officialTitle": "Phase 1 Study of the Anti-Ron Receptor Monoclonal Antibody IMC-RON8 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom No Standard Therapy is Available",
        "lillyAlias": [
            "CP21-0901",
            "I5D-IE-JRCA"
        ]
    },
    "NCT00259285": {
        "briefTitle": "Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer",
        "officialTitle": "Alimta (Pemetrexed) and Cisplatin Treatment as Neoadjuvant Therapy in Non Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-XM-S092"
        ]
    },
    "NCT01011556": {
        "briefTitle": "A Study for the Transdermal Application of Teriparatide",
        "officialTitle": "A Phase 2 Study for Transdermal Application of Teriparatide",
        "lillyAlias": [
            "I2Y-MC-GHFA(c)"
        ]
    },
    "NCT03736785": {
        "briefTitle": "A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin",
        "lillyAlias": [
            "I8H-MC-BDCM"
        ]
    },
    "NCT00191685": {
        "briefTitle": "Duloxetine in the Treatment of Melancholic Depression",
        "officialTitle": "Duloxetine in the Treatment of Melancholic Depression: An 8-Week Open-Label Dose Study",
        "lillyAlias": [
            "F1J-AY-HMCZ"
        ]
    },
    "NCT01734785": {
        "briefTitle": "Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III, Randomised, Double-blind, Parallel Group, 24 Week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg and 25 mg Compared to Placebo, All Administered as Oral Fixed Dose Combinations With Linagliptin 5 mg, in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16 Weeks Treatment With Linagliptin 5 mg Once Daily on Metformin Background Therapy.",
        "lillyAlias": [
            "2012-002270-31"
        ]
    },
    "NCT00568685": {
        "briefTitle": "Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "A Phase 3b, Randomized, Open-Label Assessment of Response to Various Doses of Atomoxetine Hydrochloride in Korean Pediatric Outpatients With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-KL-LYEC"
        ]
    },
    "NCT01299285": {
        "briefTitle": "Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects",
        "officialTitle": "Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Male Subjects",
        "lillyAlias": [
            "I4V-MC-JADG"
        ]
    },
    "NCT00266656": {
        "briefTitle": "Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome",
        "officialTitle": "Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome",
        "lillyAlias": [
            "B9R-US-GDGH"
        ]
    },
    "NCT00085956": {
        "briefTitle": "Effects of Arzoxifene on Bone Mass and the Uterus",
        "officialTitle": "Effects of Arzoxifene on Bone Mineral Density and Endometrial Histology in Postmenopausal Women.",
        "lillyAlias": [
            "H4Z-MC-GJAE"
        ]
    },
    "NCT02004132": {
        "briefTitle": "A Study of Axiron\u00ae in Healthy Participants",
        "officialTitle": "A Phase 1, Single-Dose Study to Evaluate Testosterone on Clothing After Axiron\u00ae Use in Healthy Male Subjects",
        "lillyAlias": [
            "I5E-EW-TSBE"
        ]
    },
    "NCT04752332": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer",
        "officialTitle": "eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy",
        "lillyAlias": [
            "I3Y-MC-JPCW",
            "2020-004035-24"
        ]
    },
    "NCT00398632": {
        "briefTitle": "Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction",
        "officialTitle": "Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction",
        "lillyAlias": []
    },
    "NCT04093752": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)",
        "officialTitle": "A Randomized, Phase 3, Open-label Trial Comparing the Effect of Tirzepatide Once Weekly Versus Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Metformin With or Without a Sulfonylurea",
        "lillyAlias": [
            "I8F-MC-GPHO"
        ]
    },
    "NCT01028352": {
        "briefTitle": "Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain",
        "officialTitle": "UMCC 2008.62: Prospective Pilot Study Evaluating the Use of Duloxetine for Treatment of Aromatase Inhibitor-associated Musculoskeletal Symptoms in Breast Cancer Patients",
        "lillyAlias": [
            "HUM00022455"
        ]
    },
    "NCT00055432": {
        "briefTitle": "Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-US-JMFU"
        ]
    },
    "NCT00190632": {
        "briefTitle": "To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence",
        "officialTitle": "Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBAY"
        ]
    },
    "NCT00673452": {
        "briefTitle": "A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia",
        "officialTitle": "Flexible Dosed Duloxetine Versus Placebo in the Treatment of Fibromyalgia",
        "lillyAlias": [
            "F1J-US-HMGB"
        ]
    },
    "NCT00381732": {
        "briefTitle": "A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction",
        "officialTitle": "A Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil (2.5mg and 5mg) Administered Once Daily to Men With Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVFP"
        ]
    },
    "NCT01292252": {
        "briefTitle": "Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion",
        "officialTitle": "Assessment of the Efficacy of Forteo (Teriparatide) in Patients Undergoing Posterolateral Lumbar Spinal Fusion",
        "lillyAlias": []
    },
    "NCT01130532": {
        "briefTitle": "A Study in Erectile Dysfunction",
        "officialTitle": "Tadalafil Once Daily Following As-Needed Phosphodiesterase Type 5 Inhibitor Treatment, an Assessment of Return to Normal Erectile Function",
        "lillyAlias": [
            "H6D-US-LVIP"
        ]
    },
    "NCT01584232": {
        "briefTitle": "A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 3 Study of LY2189265 Compared to Insulin Glargine in Patients With Type 2 Diabetes Mellitus on a Sulfonylurea and/or Biguanide",
        "lillyAlias": [
            "H9X-JE-GBDY"
        ]
    },
    "NCT05567159": {
        "briefTitle": "A Study of Donanemab (LY3002813) in Healthy Participants",
        "officialTitle": "A Phase 1, Open-Label Study to Characterize the Pharmacokinetics of Donanemab Following Intravenous Doses in Healthy Participants",
        "lillyAlias": [
            "I5T-MC-AACP"
        ]
    },
    "NCT01166100": {
        "briefTitle": "Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition",
        "officialTitle": "A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's and Prozac\u00aeWeekly 90 mg DR Capsules of Eli Lilly and Company, USA in Healthy Adult Human Subjects Under Fasting Conditions",
        "lillyAlias": []
    },
    "NCT03861052": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 3 Study of Tirzepatide Monotherapy Compared to Dulaglutide 0.75 mg in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-JE-GPGO"
        ]
    },
    "NCT01307800": {
        "briefTitle": "A Study of LY2140023 in Patients With Schizophrenia",
        "officialTitle": "A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study of 3 Doses of LY2140023 Monohydrate in the Acute Treatment of Patients With DSM-IV-TR Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBBN"
        ]
    },
    "NCT05469100": {
        "briefTitle": "A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function",
        "officialTitle": "A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of LOXO-292",
        "lillyAlias": [
            "J2G-OX-JZJE",
            "LOXO-RET-18023"
        ]
    },
    "NCT05172700": {
        "briefTitle": "Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer",
        "officialTitle": "Expanded Access Program for Pirtobrutinib for Previously Treated B-Cell Cancers",
        "lillyAlias": [
            "J2N-OX-Y001"
        ]
    },
    "NCT01667900": {
        "briefTitle": "A Study of Dulaglutide in Chinese Participants",
        "officialTitle": "Pharmacokinetics of a Single Dulaglutide Dose in Healthy Chinese Subjects and of Multiple Dulaglutide Doses in Chinese Patients With T2DM",
        "lillyAlias": [
            "H9X-EW-GBDL"
        ]
    },
    "NCT02836600": {
        "briefTitle": "A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1 Study of LY3039478 in Japanese Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I6F-JE-JJCC"
        ]
    },
    "NCT00097500": {
        "briefTitle": "Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Randomized, Open Label, Comparator-Controlled, Parallel Group, Multicenter Study to Compare the Effects of Exenatide and Insulin Glargine on Beta Cell Function and Cardiovascular Risk Markers in Subjects With Type 2 Diabetes Treated With Metformin Who Have Not Achieved Target HbA1c",
        "lillyAlias": []
    },
    "NCT00254800": {
        "briefTitle": "The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females",
        "officialTitle": "The Effect of Exenatide on Single and Multiple Doses Oral Contraceptive Pharmacokinetics in Healthy Female Subjects",
        "lillyAlias": []
    },
    "NCT03952559": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis",
        "lillyAlias": [
            "I4V-MC-JAIP",
            "2018-000349-38"
        ]
    },
    "NCT00767715": {
        "briefTitle": "A Study in the Treatment of Acute Mania",
        "officialTitle": "A Randomized Open Label Study on the Efficacy, Tolerability, and Total Costs of Olanzapine Versus Conventional Antipsychotics in the Treatment of Acute Mania in Sweden",
        "lillyAlias": [
            "F1D-SO-HGLY"
        ]
    },
    "NCT05659537": {
        "briefTitle": "A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India",
        "officialTitle": "A 24-week Multicenter, Open-label, Single-arm Study to Evaluate Safety in Patients With Type 2 Diabetes Mellitus in India Treated With Dulaglutide",
        "lillyAlias": [
            "H9X-IN-GBGR"
        ]
    },
    "NCT00191737": {
        "briefTitle": "An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder",
        "officialTitle": "An Open-Label Study on Effectiveness and Tolerability of Atomoxetine, as Perceived by Patients, Parents, and Physicians in Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany",
        "lillyAlias": [
            "B4Z-SB-LYDE"
        ]
    },
    "NCT00061815": {
        "briefTitle": "Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer",
        "officialTitle": "A Phase 3 Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Subjects With Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma",
        "lillyAlias": []
    },
    "NCT00330915": {
        "briefTitle": "A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.",
        "officialTitle": "A Feasibility Study of Pemetrexed Single Agent and Folic Acid Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer",
        "lillyAlias": [
            "H3E-MC-S077"
        ]
    },
    "NCT00386815": {
        "briefTitle": "Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma",
        "officialTitle": "Safety Confirmation Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma",
        "lillyAlias": [
            "H3E-JE-ME02"
        ]
    },
    "NCT06586515": {
        "briefTitle": "A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors",
        "officialTitle": "A Phase 1a/1b Trial of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors",
        "lillyAlias": [
            "J5J-OX-JZZA"
        ]
    },
    "NCT04081337": {
        "briefTitle": "A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide",
        "officialTitle": "A Randomized, Placebo-Controlled, Parallel-Arm Study to Investigate the Effect of Once-Weekly Tirzepatide on Energy Expenditure and Food Intake in Obese Subjects",
        "lillyAlias": [
            "I8F-MC-GPGU"
        ]
    },
    "NCT00059215": {
        "briefTitle": "A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)",
        "officialTitle": "A Double-Blind, Randomized, Multicenter, Dose-Ranging Trial of CS-747 Compared With Clopidogrel in Subjects Undergoing Percutaneous Coronary Intervention",
        "lillyAlias": [
            "H7T-MC-TAAH"
        ]
    },
    "NCT01660815": {
        "briefTitle": "A Study of Florbetapir (18F) in Japanese Healthy Volunteers",
        "officialTitle": "PET Whole Body Biodistribution Using Florbetapir (18F)",
        "lillyAlias": [
            "I6E-AV-AVBA"
        ]
    },
    "NCT00191815": {
        "briefTitle": "Combination Chemotherapy for Metastatic Breast Cancer",
        "officialTitle": "Phase II Study of Gemcitabine Plus Cisplatin as First-line Treatment of Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-VI-S326"
        ]
    },
    "NCT01874756": {
        "briefTitle": "The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia",
        "officialTitle": "The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia",
        "lillyAlias": []
    },
    "NCT00014209": {
        "briefTitle": "Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment",
        "officialTitle": "A Phase II Study Of Gemcitabine, Dexamethasone, And Cisplatin (GDP) In Patients With Either Hodgkin's Disease Or Aggressive Histology Non-Hodgkin's Lymphoma Which Is Relapsed Or Refractory",
        "lillyAlias": [
            "LILLY-CAN-NCIC-LY10",
            "CDR0000068518"
        ]
    },
    "NCT03647956": {
        "briefTitle": "Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors",
        "officialTitle": "Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors: a Single Arm Phase 2 Study",
        "lillyAlias": []
    },
    "NCT04618809": {
        "briefTitle": "Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer",
        "officialTitle": "Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer",
        "lillyAlias": []
    },
    "NCT00191009": {
        "briefTitle": "Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease",
        "officialTitle": "Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer's Disease",
        "lillyAlias": [
            "B4Z-MC-LYCG"
        ]
    },
    "NCT04433585": {
        "briefTitle": "A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus",
        "lillyAlias": [
            "J1P-MC-KFAJ",
            "2019-003323-38"
        ]
    },
    "NCT06311656": {
        "briefTitle": "A Study to Evaluate Safety, Tolerability of LY4100511 (DC-853) in Healthy Asian and Non-Asian Participants",
        "officialTitle": "A Placebo-controlled, Phase 1, Participant- and Investigator-blinded, Single- and Multiple- Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY4100511 (DC-853) in Healthy Asian and Non-Asian Participants",
        "lillyAlias": [
            "J5C-MC-FOAA"
        ]
    },
    "NCT01903356": {
        "briefTitle": "A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea",
        "officialTitle": "A Regulatory Requirement Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta Duo\u00ae (Linagliptin/Metformin HCl, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/1000 mg, b.i.d) in Korean Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01995656": {
        "briefTitle": "A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of LY3108743 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I7D-FW-SGAA"
        ]
    },
    "NCT06696456": {
        "briefTitle": "Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy",
        "officialTitle": "An Evaluation of the Long Term Safety and Efficacy of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
        "lillyAlias": []
    },
    "NCT00128856": {
        "briefTitle": "Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients",
        "officialTitle": "Phase II Pharmacogenomic and Clinical Trial for the Administration of Gemcitabine-doxorubicin-paclitaxel (GAT) as Neoadjuvant Treatment of Patients With Stage III Breast Cancer",
        "lillyAlias": []
    },
    "NCT00976456": {
        "briefTitle": "Efficacy Study of Avastin\u00ae With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer",
        "officialTitle": "Open-label Study of Bevacizumab (Avastin\u00ae) in Combination With Pemetrexed or Pemetrexed and Carboplatin as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer",
        "lillyAlias": [
            "ML21896"
        ]
    },
    "NCT00035256": {
        "briefTitle": "Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis",
        "officialTitle": "Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-MC-GHBQ"
        ]
    },
    "NCT00867009": {
        "briefTitle": "A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer",
        "officialTitle": "A Phase 2 Study of Pemetrexed and Cisplatin Plus Cetuximab Followed by Pemetrexed and Cetuximab Maintenance Therapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB or IV) Other Than Predominantly Squamous Cell Histology",
        "lillyAlias": [
            "H3E-MC-S104"
        ]
    },
    "NCT03025009": {
        "briefTitle": "A Study of LY3192767 in Healthy Participants",
        "officialTitle": "A Single-Site, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Glucodynamic Effects of LY3192767 in Healthy Subjects",
        "lillyAlias": [
            "I8M-MC-BIXA",
            "2016-003274-40"
        ]
    },
    "NCT04393285": {
        "briefTitle": "Abemaciclib and Letrozole to Treat Endometrial Cancer",
        "officialTitle": "A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer",
        "lillyAlias": []
    },
    "NCT04607421": {
        "briefTitle": "A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer",
        "officialTitle": "AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEAD-IN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600E-MUTANT COLORECTAL CANCER",
        "lillyAlias": [
            "2023-509405-77-00",
            "BREAKWATER"
        ]
    },
    "NCT01149421": {
        "briefTitle": "A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes",
        "officialTitle": "The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-MC-GBDN",
            "CTRI/2010/091/001444"
        ]
    },
    "NCT00149721": {
        "briefTitle": "Anterior Pituitary Function in Patients With Hydrocephalus",
        "officialTitle": "Anterior Pituitary Function in Patients With Hydrocephalus",
        "lillyAlias": []
    },
    "NCT00191490": {
        "briefTitle": "A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer",
        "officialTitle": "A Multicenter Randomized Phase II Study Evaluating the Feasibility and Activity of Two Different Combinations of Docetaxel (RP56976, TAXOTERE *) and Gemcitabine and of Cisplatin/Gemcitabine Followed by Docetaxel as First Line Therapy for Locally Advanced Unresectable or Metastatic Non Small Cell Lung Cancer",
        "lillyAlias": [
            "B9E-IT-JHSC"
        ]
    },
    "NCT02770521": {
        "briefTitle": "A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants",
        "officialTitle": "A Study to Evaluate the Safety and Tolerability of Subcutaneous Treprostinil and Pharmacokinetics of a Novel LY900014 Formulation in Healthy Japanese Subjects",
        "lillyAlias": [
            "I8B-JE-ITRK"
        ]
    },
    "NCT03363464": {
        "briefTitle": "Comparative Effectiveness of Empagliflozin in the US",
        "officialTitle": "EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) Study Program",
        "lillyAlias": []
    },
    "NCT06111521": {
        "briefTitle": "A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants",
        "officialTitle": "A PHASE 1 STUDY TO EVALUATE THE EFFECTS OF MULTIPLE DOSES OF LY3537982 ON THE SINGLE-DOSE PHARMACOKINETICS OF MIDAZOLAM, DIGOXIN, AND ROSUVASTATIN IN HEALTHY ADULT SUBJECTS",
        "lillyAlias": [
            "J3M-OX-JZQJ"
        ]
    },
    "NCT05260021": {
        "briefTitle": "A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both",
        "lillyAlias": [
            "I8F-MC-GPGV"
        ]
    },
    "NCT00993421": {
        "briefTitle": "A Weight Loss Study in Overweight Men and Women",
        "officialTitle": "LY377604 + Sibutramine Hydrochloride Monohydrate: A Phase 2 Weight Loss Efficacy Study in Overweight/Obese Men and Women",
        "lillyAlias": [
            "I1L-MC-GAEB"
        ]
    },
    "NCT06045221": {
        "briefTitle": "A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin",
        "officialTitle": "A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Oral Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-3)",
        "lillyAlias": [
            "J2A-MC-GZGU",
            "U1111-1290-6014"
        ]
    },
    "NCT03616964": {
        "briefTitle": "A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus",
        "lillyAlias": [
            "I4V-MC-JAIA",
            "2017-005027-25"
        ]
    },
    "NCT00325364": {
        "briefTitle": "Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients With Type 2 Diabetes Mellitus.",
        "lillyAlias": [
            "H7U-MC-IDAU"
        ]
    },
    "NCT03915964": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis",
        "officialTitle": "A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis",
        "lillyAlias": [
            "I4V-MC-JAJA",
            "2018-003351-37"
        ]
    },
    "NCT03857321": {
        "briefTitle": "Study of Nasal Insulin to Fight Forgetfulness - Device Study",
        "officialTitle": "Device Study for Intranasal Delivery of Insulin",
        "lillyAlias": []
    },
    "NCT02246621": {
        "briefTitle": "A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) Plus LY2835219, a CDK4/6 Inhibitor, or Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer With No Prior Systemic Therapy in This Disease Setting",
        "lillyAlias": [
            "I3Y-MC-JPBM",
            "2014-001502-18"
        ]
    },
    "NCT00194064": {
        "briefTitle": "Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine",
        "officialTitle": "Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania",
        "lillyAlias": []
    },
    "NCT00191464": {
        "briefTitle": "Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes",
        "officialTitle": "Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes: A Comparison of Premeal Insulin Lispro Mixtures to Once-Daily Insulin Glargine",
        "lillyAlias": [
            "F3Z-MC-IOOI"
        ]
    },
    "NCT00785421": {
        "briefTitle": "Chemotherapy With or Without Enoxaparin in Pancreatic Cancer",
        "officialTitle": "A Prospective, Randomized Trial Of Simultaneous Pancreatic Cancer Treatment With Enoxaparin and ChemoTherapy (PROSPECT)",
        "lillyAlias": [
            "CCT-NAPN-16752"
        ]
    },
    "NCT05767021": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis",
        "officialTitle": "A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab",
        "lillyAlias": [
            "I6T-MC-AMBZ",
            "2022-502393-16-00"
        ]
    },
    "NCT00447421": {
        "briefTitle": "A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy",
        "officialTitle": "Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-EW-S107"
        ]
    },
    "NCT00795821": {
        "briefTitle": "A Study in Adult Patients With Major Depressive Disorder",
        "officialTitle": "A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder",
        "lillyAlias": [
            "H9P-MC-LNBI"
        ]
    },
    "NCT05778864": {
        "briefTitle": "A Study of LY3473329 in Participants With Impaired and Normal Renal Function",
        "officialTitle": "Pharmacokinetics of LY3473329 Following Oral Administration in Participants With Renal Impairment Compared With Participants With Normal Renal Function",
        "lillyAlias": [
            "J2O-MC-EKBE"
        ]
    },
    "NCT04208464": {
        "briefTitle": "JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM",
        "officialTitle": "A Randomised, Phase IIa Treatment Delayed-start Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult Idiopathic Inflammatory Myopathy",
        "lillyAlias": []
    },
    "NCT01165021": {
        "briefTitle": "A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer",
        "officialTitle": "An Exploratory Phase 2 Study of Pemetrexed/Cisplatin as Pre-operative Chemotherapy in the Treatment of Stage IIIAN2 Nonsquamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-EW-JMIP"
        ]
    },
    "NCT05803421": {
        "briefTitle": "A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk",
        "officialTitle": "A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk",
        "lillyAlias": [
            "J2A-MC-GZGS",
            "2022-502833-25-00",
            "U1111-1285-6821"
        ]
    },
    "NCT03762564": {
        "briefTitle": "Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy",
        "officialTitle": "A Randomized, Multicenter Open Label Phase II Trial of Paclitaxel + Ramucirumab Versus Paclitaxel Alone in Patients With Squamous-cell Carcinoma of the Esophagus, Refractory or Intolerant to Combination Therapy With Fluoropyrimidine and Platinum-based Drugs - The RAMOS STUDY",
        "lillyAlias": [
            "AIO-STO-0216",
            "2016-003850-33"
        ]
    },
    "NCT03765502": {
        "briefTitle": "A Study Comparing User Experience of Different Delivery Devices for Glucagon",
        "officialTitle": "A Simulation Study Comparing Successful Administration, Time to Administer, and User Experience of Ready-to-Use Nasal Glucagon With Reconstitutable Injectable Glucagon",
        "lillyAlias": [
            "I8R-MC-IGBM"
        ]
    },
    "NCT00191321": {
        "briefTitle": "Teriparatide Use in Hip Replaced Subjects",
        "officialTitle": "TUHRS Study - Teriparatide Use in Hip Replaced Subjects A Pilot Study on the Use of Teriparatide in Severe Osteoporotic Women With Hip Fracture and Submitted to Hip Replacement",
        "lillyAlias": [
            "B3D-IT-GHCU"
        ]
    },
    "NCT00191243": {
        "briefTitle": "Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer",
        "officialTitle": "A Randomized Phase II Study Comparing Single-Agent Docetaxel to Alternating Docetaxel-Gemcitabine as Primary Chemotherapy in Patients With Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-MC-S241"
        ]
    },
    "NCT03952143": {
        "briefTitle": "A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes",
        "lillyAlias": [
            "I8B-FH-ITSE"
        ]
    },
    "NCT03848403": {
        "briefTitle": "Study of Ixekizumab in Healthy Participants",
        "officialTitle": "A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects",
        "lillyAlias": [
            "I1F-MC-RHCS"
        ]
    },
    "NCT05869903": {
        "briefTitle": "A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities",
        "officialTitle": "A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)",
        "lillyAlias": [
            "J2A-MC-GZGP",
            "2022-502839-19-00",
            "U1111-1289-8877"
        ]
    },
    "NCT04660643": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss",
        "officialTitle": "Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)",
        "lillyAlias": [
            "I8F-MC-GPHN"
        ]
    },
    "NCT00266643": {
        "briefTitle": "Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain",
        "officialTitle": "A Comparison of Strategies for Switching Patients From Amitriptyline to Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "F1J-US-HMDY"
        ]
    },
    "NCT01401543": {
        "briefTitle": "A Bioavailability Study of LY2452473 and Tadalafil",
        "officialTitle": "LY2452473 Formulation Exploratory Bioavailability Study",
        "lillyAlias": [
            "I4K-MC-GPEA"
        ]
    },
    "NCT02413203": {
        "briefTitle": "Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B",
        "officialTitle": "A Randomized, Double-blinded, Placebo-controlled Study Investigating the Pharmacological Response to Celecoxib Using ex Vivo Human Whole-blood Assay (hWBA) and Broad-spectrum Lipidomics Analysis",
        "lillyAlias": []
    },
    "NCT02327143": {
        "briefTitle": "A Study of LY2835219 in Healthy Participants",
        "officialTitle": "An Absolute Bioavailability Study of LY2835219 in Healthy Subjects Using the Intravenous Tracer Method",
        "lillyAlias": [
            "I3Y-MC-JPBS"
        ]
    },
    "NCT00216203": {
        "briefTitle": "Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer",
        "officialTitle": "A Phase I-IIa Dose-Ranging Study of Pemetrexed (Alimta) Plus Cetuximab (Erbitux) in Patients With Recurrent Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN04-79",
        "lillyAlias": []
    },
    "NCT06598943": {
        "briefTitle": "A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis",
        "officialTitle": "An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination With Mirikizumab for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis",
        "lillyAlias": [
            "I7P-MC-DSAG"
        ]
    },
    "NCT01556438": {
        "briefTitle": "Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma",
        "officialTitle": "A Phase 1 Study of Tabalumab (LY2127399) in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed or Refractory Multiple Myeloma",
        "lillyAlias": [
            "H9S-JE-JDCI"
        ]
    },
    "NCT01059643": {
        "briefTitle": "A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck",
        "officialTitle": "A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck",
        "lillyAlias": [
            "I1Y-MC-JFBF"
        ]
    },
    "NCT03750643": {
        "briefTitle": "A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis",
        "officialTitle": "Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis",
        "lillyAlias": [
            "J1B-MC-FRCC"
        ]
    },
    "NCT02451943": {
        "briefTitle": "A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients With Advanced or Metastatic Soft Tissue Sarcoma",
        "lillyAlias": [
            "I5B-MC-JGDJ",
            "2015-000134-30"
        ]
    },
    "NCT00877890": {
        "briefTitle": "A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)",
        "officialTitle": "A Randomized, Open-Label, Parallel-Group, Comparator-Controlled, Multicenter Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT05369403": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab",
        "officialTitle": "An Open-Label, Study to Evaluate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab",
        "lillyAlias": [
            "J2T-MC-KGBO"
        ]
    },
    "NCT01088503": {
        "briefTitle": "Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome",
        "officialTitle": "The TRANSLATE-ACS Study: Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome",
        "lillyAlias": [
            "H7T-US-B007"
        ]
    },
    "NCT01394003": {
        "briefTitle": "A Study of LY2584702 in Participants With Advanced Cancer",
        "officialTitle": "A Phase I Study of LY2584702 in Patient With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I3G-MC-JGCA"
        ]
    },
    "NCT05254743": {
        "briefTitle": "A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)",
        "officialTitle": "A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)",
        "lillyAlias": [
            "J2N-OX-JZNU",
            "LOXO-BTK-20030",
            "2021-003206-41"
        ]
    },
    "NCT05936138": {
        "briefTitle": "A Study of LY3502970 in Participants With Normal and Impaired Renal Function",
        "officialTitle": "A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment",
        "lillyAlias": [
            "J2A-MC-GZPC"
        ]
    },
    "NCT00551538": {
        "briefTitle": "24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine",
        "officialTitle": "Twenty-Four-Hour Plasma Glucose Profiles Observed in Patients With Type 2 Diabetes During Therapy Consisting of Oral Agent(s) Plus Twice-Daily Insulin Lispro Low Mixture or Once-Daily Insulin Glargine",
        "lillyAlias": [
            "F3Z-MC-IOOM"
        ]
    },
    "NCT03310879": {
        "briefTitle": "Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-type Cyclins or Amplification of CDK4 or CDK6",
        "officialTitle": "A Phase II Study of the CDK4/6 Inhibitor Abemaciclib in Patients With Solid Tumors Harboring Genetic Alterations in Genes Encoding D-type Cyclins or Amplification of CDK4 or CDK6",
        "lillyAlias": []
    },
    "NCT06085079": {
        "briefTitle": "Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study",
        "officialTitle": "A 24-week Two-armed Proof-of-concept Exploratory Analysis of Subcutaneous Ixekizumab Administration in Patients With Recalcitrant Non-infectious Intermediate, Posterior, Panuveitis, or Chronic Steroid-dependent Anterior Uveitis.",
        "lillyAlias": []
    },
    "NCT01025284": {
        "briefTitle": "A Study for Participants With Small-Cell Lung Cancer",
        "officialTitle": "A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer",
        "lillyAlias": [
            "I1Y-MC-JFBD"
        ]
    },
    "NCT00917384": {
        "briefTitle": "Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma",
        "officialTitle": "A Phase 3, Randomized, Double-Blinded Study of IMC-1121B and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy",
        "lillyAlias": [
            "2008-005964-15",
            "CP12-0715",
            "I4T-IE-JVBD"
        ]
    },
    "NCT00191984": {
        "briefTitle": "A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer",
        "officialTitle": "Open Multicenter Phase II Study in Second-Line Metastatic Colorectal Cancer Patients: Combination of ALIMTA and Irinotecan Administered Every Two-Weeks",
        "lillyAlias": [
            "H3E-FP-S057"
        ]
    },
    "NCT00793884": {
        "briefTitle": "Emory Latino Diabetes Education Program",
        "officialTitle": "Emory Latino Diabetes Education Program",
        "lillyAlias": []
    },
    "NCT00190684": {
        "briefTitle": "Long-Term, Open Label Atomoxetine Study",
        "officialTitle": "Long-Term, Open Label Safety Study of Atomoxetine Hydrochloride in Patients, 6 Years and Older With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-MC-LYAI"
        ]
    },
    "NCT01003184": {
        "briefTitle": "Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes",
        "officialTitle": "Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulphonylurea",
        "lillyAlias": []
    },
    "NCT03928379": {
        "briefTitle": "A Study of LY3305677 in Participants With Type 2 Diabetes",
        "officialTitle": "A Multiple-Ascending Dose Study in Patients With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677",
        "lillyAlias": [
            "I8P-MC-OXAD",
            "2018-004779-11"
        ]
    },
    "NCT02963779": {
        "briefTitle": "A Study of LY2775240 in Healthy Participants",
        "officialTitle": "A 2-Part, Safety, Tolerability, and Pharmacokinetic Study of LY2775240 in Healthy Subjects",
        "lillyAlias": [
            "I8W-MC-PDBA"
        ]
    },
    "NCT03040479": {
        "briefTitle": "Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function",
        "officialTitle": "A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function",
        "lillyAlias": [
            "CUD-P9-453",
            "H8H-CD-LAHF",
            "COL MIG-114"
        ]
    },
    "NCT04016584": {
        "briefTitle": "Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy",
        "officialTitle": "Diabetes Pueblo Program - The Application and Acceptability of Culturally Appropriate Education Programs for Current or Potential Insulin Therapy Users With Type 2 Diabetes in the Latino Community",
        "lillyAlias": []
    },
    "NCT01342484": {
        "briefTitle": "Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes",
        "officialTitle": "A Randomised, Double-blind, Placebo-controlled, Parallel Group Dose-finding Study of Linagliptin (1 and 5 mg Administered Orally Once Daily) Over 12 Weeks in Children and Adolescents, From 10 to 17 Years of Age, With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "2009-017004-91"
        ]
    },
    "NCT02152384": {
        "briefTitle": "A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements",
        "officialTitle": "The Effect of Treatment With Basal Insulin Peglispro or Insulin Glargine on the Dose Response Effect of Prandial Insulin Lispro in Patients With Type 1 Diabetes Mellitus.",
        "lillyAlias": [
            "I2R-MC-BIDU"
        ]
    },
    "NCT00034502": {
        "briefTitle": "A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-MC-JMDO"
        ]
    },
    "NCT01865084": {
        "briefTitle": "A Study of Tadalafil for Duchenne Muscular Dystrophy",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tadalafil for Duchenne Muscular Dystrophy",
        "lillyAlias": [
            "H6D-MC-LVJJ"
        ]
    },
    "NCT05313802": {
        "briefTitle": "A Study of LY3502970 in Healthy Overweight and Obese Participants",
        "officialTitle": "A Multiple Dose Study in Healthy Overweight and Obese Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970",
        "lillyAlias": [
            "J2A-MC-GZGK"
        ]
    },
    "NCT00656084": {
        "briefTitle": "Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell",
        "officialTitle": "A Phase II Study of Gemzar, Novantrone and Rituxan in Relapsed or Refractory Mantle Cell Lymphoma (MCL) (B9E-US-X436)",
        "lillyAlias": []
    },
    "NCT00782002": {
        "briefTitle": "Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy",
        "officialTitle": "Phase 1 Study of Weekly Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) Monoclonal Antibody IMC-18F1 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or For Whom No Standard Therapy is Available",
        "lillyAlias": [
            "CP14-0501",
            "I4Y-IE-JCDA"
        ]
    },
    "NCT01846702": {
        "briefTitle": "A Study of LY3084077 in Healthy Participants",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of LY3084077 in Healthy Subjects",
        "lillyAlias": [
            "I6P-MC-FMRA"
        ]
    },
    "NCT00620321": {
        "briefTitle": "A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
        "officialTitle": "An Open-Label Phase 2 Trial of LY2181308 Sodium Administered in Combination With Idarubicin and Cytarabine to Patients With Refractory or Relapsed Acute Myeloid Leukemia",
        "lillyAlias": [
            "H8Z-MC-JACU"
        ]
    },
    "NCT02890121": {
        "briefTitle": "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:",
        "officialTitle": "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Cross Sectional Cohort",
        "lillyAlias": []
    },
    "NCT02227784": {
        "briefTitle": "A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol",
        "officialTitle": "The Addition of Evacetrapib to Atorvastatin Compared to Placebo, High Intensity Atorvastatin, and Atorvastatin With Ezetimibe to Evaluate LDL-C Lowering in Patients With Primary Hyperlipidemia - The ACCENTUATE Study",
        "lillyAlias": [
            "I1V-MC-EIBH"
        ]
    },
    "NCT00334802": {
        "briefTitle": "Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer",
        "officialTitle": "Combination Study of LY188011 and Paclitaxel in Patients With Metastatic/Recurrent Breast Cancer After Neo-adjuvant/Adjuvant Chemotherapy With Anthracycline",
        "lillyAlias": [
            "B9E-JE-MB22"
        ]
    },
    "NCT01703702": {
        "briefTitle": "Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline",
        "officialTitle": "A Randomized, Multicenter, Multicountry Study to Evaluate the Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and to Evaluate the Relationship Between Florbetapir (18F) PET Scan Status and Cognitive Decline",
        "lillyAlias": []
    },
    "NCT00606021": {
        "briefTitle": "A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Study Comparing Pemetrexed Plus Best Supportive Care With Best Supportive Care as Maintenance, Following First-Line Treatment With Pemetrexed-Cisplatin, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-EZ-S114"
        ]
    },
    "NCT02660502": {
        "briefTitle": "An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects",
        "officialTitle": "A Double-blind, Comparator-controlled, Randomised, Three-period Crossover Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects",
        "lillyAlias": []
    },
    "NCT01391221": {
        "briefTitle": "Inflammatory Markers and Cognitive Function in Major Depression",
        "officialTitle": "Inflammatory Markers and Cognitive Function in Major Depression:a Pilot Study",
        "lillyAlias": []
    },
    "NCT01087502": {
        "briefTitle": "Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment",
        "officialTitle": "A Phase III, Randomised, Double-blind, Placebo-controlled Parallel Group Safety and Efficacy Study of Linagliptin (5 mg Administered Orally Once Daily) Over 12 Weeks Followed by a 40 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Drug Naive or Previously Treated Type 2 Diabetic Patients With Moderate to Severe Renal Impairment and Insufficient Glycaemic Control",
        "lillyAlias": [
            "2009-016971-31"
        ]
    },
    "NCT04143802": {
        "briefTitle": "A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)",
        "officialTitle": "A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3437943 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J1I-MC-GZBB"
        ]
    },
    "NCT00509821": {
        "briefTitle": "Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma",
        "officialTitle": "Enzastaurin Before and Concomitant With Radiation Therapy, Followed by Enzastaurin Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma Without Methylation of the Promoter Gene of MGMT Enzyme - a Phase II Study",
        "lillyAlias": [
            "H6Q-MC-S039"
        ]
    },
    "NCT00332202": {
        "briefTitle": "PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin",
        "officialTitle": "A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin",
        "lillyAlias": [
            "H6Q-MC-JCBJ",
            "PRELUDE"
        ]
    },
    "NCT02923921": {
        "briefTitle": "Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer",
        "officialTitle": "Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen",
        "lillyAlias": [
            "J1L-AM-JZGB",
            "AM0010-301",
            "2016-003858-33"
        ]
    },
    "NCT00044421": {
        "briefTitle": "Treatment of Peripheral Neuropathy in Patients With Diabetes",
        "officialTitle": "LY333531 Treatment of Peripheral Neuropathy in Patients With Diabetes",
        "lillyAlias": [
            "B7A-MC-MBBR"
        ]
    },
    "NCT01185964": {
        "briefTitle": "A Study of Olaratumab in Soft Tissue Sarcoma",
        "officialTitle": "A Phase 1b/2, With Phase 2 Randomized, Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFR\u03b1 Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced Soft Tissue Sarcoma",
        "lillyAlias": [
            "I5B-IE-JGDG",
            "CP15-0806"
        ]
    },
    "NCT01373164": {
        "briefTitle": "A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer",
        "officialTitle": "A Phase 1b/2 Study With Gemcitabine and LY2157299 for Patients With Metastatic Cancer (Phase 1b) and Advanced or Metastatic Unresectable Pancreatic Cancer (Phase 2)",
        "lillyAlias": [
            "H9H-MC-JBAJ"
        ]
    },
    "NCT05912621": {
        "briefTitle": "Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity",
        "officialTitle": "Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity",
        "lillyAlias": []
    },
    "NCT00322621": {
        "briefTitle": "Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)",
        "officialTitle": "Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients With Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "F1J-MC-HMEM"
        ]
    },
    "NCT00200902": {
        "briefTitle": "Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression",
        "officialTitle": "Factors of Treatment Response in Major Depressive Disorder",
        "lillyAlias": [
            "R01AT002479-02",
            "04-02-068"
        ]
    },
    "NCT01792284": {
        "briefTitle": "A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study",
        "lillyAlias": [
            "I2R-MC-BIAX"
        ]
    },
    "NCT00106002": {
        "briefTitle": "Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer",
        "officialTitle": "A Phase II Study of Alimta as First Line Chemotherapy for Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "H3E-US-S045"
        ]
    },
    "NCT04557384": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1, Nonrandomized, Open-Label Investigation of Subcutaneous Ramucirumab Administration in Participants With Advanced Solid Tumors",
        "lillyAlias": [
            "I4T-MC-JVDU"
        ]
    },
    "NCT03556202": {
        "briefTitle": "A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)",
        "officialTitle": "A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3",
        "lillyAlias": [
            "I6T-MC-AMAH",
            "2017-003299-30"
        ]
    },
    "NCT01708902": {
        "briefTitle": "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug na\u00efve Type 2 Patients",
        "officialTitle": "A Phase III Randomised, Double-blind, Double-dummy, Parallel Group Study to Compare the Efficacy and Safety of Twice Daily Administration of the Fix Dose Combination of Linagliptin 2.5 mg + Metformin 500 mg, or of Linagliptin 2.5 mg + Metformin 1000 mg, With the Individual Components of Metformin (500 mg or 1000 mg, Twice Daily), and Linagliptin (5.0 mg, Once Daily) Over 24 Weeks in Treatment na\u00efve Type 2 Diabetic Patients With Insufficient Glycaemic Control",
        "lillyAlias": []
    },
    "NCT00169702": {
        "briefTitle": "The Effect of a Weight Management Program During Treatment With Olanzapine",
        "officialTitle": "The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study",
        "lillyAlias": []
    },
    "NCT00862784": {
        "briefTitle": "A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer",
        "officialTitle": "An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B in Combination With 5-FU/FA and Oxaliplatin (Modified FOLFOX-6) as First-line Therapy in Patients With Metastatic Colorectal Cancer",
        "lillyAlias": [
            "2008-004936-19",
            "CP12-0709",
            "I4T-IE-JVBH"
        ]
    },
    "NCT04271202": {
        "briefTitle": "Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action",
        "officialTitle": "Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action",
        "lillyAlias": []
    },
    "NCT00549302": {
        "briefTitle": "Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs",
        "officialTitle": "An Extension Study to Evaluate the Long-Term Safety and Efficacy of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients With Pulmonary Arterial Hypertension",
        "lillyAlias": [
            "H6D-MC-LVGX"
        ]
    },
    "NCT06215521": {
        "briefTitle": "A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants",
        "officialTitle": "A Phase I, Single-Dose, Randomized, Partially Double-Blind, Placebo- and Positive-Controlled, 3-Way Crossover Study to Evaluate the Effect of LOXO-305 on QTc Interval in Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZNI"
        ]
    },
    "NCT01089621": {
        "briefTitle": "A Study for Adolescents With Fibromyalgia Syndrome",
        "officialTitle": "An Open-label Feasibility Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome: A Pilot Study",
        "lillyAlias": [
            "F1J-MC-HMGE"
        ]
    },
    "NCT03986502": {
        "briefTitle": "Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma",
        "officialTitle": "Pilot Randomized Study of a Proactive Financial Navigation Intervention in Patients With Newly Diagnosed Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma",
        "lillyAlias": [
            "NCI-2019-03381",
            "10200"
        ]
    },
    "NCT01473602": {
        "briefTitle": "Second Study of the Effect of Teriparatide on Hip Fracture Healing",
        "officialTitle": "Second Study of the Effect of Teriparatide on Femoral Neck Fracture Healing",
        "lillyAlias": [
            "B3D-MC-GHDQ"
        ]
    },
    "NCT00327002": {
        "briefTitle": "A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism",
        "officialTitle": "A Mechanistic Study of the Effects of LY518674 on HDL C Metabolism",
        "lillyAlias": [
            "GCRC # 0995"
        ]
    },
    "NCT04493502": {
        "briefTitle": "A Study of LY3041658 in Adults With Hidradenitis Suppurativa",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults With Moderate-to-Severe Hidradenitis Suppurativa",
        "lillyAlias": [
            "I7P-MC-DSAD"
        ]
    },
    "NCT01234402": {
        "briefTitle": "Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients",
        "officialTitle": "An Open-Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Ramucirumab (IMC-1121B) Drug Product or Icrucumab (IMC-18F1) in Combination With Capecitabine or Capecitabine Monotherapy, in Unresectable, Locally Advanced or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy",
        "lillyAlias": [
            "CP20-0903",
            "I4Y-IE-JCDD"
        ]
    },
    "NCT03907202": {
        "briefTitle": "A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM",
        "officialTitle": "A Double-blind, Placebo-controlled, Randomised, Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KBP-089 in Patients With Type II Diabetes",
        "lillyAlias": []
    },
    "NCT00035321": {
        "briefTitle": "The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression",
        "officialTitle": "The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features",
        "lillyAlias": [
            "H6P-MC-HDAO"
        ]
    },
    "NCT00542984": {
        "briefTitle": "Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis",
        "officialTitle": "Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-KL-GHCC"
        ]
    },
    "NCT00303602": {
        "briefTitle": "Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)",
        "officialTitle": "BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS)",
        "lillyAlias": [
            "F1D-CA-S063"
        ]
    },
    "NCT05633602": {
        "briefTitle": "Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study",
        "officialTitle": "Pragmatica-Lung: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "NCI-2022-09319",
            "S2302",
            "S2302",
            "U10CA180888"
        ]
    },
    "NCT05341102": {
        "briefTitle": "A Study of Single and Repeated Doses of LY3556050 in Healthy Participants",
        "officialTitle": "A Study to Evaluate the Safety and Pharmacokinetics of Single and Repeated Doses of CNTX-0290 in Healthy Subjects",
        "lillyAlias": [
            "J2P-MC-LXBB"
        ]
    },
    "NCT04848402": {
        "briefTitle": "A Device Study in Healthy Participants",
        "officialTitle": "A Study to Investigate the Safety and Tolerability of a Wearable On-body Delivery System, and Exploratory Assessment of Participant Response With an Autoinjector, Following Subcutaneous Injections of Placebo in Healthy Participants",
        "lillyAlias": [
            "H7K-MC-O005"
        ]
    },
    "NCT00538564": {
        "briefTitle": "Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia",
        "officialTitle": "Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia",
        "lillyAlias": []
    },
    "NCT00061464": {
        "briefTitle": "Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.",
        "officialTitle": "ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase II Clinical Trial",
        "lillyAlias": [
            "H3E-US-JMFX"
        ]
    },
    "NCT00216164": {
        "briefTitle": "Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",
        "officialTitle": "Phase II Study of Rituximab and Gemcitabine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Hoosier Oncology Group LYM03-64",
        "lillyAlias": []
    },
    "NCT03247790": {
        "briefTitle": "A Study of Lasmiditan in Participants With Migraine",
        "officialTitle": "An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods",
        "lillyAlias": [
            "H8H-MC-LAHC"
        ]
    },
    "NCT01088464": {
        "briefTitle": "Study of IMC-11F8 in Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1 Study of IMC-11F8 in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "CP11-0907",
            "I4X-IE-JFCA",
            "21-1901"
        ]
    },
    "NCT00530621": {
        "briefTitle": "Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer",
        "officialTitle": "A Phase 2 Double-Blind Randomized Study of Oral Enzastaurin HCl Versus Placebo Concurrently With Pemetrexed (Alimta\u00ae) as Second-Line Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H6Q-MC-JCBT"
        ]
    },
    "NCT04627064": {
        "briefTitle": "ABEMA Alone or in COMBO with MK-6482",
        "officialTitle": "A Phase I/IB Trial of Abemaciclib Alone or in Combination with MK-6482 in Advanced Renal Cell Carcinoma",
        "lillyAlias": []
    },
    "NCT01200290": {
        "briefTitle": "A Study in Participants With End-Stage Renal Disease",
        "officialTitle": "An Exploratory/Proof of Concept Investigation of the Safety and Pharmacodynamics of LY2127399 in HLA-Presensitized Patients With End-Stage Renal Disease Awaiting Transplantation",
        "lillyAlias": [
            "H9B-MC-BCDR"
        ]
    },
    "NCT01660464": {
        "briefTitle": "Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): A Feasibility and Effectiveness Study",
        "lillyAlias": []
    },
    "NCT00191503": {
        "briefTitle": "Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma",
        "officialTitle": "Phase II Study of Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma",
        "lillyAlias": [
            "H3E-CA-S070"
        ]
    },
    "NCT01787903": {
        "briefTitle": "The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA",
        "officialTitle": "The Effects of Real-time Continuous Glucose Monitoring on Glycemia and Quality of Life in Patients With Type 1 Diabetes Mellitus and Impaired Hypoglycemia Awareness",
        "lillyAlias": []
    },
    "NCT04870203": {
        "briefTitle": "Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis",
        "officialTitle": "Combination of Baricitinib and Anti-TNF vs. Baricitinib in Patients With Rheumatoid Arthritis: a Randomized Placebo-controlled Phase III Trial",
        "lillyAlias": []
    },
    "NCT03890003": {
        "briefTitle": "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes",
        "officialTitle": "An Early Feasibility Study to Evaluate the Predictive Low Glucose Suspend Functionality and Safety in an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IORC"
        ]
    },
    "NCT03367403": {
        "briefTitle": "A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)",
        "officialTitle": "Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACG"
        ]
    },
    "NCT01804803": {
        "briefTitle": "DIgital Assisted MONitoring for DiabeteS - I",
        "officialTitle": "A Telemedicine-based Intervention Study Involving Real-time and Anywhere Transmission of Blood Glucose Data to a Decision Supported Software-assisted Server With Web-based Analysis of Data and Medical Feedback on Metabolic Control.",
        "lillyAlias": []
    },
    "NCT04039503": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin",
        "officialTitle": "Randomized, Phase 3, Double-blind Trial Comparing the Effect of the Addition of Tirzepatide Versus Placebo in Patients With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin",
        "lillyAlias": [
            "I8F-MC-GPGI",
            "2019-000860-99"
        ]
    },
    "NCT00997503": {
        "briefTitle": "TAXUS Libert\u0113 Post Approval Study",
        "officialTitle": "TAXUS Libert\u0113 Post Approval Study: A U.S. Post-Approval Study of the TAXUS\u00ae Libert\u00e9\u00ae Paclitaxel-Eluting Coronary Stent System",
        "lillyAlias": [
            "S2035"
        ]
    },
    "NCT04967521": {
        "briefTitle": "SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma",
        "officialTitle": "SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma",
        "lillyAlias": []
    },
    "NCT03338803": {
        "briefTitle": "Real World Glycemic Effectiveness of Linagliptin",
        "officialTitle": "Real World Glycemic Effectiveness of Linagliptin Among Type 2 Diabetes Mellitus Adults by Age and Renal Function",
        "lillyAlias": []
    },
    "NCT01646203": {
        "briefTitle": "A Study of IMC-TR1 in Participants With Advanced Solid Tumors",
        "officialTitle": "Phase 1 Study of Anti-TGF\u03b2RII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available",
        "lillyAlias": [
            "I5I-IE-JTCA"
        ]
    },
    "NCT01393990": {
        "briefTitle": "A Study of LY2228820 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of an Oral p38 MAPK Inhibitor in Patients With Advanced Cancer",
        "lillyAlias": [
            "I1D-MC-JIAD"
        ]
    },
    "NCT01648790": {
        "briefTitle": "A Study of Prasugrel in Healthy Participants",
        "officialTitle": "Relative Bioavailability of Prasugrel Orally Disintegrating Tablet Formulations and the Effect of Food on the Bioavailability of the Orally Disintegrating Tablet in Healthy Subjects",
        "lillyAlias": [
            "H7T-EW-TAEQ"
        ]
    },
    "NCT02102490": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread",
        "officialTitle": "A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPBN",
            "2013-005548-27"
        ]
    },
    "NCT00732303": {
        "briefTitle": "Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer",
        "officialTitle": "A Phase II Study of Concurrent Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer: Hoosier Oncology Group LUN08-129",
        "lillyAlias": []
    },
    "NCT02168803": {
        "briefTitle": "A Study of Evacetrapib in Participants With Abnormal Cholesterol",
        "officialTitle": "A Phase 1b Study to Characterize the Pharmacokinetics of Evacetrapib and Potential for Accumulation After Dosing for 12, 24, and 52 Weeks",
        "lillyAlias": [
            "I1V-MC-EIBM"
        ]
    },
    "NCT02514603": {
        "briefTitle": "A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers",
        "officialTitle": "A Phase 1 Study of LY2606368 in Japanese Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I4D-JE-JTJK"
        ]
    },
    "NCT01115803": {
        "briefTitle": "A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors",
        "officialTitle": "A Phase 1b Trial of LY2584702 in Combination With Erlotinib or Everolimus in Patients With Solid Tumors",
        "lillyAlias": [
            "I3G-MC-JGCB"
        ]
    },
    "NCT00433290": {
        "briefTitle": "Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain",
        "officialTitle": "Protocol F1J-MC-HMFG Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain",
        "lillyAlias": [
            "F1J-MC-HMFG"
        ]
    },
    "NCT06280703": {
        "briefTitle": "A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)",
        "officialTitle": "A Three-Part, Randomized, Double-Blind (Part A) and Open-Label (Part B and Part C), Multi-Dose, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "J4P-MC-IYAB",
            "U1111-1301-8386",
            "2023-510365-10-00"
        ]
    },
    "NCT02188303": {
        "briefTitle": "A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants",
        "officialTitle": "A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of the Oxyntomodulin Analog, LY2944876, in Healthy Japanese Subjects and Healthy Non-Japanese Subjects",
        "lillyAlias": [
            "I7I-EW-XNAB"
        ]
    },
    "NCT01214603": {
        "briefTitle": "A Study in Participants With Acute Leukemia",
        "officialTitle": "A Phase 2 Study of LY2090314 in Participants With Acute Leukemia",
        "lillyAlias": [
            "I2H-MC-JWYB"
        ]
    },
    "NCT01798303": {
        "briefTitle": "A Study of LY2940094 in Participants With Alcohol Dependency",
        "officialTitle": "Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Patients With Alcohol Dependence",
        "lillyAlias": [
            "I5J-MC-NOAD"
        ]
    },
    "NCT03732703": {
        "briefTitle": "Myeloma-Developing Regimens Using Genomics (MyDRUG)",
        "officialTitle": "Myeloma-Developing Regimens Using Genomics (MyDRUG) (Genomics Guided Multi-arm Trial of Targeted Agents Alone or in Combination With a Backbone Regimen)",
        "lillyAlias": []
    },
    "NCT00440843": {
        "briefTitle": "Zyprexa and Task Engagement in Schizophrenia",
        "officialTitle": "Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia",
        "lillyAlias": [
            "F1D-US-X282"
        ]
    },
    "NCT01115790": {
        "briefTitle": "A Phase 1 Study in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2606368 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I4D-MC-JTJA"
        ]
    },
    "NCT00824603": {
        "briefTitle": "Impact of Continuing Medical Education (CME) Insulin Program",
        "officialTitle": "Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT06297603": {
        "briefTitle": "Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)",
        "officialTitle": "A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes, Moderate or Severe Renal Impairment With Inadequate Glycemic Control on Basal Insulin With or Without Metformin and/or SGLT2 Inhibitor",
        "lillyAlias": [
            "J1I-MC-GZQA"
        ]
    },
    "NCT04469764": {
        "briefTitle": "Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer",
        "officialTitle": "An Open Label Phase II Study of the Efficacy and Safety of Abemaciclib, a Cyclin Dependent Kinase (CDK4/6) Inhibitor in Selected Patients With Recurrent Ovarian or Endometrial Cancer",
        "lillyAlias": [
            "NCI-2020-04544"
        ]
    },
    "NCT06383390": {
        "briefTitle": "The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and Major Adverse Kidney Events in Participants With Body Mass Index \u226527 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease",
        "lillyAlias": [
            "J1I-MC-GZBO",
            "2023-508630-34-00"
        ]
    },
    "NCT05509790": {
        "briefTitle": "A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer",
        "officialTitle": "A Phase 1 Study of LY3484356 in Chinese Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "J2J-MC-JZLF"
        ]
    },
    "NCT01177943": {
        "briefTitle": "A Bioequivalence (BE) Study in Healthy Subjects",
        "officialTitle": "LY139603 Bioequivalence Study Comparing Atomoxetine Oral Solution and Capsule Formulation in Healthy Adult Male Japanese Subjects",
        "lillyAlias": [
            "B4Z-JE-LYEO"
        ]
    },
    "NCT02423343": {
        "briefTitle": "A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma",
        "officialTitle": "A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-beta Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination With Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors (Phase 1b) and in Recurrent or Refractory Non-small Cell Lung Cancer or Hepatocellular Carcinoma (Phase 2)",
        "lillyAlias": [
            "H9H-MC-JBEF",
            "2015-002093-20"
        ]
    },
    "NCT03099538": {
        "briefTitle": "Ixekizumab in the Treatment of Bullous Pemphigoid",
        "officialTitle": "Ixekizumab in the Treatment of Bullous Pemphigoid",
        "lillyAlias": []
    },
    "NCT05794243": {
        "briefTitle": "A Multiple-Dose Study of LY3493269 in Healthy Participants",
        "officialTitle": "An Open-Label, Multiple-Dose Study to Investigate the Pharmacokinetics of LY3493269 Oral Formulations Administered in a Fed or Fasted State in Healthy Participants",
        "lillyAlias": [
            "J1X-MC-GZHI"
        ]
    },
    "NCT01432938": {
        "briefTitle": "A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants",
        "officialTitle": "The Effect of Dulaglutide (LY2189265) on the Pharmacokinetics and Pharmacodynamics of Single Dose Warfarin in Healthy Subjects",
        "lillyAlias": [
            "H9X-MC-GBCS"
        ]
    },
    "NCT02107703": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer",
        "officialTitle": "MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPBL",
            "2013-004728-13"
        ]
    },
    "NCT00918203": {
        "briefTitle": "A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomized Phase 2 Study of Human Anti-PDGFR\u03b1 Monoclonal Antibody (IMC-3G3) With Paclitaxel/Carboplatin or Paclitaxel/Carboplatin Alone in Previously Untreated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "CP15-0804",
            "I5B-IE-JGDB"
        ]
    },
    "NCT01052103": {
        "briefTitle": "A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms",
        "officialTitle": "A 17-Week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment With LY2140023 Combined With Standard of Care (SOC) Compared to Placebo With SOC in the Treatment of Patients With Prominent Negative Symptoms of Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBCO"
        ]
    },
    "NCT03212638": {
        "briefTitle": "A Study of Baricitinib in Healthy Participants",
        "officialTitle": "A Bioequivalence and Food Effect Study in Healthy Subjects Comparing Baricitinib Suspension and Commercial Tablet Formulations",
        "lillyAlias": [
            "I4V-MC-JAGU"
        ]
    },
    "NCT00212043": {
        "briefTitle": "Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma",
        "officialTitle": "Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma",
        "lillyAlias": []
    },
    "NCT03962738": {
        "briefTitle": "A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine",
        "officialTitle": "RandoMized, DOuble-bliNd, PlacebO-coNtrolled Trial Of Lasmiditan in a Single Migraine Attack in Japanese Patients SuFfering From Migraine With or WithoUt Aura - the MONONOFU Study",
        "lillyAlias": [
            "H8H-JE-LAIH"
        ]
    },
    "NCT00316238": {
        "briefTitle": "A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia",
        "officialTitle": "A Double-Blind Dose-Response Study Comparing Rapid Acting Intramuscular Olanzapine and Intramuscular Placebo in Agitated Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-JE-RA02"
        ]
    },
    "NCT03367390": {
        "briefTitle": "A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)",
        "officialTitle": "An Early Feasibility Study to Evaluate the Functionality and Safety of an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IOQS"
        ]
    },
    "NCT04657003": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight",
        "officialTitle": "Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)",
        "lillyAlias": [
            "I8F-MC-GPHL"
        ]
    },
    "NCT01115738": {
        "briefTitle": "Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients",
        "officialTitle": "TRansferring From ClopIdogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome PatiEnTs: TRIPLET",
        "lillyAlias": [
            "H7T-CR-TAEH",
            "CTRI/2010/091/000348"
        ]
    },
    "NCT05929079": {
        "briefTitle": "A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight",
        "officialTitle": "A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial",
        "lillyAlias": [
            "J1I-MC-GZBK",
            "J1I-MC-GSA2",
            "2023-503658-11-00"
        ]
    },
    "NCT03027284": {
        "briefTitle": "A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer",
        "officialTitle": "A Phase I Study of Merestinib Monotherapy or in Combination With Other Anti-Cancer Agents in Japanese Patients With Advanced and/or Metastatic Cancer",
        "lillyAlias": [
            "I3O-JE-JSBG"
        ]
    },
    "NCT01454284": {
        "briefTitle": "A Study in Participants With Type I Diabetes Mellitus",
        "officialTitle": "The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 1 Diabetes Mellitus Treated With Preprandial Insulin Lispro: a Double-Blind, Randomized, 52-week Study",
        "lillyAlias": [
            "I2R-MC-BIAO",
            "2011-001253-82"
        ]
    },
    "NCT05433584": {
        "briefTitle": "A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes",
        "officialTitle": "A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes",
        "lillyAlias": [
            "I8F-MC-GPHE",
            "2022-000130-42",
            "2022-5010733-40-00",
            "U1111-1282-0263"
        ]
    },
    "NCT03718884": {
        "briefTitle": "A Study of Mirikizumab in Participants With Plaque Psoriasis",
        "officialTitle": "Evaluation of the Effect of Mirikizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I6T-MC-AMBP"
        ]
    },
    "NCT04677179": {
        "briefTitle": "A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)",
        "officialTitle": "An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis",
        "lillyAlias": [
            "J1P-MC-KFAH",
            "2020-003017-35"
        ]
    },
    "NCT02385084": {
        "briefTitle": "A Study of LY2409021 Formulations in Healthy Participants",
        "officialTitle": "A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets",
        "lillyAlias": [
            "I1R-MC-GLDM"
        ]
    },
    "NCT00497484": {
        "briefTitle": "Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)",
        "officialTitle": "Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)",
        "lillyAlias": []
    },
    "NCT01363284": {
        "briefTitle": "Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients",
        "officialTitle": "Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients Based on Assessment of Endogenous Analgesia Capabilities",
        "lillyAlias": []
    },
    "NCT05051579": {
        "briefTitle": "A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities",
        "officialTitle": "A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities",
        "lillyAlias": [
            "J2A-MC-GZGI",
            "2021-002805-88"
        ]
    },
    "NCT01512979": {
        "briefTitle": "Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes",
        "officialTitle": "A 24-week, Randomized, Double-blind, Active-controlled, Parallel Group Trial to Assess the Superiority of Oral Linagliptin and Metformin Compared to Linagliptin Monotherapy in Newly Diagnosed, Treatment-na\u00efve, Uncontrolled Type 2 Diabetes Mellitus Patients",
        "lillyAlias": [
            "2011-004158-24"
        ]
    },
    "NCT04682184": {
        "briefTitle": "A Study of Continuous Heart Rate Monitoring in Healthy Participants",
        "officialTitle": "A Study to Investigate Continuous Heart Rate Monitoring Using a Chest-worn Biosensor on the Background of Drug-induced Positive and Negative Heart Rate Changes",
        "lillyAlias": [
            "H6O-MC-O016"
        ]
    },
    "NCT01870284": {
        "briefTitle": "Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Patients With Active Ankylosing Spondylitis",
        "lillyAlias": [
            "I1F-MC-RHAO"
        ]
    },
    "NCT06181084": {
        "briefTitle": "A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants",
        "officialTitle": "A Pilot Study Comparing LY3410738 Capsule and Tablet Formulations and Effect of a Low-fat Meal and a Proton Pump Inhibitor on the Single-dose Pharmacokinetics of LY3410738 Tablets in Healthy Adult Subjects",
        "lillyAlias": [
            "I9Y-OX-JDHE"
        ]
    },
    "NCT01481779": {
        "briefTitle": "A Study in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 1 Diabetes Mellitus Treated With Preprandial Insulin Lispro: An Open-Label, Randomized, 78-Week Study - The IMAGINE 1 Study",
        "lillyAlias": [
            "I2R-MC-BIAN",
            "2011-001261-40"
        ]
    },
    "NCT01632579": {
        "briefTitle": "A Single Dose Study of LY3023703 in Healthy Participants",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3023703 in Healthy Subjects",
        "lillyAlias": [
            "I6H-MC-MCBA"
        ]
    },
    "NCT00838084": {
        "briefTitle": "A Safety Study of LY2811376 Single Doses in Healthy Subjects",
        "officialTitle": "Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY2811376 in Healthy Subjects",
        "lillyAlias": [
            "I3J-MC-LACE"
        ]
    },
    "NCT02192190": {
        "briefTitle": "A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of LY2951742 in Patients With Mild to Moderate Osteoarthritis Pain of the Knee",
        "lillyAlias": [
            "I5Q-MC-CGAF"
        ]
    },
    "NCT01122264": {
        "briefTitle": "A Study in Patients With Erectile Dysfunction",
        "officialTitle": "Impact of Tadalafil (LY450190) Once a Day or Tadalafil on Demand Compared to Sildenafil Citrate on Demand on Treatment Discontinuation in Patients With Erectile Dysfunction Who Are na\u00efve to PDE5 Inhibitors",
        "lillyAlias": [
            "H6D-EW-LVIJ"
        ]
    },
    "NCT03259490": {
        "briefTitle": "This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin/Metformin Extended Release Compared to the Free Combination of Empagliflozin, Linagliptin, and Metformin Extended Release Tablets Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Study)",
        "lillyAlias": [
            "2017-000425-12"
        ]
    },
    "NCT00049764": {
        "briefTitle": "Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis",
        "officialTitle": "Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis",
        "lillyAlias": [
            "F1K-MC-EVBP"
        ]
    },
    "NCT02106364": {
        "briefTitle": "A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Na\u00efve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study",
        "lillyAlias": [
            "I2R-MC-BIDB"
        ]
    },
    "NCT03650764": {
        "briefTitle": "Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma",
        "officialTitle": "A Prospective Phase I and II Trial of Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma",
        "lillyAlias": []
    },
    "NCT01648764": {
        "briefTitle": "A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread",
        "officialTitle": "Phase 1 Dose Escalation Study of LY2334737 Using 2 Dosing Regimens in Patients With Advanced and/or Metastatic Solid Tumors",
        "lillyAlias": [
            "2008-000807-28",
            "I1C-MC-JLBE"
        ]
    },
    "NCT01015287": {
        "briefTitle": "A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction",
        "officialTitle": "A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pretreatment At the Time of Diagnosis in Patients With Non-ST-Elevation Myocardial Infarction (NSTEMI): The ACCOAST Study",
        "lillyAlias": [
            "H7T-MC-TADF"
        ]
    },
    "NCT04260087": {
        "briefTitle": "New Daily Persistent Headache Biomarkers Study",
        "officialTitle": "Plasma Calcitonin Gene-Related Peptide and Nerve Growth Factor Levels in New Daily Persistent Headache and Chronic Migraine to Identify Potential Biomarkers and Therapeutics Targets",
        "lillyAlias": []
    },
    "NCT01705587": {
        "briefTitle": "Fracture (FX) Improvement With Teriparatide: FiX-IT Study",
        "officialTitle": "Fracture (FX) Improvement With Teriparatide: FiX-IT Study",
        "lillyAlias": []
    },
    "NCT04647487": {
        "briefTitle": "A Study of LY3484356 in Women With Breast Cancer Before Having Surgery",
        "officialTitle": "EMBER-2: A Phase 1, Open-Label, Preoperative Window Study Evaluating the Biological Effects of LY3484356 in Post-menopausal Women With Stage I-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer",
        "lillyAlias": [
            "J2J-MC-JZLB",
            "2020-002810-42"
        ]
    },
    "NCT02846987": {
        "briefTitle": "Study of Abemaciclib in Dedifferentiated Liposarcoma",
        "officialTitle": "Phase 2 Study of Abemaciclib (LY2835219) in Dedifferentiated Liposarcoma",
        "lillyAlias": []
    },
    "NCT03325387": {
        "briefTitle": "A Study of Multiple Doses of LY3305677 in Healthy Participants",
        "officialTitle": "A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677 in Healthy Subjects",
        "lillyAlias": [
            "I8P-MC-OXAB"
        ]
    },
    "NCT02018887": {
        "briefTitle": "A Study of LY2969822 in Healthy Participants",
        "officialTitle": "A Single- and Multiple-Ascending Dose, Safety, Tolerability,Pharmacokinetic and Pharmacodynamic Study of LY2969822 in Healthy Subjects",
        "lillyAlias": [
            "I4W-FW-HMJD"
        ]
    },
    "NCT01468987": {
        "briefTitle": "A Study in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus Advanced to Multiple Injection Bolus Insulin With Insulin Lispro: a Double-Blind, Randomized, 26-week Study - The IMAGINE 4 Study",
        "lillyAlias": [
            "I2R-MC-BIAM",
            "2011-001254-29"
        ]
    },
    "NCT01279187": {
        "briefTitle": "The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone",
        "officialTitle": "The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone",
        "lillyAlias": []
    },
    "NCT03131687": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 2 Study of Once-Weekly LY3298176 Compared With Placebo and Dulaglutide in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-MC-GPGB",
            "2016-004179-33"
        ]
    },
    "NCT03545087": {
        "briefTitle": "A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants",
        "officialTitle": "Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function",
        "lillyAlias": [
            "I8D-MC-AZEN"
        ]
    },
    "NCT01682187": {
        "briefTitle": "A Dose-Escalation Study in Participants With Recurrent Malignant Glioma",
        "officialTitle": "Phase 1 Dose-Escalation Study of LY2157299 Monotherapy and in Combination With Lomustine in Patients With Recurrent Malignant Glioma",
        "lillyAlias": [
            "H9H-MC-JBAH"
        ]
    },
    "NCT01227187": {
        "briefTitle": "Safety and Dose Finding Study of Xigris in Hemodialysis Patients",
        "officialTitle": "Safety and Dose Finding Study of Xigris (Drotrecogin Alfa Activated) as an Anti-coagulant in End Stage Renal Disease (ESRD) Patients Treated With Hemodialysis (HD)",
        "lillyAlias": []
    },
    "NCT03099109": {
        "briefTitle": "A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of LY3321367, an Anti-TIM-3 Antibody, Administered Alone or in Combination With LY3300054, an Anti-PD-L1 Antibody, in Advanced Relapsed/Refractory Solid Tumors",
        "lillyAlias": [
            "I9A-MC-JLDA",
            "2016-003195-42"
        ]
    },
    "NCT01683409": {
        "briefTitle": "A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2 Study to Evaluate the Safety and Renal Efficacy of Baricitinib in Patients With Diabetic Kidney Disease",
        "lillyAlias": [
            "I4V-MC-JAGQ"
        ]
    },
    "NCT02121509": {
        "briefTitle": "Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release (2.5 mg/750 mg) Compared With the Free Combination of Linagliptin and Metformin Extended Release Tablets in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Trial)",
        "lillyAlias": [
            "2013-005143-85"
        ]
    },
    "NCT04634409": {
        "briefTitle": "A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness",
        "officialTitle": "A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)",
        "lillyAlias": [
            "J2X-MC-PYAH"
        ]
    },
    "NCT04031885": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer",
        "officialTitle": "A Multicenter, Open-Label, Randomized-Controlled Study of Abemaciclib, a CDK4 and 6 Inhibitor, in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer With Visceral Metastases",
        "lillyAlias": [
            "I3Y-MC-JPCU"
        ]
    },
    "NCT02623478": {
        "briefTitle": "A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel Insulin Lispro Formulation in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy",
        "lillyAlias": [
            "F3Z-FW-ITCD",
            "2015-003353-18"
        ]
    },
    "NCT00440778": {
        "briefTitle": "A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI",
        "officialTitle": "A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute Myocardial Infarction: The EASY-MI Pilot Study.",
        "lillyAlias": []
    },
    "NCT00220571": {
        "briefTitle": "CARESS in Acute Myocardial Infarction",
        "officialTitle": "Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction",
        "lillyAlias": [
            "2003OE001B"
        ]
    },
    "NCT00191971": {
        "briefTitle": "2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen",
        "officialTitle": "A Phase II Study of Gemcitabine in Transitional Cell Carcinoma of the Urothelium",
        "lillyAlias": [
            "B9E-JE-BL21"
        ]
    },
    "NCT02696785": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis",
        "lillyAlias": [
            "I1F-MC-RHBV",
            "2015-003932-11"
        ]
    },
    "NCT01671085": {
        "briefTitle": "A Study of LY3015014 in Healthy Participants With High Cholesterol",
        "officialTitle": "A Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3015014 in Subjects With Elevated LDL-C on a Stable Statin Therapy",
        "lillyAlias": [
            "I5S-EW-EFJD"
        ]
    },
    "NCT03743285": {
        "briefTitle": "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)",
        "officialTitle": "An Early Feasibility Study to Evaluate the Functionality and Safety of an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IOQW"
        ]
    },
    "NCT06607185": {
        "briefTitle": "A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors",
        "lillyAlias": [
            "J5Q-OX-JRDA"
        ]
    },
    "NCT04867785": {
        "briefTitle": "A Study of LY3437943 in Participants With Type 2 Diabetes",
        "officialTitle": "A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes",
        "lillyAlias": [
            "J1I-MC-GZBD"
        ]
    },
    "NCT01372085": {
        "briefTitle": "Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702",
        "officialTitle": "A Single Ascending Dose and Relative Bioavailability Study of LY2584702 in Healthy Subjects",
        "lillyAlias": [
            "I3G-FW-JGCE"
        ]
    },
    "NCT00463515": {
        "briefTitle": "Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC",
        "officialTitle": "A Multicenter Phase II Study of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation in Patients With Non-resectable Stage III Non-Small-Cell-Lung Cancer",
        "lillyAlias": []
    },
    "NCT06561685": {
        "briefTitle": "A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors",
        "officialTitle": "An Open-label, Multicenter Study of LY4050784, a Selective SMARCA2/BRM Inhibitor, in Advanced Solid Tumor Malignancies With SMARCA4/BRG1 Alterations",
        "lillyAlias": [
            "J5M-OX-JOXA"
        ]
    },
    "NCT02365571": {
        "briefTitle": "A Study of LY3154207 in Healthy Participants",
        "officialTitle": "Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Cytochrome P450 Interaction Study of LY3154207 in Healthy Subjects",
        "lillyAlias": [
            "I7S-EW-HBEA"
        ]
    },
    "NCT00481871": {
        "briefTitle": "Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies",
        "officialTitle": "A Phase 1/2a Open-label Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid Supplementation in Patients With Relapsed or Refractory Lymphoproliferative Malignancies",
        "lillyAlias": []
    },
    "NCT00536471": {
        "briefTitle": "A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients",
        "officialTitle": "Duloxetine Versus Placebo in Patients With Major Depressive Disorder (MDD): Assessment of Energy and Vitality in MDD",
        "lillyAlias": [
            "F1J-US-HMFS"
        ]
    },
    "NCT01621178": {
        "briefTitle": "A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)",
        "officialTitle": "A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease",
        "lillyAlias": [
            "H9X-MC-GBDX",
            "2012-000829-44"
        ]
    },
    "NCT02688088": {
        "briefTitle": "A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body",
        "officialTitle": "Effects of Multiple Doses of Abemaciclib on the Pharmacokinetics of Cytochrome P450 (CYP) 1A2, CYP2C9, CYP2D6, and CYP3A Substrates (Caffeine, Warfarin, Dextromethorphan, and Midazolam) in Cancer Patients",
        "lillyAlias": [
            "I3Y-MC-JPCB"
        ]
    },
    "NCT00384332": {
        "briefTitle": "Medication, Weight Gain and GI Hormones",
        "officialTitle": "Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones",
        "lillyAlias": []
    },
    "NCT01746732": {
        "briefTitle": "A Study of Evacetrapib in Healthy Female Participants",
        "officialTitle": "Effects of Evacetrapib (LY2484595) on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Subjects",
        "lillyAlias": [
            "I1V-MC-EIAP"
        ]
    },
    "NCT02758171": {
        "briefTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects",
        "officialTitle": "Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Crossover Study)",
        "lillyAlias": [
            "2015-004234-98"
        ]
    },
    "NCT01215071": {
        "briefTitle": "Eingeschr\u00e4nkte vs Ausgedehnte Lymphadenektomie LEA",
        "officialTitle": "Prospektiv Randomisierte Studie Zum Vergleich Einer Ausgedehnten Mit Einer eingeschr\u00e4nkten Pelvinen Lymphadenektomie Bei Der Operativen Therapie Des Harnblasenkarzinoms",
        "lillyAlias": []
    },
    "NCT00822471": {
        "briefTitle": "Feasibility and Impact of \"ABCs of Diabetes\" Self-Management Education Program at an Urban Public Library",
        "officialTitle": "Feasibility and Impact of of \"ABC's of Diabetes\" Self Management Education (DSME) Program for African Americans at an Urban Public Library on A1C, Lipid Lowering Agent Prescriptions and Emergency Department Visits",
        "lillyAlias": []
    },
    "NCT01400971": {
        "briefTitle": "An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes",
        "officialTitle": "A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study",
        "lillyAlias": [
            "F3Z-MC-B010"
        ]
    },
    "NCT01440478": {
        "briefTitle": "The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects",
        "officialTitle": "Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects",
        "lillyAlias": [
            "H8Y-EW-HBBX",
            "2011-003215-36"
        ]
    },
    "NCT00444678": {
        "briefTitle": "Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer",
        "officialTitle": "A Phase II Study of Cetuximab Plus Biweekly Capecitabine and Oxaliplatin (C-CO2) in the Treatment of Patients With KRAS Wild Type Metastatic Colorectal Cancer",
        "lillyAlias": [
            "CA225056"
        ]
    },
    "NCT01983878": {
        "briefTitle": "A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer",
        "officialTitle": "A Phase 2 Study of Ramucirumab in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First Line Platinum- or Fluoropyrimidine-Containing Combination Therapy in Japanese Patients",
        "lillyAlias": [
            "I4T-JE-JVCL"
        ]
    },
    "NCT06603571": {
        "briefTitle": "A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes",
        "officialTitle": "A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management With LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes",
        "lillyAlias": [
            "W8M-MC-LAA2",
            "W8M-MC-CWMM Master Protocol"
        ]
    },
    "NCT04392271": {
        "briefTitle": "A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants",
        "officialTitle": "Assessment of Brain O-GlcNAcase (OGA) Enzyme Occupancy After Multiple Oral Doses of LY3372689 as Measured by Positron Emission Tomography (PET) With the Radioligand [18F]LY3316612 in Healthy Subjects",
        "lillyAlias": [
            "I9X-MC-MTAD"
        ]
    },
    "NCT01937871": {
        "briefTitle": "A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once-Daily Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia and Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVJE"
        ]
    },
    "NCT01285037": {
        "briefTitle": "A Study of LY2801653 in Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2801653 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I3O-MC-JSBA"
        ]
    },
    "NCT01524237": {
        "briefTitle": "A Study of LY2979165 and LY2140023 in Healthy Volunteers",
        "officialTitle": "Biomarker Study: Impact of Single Doses of LY2979165 and LY2140023 on the Ketamine-Challenge Pharmacological MRI Assay in Healthy Male Subjects",
        "lillyAlias": [
            "I4S-EW-HHCC"
        ]
    },
    "NCT04211337": {
        "briefTitle": "A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer",
        "officialTitle": "A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Na\u00efve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)",
        "lillyAlias": [
            "J2G-MC-JZJB",
            "2019-001978-28"
        ]
    },
    "NCT04148937": {
        "briefTitle": "A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Multicenter Global First in Human Study of the CD73 Inhibitor LY3475070 as Monotherapy or in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies",
        "lillyAlias": [
            "J2I-MC-JZMA",
            "2019-003270-64",
            "Keynote A57"
        ]
    },
    "NCT02132637": {
        "briefTitle": "A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes",
        "officialTitle": "A Comparison of Pharmacodynamics When Receiving a Double Dose of Insulin Peglispro or Insulin Glargine in Patients With Type 2 Diabetes Mellitus: A Double-Blind, Crossover Design Study",
        "lillyAlias": [
            "I2R-MC-BIDD",
            "2012-005174-56"
        ]
    },
    "NCT01237587": {
        "briefTitle": "A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome",
        "officialTitle": "Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome",
        "lillyAlias": [
            "F1J-MC-HMGW",
            "CTRI/2011/07/001866"
        ]
    },
    "NCT02752087": {
        "briefTitle": "A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants",
        "officialTitle": "A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY900014 Test Versus Reference Formulations in Healthy Subjects",
        "lillyAlias": [
            "I8B-MC-ITRP"
        ]
    },
    "NCT03275311": {
        "briefTitle": "Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008",
        "officialTitle": "Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008",
        "lillyAlias": []
    },
    "NCT00762411": {
        "briefTitle": "Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo",
        "officialTitle": "Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo",
        "lillyAlias": [
            "H6L-MC-LFBC"
        ]
    },
    "NCT04541628": {
        "briefTitle": "Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A",
        "officialTitle": "A Phase 1/2 Open-Label, Dose-Escalation, Safety, Tolerability, and Efficacy Study of SIG-001 in Adult Patients With Severe or Moderately-Severe Haemophilia A Without Inhibitors (SIG-001-121)",
        "lillyAlias": []
    },
    "NCT00191711": {
        "briefTitle": "Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.",
        "officialTitle": "Phase II Study of 6 Weeks Intravesical Gemcitabine Instillation Followed By Transurethral Resection in Patients Affected By Superficial Bladder Cancer at Low Risk",
        "lillyAlias": [
            "B9E-MC-S346"
        ]
    },
    "NCT00490711": {
        "briefTitle": "Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer",
        "officialTitle": "Phase II Study of Sequential Therapy With Paclitaxel Plus Carboplatin Followed by Gemzar Plus Carboplatin in the Treatment of Patients With Epithelial Ovarian Cancer FIGO Stages III-IV",
        "lillyAlias": [
            "B9E-MC-S205"
        ]
    },
    "NCT00326911": {
        "briefTitle": "Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer",
        "officialTitle": "A Phase II, Randomized, Open-Label Study of Cetuximab and Bevacizumab Alone or in Combination With Fixed-Dose Rate Gemcitabine as First-Line Therapy of Patients With Metastatic Adenocarcinoma of the Pancreas",
        "lillyAlias": []
    },
    "NCT00546728": {
        "briefTitle": "The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes",
        "officialTitle": "The Chronic and Acute Postprandial Vascular Effects of Exenatide vs. Metformin in Abdominally Obese Patients With Impaired Glucose Tolerance",
        "lillyAlias": []
    },
    "NCT02663128": {
        "briefTitle": "A Study of Lanabecestat (LY3314814) in Healthy Participants",
        "officialTitle": "A Bioequivalence and Food Effect Study in Healthy Subjects Administered 2 Different Tablet Formulations of LY3314814",
        "lillyAlias": [
            "I8D-MC-AZEH"
        ]
    },
    "NCT03157128": {
        "briefTitle": "A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)",
        "officialTitle": "A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)",
        "lillyAlias": [
            "J2G-OX-JZJA",
            "LOXO-RET-17001",
            "2017-000800-59"
        ]
    },
    "NCT06643728": {
        "briefTitle": "A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight",
        "officialTitle": "A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of Bimagrumab and Tirzepatide, Alone or in Combination, to Investigate the Efficacy and Safety in Adult Participants With Obesity or Overweight Without Type 2 Diabetes",
        "lillyAlias": [
            "J4Z-MC-GIDF"
        ]
    },
    "NCT00551356": {
        "briefTitle": "Lispro Mix 25 vs. Glargine in Type 2 Diabetics",
        "officialTitle": "Comparison of the Insulin Therapies: Insulin Lispro Low Mix (25%) and Insulin Glargine in Patients With Diabetes Mellitus Type 2",
        "lillyAlias": [
            "F3Z-ME-IOOL"
        ]
    },
    "NCT01226485": {
        "briefTitle": "A Study in Advanced Cancer",
        "officialTitle": "A Phase 1 Dose-Escalation Study of LY2940680 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I4J-MC-HHBB"
        ]
    },
    "NCT01247285": {
        "briefTitle": "90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions",
        "officialTitle": "A Relative Bioavailability Study of 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions",
        "lillyAlias": []
    },
    "NCT00050609": {
        "briefTitle": "Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of IC351 (LY450190) in Patients With Diabetic Gastroparesis",
        "lillyAlias": [
            "H6D-MC-LVDC"
        ]
    },
    "NCT06557356": {
        "briefTitle": "A Study of LY3532226 in Participants With Obesity",
        "officialTitle": "A Dose-Escalation Phase 1, Investigator- and Participant-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of LY3532226 in Participants With Obesity",
        "lillyAlias": [
            "J2V-MC-GZLD"
        ]
    },
    "NCT06390956": {
        "briefTitle": "Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma (R+Pirto in Newly Diagnosed MZL)",
        "officialTitle": "A Phase II Study of Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma: A Risk Adapted Approach",
        "lillyAlias": []
    },
    "NCT01929109": {
        "briefTitle": "A Study of LY2409021 in Participants With Different Levels of Kidney Function",
        "officialTitle": "Pharmacokinetics of LY2409021 Following Administration to Subjects With Varying Degrees of Renal Function",
        "lillyAlias": [
            "I1R-MC-GLBT"
        ]
    },
    "NCT00371956": {
        "briefTitle": "Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy",
        "officialTitle": "Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy: a Randomized Double-blind Placebo-controlled Study",
        "lillyAlias": []
    },
    "NCT04088409": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis",
        "officialTitle": "An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis",
        "lillyAlias": [
            "I4V-MC-JAHW",
            "2019-000119-10"
        ]
    },
    "NCT00191178": {
        "briefTitle": "Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes",
        "officialTitle": "Pilot Study Investigating the Effects of Insulin Lispro Low Mixture Therapy Compared With Insulin Glargine on Perceived Mood Symptoms in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IOOC"
        ]
    },
    "NCT06644378": {
        "briefTitle": "A Study of [14C]-LY3866288 in Healthy Participants",
        "officialTitle": "A Phase 1, Open-label, 2-part Study of the Absorption, Metabolism, and Excretion, and Absolute Bioavailability of [14C]-LY3866288 in Healthy Participants",
        "lillyAlias": [
            "J4G-OX-JZVB"
        ]
    },
    "NCT00438971": {
        "briefTitle": "The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder",
        "officialTitle": "The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder",
        "lillyAlias": []
    },
    "NCT00035971": {
        "briefTitle": "EVA: Evista Alendronate Comparison",
        "officialTitle": null,
        "lillyAlias": [
            "H3S-US-GGKO"
        ]
    },
    "NCT04285671": {
        "briefTitle": "Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer",
        "officialTitle": "UCLA L-08: A Phase Ib/II Study of Combined HER Inhibition Adding Necitumumab and Trastuzumab to Osimertinib in Patients With Refractory EGFR-Mutated Lung Cancer",
        "lillyAlias": [
            "NCI-2020-00677"
        ]
    },
    "NCT01885078": {
        "briefTitle": "An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis",
        "officialTitle": "A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis",
        "lillyAlias": [
            "I4V-MC-JADY",
            "2012-003686-17"
        ]
    },
    "NCT02624778": {
        "briefTitle": "A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD",
        "officialTitle": "A Single- and Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous Doses of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACD"
        ]
    },
    "NCT00451178": {
        "briefTitle": "A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only",
        "officialTitle": "An Open-label, Randomized, Phase 2 Study of R-CHOP Plus Enzastaurin Versus R-CHOP in the First-Line Treatment of Patients With Intermediate and High-Risk Diffuse Large B-Cell Lymphoma",
        "lillyAlias": [
            "H6Q-MC-S028"
        ]
    },
    "NCT00190671": {
        "briefTitle": "A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients",
        "officialTitle": "A Phase 1/2 Dose-Escalating Study of ALIMTA and Cyclophosphamide Administered Every 21 Days in Patients With Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "H3E-MC-JMDV"
        ]
    },
    "NCT01257178": {
        "briefTitle": "A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment",
        "officialTitle": "A Single Dose Pharmacokinetics Study of LY2624803 in Subjects With Hepatic Impairment",
        "lillyAlias": [
            "I2K-MC-ZZBL"
        ]
    },
    "NCT02197078": {
        "briefTitle": "Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin",
        "officialTitle": "Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin",
        "lillyAlias": []
    },
    "NCT01687478": {
        "briefTitle": "A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression",
        "officialTitle": "A Study to Assess the Short-Term Efficacy and Safety of Olanzapine and Fluoxetine Compared to Placebo and Fluoxetine for Nonpsychotic Treatment-Resistant Depression",
        "lillyAlias": [
            "F1D-CR-HGNB"
        ]
    },
    "NCT06588478": {
        "briefTitle": "A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "officialTitle": "A Phase 2, Open-Label, Randomized Study Evaluating the Efficacy and Safety of 3 Doses of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who Previously Received Treatment With a Covalent Bruton Tyrosine Kinase Inhibitor",
        "lillyAlias": [
            "J2N-MC-JZNX",
            "2024-515689-15-00"
        ]
    },
    "NCT00385671": {
        "briefTitle": "An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain",
        "officialTitle": "An Open-Label, Randomized Comparison of Duloxetine, Pregabalin, and the Combination of Duloxetine and Gabapentin Among Patients With Inadequate Response to Gabapentin for the Management of Diabetic Peripheral Neuropathic Pain",
        "lillyAlias": [
            "F1J-US-HMEZ"
        ]
    },
    "NCT03773978": {
        "briefTitle": "A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)",
        "lillyAlias": [
            "I4V-MC-JAHV",
            "2017-004518-24"
        ]
    },
    "NCT01220271": {
        "briefTitle": "A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma",
        "officialTitle": "Phase 1b/2a Study Combining LY2157299 With Standard Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma",
        "lillyAlias": [
            "H9H-MC-JBAI"
        ]
    },
    "NCT01871493": {
        "briefTitle": "A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Pharmacokinetics of LY2605541 Injection and Insulin Lispro Injection Administered as Mixture or as Individual Components in Healthy Subjects",
        "lillyAlias": [
            "I6O-FW-BHBA"
        ]
    },
    "NCT03315793": {
        "briefTitle": "A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder",
        "officialTitle": "A Double-blind, Efficacy and Safety Study of Duloxetine Hydrochloride Versus Placebo in the Treatment of Japanese Children and Adolescents With Depressive Disorder",
        "lillyAlias": [
            "F1J-JE-B058",
            "1701A3631"
        ]
    },
    "NCT00408993": {
        "briefTitle": "Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China",
        "officialTitle": "Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China",
        "lillyAlias": [
            "F1J-MC-HMEQ(a)"
        ]
    },
    "NCT00103571": {
        "briefTitle": "Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia",
        "officialTitle": "Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-US-HGLS"
        ]
    },
    "NCT00645593": {
        "briefTitle": "Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer",
        "officialTitle": "Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma",
        "lillyAlias": []
    },
    "NCT00051493": {
        "briefTitle": "ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.",
        "officialTitle": "ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.",
        "lillyAlias": [
            "H3E-MC-JMEZ"
        ]
    },
    "NCT02652871": {
        "briefTitle": "LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
        "officialTitle": "A Phase 1b, Open-label Study of LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
        "lillyAlias": [
            "NCI-2016-00259"
        ]
    },
    "NCT02188693": {
        "briefTitle": "Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer",
        "officialTitle": "Maintenance Versus Observation With 6 Cycles of Gemcitabine Plus Taxol Sequential Gemcitabine Single Agent in Patients With Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT04127578": {
        "briefTitle": "Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)",
        "officialTitle": "A Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of LY3884961 in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)",
        "lillyAlias": []
    },
    "NCT03465878": {
        "briefTitle": "A Study of LY900014 in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I8B-MC-ITSA",
            "2017-003220-78"
        ]
    },
    "NCT02561078": {
        "briefTitle": "An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "Safety and Efficacy of Human Regular U-500 Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Parallel Clinical Trial",
        "lillyAlias": [
            "B5K-MC-IBHD"
        ]
    },
    "NCT01742078": {
        "briefTitle": "A Study of LY2541546 in Healthy Postmenopausal Women",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2541546 in Healthy Postmenopausal Women",
        "lillyAlias": [
            "I2M-MC-GSDA"
        ]
    },
    "NCT01443078": {
        "briefTitle": "Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",
        "officialTitle": "Phase II Trial of Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",
        "lillyAlias": []
    },
    "NCT00252278": {
        "briefTitle": "Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents",
        "officialTitle": "The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents",
        "lillyAlias": []
    },
    "NCT00485771": {
        "briefTitle": "Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression",
        "officialTitle": "Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression",
        "lillyAlias": [
            "H6P-US-HDAQ"
        ]
    },
    "NCT04501978": {
        "briefTitle": "ACTIV-3: Therapeutics for Inpatients With COVID-19",
        "officialTitle": "A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19",
        "lillyAlias": []
    },
    "NCT02152371": {
        "briefTitle": "A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes",
        "officialTitle": "A Randomized, Double-Blind Trial Comparing the Effect of Dulaglutide 1.5 mg With Placebo on Glycemic Control in Patients With Type 2 Diabetes on Basal Insulin Glargine",
        "lillyAlias": [
            "H9X-MC-GBDI",
            "2012-004229-25"
        ]
    },
    "NCT01996488": {
        "briefTitle": "Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition",
        "officialTitle": "An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Olanzapine Orally Disintegrating 5mg Tablets (Test Formulation; Torrent Pharmaceuticals Ltd., India) Versus Zyprexa\u00ae Zydis\u00ae 5 mg Tablets (Reference Formulation; Eli Lilly and Company, USA) in Healthy Human Volunteers Under Fasting Condition.",
        "lillyAlias": []
    },
    "NCT01408888": {
        "briefTitle": "A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes",
        "officialTitle": "Study to Evaluate the Effect of LY2189265 on Sitagliptin Pharmacokinetics in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-MC-GBDW"
        ]
    },
    "NCT00380588": {
        "briefTitle": "Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer",
        "officialTitle": "A Randomized Study of Gemcitabine/Cisplatin Versus Single-Agent Gemcitabine in Patients With Biliary Tract Cancer",
        "lillyAlias": [
            "B9E-JE-BT22"
        ]
    },
    "NCT01593293": {
        "briefTitle": "Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer",
        "officialTitle": "A Randomized, Open-label, Phase III Study Comparing Pemetrexed With and Without Carboplatin in Elderly Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "AMC 2011-0857"
        ]
    },
    "NCT02416271": {
        "briefTitle": "The Forteo Alendronate Comparator Trial",
        "officialTitle": "Teriparatide Compared With Alendronate on Spine Bone Mineral Density in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-MC-GHBM"
        ]
    },
    "NCT00836693": {
        "briefTitle": "Effect of Tadalafil Once a Day in Men With Erectile Dysfunction",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy and Safety of Tadalafil (LY450190) Once a Day in Subjects With Erectile Dysfunction Who Are Na\u00efve to PDE5 Inhibitors",
        "lillyAlias": [
            "H6D-MC-LVHX"
        ]
    },
    "NCT03675893": {
        "briefTitle": "RESOLVE: Abemaciclib + Letrozole +/- Metformin or Zotatifin in Endometrial or Low-Grade Serous Ovarian Cancer",
        "officialTitle": "RESOLVE: LetRozole AbEmaciclib CombinationS in EndOmetriaL and OVarian CancEr: a Multi-Cohort Phase 2 Study of Letrozole/Abemaciclib Alone and in Combination with Metformin and Zotatifin",
        "lillyAlias": []
    },
    "NCT04965493": {
        "briefTitle": "A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)",
        "officialTitle": "A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)",
        "lillyAlias": [
            "J2N-OX-JZNO"
        ]
    },
    "NCT00849693": {
        "briefTitle": "A Study in the Treatment of Children and Adolescents With Major Depressive Disorder",
        "officialTitle": "A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMCL"
        ]
    },
    "NCT00696293": {
        "briefTitle": "Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults",
        "officialTitle": "Optimizing Outcomes in Older Adults With Low Back Pain and Depression",
        "lillyAlias": []
    },
    "NCT01328093": {
        "briefTitle": "A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients",
        "officialTitle": "A Phase 3, Multicenter, Double-Blind Comparison of LY2140023 and Aripiprazole in Patients With DSM-IV-TR Schizophrenia Followed by Open-Label Treatment With LY2140023",
        "lillyAlias": [
            "H8Y-MC-HBDE"
        ]
    },
    "NCT00174993": {
        "briefTitle": "Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes",
        "officialTitle": "PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy",
        "lillyAlias": [
            "U1111-1114-2854"
        ]
    },
    "NCT06109311": {
        "briefTitle": "A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor",
        "officialTitle": "A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once Daily Oral Orforglipron Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor",
        "lillyAlias": [
            "J2A-MC-GZGW",
            "U1111-1294-2797",
            "2023-507280-18-00"
        ]
    },
    "NCT01754493": {
        "briefTitle": "Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression",
        "officialTitle": "Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression",
        "lillyAlias": [
            "F1J-US-X037"
        ]
    },
    "NCT00568893": {
        "briefTitle": "An Open Label Study of Severe Sepsis in Adults",
        "officialTitle": "An Open Label Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis and Multiple Organ Dysfunctions A Phase IV Protocol",
        "lillyAlias": [
            "F1K-BX-S001"
        ]
    },
    "NCT00191893": {
        "briefTitle": "Bone Effects of Teriparatide Following Alendronate",
        "officialTitle": "Bone Effects of Subcutaneous Teriparatide Following Discontinuation of Alendronate Treatment in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-VI-GHCK"
        ]
    },
    "NCT05901311": {
        "briefTitle": "A Study of [14C]-LY3537982 in Healthy Participants",
        "officialTitle": "A Phase I, Open-label, Two-part Study of the Absorption, Metabolism, Excretion, and the Absolute Bioavailability of [14C]-LY3537982 in Healthy Adult Subjects",
        "lillyAlias": [
            "J3M-OX-JZQE"
        ]
    },
    "NCT00982111": {
        "briefTitle": "First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin",
        "officialTitle": "A Randomized, Multicenter, Open-Label Phase 3 Study of Pemetrexed-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Pemetrexed-Cisplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "2009-012574-12",
            "CP11-0805",
            "I4X-IE-JFCB"
        ]
    },
    "NCT02609828": {
        "briefTitle": "Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy",
        "officialTitle": "A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB (PF-04383119) IN SUBJECTS WITH CANCER PAIN PREDOMINANTLY DUE TO BONE METASTASIS RECEIVING BACKGROUND OPIOID THERAPY",
        "lillyAlias": [
            "2013-002223-42",
            "CANCER PAIN PH 3 SC STUDY"
        ]
    },
    "NCT00485628": {
        "briefTitle": "Safety Study in Outpatient Japanese Children With ADHD",
        "officialTitle": "An Open-Label, Dose Titration Safety Study of Atomoxetine Hydrochloride in Outpatient Japanese Children With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-JE-LYBD"
        ]
    },
    "NCT01910311": {
        "briefTitle": "A Study of Baricitinib and Rifampicin in Healthy Participants",
        "officialTitle": "The Effect of CYP3A Induction by Rifampicin on the Pharmacokinetics of Baricitinib in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGK"
        ]
    },
    "NCT01175811": {
        "briefTitle": "A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Comparison of Premixed and Basal-Bolus Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus With Inadequate Glycaemic Control on Twice-daily Premixed Insulin",
        "lillyAlias": [
            "F3Z-CR-IOQD"
        ]
    },
    "NCT00781911": {
        "briefTitle": "A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer",
        "officialTitle": "A Phase 2, Multicenter, Two Tier Study of IMC-A12 in Combination With Depot Octreotide in Patients With Metastatic, Well or Moderately Differentiated Carcinoid or Islet Cell Carcinoma",
        "lillyAlias": [
            "CP13-0710",
            "I5A-IE-JAEE"
        ]
    },
    "NCT06313528": {
        "briefTitle": "A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943",
        "officialTitle": "A Randomized, Double-Blind, Phase 1 Study to Investigate the Effect of LY3437943 Versus Placebo on Calorie Intake and Energy Expenditure in Participants With Obesity Under Calorie Restriction",
        "lillyAlias": [
            "J1I-MC-GZBW"
        ]
    },
    "NCT00837811": {
        "briefTitle": "An Open Label Extension Study in Participants With Rheumatoid Arthritis",
        "officialTitle": "An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.",
        "lillyAlias": [
            "H9B-MC-BCDI",
            "CTRI/2009/091/000765"
        ]
    },
    "NCT01558271": {
        "briefTitle": "A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 3 Study of LY2189265 Monotherapy Compared to Placebo and Liraglutide in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "H9X-JE-GBDP"
        ]
    },
    "NCT01253278": {
        "briefTitle": "A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Multiple Escalating Oral Doses of LY2393910 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I4B-FW-GPCB"
        ]
    },
    "NCT03988088": {
        "briefTitle": "A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine",
        "officialTitle": "A Phase 1, Open-Label, Single-Dose Pharmacokinetic Study of Lasmiditan in Pediatric Patients With Migraine",
        "lillyAlias": [
            "H8H-MC-LAHX"
        ]
    },
    "NCT00422578": {
        "briefTitle": "Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction",
        "officialTitle": "Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction (ED) Patients Previously Treated With Other Oral ED Therapy",
        "lillyAlias": [
            "H6D-HL-LVGD"
        ]
    },
    "NCT04840888": {
        "briefTitle": "A Study of LY3484356 in Healthy Female Participants",
        "officialTitle": "Evaluation of the Effect of Food, Omeprazole, Itraconazole, and Carbamazepine on the Pharmacokinetics of LY3484356 in Healthy Females of Non-Child-Bearing Potential",
        "lillyAlias": [
            "J2J-MC-JZLD"
        ]
    },
    "NCT00447278": {
        "briefTitle": "A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents",
        "officialTitle": "A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Na\u00efve Children and Adolescents",
        "lillyAlias": [
            "B4Z-EW-LYDY"
        ]
    },
    "NCT00051909": {
        "briefTitle": "Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease",
        "officialTitle": "Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease",
        "lillyAlias": [
            "H6N-MC-LEAM"
        ]
    },
    "NCT00148109": {
        "briefTitle": "Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas",
        "officialTitle": "Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas",
        "lillyAlias": [
            "Legacy IRB #2005-0072"
        ]
    },
    "NCT00529893": {
        "briefTitle": "Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD",
        "officialTitle": "Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD",
        "lillyAlias": []
    },
    "NCT05940493": {
        "briefTitle": "Abemaciclib in Newly Diagnosed Meningioma Patients",
        "officialTitle": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
        "lillyAlias": [
            "23-500-352-34-38"
        ]
    },
    "NCT00034593": {
        "briefTitle": "A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-MC-JMEV"
        ]
    },
    "NCT04293393": {
        "briefTitle": "Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients",
        "officialTitle": "Phase II, Randomized, Open-label, International, Multicenter Study to Compare Efficacy of Standard Chemotherapy vs. Letrozole Plus Abemaciclib as Neoadjuvant Therapy in HR-positive/HER2-negative High/Intermediate Risk Breast Cancer Patients",
        "lillyAlias": [
            "2019-002123-15"
        ]
    },
    "NCT02163993": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache",
        "officialTitle": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine",
        "lillyAlias": [
            "I5Q-MC-CGAB"
        ]
    },
    "NCT01897493": {
        "briefTitle": "A Study of Evacetrapib and Digoxin in Healthy Participants",
        "officialTitle": "Effect of Evacetrapib on the Pharmacokinetics of Digoxin in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAQ"
        ]
    },
    "NCT01263093": {
        "briefTitle": "A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel",
        "officialTitle": "Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of R-130964, the Active Metabolite of Clopidogrel, in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNBY"
        ]
    },
    "NCT00418093": {
        "briefTitle": "Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma",
        "officialTitle": "A Phase II Evaluation of Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma",
        "lillyAlias": []
    },
    "NCT05432193": {
        "briefTitle": "FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)",
        "officialTitle": "FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)",
        "lillyAlias": []
    },
    "NCT00424593": {
        "briefTitle": "Duloxetine Versus Placebo in Chronic Low Back Pain",
        "officialTitle": "Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients With Chronic Low Back Pain",
        "lillyAlias": [
            "F1J-MC-HMEN"
        ]
    },
    "NCT03418493": {
        "briefTitle": "A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis",
        "officialTitle": "A Phase 1 Randomized, Placebo-Controlled Study of LY3316531 in Healthy Subjects and an Open-Label, Single-Dose Study in Patients With Psoriasis",
        "lillyAlias": [
            "I9H-MC-FFAA"
        ]
    },
    "NCT00583193": {
        "briefTitle": "Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder",
        "officialTitle": "A Study of the Effectiveness and Tolerability of Duloxetine (Cymbalta) in the Treatment of PTSD.",
        "lillyAlias": []
    },
    "NCT00190593": {
        "briefTitle": "Raloxifene Use for The Heart",
        "officialTitle": "Raloxifene Hydrochloride or Placebo in Postmenopausal Women at Risk for Major Coronary Events",
        "lillyAlias": [
            "H3S-MC-GGIO"
        ]
    },
    "NCT01511393": {
        "briefTitle": "An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)",
        "officialTitle": "Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry",
        "lillyAlias": [
            "U1111-1125-4362"
        ]
    },
    "NCT04311411": {
        "briefTitle": "A Study of Tirzepatide in Overweight and Very Overweight Participants",
        "officialTitle": "Effect of Tirzepatide on Energy Intake and Appetite-and Reward-Related Brain Areas in Overweight/Obese Subjects: A Placebo-Controlled 6-Week Study With Functional MRI",
        "lillyAlias": [
            "I8F-MC-GPHH"
        ]
    },
    "NCT01226511": {
        "briefTitle": "A Study in Pediatric Participants With Generalized Anxiety Disorder",
        "officialTitle": "A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Generalized Anxiety Disorder",
        "lillyAlias": [
            "F1J-MC-HMGI"
        ]
    },
    "NCT01369511": {
        "briefTitle": "A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement",
        "officialTitle": "A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Undergoing Elective Total Hip Arthroplasty",
        "lillyAlias": [
            "I1Q-MC-JDDE"
        ]
    },
    "NCT05533411": {
        "briefTitle": "A Study of Donanemab (LY3002813) in Healthy Chinese Participants",
        "officialTitle": "A Parallel-group Treatment, Phase 1, Participant- and Investigator-Blind, Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Intravenous Dose of Donanemab Compared With Placebo in Healthy Chinese Participants",
        "lillyAlias": [
            "I5T-MC-AACK"
        ]
    },
    "NCT00259311": {
        "briefTitle": "Efficacy Study of LY2422347 to Treat Insomnia",
        "officialTitle": "A Randomized, Double-Blind Comparison of 5 mg of LY2422347, 15 mg of LY2422347, and Placebo in the Treatment of Patients With Primary Insomnia",
        "lillyAlias": [
            "H9U-MC-MDBD"
        ]
    },
    "NCT02263911": {
        "briefTitle": "A Study of Baricitinib in Healthy Japanese Participants",
        "officialTitle": "Relative Bioavailability of the Baricitinib (LY3009104) Commercial Tablet Compared to the Phase 2 Tablets and the Effect of Food on the Bioavailability of the Commercial Tablet in Healthy Japanese Subjects",
        "lillyAlias": [
            "I4V-MC-JAGO"
        ]
    },
    "NCT01140893": {
        "briefTitle": "Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes",
        "officialTitle": "Effects of EXEnatide on Glycemic Control and Weight Over 26 Weeks in Continuous Subcutaneous Insulin Infusion (CSII) Treated Patients With Type 2 Diabetes : a Phase 2/3 Double Blind randoMized Placebo-controlled Trial.",
        "lillyAlias": []
    },
    "NCT01064687": {
        "briefTitle": "A Study in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized, Placebo-Controlled Comparison of the Effects of Two Doses of LY2189265 or Exenatide on Glycemic Control in Patients With Type 2 Diabetes on Stable Doses of Metformin and Pioglitazone (AWARD-1: Assessment of Weekly Administration of LY2189265 in Diabetes-1)",
        "lillyAlias": [
            "H9X-MC-GBDA"
        ]
    },
    "NCT00331487": {
        "briefTitle": "Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia",
        "officialTitle": "Pioglitazone Versus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia",
        "lillyAlias": [
            "U1111-1115-9039"
        ]
    },
    "NCT02337387": {
        "briefTitle": "A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women",
        "officialTitle": "A Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of 2 Formulations of Blosozumab in Postmenopausal Women",
        "lillyAlias": [
            "I2M-MC-GSDT"
        ]
    },
    "NCT00044187": {
        "briefTitle": "The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder",
        "officialTitle": "The Assessment of a Anti-Obesity Agent for the Treatment of Olanzapine-Associated Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder and Bipolar I Disorder",
        "lillyAlias": [
            "F1D-MC-HGJJ"
        ]
    },
    "NCT01537887": {
        "briefTitle": "A Study of LY2484595 on the Electrical Activity of the Heart",
        "officialTitle": "A Placebo- and Positive-Controlled Study of the Effect of LY2484595 on QT Interval in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAK"
        ]
    },
    "NCT00822354": {
        "briefTitle": "Tadalafil for the Treatment of Raynaud's",
        "officialTitle": "Tadalafil for the Treatment of Secondary Raynaud's Phenomenon",
        "lillyAlias": []
    },
    "NCT01903083": {
        "briefTitle": "Chemoimmunotherapy and Radiation in Pancreatic Cancer",
        "officialTitle": "Phase I Trial of Chemoimmunotherapy and Hypofractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.",
        "lillyAlias": []
    },
    "NCT00320528": {
        "briefTitle": "Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder With or Without Comorbid Conditions",
        "lillyAlias": [
            "B4Z-IT-LYDS"
        ]
    },
    "NCT00826228": {
        "briefTitle": "Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)",
        "officialTitle": "Effect of PTH Combined With Weight-Bearing on Bone Density and Bone Architecture in People With Spinal Cord Injury",
        "lillyAlias": []
    },
    "NCT00434928": {
        "briefTitle": "Dietary Intake and Nutrient Status of Children With ADHD",
        "officialTitle": "Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "lillyAlias": [
            "W05-0185"
        ]
    },
    "NCT05860933": {
        "briefTitle": "A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Evaluate the Effects of Multiple Doses of Itraconazole or Carbamazepine on the Single-Dose Pharmacokinetics of LY3537982 in Healthy Adult Subjects",
        "lillyAlias": [
            "J3M-OX-JZQD"
        ]
    },
    "NCT00065533": {
        "briefTitle": "Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer",
        "officialTitle": "Study of Two Doses of ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer",
        "lillyAlias": [
            "H3E-MC-JMGE"
        ]
    },
    "NCT00191633": {
        "briefTitle": "Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes",
        "officialTitle": "A 3 Month Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder; Symptomatic and Functional Outcomes.",
        "lillyAlias": [
            "B4Z-CA-S012"
        ]
    },
    "NCT05630287": {
        "briefTitle": "A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants",
        "officialTitle": "A Phase 1, Open-label, Two-part Study to Investigate the Absorption, Metabolism, and Excretion, and the Absolute Bioavailability of [14C]-LOXO-292 in Healthy Male Subjects",
        "lillyAlias": [
            "J2G-OX-JZJT",
            "LOXO-RET-18016"
        ]
    },
    "NCT02431754": {
        "briefTitle": "A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).",
        "officialTitle": "A Post-Marketing Clinical Study of LY450190 (Combined With Alpha1 Blocker Treatment)",
        "lillyAlias": [
            "H6D-JE-LVJK"
        ]
    },
    "NCT01427933": {
        "briefTitle": "A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer",
        "officialTitle": "An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy",
        "lillyAlias": [
            "I4T-IE-JVCD",
            "CP12-1134"
        ]
    },
    "NCT04998487": {
        "briefTitle": "A Single-Dose Study of LY3471851 in Healthy Participants",
        "officialTitle": "A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Healthy Participants",
        "lillyAlias": [
            "J1P-MC-KFAL"
        ]
    },
    "NCT00490854": {
        "briefTitle": "A Study for Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Crossover Study to Evaluate the Efficacy and Safety of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Once-Daily NPH in Insulin-Na\u00efve Patients With Type 2 Diabetes Mellitus on Oral Agents",
        "lillyAlias": [
            "H7U-JE-IDBF"
        ]
    },
    "NCT05262387": {
        "briefTitle": "A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes",
        "officialTitle": "Effectiveness of a Basal Rate Reduction With LyumjevTM Versus Humalog\u00ae on the Protection From Exercise-Induced Hypoglycemia in Individuals With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion",
        "lillyAlias": [
            "I8B-MC-ITSU"
        ]
    },
    "NCT04172987": {
        "briefTitle": "A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants",
        "officialTitle": "Effect of Tirzepatide on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects",
        "lillyAlias": [
            "I8F-MC-GPGR"
        ]
    },
    "NCT02572687": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies",
        "officialTitle": "An Open-Label, Multicenter, Phase 1 Study of Ramucirumab Plus MEDI4736 in Patients With Locally Advanced and Unresectable or Metastatic Gastrointestinal or Thoracic Malignancies",
        "lillyAlias": [
            "I4T-MC-JVDJ",
            "2015-003013-14"
        ]
    },
    "NCT00087087": {
        "briefTitle": "Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer",
        "officialTitle": "A Phase II Evaluation Of Pemetrexed (ALIMTA LY231514, IND #40061) In The Treatment Of Recurrent Or Persistent Platinum-Resistant Ovarian Or Primary Peritoneal Carcinoma",
        "lillyAlias": [
            "LILLY-H3E-US-JMGP",
            "CDR0000372919"
        ]
    },
    "NCT00755807": {
        "briefTitle": "Duloxetine for Multiple Sclerosis Pain",
        "officialTitle": "Duloxetine in Patients With Central Neuropathic Pain Due to Multiple Sclerosis.",
        "lillyAlias": [
            "F1J-US-HMFR"
        ]
    },
    "NCT00520507": {
        "briefTitle": "An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients",
        "officialTitle": "An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients",
        "lillyAlias": []
    },
    "NCT01324388": {
        "briefTitle": "A Study of the Effect of LY2189265 on Two Blood Pressure Drugs",
        "officialTitle": "Pharmacokinetic and Pharmacodynamic Effect of LY2189265 on Lisinopril in Subjects With Hypertension and Metoprolol in Healthy Subjects",
        "lillyAlias": [
            "H9X-MC-GBCO"
        ]
    },
    "NCT00036309": {
        "briefTitle": "Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder",
        "officialTitle": "Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder",
        "lillyAlias": [
            "F1J-MC-HMBC"
        ]
    },
    "NCT06124807": {
        "briefTitle": "A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight",
        "officialTitle": "A Phase 2, Parallel-Group, Double-Blind, 4-Arm Study to Investigate Weight Management With LY3305677 Compared With Placebo and in Adult Participants With Obesity or Overweight",
        "lillyAlias": [
            "W8M-MC-OXA1",
            "CWMM Master Protocol",
            "2022-502816-35-00"
        ]
    },
    "NCT00569907": {
        "briefTitle": "Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide",
        "officialTitle": "Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide",
        "lillyAlias": []
    },
    "NCT00689507": {
        "briefTitle": "A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib",
        "officialTitle": "A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma",
        "lillyAlias": []
    },
    "NCT04276207": {
        "briefTitle": "A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps",
        "officialTitle": "Effects of LY900014 on Recovery From Hyperglycemia Compared to Humalog in Subjects With Type 1 Diabetes Mellitus (T1DM) on Continuous Subcutaneous Insulin Infusion",
        "lillyAlias": [
            "I8B-MC-ITST",
            "2019-003493-13"
        ]
    },
    "NCT01613807": {
        "briefTitle": "Humalog\u00ae Mix50/50(tm) as a Treatment for Gestational Diabetes",
        "officialTitle": "Phase 4 Humalog\u00ae Mix50/50(tm) for the Treatment of Insulin Requiring Gestational Diabetes",
        "lillyAlias": [
            "F3Z-US-X031"
        ]
    },
    "NCT01460407": {
        "briefTitle": "A Study to Evaluate the Effect of Clarithromycin on LY2216684",
        "officialTitle": "Effect of Clarithromycin on the Pharmacokinetics of LY2216684 in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNEB"
        ]
    },
    "NCT02759107": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)",
        "officialTitle": "A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-MC-GPGA"
        ]
    },
    "NCT01352507": {
        "briefTitle": "A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China",
        "officialTitle": "An Evaluation of Tadalafil and Sildenafil Treatment in Men With Erectile Dysfunction in China",
        "lillyAlias": [
            "H6D-CR-LVIZ"
        ]
    },
    "NCT01867307": {
        "briefTitle": "Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls",
        "officialTitle": "An Open-label Mechanistic Study to Examine the Effect of Oral Empagliflozin (25 mg q.d.) on Kinetics of Renal Glucose Reabsorption in Patients With Type 2 Diabetes Mellitus and Healthy Controls",
        "lillyAlias": []
    },
    "NCT05237388": {
        "briefTitle": "Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease",
        "officialTitle": "Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease",
        "lillyAlias": [
            "R01MD016401-01"
        ]
    },
    "NCT04450407": {
        "briefTitle": "A Study of LY3209590 in Participants With Type 1 Diabetes",
        "officialTitle": "A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy",
        "lillyAlias": [
            "I8H-MC-BDCP",
            "2019-003589-41"
        ]
    },
    "NCT00885807": {
        "briefTitle": "A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)",
        "officialTitle": "Psychometric Validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record in Patients With Attention-Deficit Hyperactivity Disorder",
        "lillyAlias": []
    },
    "NCT01155661": {
        "briefTitle": "A Safety Study in Participants With Major Depressive Disorder",
        "officialTitle": "Long-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment",
        "lillyAlias": [
            "H9P-MC-LNBO"
        ]
    },
    "NCT00035061": {
        "briefTitle": "A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium",
        "officialTitle": null,
        "lillyAlias": [
            "H3E-MC-JMEU"
        ]
    },
    "NCT02406261": {
        "briefTitle": "A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants",
        "officialTitle": "A Study to Characterize LY3314814 Pharmacokinetics as a Function of Dosing Duration and to Determine the Effect of LY3314814 on the Pharmacokinetics of CYP3A Substrates in Healthy Subjects",
        "lillyAlias": [
            "I8D-MC-AZER"
        ]
    },
    "NCT01281228": {
        "briefTitle": "The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes",
        "officialTitle": "The Effect of GLP-1 Receptor Activation on Central Reward and Satiety Circuits in Response to Food Stimuli in Obesity and Diabetes",
        "lillyAlias": [
            "2010-023635-42"
        ]
    },
    "NCT00960661": {
        "briefTitle": "A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes",
        "officialTitle": "A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea",
        "lillyAlias": []
    },
    "NCT06719128": {
        "briefTitle": "A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants",
        "officialTitle": "An Open-Label, Nonrandomized, Single-Dose, Safety and Pharmacokinetic Study of LY3537982 in Participants With Hepatic Impairment and Healthy Participants",
        "lillyAlias": [
            "J3M-OX-JZQF"
        ]
    },
    "NCT04014361": {
        "briefTitle": "A Study of LY3154885 in Healthy Participants",
        "officialTitle": "Single- and Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3154885 in Healthy Subjects",
        "lillyAlias": [
            "J1Z-MC-HUAA"
        ]
    },
    "NCT00803361": {
        "briefTitle": "Duloxetine for the Treatment of Generalized Anxiety Disorder",
        "officialTitle": "Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China",
        "lillyAlias": [
            "F1J-MC-HMFJ"
        ]
    },
    "NCT03083561": {
        "briefTitle": "A Study of LY3337641 in Japanese and Caucasian Healthy Participants",
        "officialTitle": "A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3337641 in Japanese and Caucasian Healthy Subjects",
        "lillyAlias": [
            "I8K-JE-JPDB"
        ]
    },
    "NCT00689728": {
        "briefTitle": "A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNF\u03b1 Inhibitor Therapy",
        "officialTitle": "A Phase 2 Study of Multiple Intravenous Doses of LY2127399 in Patients With Rheumatoid Arthritis on Concomitant Methotrexate and an Inadequate Response to TNF\u03b1 Inhibitor Therapy",
        "lillyAlias": [
            "H9B-MC-BCDG"
        ]
    },
    "NCT04040361": {
        "briefTitle": "Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)",
        "officialTitle": "Efficacy and Safety of Neoadjuvant Therapy of Pembrolizumab Combined With Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer: An Open-label Single-arm Phase II Study",
        "lillyAlias": []
    },
    "NCT02614261": {
        "briefTitle": "Evaluation of Galcanezumab in the Prevention of Chronic Migraine",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study",
        "lillyAlias": [
            "I5Q-MC-CGAI",
            "2015-001883-21"
        ]
    },
    "NCT05407961": {
        "briefTitle": "A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase 1b, 2-Part, Investigator- and Participant-Blind, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3532226 in Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "2021-003257-31",
            "J2V-MC-GZLB"
        ]
    },
    "NCT00532428": {
        "briefTitle": "Long Term Effects of Raloxifene Treatment on Bone Quality",
        "officialTitle": "Long-Term Effects of Raloxifene Treatment on Bone Quality: A Cross-Sectional Study of Postmenopausal Women With Osteoporosis Previously Enrolled in the Continuing Outcomes Relevant to Evista Study",
        "lillyAlias": [
            "H3S-MC-GGLF"
        ]
    },
    "NCT04183283": {
        "briefTitle": "A Study of LY3526318 in Healthy Women",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Oral Single-Doses of LY3526318 on Cinnamaldehyde-Induced Dermal Blood Flow in Healthy Females",
        "lillyAlias": [
            "J2D-MC-CVAB",
            "2019-003613-34"
        ]
    },
    "NCT00046228": {
        "briefTitle": "A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)",
        "officialTitle": "A Muticenter, Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy and Safety of Reteplease and Abciximab Combination Therapy With Abciximab Alone Administered Early or Just Prior to Primary Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.",
        "lillyAlias": [
            "FINESSE",
            "CR005410"
        ]
    },
    "NCT06370728": {
        "briefTitle": "A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants",
        "officialTitle": "A Drug-Drug Interaction Study to Assess the Effect of Carbamazepine on the Pharmacokinetics of Orforglipron in Healthy Participants",
        "lillyAlias": [
            "J2A-MC-GZPJ"
        ]
    },
    "NCT00402883": {
        "briefTitle": "Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer",
        "officialTitle": "A Phase II Study of Pemetrexed/Carboplatin/Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT00191061": {
        "briefTitle": "A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder",
        "officialTitle": "A Comparison of Duloxetine Dosing Strategies in The Treatment of Patients With Major Depression",
        "lillyAlias": [
            "F1D-US-HMDR"
        ]
    },
    "NCT00510211": {
        "briefTitle": "An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.",
        "officialTitle": "An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.",
        "lillyAlias": [
            "F1D-FR-B035"
        ]
    },
    "NCT02702011": {
        "briefTitle": "Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus",
        "officialTitle": "A Phase II, Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Once Daily, Oral Doses of Empagliflozin as Adjunctive to Insulin Therapy for 28 Days in Japanese Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT00073411": {
        "briefTitle": "Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression",
        "officialTitle": "Duloxetine Versus Escitalopram and Placebo in the Treatment of Patients With Major Depression",
        "lillyAlias": [
            "F1J-US-HMCR"
        ]
    },
    "NCT01896011": {
        "briefTitle": "Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures",
        "officialTitle": "Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures: a Randomized Controlled Trial",
        "lillyAlias": [
            "Control # 164050"
        ]
    },
    "NCT00785928": {
        "briefTitle": "A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy",
        "officialTitle": "Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy",
        "lillyAlias": [
            "H9B-MC-BCDH"
        ]
    },
    "NCT04276428": {
        "briefTitle": "A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Multiple-Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 in Japanese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-JE-BDCK"
        ]
    },
    "NCT05894928": {
        "briefTitle": "A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants",
        "officialTitle": "A Phase 1 Study to Investigate the Effect of Cholestyramine on the Pharmacokinetics of LOXO-783 in Healthy Adults",
        "lillyAlias": [
            "J4C-OX-JZUD"
        ]
    },
    "NCT00191828": {
        "briefTitle": "A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme",
        "officialTitle": "A Prospective/Parallel Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme",
        "lillyAlias": [
            "F1D-IT-HGLE"
        ]
    },
    "NCT04004611": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)",
        "officialTitle": "A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis",
        "lillyAlias": [
            "I6T-MC-AMBU",
            "2019-001298-96"
        ]
    },
    "NCT01784211": {
        "briefTitle": "A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes",
        "officialTitle": "The Pharmacokinetic and Pharmacodynamic Intra-subject Variability of LY2605541 and the Effect of Exercise on LY2605541 Pharmacokinetics in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIAW"
        ]
    },
    "NCT01997411": {
        "briefTitle": "Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes",
        "officialTitle": "Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes",
        "lillyAlias": [
            "I8R-MC-IGBB",
            "INGluc002",
            "AMG103"
        ]
    },
    "NCT04437511": {
        "briefTitle": "A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)",
        "officialTitle": "Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease",
        "lillyAlias": [
            "I5T-MC-AACI",
            "2020-000077-25"
        ]
    },
    "NCT03482011": {
        "briefTitle": "A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1",
        "lillyAlias": [
            "I6T-MC-AMAK",
            "2017-003298-32"
        ]
    },
    "NCT00527111": {
        "briefTitle": "Pre-op Rectal ChemoRad +/- Cetuximab",
        "officialTitle": "A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum",
        "lillyAlias": [
            "CA225269"
        ]
    },
    "NCT01848028": {
        "briefTitle": "PsoBest - the German Psoriasis Registry",
        "officialTitle": "Long-Term Benefits and Safety of Systemic Psoriasis Therapy: German Registry on the Treatment of Psoriasis with Biologics and Systemic Therapeutics",
        "lillyAlias": []
    },
    "NCT00087711": {
        "briefTitle": "A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 3 Trial of ALIMTA and Cisplatin Versus GEMZAR and Cisplatin in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-MC-JMDB"
        ]
    },
    "NCT03310411": {
        "briefTitle": "A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants",
        "officialTitle": "A Randomized, Double-Blind, Four-Period, Crossover Study to Evaluate the Cardiovascular Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Subjects",
        "lillyAlias": [
            "H8H-MC-LAHU"
        ]
    },
    "NCT00570011": {
        "briefTitle": "Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients",
        "officialTitle": "Efficacy of Two Different Dose Regimens of Somatropin in Growth Hormone Deficient Adult Patients",
        "lillyAlias": [
            "B9R-EW-GDED"
        ]
    },
    "NCT02718911": {
        "briefTitle": "A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1a/1b Trial Investigating the CSF-1R Inhibitor LY3022855 in Combination With Durvalumab (MEDI4736) or Tremelimumab in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I5F-MC-JSCC",
            "2016-000427-11"
        ]
    },
    "NCT00063128": {
        "briefTitle": "Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.",
        "officialTitle": "Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "H7U-MC-IDAI"
        ]
    },
    "NCT02628028": {
        "briefTitle": "A Study of LY3337641 in Rheumatoid Arthritis",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study",
        "lillyAlias": [
            "I8K-MC-JPDA",
            "2015-003289-97"
        ]
    },
    "NCT04411628": {
        "briefTitle": "A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19",
        "officialTitle": "A Randomized, Placebo-Controlled, Double-Blind, Sponsor Unblinded, Single Ascending Dose, Phase 1 First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous LY3819253 in Participants Hospitalized for COVID-19",
        "lillyAlias": [
            "J2W-MC-PYAA"
        ]
    },
    "NCT01625988": {
        "briefTitle": "A Study of LY2951742 in Participants With Migraine",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine",
        "lillyAlias": [
            "ART-01"
        ]
    },
    "NCT01663207": {
        "briefTitle": "Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes",
        "officialTitle": "Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes",
        "lillyAlias": []
    },
    "NCT01134107": {
        "briefTitle": "Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use",
        "officialTitle": "A Double-Blind, Randomized, Crossover Trial of CSII Reservoir In-use Comparing Insulin Lispro Formulation to Insulin Aspart in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "F3Z-MC-IOPW"
        ]
    },
    "NCT00532207": {
        "briefTitle": "Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis",
        "officialTitle": "Efficacy and Safety of Teriparatide 20 Micrograms in the Treatment of Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-MW-GHCR"
        ]
    },
    "NCT00291707": {
        "briefTitle": "Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer",
        "officialTitle": "A Phase I Trial of Cetuximab (C225) and Pemetrexed With Concurrent Radiation in Head and Neck Cancer",
        "lillyAlias": []
    },
    "NCT06517888": {
        "briefTitle": "Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma",
        "officialTitle": "A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma",
        "lillyAlias": []
    },
    "NCT05914688": {
        "briefTitle": "A Study to Compare Two Formulations of LY3209590 in Healthy Participants",
        "officialTitle": "A Bioequivalence Study of Subcutaneous Injections of LY3209590 in Two Formulations in Healthy Participants",
        "lillyAlias": [
            "I8H-MC-BDDF"
        ]
    },
    "NCT04495478": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Healthy Participants",
        "officialTitle": "A Single-Dose Study in Healthy Participants to Characterize Ramucirumab Pharmacokinetics and Investigate Injection Site Reactions Following an Intravenous Infusion or Subcutaneous Administration of Ramucirumab",
        "lillyAlias": [
            "I4T-MC-JVDT"
        ]
    },
    "NCT06627088": {
        "briefTitle": "A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participants",
        "officialTitle": "A Phase 1, Open-label, Two-part Study of the Absorption, Metabolism, Excretion, and Bioavailability of LY4100511 (DC-853) Following Administration of [14C]-LY4100511 in Healthy Male Participants",
        "lillyAlias": [
            "J5C-MC-FOAE"
        ]
    },
    "NCT00190788": {
        "briefTitle": "Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion",
        "officialTitle": "A Phase IIIb Study to Determine Efficacy and Safety of Extended Drotrecogin Alfa (Activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96 Hour Infusion With Commercial Drotrecogin Alfa (Activated)",
        "lillyAlias": [
            "F1K-MC-EVBQ"
        ]
    },
    "NCT01374178": {
        "briefTitle": "A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects",
        "officialTitle": "Relative Bioavailability of LY2963016 to LANTUS\u00ae After Single Dose Subcutaneous Administration to Healthy Subjects",
        "lillyAlias": [
            "I4L-MC-ABEI"
        ]
    },
    "NCT01859078": {
        "briefTitle": "A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants",
        "officialTitle": "Effect of Baricitinib on the Pharmacokinetics of Digoxin in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JAGL"
        ]
    },
    "NCT00088478": {
        "briefTitle": "Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia",
        "officialTitle": "A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia",
        "lillyAlias": [
            "F1D-MC-HGJZ"
        ]
    },
    "NCT06031688": {
        "briefTitle": "Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)",
        "officialTitle": "A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)",
        "lillyAlias": [
            "NCI-2023-04727",
            "S1900K",
            "S1900K",
            "U10CA180888"
        ]
    },
    "NCT06365788": {
        "briefTitle": "Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer",
        "officialTitle": "A Multicenter Single Arm Phase II Study with Bicalutamide in Combination with Abemaciclib in 4 Cohorts of Locoregionally Advanced Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer",
        "lillyAlias": [
            "2022-502272-23-00"
        ]
    },
    "NCT01763788": {
        "briefTitle": "A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "An Open-Label, Multicenter, Phase 1b/2 Study to Evaluate Necitumumab in Combination With Gemcitabine and Cisplatin in the First-Line Treatment of Patients With Advanced (Stage IV) Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4X-JE-JFCM"
        ]
    },
    "NCT01769378": {
        "briefTitle": "Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)",
        "officialTitle": "A Randomized, Parallel-Arm, Double-Blinded Study Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Patients With Type 2 Diabetes Mellitus on Sulfonylurea Therapy (AWARD-8: Assessment of Weekly AdministRation of LY2189265 in Diabetes - 8)",
        "lillyAlias": [
            "H9X-MC-GBDG"
        ]
    },
    "NCT06190678": {
        "briefTitle": "Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants",
        "officialTitle": "An Open-label, Nonrandomized, Single-dose, Parallel-group, Safety, Tolerance, and Pharmacokinetic Study of LOXO-305 Administered to Fasted Renally Impaired Male and Female Subjects and Fasted Matched-control Healthy Subjects",
        "lillyAlias": [
            "J2N-OX-JZNG"
        ]
    },
    "NCT02150707": {
        "briefTitle": "The Differential Effects of Diabetes Therapy on Inflammation",
        "officialTitle": "The Differential Effects of Diabetes Therapy on Inflammation",
        "lillyAlias": []
    },
    "NCT01929707": {
        "briefTitle": "A Study of LY3050258 in Healthy Participants",
        "officialTitle": "A Single-Dose, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of LY3050258",
        "lillyAlias": [
            "I6R-MC-DLAA"
        ]
    },
    "NCT00845507": {
        "briefTitle": "Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults",
        "officialTitle": "A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder",
        "lillyAlias": []
    },
    "NCT01097707": {
        "briefTitle": "A Study in Men With Benign Prostatic Hyperplasia",
        "officialTitle": "A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)",
        "lillyAlias": [
            "I1A-MC-BPAE"
        ]
    },
    "NCT03368807": {
        "briefTitle": "Assessment of Mealtime Bolus Insulin Behavior",
        "officialTitle": "An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors",
        "lillyAlias": [
            "F3Z-MC-IOQV"
        ]
    },
    "NCT01187407": {
        "briefTitle": "A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment",
        "officialTitle": "A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 mg to 18 mg Once Daily and LY2216684 Fixed-Dose 6 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment",
        "lillyAlias": [
            "H9P-MC-LNBQ"
        ]
    },
    "NCT01739309": {
        "briefTitle": "Study of LY2835219 for Mantle Cell Lymphoma",
        "officialTitle": "Phase 2 Study of a CDK4/6 Inhibitor for Patients With Relapsed or Refractory Mantle Cell Lymphoma",
        "lillyAlias": [
            "I3Y-MC-JPBB",
            "2012-003614-14"
        ]
    },
    "NCT00356109": {
        "briefTitle": "Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes",
        "officialTitle": "A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "H7U-MC-IDAV"
        ]
    },
    "NCT02584309": {
        "briefTitle": "Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma",
        "officialTitle": "A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma",
        "lillyAlias": []
    },
    "NCT05959109": {
        "briefTitle": "A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants",
        "officialTitle": "A Phase 1, Single-Dose Study to Assess the Relative Bioavailability and Tolerability of Subcutaneous Peresolimab Test Formulations in Healthy Participants",
        "lillyAlias": [
            "J1A-MC-KDAI"
        ]
    },
    "NCT02392507": {
        "briefTitle": "A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC",
        "officialTitle": "A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Nab\u00ae-Paclitaxel (Abraxane\u00ae) and Carboplatin Chemotherapy Plus Necitumumab (LY3012211) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "I4X-MC-JFCP"
        ]
    },
    "NCT00386009": {
        "briefTitle": "Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia",
        "lillyAlias": [
            "H6D-MC-LVHK"
        ]
    },
    "NCT03364309": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBH"
        ]
    },
    "NCT00315861": {
        "briefTitle": "Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies",
        "officialTitle": "A Phase I Study of Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies",
        "lillyAlias": [
            "105114",
            "H3E-US-I013 LILLY"
        ]
    },
    "NCT02636361": {
        "briefTitle": "A Study of Various Formulations of LY900014 in Healthy Participants",
        "officialTitle": "Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Multiple LY900014 Formulations",
        "lillyAlias": [
            "I8B-FW-ITRJ"
        ]
    },
    "NCT01991483": {
        "briefTitle": "A Study of LY2928057 in Hemodialysis Participants",
        "officialTitle": "A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2928057 in Hemodialysis Patients",
        "lillyAlias": [
            "I5M-MC-FABC"
        ]
    },
    "NCT04603183": {
        "briefTitle": "ABemaciclib, ET \u00b1 paclItaxel in aGgressive HR+/HER2- MBC trIaL",
        "officialTitle": "A Randomized, 2-Arm, Open-Label, Ph-II Study of Abemaciclib Combined With ET w/ or w/o CT With Paclitaxel as 1L in Patients With Unresectable Locally Advanced or Metastatic HR(+)/HER2(-) BC With Aggressive Disease Criteria",
        "lillyAlias": [
            "2020-001648-24"
        ]
    },
    "NCT00547183": {
        "briefTitle": "Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection",
        "officialTitle": "A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil (2.5 mg and 5 mg) Administered Once Daily to Men With Diabetes Mellitus and Erectile Dysfunction",
        "lillyAlias": [
            "H6D-MC-LVFZ"
        ]
    },
    "NCT00786383": {
        "briefTitle": "Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy",
        "officialTitle": "Phase 1 Study of Every Other Week Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Monoclonal Antibody IMC-1121B in Patients With Advanced Solid Tumors Who Have Not Responded To Standard Therapy",
        "lillyAlias": [
            "CP12-0402",
            "I4T-IE-JVBN"
        ]
    },
    "NCT02603861": {
        "briefTitle": "A Study of LY3154207 on Sleep in Healthy Male Participants",
        "officialTitle": "An Evaluation of the Impact of Single Doses of LY3154207 on Sleep Latency in Sleep-Deprived Healthy Subjects",
        "lillyAlias": [
            "I7S-EW-HBEB"
        ]
    },
    "NCT00191997": {
        "briefTitle": "Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode",
        "officialTitle": "Optimal Treatment Duration With Olanzapine Following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies.",
        "lillyAlias": [
            "F1D-XM-HGLW"
        ]
    },
    "NCT01904383": {
        "briefTitle": "PMS of Trazenta on the Long-term Use as Add-on Therapy",
        "officialTitle": "Post Marketing Surveillance on Long Term Drug Use of Trazenta\u00ae Tablets as add-on Therapy in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01263197": {
        "briefTitle": "A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol",
        "officialTitle": "Effect of LY2216684 on Heart Rate and Blood Pressure in Healthy Subjects Receiving Oral Doses of Albuterol or Propranolol",
        "lillyAlias": [
            "H9P-EW-LNCI"
        ]
    },
    "NCT00190697": {
        "briefTitle": "A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment",
        "officialTitle": "Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer",
        "lillyAlias": [
            "H4Z-MC-JWXM"
        ]
    },
    "NCT02121483": {
        "briefTitle": "Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus",
        "officialTitle": "An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "2013-002304-14"
        ]
    },
    "NCT00448097": {
        "briefTitle": "Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy",
        "officialTitle": "A Randomized Study of Cetuximab or Cetuximab Plus Docetaxel Followed by Radical Prostatectomy for Patients With Adenocarcinoma of the Prostate",
        "lillyAlias": [
            "E-VS-ET-2006"
        ]
    },
    "NCT05893797": {
        "briefTitle": "A Study of LY8888AX in Participants Using a Connected Insulin Management Platform",
        "officialTitle": "Assessment of Participant Adherence and Glucose Control While Using a Connected Insulin Management Platform",
        "lillyAlias": [
            "F3Z-MC-IORW",
            "2022-A02807-36"
        ]
    },
    "NCT01870297": {
        "briefTitle": "A Study of LY3025876 in Participants With Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of LY3025876 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I6D-MC-SMRB"
        ]
    },
    "NCT02075697": {
        "briefTitle": "Spanish Registry of Systemic Treatments in Psoriasis",
        "officialTitle": "Spanish Registry of Systemic Treatments in Psoriasis",
        "lillyAlias": [
            "Biobadaderm"
        ]
    },
    "NCT04626297": {
        "briefTitle": "A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)",
        "officialTitle": "A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-MC-KGAK",
            "2020-002572-12"
        ]
    },
    "NCT00421083": {
        "briefTitle": "Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess Efficacy and Safety of Tadalafil (LY450190) in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury",
        "lillyAlias": [
            "H6D-MC-LVFY"
        ]
    },
    "NCT01487083": {
        "briefTitle": "A Long-Term Study in Schizophrenia",
        "officialTitle": "Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBBV"
        ]
    },
    "NCT00971997": {
        "briefTitle": "A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients",
        "officialTitle": "The Study of Stepwise Introduction of Insulin Analog Mixture as a Post-marketing Clinical Trial of Lispro Mix 50/50 to Evaluate Efficacy and Safety in Type 2 Diabetic Patients With Inadequate Glycemic Control on Oral Therapy. (SIMPLE Study)",
        "lillyAlias": [
            "F3Z-JE-IOPU"
        ]
    },
    "NCT00486083": {
        "briefTitle": "Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD",
        "officialTitle": "A Randomized, Double-Blind Comparison, Safety and Efficacy Trial of Atomoxetine Hydrochloride and Methylphenidate Hydrochloride in Pediatric Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-MC-LYBR"
        ]
    },
    "NCT04030728": {
        "briefTitle": "Implementing Patients\u00b4 Competence in Oral Breast Cancer Therapy",
        "officialTitle": "A Randomized, Controlled Study of Standardized Patient Coaching Versus Patient Management According to Local Practice for Patients With Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer Treated With Abemaciclib",
        "lillyAlias": []
    },
    "NCT00074828": {
        "briefTitle": "New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery",
        "officialTitle": "A Comparison of the Oral Anticoagulant LY517717 Difumarate to Subcutaneous Enoxaparin for the Prevention of Venous Thromboembolic Events (VTE) Post-Total Hip Replacement (THR) and Post-Total Knee Replacement (TKR) Surgery",
        "lillyAlias": [
            "H8G-MC-EPBB"
        ]
    },
    "NCT00456261": {
        "briefTitle": "First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC",
        "officialTitle": "A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients With Advanced Non-Small Cell Lung Cancer",
        "lillyAlias": []
    },
    "NCT02443883": {
        "briefTitle": "A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer",
        "officialTitle": "Randomized Phase 2 Trial Evaluating Pharmacokinetics and Safety of Four Ramucirumab Dosing Regimens in Second-Line Gastric or Gastroesophageal Junction Adenocarcinoma",
        "lillyAlias": [
            "I4T-MC-JVDB",
            "2014-003791-23"
        ]
    },
    "NCT03232983": {
        "briefTitle": "A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants",
        "officialTitle": "Effect of Injection Site on the Relative and Absolute Bioavailability of Single Dose of LY900014 in Healthy Subjects",
        "lillyAlias": [
            "I8B-MC-ITRT"
        ]
    },
    "NCT00857961": {
        "briefTitle": "A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations",
        "officialTitle": "A Phase II, Randomised, Four-way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered Dose (MD) Lotion\u00ae Formulations and Doses in Hypogonadal Men",
        "lillyAlias": [
            "MTE07",
            "I5E-MC-TSAG"
        ]
    },
    "NCT04417361": {
        "briefTitle": "Galcanezumab for Vestibular Migraine",
        "officialTitle": "A Pilot Trial of Galcanezumab for Vestibular Migraine",
        "lillyAlias": [
            "P0541760"
        ]
    },
    "NCT01241461": {
        "briefTitle": "A Study of LY2584702 in Solid Tumors",
        "officialTitle": "A Phase 1 Study of LY2584702 in Japanese Patients With Solid Tumors",
        "lillyAlias": [
            "I3G-JE-JGCC"
        ]
    },
    "NCT00097383": {
        "briefTitle": "Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer",
        "officialTitle": "A Phase 2 Study of Alimta and Epirubicin Administered Every 21 Days in Patients With Locally Advanced or Metastatic Breast Cancer",
        "lillyAlias": [
            "H3E-MC-JMDU"
        ]
    },
    "NCT01078805": {
        "briefTitle": "Study of FORTEO Use in Subjects in the Community Setting",
        "officialTitle": "Direct Assessment of Non-Vertebral Fractures in Community Experience (DANCE)",
        "lillyAlias": [
            "B3D-US-GHCQ"
        ]
    },
    "NCT01000805": {
        "briefTitle": "A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms",
        "officialTitle": "A Phase 4, 8-Week, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of Duloxetine 60 mg Once Daily in Outpatients With Major Depressive Disorder and Associated Painful Physical Symptoms",
        "lillyAlias": [
            "F1J-US-HMGR"
        ]
    },
    "NCT06662383": {
        "briefTitle": "A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity",
        "officialTitle": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity",
        "lillyAlias": [
            "J1I-MC-GZBP",
            "2024-511450-49-00"
        ]
    },
    "NCT01545583": {
        "briefTitle": "A Study of LY3016859 in Healthy Volunteers",
        "officialTitle": "Study of the Safety, Tolerability and Pharmacokinetics of LY3016859 After Single Intravenous and Subcutaneous Dosing in Healthy Volunteers",
        "lillyAlias": [
            "2011-005596-17",
            "I5V-MC-TGAA"
        ]
    },
    "NCT00485498": {
        "briefTitle": "Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics",
        "officialTitle": "Managing Acute Schizophrenia, a Double Blind Comparison Between Two Atypical Antipsychotics - Olanzapine and Risperidone",
        "lillyAlias": [
            "F1D-GH-S036"
        ]
    },
    "NCT03381547": {
        "briefTitle": "A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)",
        "officialTitle": "An Open Label, Randomized, Single Dose, 3-Way Crossover Study to Evaluate the Pharmacokinetics of Different Dose Levels and Dose Formulations of AM0010 in Healthy Adult Subjects",
        "lillyAlias": [
            "J1L-AM-JZGF",
            "AM0010-802"
        ]
    },
    "NCT04086745": {
        "briefTitle": "A Study of Baricitinib in Participants With Rheumatoid Arthritis",
        "officialTitle": "A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis",
        "lillyAlias": [
            "I4V-MC-JAJD"
        ]
    },
    "NCT00760747": {
        "briefTitle": "Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)",
        "officialTitle": "A Randomized, Controlled, Open-Label Comparison Study of the Efficacy and Safety of Slow Transitioning Compared With Fast Transitioning From a Stimulant Medication to Atomoxetine in Pediatric and Adolescent Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "lillyAlias": [
            "B4Z-EW-LYFJ"
        ]
    },
    "NCT04043845": {
        "briefTitle": "ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies",
        "officialTitle": "A Phase 1 Study Targeting ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies",
        "lillyAlias": []
    },
    "NCT01250145": {
        "briefTitle": "A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women",
        "officialTitle": "A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women",
        "lillyAlias": [
            "I2Y-EW-GHFO"
        ]
    },
    "NCT01503398": {
        "briefTitle": "Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions",
        "officialTitle": "An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Olanzapine Tablets 5 mg With Zyprexa\u00ae Tablets 5 mg in Healthy Subjects Under Fasting Conditions",
        "lillyAlias": []
    },
    "NCT05457998": {
        "briefTitle": "BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers",
        "officialTitle": "BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers",
        "lillyAlias": []
    },
    "NCT03464045": {
        "briefTitle": "Empa PASS on Urinary Tract Malignancies",
        "officialTitle": "Post-authorisation Safety Study to Assess the Risk of Urinary Tract Malignancies in Relation to Empagliflozin Exposure in Patients With Type 2 Diabetes: a Multi-database European Study",
        "lillyAlias": []
    },
    "NCT01476345": {
        "briefTitle": "A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants",
        "officialTitle": "Bioequivalence Study Comparing the Pharmacokinetics and Pharmacodynamics of LY2963016 With Insulin Glargine in Healthy Volunteers",
        "lillyAlias": [
            "I4L-MC-ABEA"
        ]
    },
    "NCT05882045": {
        "briefTitle": "A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease",
        "officialTitle": "A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease",
        "lillyAlias": [
            "J1I-MC-GZBM",
            "2023-503659-88-00"
        ]
    },
    "NCT03695198": {
        "briefTitle": "A Study of LY3361237 in Healthy Participants",
        "officialTitle": "A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3361237 in Healthy Subjects",
        "lillyAlias": [
            "I9S-MC-BTAA"
        ]
    },
    "NCT00945945": {
        "briefTitle": "A Study of Duloxetine in Patients With Osteoarthritis Knee Pain",
        "officialTitle": "A Phase 3b Study to Assess the Efficacy of Duloxetine 60 mg Once Daily Compared With Placebo on the Reduction of Pain Caused by Osteoarthritis of the Knee, in a 13-week, Double-blind, Randomized Study",
        "lillyAlias": [
            "F1J-MC-HMGP"
        ]
    },
    "NCT01746745": {
        "briefTitle": "A Study of LY2940680 in Healthy Participants",
        "officialTitle": "Disposition of [14C]-LY2940680 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I4J-MC-HHBF"
        ]
    },
    "NCT06181045": {
        "briefTitle": "A Study of LY3410738 in Healthy Adult Participants",
        "officialTitle": "A Phase 1, Single-Ascending-Dose, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3410738 in Healthy Adult Subjects",
        "lillyAlias": [
            "I9Y-OX-JDHD"
        ]
    },
    "NCT00191698": {
        "briefTitle": "Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD",
        "officialTitle": "A Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride and Placebo in Child and Adolescent Outpatients With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder",
        "lillyAlias": [
            "B4Z-MC-LYBX"
        ]
    },
    "NCT00159445": {
        "briefTitle": "Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer",
        "officialTitle": "Phase II Study of Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer",
        "lillyAlias": []
    },
    "NCT01597245": {
        "briefTitle": "A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBA"
        ]
    },
    "NCT06366347": {
        "briefTitle": "ALPINE: Maintenance Letrozole/Abemaciclib Vs Pembrolizumab",
        "officialTitle": "Phase 2, Randomized, Trial of Maintenance Letrozole/Abemaciclib Vs Pembrolizumab After Systemic Therapy in Patients with Advanced or Recurrent Estrogen Receptor Positive, Mismatch Repair Proficient, TP53 Wild-type Endometrial Cancer",
        "lillyAlias": []
    },
    "NCT03993847": {
        "briefTitle": "CLassification of Axial SpondyloarthritiS Inception Cohort",
        "officialTitle": "CLassification of Axial SpondyloarthritiS Inception Cohort",
        "lillyAlias": []
    },
    "NCT05596747": {
        "briefTitle": "A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Chinese Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-MC-BDDC"
        ]
    },
    "NCT03057145": {
        "briefTitle": "Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors",
        "officialTitle": "Phase 1 Combination Study of Prexasertib (LY2606368), CHK1 Inhibitor, and Olaparib, PARP Inhibitor, in Patients With Advanced Solid Tumors",
        "lillyAlias": []
    },
    "NCT02789345": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer",
        "officialTitle": "An Open-Label, Multicenter, Phase 1 Study With Expansion Cohorts of Ramucirumab or Necitumumab in Combination With Osimertinib in Patients With Advanced T790M-Positive EGFR-Mutant Non-Small Cell Lung Cancer After Progression on First-Line EGFR TKI Therapy",
        "lillyAlias": [
            "I4T-MC-JVDL",
            "2015-005296-25"
        ]
    },
    "NCT00087698": {
        "briefTitle": "Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma",
        "officialTitle": "A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (Alimta) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma",
        "lillyAlias": [
            "H3E-US-JMGA"
        ]
    },
    "NCT01140347": {
        "briefTitle": "A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib (REACH)",
        "lillyAlias": [
            "CP12-0919",
            "I4T-IE-JVBF",
            "2010-019318-26"
        ]
    },
    "NCT05086445": {
        "briefTitle": "A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J2A-JE-GZGB"
        ]
    },
    "NCT02140645": {
        "briefTitle": "Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy",
        "officialTitle": "Association of Clinical Covariates With Non-insulin Diabetes Medication Initiation Using Electronic Medical Records (EMR)",
        "lillyAlias": []
    },
    "NCT02972645": {
        "briefTitle": "A Study of LY3305677 in Healthy Participants",
        "officialTitle": "A First-in-Human, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677 in Healthy Subjects",
        "lillyAlias": [
            "I8P-MC-OXAA"
        ]
    },
    "NCT01066845": {
        "briefTitle": "Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension",
        "officialTitle": "Safety and Effectiveness of Adcirca (Tadalafil) in Japanese Patients With Pulmonary Arterial Hypertension: Open-label, Non-interventional Observational Study in Japan",
        "lillyAlias": [
            "H6D-JE-TD01"
        ]
    },
    "NCT06649045": {
        "briefTitle": "A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight",
        "officialTitle": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obstructive Sleep Apnea and Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial",
        "lillyAlias": [
            "J5P-MC-GZRA",
            "J5P-MC-GZ01",
            "J5P-MC-GZ02"
        ]
    },
    "NCT06025747": {
        "briefTitle": "Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma",
        "officialTitle": "A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for High-Risk Adipocytic Retroperitoneal Sarcomas",
        "lillyAlias": [
            "NCI-2023-05595",
            "RG1123382"
        ]
    },
    "NCT05205447": {
        "briefTitle": "Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants",
        "officialTitle": "A Phase 1, Two-part, Open-label, Fixed-sequence Study to Evaluate the Effects of Multiple Doses of Itraconazole and Carbamazepine on the Single-dose Pharmacokinetics of LY3410738 in Healthy Adult Subjects",
        "lillyAlias": [
            "I9Y-OX-JDHF"
        ]
    },
    "NCT01159847": {
        "briefTitle": "Protective Effects of Sitagliptin on \u03b2 Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)",
        "officialTitle": "Protective Effects of Sitagliptin on \u03b2 Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)",
        "lillyAlias": []
    },
    "NCT01852383": {
        "briefTitle": "Duloxetine Treatment in Elderly With Dysthymia",
        "officialTitle": "An Open Treatment Trial of Duloxetine in Elderly Patients With Dysthymic Disorder",
        "lillyAlias": []
    },
    "NCT06104683": {
        "briefTitle": "A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis",
        "officialTitle": "A Phase 2, Randomized Study of Pirtobrutinib Versus Placebo in Patients With Relapsing Multiple Sclerosis",
        "lillyAlias": [
            "J2N-MC-KLAA",
            "2022-502376-24-00"
        ]
    },
    "NCT00904683": {
        "briefTitle": "Effect of LY2062430 on the Progression of Alzheimer's Disease",
        "officialTitle": "Effect of Passive Immunization on the Progression of Alzheimer's Disease: LY2062430 Versus Placebo",
        "lillyAlias": [
            "H8A-MC-LZAN"
        ]
    },
    "NCT02614183": {
        "briefTitle": "Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study",
        "lillyAlias": [
            "I5Q-MC-CGAG"
        ]
    },
    "NCT00475397": {
        "briefTitle": "Duloxetine Stress Urinary Incontinence Efficacy and Safety Study",
        "officialTitle": "Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBBU"
        ]
    },
    "NCT03761797": {
        "briefTitle": "A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes",
        "officialTitle": "Post Marketing Surveillance in Japan on Long Term Drug Use of TRADIANCE\u00ae Combination Tablets AP and BP in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT01760005": {
        "briefTitle": "Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001",
        "officialTitle": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
        "lillyAlias": [
            "The Alzheimer's Association",
            "U01AG042791",
            "2013-000307-17",
            "R01AG046179",
            "REec-2014-0817",
            "The Alzheimer's Association",
            "GHR Foundation",
            "Alzheimer's Association",
            "The Alzheimer's Association",
            "R56AG053267",
            "U01AG059798",
            "R01AG053267"
        ]
    },
    "NCT05810597": {
        "briefTitle": "A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices",
        "officialTitle": "A Bioequivalence Study to Compare the Pharmacokinetics of Tirzepatide Administered Subcutaneously by a Test Device (Test Formulation) Versus Reference Device (Reference Formulation) in Healthy Participants",
        "lillyAlias": [
            "I8F-MC-GPIP"
        ]
    },
    "NCT01215097": {
        "briefTitle": "Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy",
        "officialTitle": "A Randomized, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 Over 24 Weeks in T2D Patients With Insufficient Glycaemic Control Despite Metformin Therapy",
        "lillyAlias": []
    },
    "NCT04657783": {
        "briefTitle": "French National Cohort of People With Type 1 Diabetes",
        "officialTitle": "French National Cohort of People With Type 1 Diab\u00e8tes: the SFDT1 Study",
        "lillyAlias": []
    },
    "NCT00208897": {
        "briefTitle": "Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?",
        "officialTitle": "Does Fluoxetine Reverse the Effects of Early Life Stress on the CNS Corticotropin-Releasing Factor System and Improve Psychological and Neuroendocrine Function?: A Therapy Outcome Study in Women With Childhood Abuse Experiences",
        "lillyAlias": [
            "B1Y-MC-X176"
        ]
    },
    "NCT02568397": {
        "briefTitle": "A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants",
        "officialTitle": "Effect of LY3314814 on the Pharmacokinetics of Dabigatran in Healthy Subjects",
        "lillyAlias": [
            "I8D-MC-AZEE"
        ]
    },
    "NCT03155997": {
        "briefTitle": "Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer",
        "officialTitle": "A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPCF",
            "2016-004362-26",
            "NSABP B-58"
        ]
    },
    "NCT00489983": {
        "briefTitle": "Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy",
        "officialTitle": "A Multicenter Phase 2 Randomized Trial of Single-Agent ALIMTA or ALIMTA With Sequentially Administered GEMZAR as First-Line Chemotherapy in Elderly Patients or Patients Who Are Not Eligible for Platinum-Based Chemotherapy With Advanced NSCLC",
        "lillyAlias": [
            "H3E-EW-JMEM"
        ]
    },
    "NCT04534283": {
        "briefTitle": "A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.",
        "officialTitle": "A Phase 2 Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib for Patients Whose Tumors Harbor Pathogenic Alterations in BRAF, RAF1, MEK1/2, ERK1/2, and NF1.",
        "lillyAlias": []
    },
    "NCT05016297": {
        "briefTitle": "Efficacy and Safety of Baricitinib in Sjogren's Syndrome",
        "officialTitle": "A Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients",
        "lillyAlias": []
    },
    "NCT00259298": {
        "briefTitle": "Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis",
        "officialTitle": "The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women With Osteoporosis",
        "lillyAlias": [
            "B3D-US-GHCV"
        ]
    },
    "NCT00464698": {
        "briefTitle": "Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)",
        "officialTitle": "Duloxetine for the Treatment of Obsessive Compulsive Disorder",
        "lillyAlias": [
            "FIJ-MC-1003"
        ]
    },
    "NCT01133405": {
        "briefTitle": "A Safety Study of LY2886721 Single Doses in Healthy Subjects",
        "officialTitle": "Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects",
        "lillyAlias": [
            "I4O-MC-BACA"
        ]
    },
    "NCT05263505": {
        "briefTitle": "Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid",
        "officialTitle": "Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid",
        "lillyAlias": []
    },
    "NCT06647498": {
        "briefTitle": "A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation",
        "officialTitle": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
        "lillyAlias": [
            "5U01AG059798"
        ]
    },
    "NCT01606397": {
        "briefTitle": "A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes",
        "officialTitle": "The Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Multiple Escalating Doses of LY2409021 in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-FW-GLBB"
        ]
    },
    "NCT01370005": {
        "briefTitle": "12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg, 25 mg) Administered Orally, Once Daily Over 12 Weeks in Hypertensive Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "2011-000347-25"
        ]
    },
    "NCT03555305": {
        "briefTitle": "A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants",
        "officialTitle": "Relative Bioavailability of LY2963016 to LANTUS\u00ae After Single-Dose Subcutaneous Administration in Healthy Chinese Subjects",
        "lillyAlias": [
            "I4L-MC-ABEF"
        ]
    },
    "NCT03901105": {
        "briefTitle": "Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease",
        "officialTitle": "Evaluation of the Relationship Between Baseline Flortaucipir PET Signal and Cognitive Change in Subjects With Early Alzheimer's Disease Participating in the I8D-MC-AZES Protocol Addendum D5010C00009 (2.1) (Tau Imaging)",
        "lillyAlias": []
    },
    "NCT00486005": {
        "briefTitle": "Weight Gain Management in Patients With Schizophrenia",
        "officialTitle": "Weight Gain Management in Patients With Schizophrenia During Treatment With Olanzapine in Association With Nizatidine",
        "lillyAlias": [
            "F1D-BL-HGLA"
        ]
    },
    "NCT01450098": {
        "briefTitle": "A Study of LY2484595 in Healthy Subjects",
        "officialTitle": "Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIAJ"
        ]
    },
    "NCT06243198": {
        "briefTitle": "A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants",
        "officialTitle": "A Phase 1, Participant- and Investigator-blinded, Randomized, Single-dose Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants",
        "lillyAlias": [
            "J2T-MC-KGBV"
        ]
    },
    "NCT00140998": {
        "briefTitle": "Estrogen Treatment (Oral vs. Patches) in Turner Syndrome",
        "officialTitle": "Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery",
        "lillyAlias": []
    },
    "NCT02265705": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy",
        "lillyAlias": [
            "I4V-CR-JAGS"
        ]
    },
    "NCT05723198": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata",
        "officialTitle": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata",
        "lillyAlias": [
            "I4V-MC-JAIO",
            "2022-502700-78-00"
        ]
    },
    "NCT01237405": {
        "briefTitle": "A Study of FolateScan in Patients With Knee Osteoarthritis",
        "officialTitle": "Study of 99mTc-EC20 Imaging (FolateScan) in Participants With Knee Osteoarthritis",
        "lillyAlias": [
            "Protocol H7L-MC-MDAB(b)"
        ]
    },
    "NCT00389805": {
        "briefTitle": "Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors",
        "officialTitle": "Phase I/II Study of Two Different Schedules of Bortezomib (VELCADE, PS-341) and Pemetrexed (ALIMTA) in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": [
            "200412739",
            "H3E-US-X038"
        ]
    },
    "NCT02951598": {
        "briefTitle": "A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)",
        "officialTitle": "Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)",
        "lillyAlias": [
            "H8A-US-B004"
        ]
    },
    "NCT01919398": {
        "briefTitle": "A Study of LY2940680 in Japanese Participants With Advanced Cancers",
        "officialTitle": "A Phase 1 Study of LY2940680 in Japanese Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "I4J-MC-HHBH"
        ]
    },
    "NCT01836198": {
        "briefTitle": "The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream",
        "officialTitle": "Effects of Potent Inhibition of CYP2C8, CYP2J2, and CYP3A4, Using Gemfibrozil, Ketoconazole, and Clarithromycin as Probes, on the Pharmacokinetics of LY2409021 in Healthy Subjects",
        "lillyAlias": [
            "I1R-MC-GLBZ"
        ]
    },
    "NCT01818245": {
        "briefTitle": "A Study of LY2605541 in Healthy Participants and in the Elderly",
        "officialTitle": "Effect of Injection Site on the Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Doses of LY2605541 in Healthy Subjects, and Impact of Body Mass Index and Age on the Pharmacokinetics of LY2605541",
        "lillyAlias": [
            "I2R-MC-BIDF"
        ]
    },
    "NCT00515697": {
        "briefTitle": "A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma",
        "officialTitle": "Phase II Single Arm Study of IMC-1121B in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy",
        "lillyAlias": [
            "I4T-IE-JVBP",
            "CP12-0605"
        ]
    },
    "NCT05307705": {
        "briefTitle": "A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors",
        "officialTitle": "A Study of LOXO-783 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With Advanced Breast Cancer and Other Solid Tumors With a PIK3CA H1047R Mutation",
        "lillyAlias": [
            "J4C-OX-JZUA",
            "2022-000175-40"
        ]
    },
    "NCT00088205": {
        "briefTitle": "Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma",
        "officialTitle": "A Phase 2 Study of Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma",
        "lillyAlias": [
            "H6Q-MC-JCAO"
        ]
    },
    "NCT00191945": {
        "briefTitle": "Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)",
        "officialTitle": "A Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 Weeks in Newly Diagnosed Children and Adolescents Outpatients With Attention-Deficit/Hyperactivity Disorder",
        "lillyAlias": [
            "B4Z-XM-LYDM"
        ]
    },
    "NCT01084005": {
        "briefTitle": "Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Linagliptin (5 mg) Administered Orally Once Daily Over 24 Weeks in Type 2 Diabetic Patients (Age >= 70 Years) With Insufficient Glycaemic Control( HbA1c >= 7.0) Despite Metformin and/or Sulphonylurea and/or Insulin Therapy",
        "lillyAlias": [
            "2009-015255-25"
        ]
    },
    "NCT02138097": {
        "briefTitle": "Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns",
        "officialTitle": "A Description of Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns Including Initiation, Switching, and Discontinuation",
        "lillyAlias": []
    },
    "NCT01695005": {
        "briefTitle": "A Study of LY3039478 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I6F-MC-JJCA"
        ]
    },
    "NCT03531645": {
        "briefTitle": "Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma",
        "officialTitle": "A Pilot Phase II Study of Neoadjuvant Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma",
        "lillyAlias": [
            "NCI-2018-00941"
        ]
    },
    "NCT00505245": {
        "briefTitle": "New Assessment System in Measuring Symptom Distress in Cancer Patients",
        "officialTitle": "Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System",
        "lillyAlias": [
            "NCI-2018-02461",
            "BS99-094",
            "P30CA016672",
            "R01CA205146"
        ]
    },
    "NCT04881747": {
        "briefTitle": "A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants",
        "officialTitle": "Bioequivalence of Lasmiditan Oral Disintegrating Tablet Compared to Current Immediate-Release Tablet Formulation to Support Treatment of Migraine",
        "lillyAlias": [
            "H8H-MC-LAIA"
        ]
    },
    "NCT03414047": {
        "briefTitle": "A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer",
        "officialTitle": "A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer",
        "lillyAlias": [
            "I4D-MC-JTJN",
            "2017-004009-42"
        ]
    },
    "NCT04294147": {
        "briefTitle": "A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist",
        "officialTitle": "A Phase 4 Single-Blind Study of Gastrointestinal Transit Time in Adult Patients With Migraine Before and After Initiation of a mAb CGRP Antagonist",
        "lillyAlias": [
            "I5Q-MC-CGBC"
        ]
    },
    "NCT05024045": {
        "briefTitle": "Study of Oral LOXO-338 in Patients With Advanced Blood Cancers",
        "officialTitle": "A Phase 1 Study of Oral LOXO-338, a Selective BCL-2 Inhibitor, in Patients With Advanced Hematologic Malignancies",
        "lillyAlias": [
            "2021-000060-30",
            "J3N-OX-JZRA"
        ]
    },
    "NCT00954447": {
        "briefTitle": "Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group Efficacy and Safety Study of Linagliptin (5 mg), Administered Orally Once Daily for at Least 52 Weeks in Type 2 Diabetic Patients in Combination With Basal Insulin Therapy",
        "lillyAlias": [
            "2008-008296-33"
        ]
    },
    "NCT00190645": {
        "briefTitle": "To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence",
        "officialTitle": "Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBAW"
        ]
    },
    "NCT01421147": {
        "briefTitle": "A Study in Adults With Type 1 Diabetes",
        "officialTitle": "A Prospective, Randomized, Open-label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus in Combination With Mealtime Insulin Lispro in Adult Patients With Type 1 Diabetes Mellitus",
        "lillyAlias": [
            "I4L-MC-ABEB",
            "2011-000829-73"
        ]
    },
    "NCT01707147": {
        "briefTitle": "A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus",
        "officialTitle": "A Regulatory Requirement Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus(SELINA Study)",
        "lillyAlias": []
    },
    "NCT00699998": {
        "briefTitle": "A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects",
        "officialTitle": "A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects With Unstable Angina/Non-ST-Elevation Myocardial Infarction Who Are Medically Managed",
        "lillyAlias": [
            "H7T-MC-TABY(b)"
        ]
    },
    "NCT01148498": {
        "briefTitle": "A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's",
        "officialTitle": "Plasma Amyloid Beta Species After a Single Solanezumab Infusion in Nondemented Individuals and Those With Mild Dementia of the Alzheimer's Type",
        "lillyAlias": [
            "H8A-MC-LZAT"
        ]
    },
    "NCT02718898": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Versus Placebo in Patients With Moderate-to-Severe Genital Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBQ",
            "2015-002628-14"
        ]
    },
    "NCT02696798": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis",
        "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis",
        "lillyAlias": [
            "I1F-MC-RHBW",
            "2015-003937-84"
        ]
    },
    "NCT01524705": {
        "briefTitle": "FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)",
        "officialTitle": "FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR",
        "lillyAlias": []
    },
    "NCT01687998": {
        "briefTitle": "A Study of Evacetrapib in High-Risk Vascular Disease",
        "officialTitle": "Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High-Risk for Vascular Outcomes",
        "lillyAlias": [
            "I1V-MC-EIAN"
        ]
    },
    "NCT02564198": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors",
        "officialTitle": "A Phase 1 Study Of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children With Refractory Solid Tumors, Including CNS Tumors",
        "lillyAlias": [
            "I4T-MC-JVDA",
            "ADVL1416"
        ]
    },
    "NCT01236105": {
        "briefTitle": "Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject",
        "officialTitle": "Evaluation of the Impact of Activated Charcoal and Time of Dose on the Absorption of LY2624803 in Healthy Subjects",
        "lillyAlias": [
            "I2K-MC-ZZBQ"
        ]
    },
    "NCT03072147": {
        "briefTitle": "Teriparatide as a Chondroregenerative Therapy in OA",
        "officialTitle": "Evaluating Teriparatide as a Chondroregenerative Therapy in Human Osteoarthritis",
        "lillyAlias": []
    },
    "NCT01969747": {
        "briefTitle": "Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days",
        "officialTitle": "A 28-day Randomised, Placebo-controlled, Double-blind Parallel Group Phase IIa Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Once Daily Oral Doses of 2.5 mg, 10 mg, and 25 mg Empagliflozin as Adjunctive to Insulin in Patients With Type 1 Diabetes Mellitus (EASE-2)",
        "lillyAlias": [
            "2011-004354-25"
        ]
    },
    "NCT05696847": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity",
        "officialTitle": "A Safety, Tolerability and Pharmacokinetic Study of Tirzepatide for the Treatment of Pediatric Participants (6 Years to 11 Years) With Obesity",
        "lillyAlias": [
            "I8F-MC-GPHV"
        ]
    },
    "NCT00191347": {
        "briefTitle": "A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer",
        "officialTitle": "A Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer",
        "lillyAlias": [
            "H3E-CA-S050"
        ]
    },
    "NCT00801177": {
        "briefTitle": "Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy",
        "officialTitle": "Phase I Study of the Fully Human Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody IMC-11F8 in Patients With Solid Tumors Who Have Failed Standard Therapy",
        "lillyAlias": [
            "2004-002072-42",
            "CP11-0401"
        ]
    },
    "NCT04372277": {
        "briefTitle": "Taltz in Combination With Enstilar for Psoriasis",
        "officialTitle": "Open Label Study, Evaluating Taltz in Combination With Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam in Psoriasis Patients",
        "lillyAlias": []
    },
    "NCT00359047": {
        "briefTitle": "Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme",
        "officialTitle": "Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme",
        "lillyAlias": []
    },
    "NCT01765400": {
        "briefTitle": "Platelet Inhibition in Patients With Systolic Heart Failure",
        "officialTitle": "Platelet Reactivity With Clopidogrel Versus Prasugrel in Patients With Systolic Heart Failure",
        "lillyAlias": []
    },
    "NCT06194500": {
        "briefTitle": "A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants",
        "officialTitle": "An Open-label, Two-part Study of the Disposition and Absolute Bioavailability of [14C]-LY3549492 in Healthy Participants",
        "lillyAlias": [
            "J3H-MC-GZNC",
            "U1111-1293-8652"
        ]
    },
    "NCT03073200": {
        "briefTitle": "Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis",
        "officialTitle": "Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHCD",
            "2016-003331-38"
        ]
    },
    "NCT00343252": {
        "briefTitle": "Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis",
        "officialTitle": "The Effect of Teriparatide Compared With Risedronate on Back Pain in Postmenopausal Women With Osteoporotic Vertebral Fractures",
        "lillyAlias": [
            "B3D-MC-GHCY"
        ]
    },
    "NCT05275400": {
        "briefTitle": "A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin",
        "officialTitle": "A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)",
        "lillyAlias": [
            "I8H-MC-BDCU",
            "2021-002569-16"
        ]
    },
    "NCT04819100": {
        "briefTitle": "A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC",
        "lillyAlias": [
            "J2G-MC-JZJX",
            "2020-005191-35",
            "2023-506784-33-00"
        ]
    },
    "NCT01748552": {
        "briefTitle": "A Study of LY2922083 in Healthy Participants and Participants With Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of LY2922083 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I6J-FW-PRBA"
        ]
    },
    "NCT05445232": {
        "briefTitle": "A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants",
        "officialTitle": "A Multiple-Dose Drug-Drug Interaction Study to Determine the Effect of LY3437943 on Drug Metabolizing Enzymes",
        "lillyAlias": [
            "J1I-MC-GZBI"
        ]
    },
    "NCT03963232": {
        "briefTitle": "A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine",
        "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Galcanezumab in Patients With Episodic Migraine-the Persist Study",
        "lillyAlias": [
            "I5Q-MC-CGAX"
        ]
    },
    "NCT06045000": {
        "briefTitle": "Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants",
        "officialTitle": "A Phase 1 Study to Assess the Excretion Balance, Pharmacokinetics, and Metabolism of [14C]-DC-806 in Healthy Male Participants",
        "lillyAlias": [
            "2023-505367-36-00"
        ]
    },
    "NCT04081259": {
        "briefTitle": "LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy",
        "officialTitle": "A Phase 1 Study of LY3214996, an ERK1/2 Inhibitor, in Patients With AML Who Are Not Candidates for Standard Therapy",
        "lillyAlias": []
    },
    "NCT00159952": {
        "briefTitle": "Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock",
        "officialTitle": "Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock",
        "lillyAlias": [
            "Lilly F1K0020",
            "MIUR 2004060419"
        ]
    },
    "NCT00816959": {
        "briefTitle": "Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma",
        "officialTitle": "Phase III Randomized, Multi-center Study to Evaluate the Effect of R-mabHDI in Patients With Lymphocytic Predominant Hodgkin's Lymphoma",
        "lillyAlias": []
    },
    "NCT00725400": {
        "briefTitle": "Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma",
        "officialTitle": "Phase II Open Label Comparative Study of Cetuximab and Radiation Therapy Vs Surgery Before or After Radiation Therapy in Patients With Stage II to IV Colorectal Carcinoma",
        "lillyAlias": [
            "JLRH-0000292008",
            "IORG-0000392008",
            "BMS-192008",
            "IMCL-II-ASI-IORG-92008",
            "ASI-CRCII0708"
        ]
    },
    "NCT01469000": {
        "briefTitle": "A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomised Phase 2 Trial of Pemetrexed and Gefitinib Versus Gefitinib as First Line Treatment for Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations",
        "lillyAlias": [
            "H3E-CR-JMIT"
        ]
    },
    "NCT01159600": {
        "briefTitle": "Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes",
        "officialTitle": "A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg, 25 mg) Administered Orally, Once Daily Over 24 Weeks in Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea",
        "lillyAlias": [
            "2009-016258-41"
        ]
    },
    "NCT00529100": {
        "briefTitle": "Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer",
        "officialTitle": "A Phase I/II Study of Concurrent Pemetrexed/Cisplatin/Radiation in Stage IIIA/B Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-CA-JMHU"
        ]
    },
    "NCT01248052": {
        "briefTitle": "A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers",
        "officialTitle": "Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of LY2979165 in Healthy Subjects",
        "lillyAlias": [
            "I4S-EW-HHCA"
        ]
    },
    "NCT04486352": {
        "briefTitle": "A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer",
        "officialTitle": "A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer",
        "lillyAlias": []
    },
    "NCT00269152": {
        "briefTitle": "Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer",
        "officialTitle": "A Randomized Phase 2 Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Chemotherapy in Patients With Completely Resected Stage Ib or II Non-Small Cell Lung Cancer",
        "lillyAlias": [
            "H3E-SB-S089"
        ]
    },
    "NCT05225259": {
        "briefTitle": "Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor",
        "officialTitle": "Expanded Access of LOXO-260 in Participants With RET Mutant or RET Fusion Tumors Refractory to Prior RET Selective TKI Treatment",
        "lillyAlias": []
    },
    "NCT01389752": {
        "briefTitle": "A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects",
        "officialTitle": "Effect of Activated Charcoal on the Pharmacokinetics of LY2216684 in Healthy Subjects",
        "lillyAlias": [
            "H9P-EW-LNCU"
        ]
    },
    "NCT02123459": {
        "briefTitle": "A Study of Cephalexin Suspension in Healthy Participants",
        "officialTitle": "A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Suspension With 250 mg/5 ml of Cephalexin (Keflex\u00ae Liquido Made in Mexico by Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V. vs. Keflex\u00ae Liquido Made by Antibioticos do Brasil Ltda for Eli Lilly y Compa\u00f1\u00eda de M\u00e9xico, S.A. de C.V.) in Fasting Healthy Volunteers",
        "lillyAlias": [
            "A3Q-ME-AFBQ"
        ]
    },
    "NCT05821959": {
        "briefTitle": "Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss",
        "officialTitle": "A Trial of AAVAnc80-hOTOF Gene Therapy in Individuals with Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
        "lillyAlias": []
    },
    "NCT00036088": {
        "briefTitle": "Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia",
        "officialTitle": null,
        "lillyAlias": [
            "F1D-MC-HGHJ"
        ]
    },
    "NCT00942188": {
        "briefTitle": "A Study of LY2189102 in Patients With Type 2 Diabetes",
        "officialTitle": "Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.",
        "lillyAlias": [
            "H9C-MC-BBDK"
        ]
    },
    "NCT04004988": {
        "briefTitle": "A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants",
        "officialTitle": "A Study to Compare the Pharmacokinetics of Tirzepatide Administered Subcutaneously by an Autoinjector Versus Prefilled Syringe in Healthy Subjects",
        "lillyAlias": [
            "I8F-MC-GPGS"
        ]
    },
    "NCT00192088": {
        "briefTitle": "A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma",
        "officialTitle": "Open-Label Single-Arm Phase II Study of ALIMTA in Combination With Oxaliplatin as First-Line Therapy in Advanced Gastric Carcinoma",
        "lillyAlias": [
            "H3E-IT-S043"
        ]
    },
    "NCT03559088": {
        "briefTitle": "A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care",
        "officialTitle": "Impact of Integrating a Disease-Specific Migraine App Into the Management of Patients in the Primary Care Setting",
        "lillyAlias": [
            "I5Q-MC-CGBA"
        ]
    },
    "NCT01870388": {
        "briefTitle": "A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease",
        "officialTitle": "A Pharmacokinetic Study of Baricitinib in Subjects With Hepatic Dysfunction",
        "lillyAlias": [
            "I4V-MC-JAGC"
        ]
    },
    "NCT04644809": {
        "briefTitle": "A Study of LY3561774 in Participants With Dyslipidemia",
        "officialTitle": "A Single-Ascending and Repeat-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3561774",
        "lillyAlias": [
            "J3F-MC-EZCA"
        ]
    },
    "NCT00182507": {
        "briefTitle": "Olanzapine in the Treatment of Hair Pulling (Trichotillomania)",
        "officialTitle": "A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania",
        "lillyAlias": []
    },
    "NCT01139788": {
        "briefTitle": "A Study of LY2624587 in Patients With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2624587 in Patients With Advanced Cancer",
        "lillyAlias": [
            "I4N-MC-CXBA"
        ]
    },
    "NCT00485407": {
        "briefTitle": "Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine",
        "officialTitle": "Guiding Dose Increases In Patients Incompletely Responsive to Usual Doses of Atomoxetine by Determining Plasma Atomoxetine Concentrations: a Randomized, Double-Blind Study",
        "lillyAlias": [
            "B4Z-MC-LYCL"
        ]
    },
    "NCT03556007": {
        "briefTitle": "A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)",
        "officialTitle": "A Phase 1, Double-blind, Randomized, Placebo-controlled, Ascending Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous NKTR-358 in Patients With Systemic Lupus Erythematosus",
        "lillyAlias": [
            "J1P-MC-KFAB",
            "17-358-02"
        ]
    },
    "NCT01212107": {
        "briefTitle": "A Phase 1 Study of LY2874455 in Participants With Advanced Cancer",
        "officialTitle": "A Phase 1 Study of LY2874455 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Advanced Cancer.",
        "lillyAlias": [
            "I4R-MC-FGAA"
        ]
    },
    "NCT00063388": {
        "briefTitle": "Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer",
        "officialTitle": "A Phase II Trial of Cetuximab (C225) as Therapy for Recurrent Non-Small Cell Lung Cancer (NSCLC)",
        "lillyAlias": []
    },
    "NCT04586907": {
        "briefTitle": "A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3537021 in Healthy Participants and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "J2R-MC-YAAB"
        ]
    },
    "NCT02899988": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis",
        "officialTitle": "A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects With Moderate-to- Severe Plaque Psoriasis",
        "lillyAlias": [
            "I6T-MC-AMAF",
            "2016-001098-34"
        ]
    },
    "NCT00561509": {
        "briefTitle": "Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months",
        "officialTitle": "A Prospective, Observational Study Comparing the Frequency of Treatment-Emergent Sexual Dysfunction Over 8 Weeks in Patients With Major Depressive Disorder Treated With Either Duloxetine Hydrochloride or a Selective Serotonin Reuptake Inhibitor Antidepressant and Evaluated Over 6 Months",
        "lillyAlias": [
            "F1J-MC-B019"
        ]
    },
    "NCT00191607": {
        "briefTitle": "A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.",
        "officialTitle": "A Randomized Phase III Trial of Gemzar Versus Doxil With Crossover Treatment Option for Patients With Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer Undergoing Second or Third-Line Chemotherapy",
        "lillyAlias": [
            "B9E-US-S301"
        ]
    },
    "NCT05994807": {
        "briefTitle": "A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants",
        "officialTitle": "A Phase 1, Single-Center, Open-Label, 2-Cohort, Fixed-Sequence, Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants",
        "lillyAlias": []
    },
    "NCT00203307": {
        "briefTitle": "A Research Study Examining the Use of Olanzapine for the Prevention of Migraine",
        "officialTitle": "A Single-Site, Double-Blind, Placebo-Controlled Cross-Over Trial Examining the Safety and Efficacy of Olanzapine Taken Daily for the Prevention of Episodic Migraine.",
        "lillyAlias": [
            "080-19000-H55901"
        ]
    },
    "NCT00082407": {
        "briefTitle": "Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin",
        "officialTitle": "Efficacy of Exenatide (AC2993, Synthetic Exendin-4, LY2148568) Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin",
        "lillyAlias": []
    },
    "NCT02095288": {
        "briefTitle": "Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A",
        "officialTitle": "Broad-spectrum Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in In Vitro Human Whole-blood Assay (hWBA)",
        "lillyAlias": []
    },
    "NCT00687609": {
        "briefTitle": "Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE",
        "officialTitle": "An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents With Attention Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse.",
        "lillyAlias": [
            "B4Z-UT-LYEL"
        ]
    },
    "NCT05167409": {
        "briefTitle": "A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer",
        "officialTitle": "A Phase II Study (With Safety run-in) of Evorpacept (ALX148) in Combination With Cetuximab and Pembrolizumab in Patients With Refractory Microsatellite Stable Metastatic Colorectal Cancer",
        "lillyAlias": [
            "NCI-2022-02019",
            "AGICC-ALX148 21CRC01"
        ]
    },
    "NCT03206177": {
        "briefTitle": "Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary",
        "officialTitle": "Feasibility IB Trial of Paclitaxel/Carboplatin + Galunisertib (a Small Molecule Inhibitor of the Kinase Domain of Type 1 TGF-B Receptor) in Patients With Newly Diagnosed, Persistent or Recurrent Carcinosarcoma of the Uterus or Ovary",
        "lillyAlias": []
    },
    "NCT04640077": {
        "briefTitle": "A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)",
        "officialTitle": "Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments",
        "lillyAlias": [
            "I5T-MC-AACH"
        ]
    },
    "NCT00049777": {
        "briefTitle": "A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Heparin in Patients With Severe Sepsis and Higher Disease Severity Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)",
        "lillyAlias": [
            "F1K-MC-EVBR"
        ]
    },
    "NCT00061477": {
        "briefTitle": "Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma",
        "officialTitle": "ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma: A Phase II Clinical Trial",
        "lillyAlias": [
            "H3E-US-JMFZ"
        ]
    },
    "NCT02993471": {
        "briefTitle": "A Study of Ixekizumab in Participants With Plaque Psoriasis",
        "officialTitle": "Evaluation of the Effect of Ixekizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients With Moderate-to-Severe Plaque Psoriasis",
        "lillyAlias": [
            "I1F-MC-RHBU"
        ]
    },
    "NCT01027871": {
        "briefTitle": "A Study for Patients With Type 2 Diabetes",
        "officialTitle": "A Phase 2 Study of LY2605541 Compared With Insulin Glargine in the Treatment of Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I2R-MC-BIAC"
        ]
    },
    "NCT01606371": {
        "briefTitle": "A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2409021 After Escalating Single Oral Dose Administration in Healthy Subjects and Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I1R-FW-GLBA"
        ]
    },
    "NCT03519945": {
        "briefTitle": "A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)",
        "officialTitle": "A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3",
        "lillyAlias": [
            "I6T-MC-AMAP",
            "2017 004092 31",
            "2023-507657-15-00"
        ]
    },
    "NCT02890147": {
        "briefTitle": "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control",
        "officialTitle": "Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control",
        "lillyAlias": []
    },
    "NCT01155245": {
        "briefTitle": "Teriparatide (PTH) and Bone Strength in Postmenopausal Women",
        "officialTitle": "Study on the Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Postmenopausal Women With Osteoporosis",
        "lillyAlias": []
    },
    "NCT00532545": {
        "briefTitle": "Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis",
        "officialTitle": "Bone Marker Changes In One Month Treatment With TERIPARATIDE (LY333334) Injections (rDNA Origin) in Men and Postmenopausal Women With Severe Osteoporosis",
        "lillyAlias": [
            "B3D-SU-S001"
        ]
    },
    "NCT02632747": {
        "briefTitle": "Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study",
        "officialTitle": "A Double-blind, Placebo Controlled, Cross-over Renal Mechanistic Trial to Assess the Effect of Adding Empagliflozin Versus Placebo on Renal Hyperfiltration on a Background of the Angiotensin Converting Enzyme Inhibitor (ACEi) Ramipril: BETWEEN Study",
        "lillyAlias": []
    },
    "NCT00393705": {
        "briefTitle": "Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)",
        "officialTitle": "A Comparison of Insulin Lispro MM Intensive Mixture Therapy With Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70",
        "lillyAlias": [
            "F3Z-VI-S019"
        ]
    },
    "NCT00051298": {
        "briefTitle": "Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia",
        "officialTitle": "Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia",
        "lillyAlias": [
            "F1D-MC-HGIN"
        ]
    },
    "NCT02111083": {
        "briefTitle": "A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants",
        "officialTitle": "Evaluation of the Bioequivalence of Two Formulations of Insulin Lispro in Healthy Subjects",
        "lillyAlias": [
            "F3Z-EW-IOQM"
        ]
    },
    "NCT00517283": {
        "briefTitle": "A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes",
        "officialTitle": "A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes",
        "lillyAlias": []
    },
    "NCT03846583": {
        "briefTitle": "Tucatinib + Abemaciclib + Herceptin for HER2+ MBC",
        "officialTitle": "Phase Ib Trial of Tucatinib in Combination With Abemaciclib and Trastuzumab for Patients With HER2-Positive Metastatic Breast Cancer",
        "lillyAlias": []
    },
    "NCT00385697": {
        "briefTitle": "The Prot\u00e9g\u00e9 Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus",
        "officialTitle": "A Phase 2/3, Randomized, Double-Blind, Multicenter, Multinational, 4-Arm, Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of MGA031, a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT03577197": {
        "briefTitle": "Southeast Netherlands Advanced Metastatic Breast Cancer Registry",
        "officialTitle": "Southeast Netherlands Advanced Breast Cancer Registry",
        "lillyAlias": []
    },
    "NCT01649297": {
        "briefTitle": "A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy",
        "officialTitle": "A Randomised, Double Blind, Placebo Controlled, Parallel Group Efficacy and Safety Study of Oral Administration of Empagliflozin Twice Daily Versus Once Daily in Two Different Daily Doses Over 16 Weeks as add-on Therapy to a Twice Daily Dosing Regimen of Metformin in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control",
        "lillyAlias": [
            "2012-000905-53"
        ]
    },
    "NCT00190905": {
        "briefTitle": "Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.",
        "officialTitle": "Study of Duloxetine HCl in Women of Different Demographic Characteristics and Co-Morbidities With Stress Urinary Incontinence: Evaluation of Efficacy and Safety",
        "lillyAlias": [
            "F1J-US-SBCD"
        ]
    },
    "NCT05735483": {
        "briefTitle": "A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis",
        "officialTitle": "A Phase 3, Multicenter, Long-Term Extension Study to Assess the Safety and Efficacy of Lebrikizumab in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis",
        "lillyAlias": [
            "J2T-MC-KGBJ/DRM06-AD16",
            "2022-501478-21-00"
        ]
    },
    "NCT00190983": {
        "briefTitle": "A Trial for Patients With Advanced/Recurrent Cervical Cancer",
        "officialTitle": "A Phase II Evaluation of Pemetrexed (Alimta) in the Treatment of Recurrent Carcinoma of the Cervix",
        "lillyAlias": [
            "H3E-US-JMGS"
        ]
    },
    "NCT06588283": {
        "briefTitle": "Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight",
        "officialTitle": "Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsO)",
        "lillyAlias": [
            "I1F-MC-RHDC"
        ]
    },
    "NCT06235983": {
        "briefTitle": "A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors",
        "officialTitle": "An Open-label, Single-arm, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Antitumor Activity of LY3537982 in Chinese Patients With KRAS G12C-Mutant Advanced Solid Tumors",
        "lillyAlias": [
            "J3M-MC-JZQC"
        ]
    },
    "NCT04342897": {
        "briefTitle": "A Study of LY3127804 in Participants With COVID-19",
        "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19",
        "lillyAlias": [
            "I7W-MC-UDAA"
        ]
    },
    "NCT00191477": {
        "briefTitle": "Instillation of Gemcitabine in Patients With Superficial Bladder Cancer",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Phase 3 Multicenter Study of Immediate Postoperative Instillation of Gemcitabine in Patients With Superficial Transitional Cell Carcinoma of the Bladder",
        "lillyAlias": [
            "B9E-MC-S274"
        ]
    },
    "NCT03367377": {
        "briefTitle": "A Study of LY3209590 in Participants With Type 2 Diabetes",
        "officialTitle": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8H-MC-BDCB"
        ]
    },
    "NCT02711553": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer",
        "officialTitle": "Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer",
        "lillyAlias": [
            "I3O-MC-JSBF",
            "2015-004699-31"
        ]
    },
    "NCT00226577": {
        "briefTitle": "Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.",
        "officialTitle": "Phase II Study of Neoadjuvant Chemotherapy With Gemcitabine and Pemetrexed in Resectable Non-Small-Cell Lung Cancer (NSCLC) With Pharmacogenomic Correlates.",
        "lillyAlias": [
            "H3E-US-X009"
        ]
    },
    "NCT00190853": {
        "briefTitle": "Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence",
        "officialTitle": "Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women With Stress Urinary Incontinence",
        "lillyAlias": [
            "F1J-MC-SBCT"
        ]
    },
    "NCT00332553": {
        "briefTitle": "Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen",
        "officialTitle": "Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen",
        "lillyAlias": [
            "H3S-US-GGKM"
        ]
    },
    "NCT01330953": {
        "briefTitle": "A First Human Study of a Ferroportin Antibody",
        "officialTitle": "A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2928057 in Healthy Subjects",
        "lillyAlias": [
            "I5M-FW-FABA"
        ]
    },
    "NCT03433677": {
        "briefTitle": "A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes",
        "officialTitle": "A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Patients With Type 1 Diabetes (PRONTO-Pump)",
        "lillyAlias": [
            "I8B-MC-ITSI",
            "2017-002374-39"
        ]
    },
    "NCT02528253": {
        "briefTitle": "A Phase 3 Study of Tanezumab for Chronic Low Back Pain",
        "officialTitle": "A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN",
        "lillyAlias": [
            "2012-005495-34",
            "CLBP SC STUDY",
            "A4091059",
            "TANGO"
        ]
    },
    "NCT06439277": {
        "briefTitle": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)",
        "officialTitle": "Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)",
        "lillyAlias": [
            "I8F-MC-GPIX"
        ]
    },
    "NCT01725451": {
        "briefTitle": "A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants",
        "officialTitle": "Effects of Deodorant and Antiperspirant Use and the Presence of Axillary Hair on the Absorption of Testosterone Applied as Testosterone 2% Solution",
        "lillyAlias": [
            "I5E-MC-TSBD"
        ]
    },
    "NCT01536951": {
        "briefTitle": "A Study of LY3009104 in Healthy Participants",
        "officialTitle": "A Placebo-Controlled, Single Dose, Dose Escalation (Part A) and a Placebo- and Positive-Controlled Study of the Effect on the Electrocardiographic QT Interval of a Single Dose (Part B) of LY3009104 in Healthy Subjects",
        "lillyAlias": [
            "I4V-MC-JADO"
        ]
    },
    "NCT00434954": {
        "briefTitle": "Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes",
        "officialTitle": "Effect of Exenatide Plus Metformin vs. Premixed Human Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Inadequate Control of Type 2 Diabetes on Oral Antidiabetic Treatment",
        "lillyAlias": []
    },
    "NCT01582451": {
        "briefTitle": "A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study",
        "lillyAlias": [
            "I2R-MC-BIDJ"
        ]
    },
    "NCT01074151": {
        "briefTitle": "The Cymbalta Pregnancy Registry",
        "officialTitle": "The Cymbalta Pregnancy Registry",
        "lillyAlias": [
            "F1J-MC-B034"
        ]
    },
    "NCT05936151": {
        "briefTitle": "A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes",
        "officialTitle": "A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes",
        "lillyAlias": [
            "J1I-MC-GZBU",
            "2023-504583-42-00"
        ]
    },
    "NCT02293551": {
        "briefTitle": "A Study of Lispro Formulations in Healthy Participants",
        "officialTitle": "Safety, Tolerability, and Pharmacokinetics of Multiple Novel Insulin Lispro Formulations",
        "lillyAlias": [
            "F3Z-FW-ITCA"
        ]
    },
    "NCT01587651": {
        "briefTitle": "Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease",
        "officialTitle": "A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents",
        "lillyAlias": []
    },
    "NCT03151551": {
        "briefTitle": "A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis",
        "officialTitle": "A 52-Week Multicenter, Randomized, Open-Label, Parallel- Group Study Evaluating the Efficacy and Safety of Ixekizumab Versus Adalimumab in Patients With Psoriatic Arthritis Who Are Biologic Disease-Modifying Anti-Rheumatic Drug Naive",
        "lillyAlias": [
            "I1F-MC-RHCF",
            "2016-004585-25"
        ]
    },
    "NCT00324051": {
        "briefTitle": "Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet",
        "officialTitle": "PREFERENCE: 12-Week Open Label Trial On Olanzapine Orodispersible Tablet Vs. Oral Olanzapine Preference Study",
        "lillyAlias": [
            "F1D-VI-S067"
        ]
    },
    "NCT00853151": {
        "briefTitle": "A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes",
        "officialTitle": "A Proof of Concept Study to Evaluate the Coadministration of TT223 Given Daily and LY2428757 Given Once-Weekly for Four Weeks in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I3H-MC-GAFA(b)"
        ]
    },
    "NCT00490451": {
        "briefTitle": "A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma",
        "officialTitle": "A Phase 2 Study of LY573636-Sodium Administered as Second-line or Third-line Treatment in Patients With Unresectable or Metastatic Soft Tissue Sarcoma",
        "lillyAlias": [
            "H8K-MC-JZAD"
        ]
    },
    "NCT02779751": {
        "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer",
        "officialTitle": "A Phase 1b Study of Abemaciclib in Combination With Pembrolizumab for Patients With Stage IV Non-Small Cell Lung Cancer or Hormone Receptor Positive, HER2 Negative Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPCE",
            "2015-005156-94",
            "KEYNOTE 287"
        ]
    },
    "NCT00883051": {
        "briefTitle": "Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment",
        "officialTitle": "A Double Blind Randomized Placebo-Controlled Parallel Group Dose-Ranging Study of Oral COL-144 in the Acute Treatment of Migraine",
        "lillyAlias": [
            "H8H-CD-LAHO",
            "2008-005010-43",
            "COL MIG-202"
        ]
    },
    "NCT03286751": {
        "briefTitle": "A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants",
        "officialTitle": "A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 and Humalog Across Different Subcutaneous Doses in Healthy Subjects",
        "lillyAlias": [
            "2017-001859-32",
            "I8B-MC-ITSH"
        ]
    },
    "NCT00406354": {
        "briefTitle": "Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany",
        "officialTitle": "A Randomized, Double-Blind Comparison of Atomoxetine Versus Placebo in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder",
        "lillyAlias": [
            "B4Z-SB-LYDW"
        ]
    },
    "NCT02959177": {
        "briefTitle": "A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 (Galcanezumab) in Japanese Patients With Episodic Migraine",
        "lillyAlias": [
            "I5Q-JE-CGAN"
        ]
    },
    "NCT03616977": {
        "briefTitle": "Study to Compare 2 Formulations of LY900014 in Healthy Participants",
        "officialTitle": "Bioequivalence Study Comparing 2 Formulations of LY900014 in Healthy Subjects",
        "lillyAlias": [
            "I8B-MC-ITSS"
        ]
    },
    "NCT01845077": {
        "briefTitle": "Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets",
        "officialTitle": "Relative Bioavailability of Two Newly Developed Extended Release FDC Tablet Strengths (5mg/1000mg and 2.5 mg/750 mg) of Linagliptin/Metformin Extended Release Compared With the Free Combination of Linagliptin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)",
        "lillyAlias": []
    },
    "NCT06009653": {
        "briefTitle": "Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity",
        "officialTitle": "Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity",
        "lillyAlias": [
            "P50MD017344"
        ]
    },
    "NCT04634253": {
        "briefTitle": "A Study of LY3462817 in Participants With Rheumatoid Arthritis",
        "officialTitle": "A Phase 2 Study to Evaluate the Efficacy and Safety of LY3462817 in Participants With Moderately to Severely Active Rheumatoid Arthritis",
        "lillyAlias": [
            "J1A-MC-KDAD",
            "2020-002673-10"
        ]
    },
    "NCT03339453": {
        "briefTitle": "A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "Comparison of Glucagon Administered by Either the Nasal (LY900018) or Intra-muscular (GlucaGen\u00ae) Routes in Adult Patients With Type 1 Diabetes Mellitus During Controlled Insulin-Induced Hypoglycemia",
        "lillyAlias": [
            "I8R-MC-IGBI",
            "2017-000249-33"
        ]
    },
    "NCT04099277": {
        "briefTitle": "A Study of LY3435151 in Participants With Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of LY3435151 Administered to Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "J1Q-MC-JZIA"
        ]
    },
    "NCT04517253": {
        "briefTitle": "A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS",
        "officialTitle": "A Phase 2/3, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Baricitinib in Adult and Pediatric Japanese Patients With NNS/CANDLE, SAVI, and AGS",
        "lillyAlias": [
            "I4V-JE-JAJE"
        ]
    },
    "NCT04864977": {
        "briefTitle": "A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes",
        "officialTitle": "Novel Approach for Basal Insulin Titration: A Proof-of-Concept Study",
        "lillyAlias": [
            "I4L-MC-YCAA"
        ]
    },
    "NCT03057977": {
        "briefTitle": "EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)",
        "officialTitle": "A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)",
        "lillyAlias": [
            "2016-002280-34"
        ]
    },
    "NCT00207077": {
        "briefTitle": "Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors",
        "officialTitle": "A Phase I Study of Cetuximab in Combination With Erlotinib in Patients With Advanced Solid Malignancies",
        "lillyAlias": []
    },
    "NCT02529553": {
        "briefTitle": "A Study of LY3076226 in Participants With Advanced or Metastatic Cancer",
        "officialTitle": "A Phase 1 Study of LY3076226, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody-Drug Conjugate, in Patients With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I7O-MC-JOBA"
        ]
    },
    "NCT05509777": {
        "briefTitle": "A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease",
        "officialTitle": "A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn's Disease",
        "lillyAlias": [
            "I6T-MC-AMAY",
            "2022-000811-29",
            "MACARONI-23",
            "PLATFORMPBCRD3001",
            "I6T-MC-PIBD"
        ]
    },
    "NCT00957853": {
        "briefTitle": "Preoperative Treatment With Cetuximab and/or IMC-A12",
        "officialTitle": "An Exploratory Study to Assess the Modulation of Biomarkers in Patients With Squamous Cell Carcinomas of the Head and Neck Randomized to Receive Preoperative Treatment With Cetuximab and/or IMC-A12, an Anti-insulin-like Growth Factor-1 Receptor Monoclonal Antibody",
        "lillyAlias": [
            "NCI-2011-03039"
        ]
    },
    "NCT00494377": {
        "briefTitle": "Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression",
        "officialTitle": "Duloxetine Versus Duloxetine Plus Non-Pharmacological Intervention in the Treatment of Depression",
        "lillyAlias": [
            "F1J-MC-HMDD"
        ]
    },
    "NCT01144377": {
        "briefTitle": "A Study of LY2541546 in Women With Low Bone Mineral Density",
        "officialTitle": "A Phase 2 Randomized Study of LY2541546 Versus Placebo in Postmenopausal Women With Low Bone Mineral Density: An Evaluation of the Dose Response Relationship Using Bone Mineral Density",
        "lillyAlias": [
            "I2M-MC-GSDB"
        ]
    },
    "NCT05644353": {
        "briefTitle": "A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants",
        "officialTitle": "A Bioequivalence Study of Subcutaneous Injections of Mirikizumab Reference Solution Using Investigational 1-mL and 2-mL Prefilled Syringes and Mirikizumab Test Solution Formulation Using Investigational 1-mL and 2-mL Prefilled Syringes in Healthy Participants",
        "lillyAlias": [
            "I6T-MC-AMBY"
        ]
    },
    "NCT02226653": {
        "briefTitle": "A Study of Evacetrapib in Healthy Japanese Participants",
        "officialTitle": "A Bioequivalence and Food Effect Study of Evacetrapib Evaluating a Single Tablet Compared to Two Tablets in Healthy Japanese Subjects",
        "lillyAlias": [
            "I1V-JE-EIAY"
        ]
    },
    "NCT05841277": {
        "briefTitle": "A Study of LY3819469 in Participants With Impaired and Normal Renal Function",
        "officialTitle": "Pharmacokinetics of LY3819469 Following Subcutaneous Dose in Participants With Renal Impairment Compared With Participants With Normal Renal Function",
        "lillyAlias": [
            "J3L-MC-EZED"
        ]
    },
    "NCT01659177": {
        "briefTitle": "A Study of LY2140023 in Healthy Participants",
        "officialTitle": "The Effect of Food on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects After Administration of the Commercial Tablet Formulation of LY2140023",
        "lillyAlias": [
            "H8Y-MC-HBDJ"
        ]
    },
    "NCT00797277": {
        "briefTitle": "Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia",
        "officialTitle": "An Open-label, Randomized Trial of Intramuscular (IM) Olanzapine Versus Intramuscular Combination of Haloperidol and Lorazepam in the Treatment of Acute Agitation in Schizophrenia",
        "lillyAlias": []
    },
    "NCT02898077": {
        "briefTitle": "A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer",
        "officialTitle": "A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine",
        "lillyAlias": [
            "I4T-CR-JVCR"
        ]
    },
    "NCT00785577": {
        "briefTitle": "A Study for Treatment of Pain in Patients With Diabetic Neuropathy.",
        "officialTitle": "A Phase 2 Study of the Effects of LY545694, an iGluR5 Antagonist, in the Treatment of Subjects With Painful Diabetic Neuropathy.",
        "lillyAlias": [
            "H8C-MC-LQBF"
        ]
    },
    "NCT00394147": {
        "briefTitle": "Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer",
        "officialTitle": "Phase II Trial of Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer (SCCHN)",
        "lillyAlias": []
    },
    "NCT01354353": {
        "briefTitle": "A Study of Safety and Tolerability in Subjects With Schizophrenia",
        "officialTitle": "Safety and Tolerability of Multiple Ascending Doses of LY2140023 in Subjects With Schizophrenia",
        "lillyAlias": [
            "H8Y-MC-HBDB"
        ]
    },
    "NCT01432951": {
        "briefTitle": "A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma",
        "officialTitle": "Pharmacokinetics of Enzastaurin HCl in Native Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma",
        "lillyAlias": [
            "H6Q-FW-JCCC"
        ]
    },
    "NCT00191451": {
        "briefTitle": "A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer",
        "officialTitle": "Phase II Trial of Gemzar Plus Paraplatin (Plus Herceptin in HER2+ Patients) in Metastatic Breast Cancer",
        "lillyAlias": [
            "B9E-US-S359"
        ]
    },
    "NCT00061451": {
        "briefTitle": "Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial",
        "officialTitle": "ALIMTA Plus Gemcitabine as Front-line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer: A Phase II Clinical Trial",
        "lillyAlias": [
            "H3E-US-JMFY"
        ]
    },
    "NCT06007651": {
        "briefTitle": "A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)",
        "officialTitle": "A Phase 1, Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial of LY3885125 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Ascending Dose in Participants With Dyslipidemia and Repeat-Doses in Participants With NAFLD",
        "lillyAlias": [
            "J4N-MC-YFAA"
        ]
    },
    "NCT01115751": {
        "briefTitle": "A Study in Patients With Advanced or Metastatic Cancer",
        "officialTitle": "A Phase I Trial of Single-Agent LY2780301 in Patients With Advanced or Metastatic Cancer",
        "lillyAlias": [
            "I4H-MC-JWAA"
        ]
    },
    "NCT00402051": {
        "briefTitle": "Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)",
        "officialTitle": "A Randomized Phase 2 Study of Pemetrexed in Combination With Cisplatin or Carboplatin in the First Line Therapy of Advanced NSCLC",
        "lillyAlias": [
            "H3E-SB-S109"
        ]
    },
    "NCT04565054": {
        "briefTitle": "Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC",
        "officialTitle": "Adj. Dynamic Marker - Adjusted Personalized Therapy Comparing Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy in (Clinical or Genomic) High Risk, HR+/HER2- EBC",
        "lillyAlias": [
            "2019-001488-60"
        ]
    },
    "NCT05256654": {
        "briefTitle": "A Study of LY3561774 in Participants With Mixed Dyslipidemia",
        "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia",
        "lillyAlias": [
            "J3F-MC-EZCB",
            "2021-005407-13"
        ]
    },
    "NCT03101254": {
        "briefTitle": "LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma",
        "officialTitle": "A Phase I/II Study of LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma",
        "lillyAlias": []
    },
    "NCT04392154": {
        "briefTitle": "Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)",
        "officialTitle": "A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)",
        "lillyAlias": [
            "2020-001211-24",
            "J2T-DM-KGAA",
            "DRM06-AD07"
        ]
    },
    "NCT06653153": {
        "briefTitle": "A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)",
        "officialTitle": "A Study of Remternetug Versus Placebo in Early Alzheimer's Disease Participants at Risk for Cognitive and Functional Decline",
        "lillyAlias": [
            "J1G-MC-LAKI",
            "2024-515656-20-00"
        ]
    },
    "NCT03395353": {
        "briefTitle": "A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder",
        "officialTitle": "A Long-term Safety Study of Duloxetine Hydrochloride in the Treatment of Japanese Children and Adolescents With Depressive Disorder",
        "lillyAlias": [
            "F1J-JE-HMHF",
            "1702A3632"
        ]
    },
    "NCT02576951": {
        "briefTitle": "A Study of Galcanezumab in Healthy Participants",
        "officialTitle": "Tolerability, Pharmacokinetics and Pharmacodynamics of LY2951742 in Healthy Subjects Following a Subcutaneous Administration of a Lyophilized Formulation or a Solution Formulation",
        "lillyAlias": [
            "I5Q-MC-CGAO"
        ]
    },
    "NCT01736254": {
        "briefTitle": "A Study of Evacetrapib in Healthy Participants",
        "officialTitle": "Effect of Gemfibrozil on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects",
        "lillyAlias": [
            "I1V-MC-EIBD"
        ]
    },
    "NCT02407054": {
        "briefTitle": "A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer",
        "officialTitle": "A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer",
        "lillyAlias": [
            "I6A-MC-CBBD"
        ]
    },
    "NCT06180954": {
        "briefTitle": "A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Participants",
        "officialTitle": "A Phase I, Open-label, Two-part Study of the Absorption, Metabolism, Excretion, and the Absolute Bioavailability of [14C]-LOXO-305 in Healthy Male Subjects",
        "lillyAlias": [
            "J2N-OX-JZNB"
        ]
    },
    "NCT00254254": {
        "briefTitle": "A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized, Single-Blind, Dose-Rising, Placebo-Controlled, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus",
        "lillyAlias": []
    },
    "NCT04232553": {
        "briefTitle": "A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease",
        "officialTitle": "A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease",
        "lillyAlias": [
            "I6T-MC-AMAX",
            "2022-502841-91-00"
        ]
    },
    "NCT03951753": {
        "briefTitle": "A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)",
        "officialTitle": "The Effect of Tirzepatide on \u03b1 and \u03b2 Cell Function and Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-MC-GPGT",
            "2018-003343-37"
        ]
    },
    "NCT04050553": {
        "briefTitle": "A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus",
        "officialTitle": "A Randomized, Placebo-Controlled, Crossover Study to Investigate the Effect of Once-Weekly Tirzepatide on the Counter-Regulatory Response to Hypoglycemia in Patients With Type 2 Diabetes Mellitus",
        "lillyAlias": [
            "I8F-MC-GPHG",
            "2019-001360-29"
        ]
    },
    "NCT02240433": {
        "briefTitle": "A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)",
        "officialTitle": "A Phase 1b Study of LY2157299 in Combination With Sorafenib in Patients With Unresectable Hepatocellular Carcinoma",
        "lillyAlias": [
            "H9H-JE-JBAP"
        ]
    },
    "NCT03921554": {
        "briefTitle": "JAK Inhibitor Treatment in AGS",
        "officialTitle": "Janus Kinase Inhibitor (Baricitinib) for Aicardi Gouti\u00e8res Syndrome",
        "lillyAlias": []
    },
    "NCT03654833": {
        "briefTitle": "Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma",
        "officialTitle": "Mesothelioma Stratified Therapy (MiST): A Stratified Multi-arm Phase IIa Clinical Trial to Enable Accelerated Evaluation of Targeted Therapies for Relapsed Malignant Mesothelioma",
        "lillyAlias": []
    },
    "NCT00465387": {
        "briefTitle": "FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study",
        "officialTitle": "Falls, Fracture, and Osteoporosis Risk Control Evaluation (FORCE) Study: A Randomized Controlled Trial With Community Partnerships in Northern Ontario",
        "lillyAlias": []
    },
    "NCT01947933": {
        "briefTitle": "A Safety Study of Mirikizumab (LY3074828)",
        "officialTitle": "A Phase I, Randomized, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody",
        "lillyAlias": [
            "I6T-MC-AMAA"
        ]
    },
    "NCT00471354": {
        "briefTitle": "A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine",
        "officialTitle": "Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride",
        "lillyAlias": [
            "B4Z-CR-S018"
        ]
    },
    "NCT02917733": {
        "briefTitle": "A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants",
        "officialTitle": "Disposition of [\u00b9\u2074C\u2082]-Labeled LY3039478 Following Oral Administration in Healthy Subjects",
        "lillyAlias": [
            "I6F-MC-JJCF"
        ]
    },
    "NCT00496587": {
        "briefTitle": "Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma",
        "officialTitle": "Phase II Safety and Efficacy Study of Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Metastatic or Unresectable Sarcomatoid Renal Cell Carcinoma",
        "lillyAlias": [
            "NCI-2012-01511"
        ]
    },
    "NCT00191854": {
        "briefTitle": "Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line",
        "officialTitle": "Randomized Phase II Study of Biweekly Gemcitabine-Paclitaxel, Biweekly Gemcitabine-Carboplatin and Biweekly Gemcitabine-Cisplatin as First-Line Treatment in Metastatic Breast Cancer After Anthracycline Failure",
        "lillyAlias": [
            "B9E-AA-S355"
        ]
    },
    "NCT05985954": {
        "briefTitle": "Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination with Cetuximab and Encorafenib in Patients with Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy",
        "officialTitle": "Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination with Cetuximab and Encorafenib in Patients with Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy",
        "lillyAlias": [
            "NCI-2023-06254"
        ]
    },
    "NCT04607733": {
        "briefTitle": "A Study of Mirikizumab in Healthy Participants",
        "officialTitle": "A Bioequivalence Study of Injections of Mirikizumab Solution Using an Investigational 1-mL Pre-Filled Syringe and an Investigational 1-mL Autoinjector in Healthy Participants",
        "lillyAlias": [
            "I6T-MC-AMBW"
        ]
    },
    "NCT01127633": {
        "briefTitle": "Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease",
        "officialTitle": "Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid \u03b2 Antibody in Patients With Alzheimer's Disease",
        "lillyAlias": [
            "H8A-MC-LZAO"
        ]
    },
    "NCT02435433": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein",
        "officialTitle": "Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib",
        "lillyAlias": [
            "I4T-MC-JVDE",
            "2014-005068-13"
        ]
    },
    "NCT05377333": {
        "briefTitle": "A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes",
        "officialTitle": "Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3457263 Alone and in Combination With GLP-1 RA in Patients With Type 2 Diabetes",
        "lillyAlias": [
            "J1R-MC-GZFB"
        ]
    },
    "NCT04974333": {
        "briefTitle": "Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes",
        "officialTitle": "Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes at the First Level of Medical Care for the Health Sector in Mexico",
        "lillyAlias": []
    },
    "NCT01624233": {
        "briefTitle": "A Study in Japanese Participants With Moderate-to-Severe Psoriasis",
        "officialTitle": "A Multicenter, Open-Label, Long-Term Study to Evaluate the Efficacy and Safety of LY2439821 in Japanese Patients With Moderate-to-Severe Psoriasis",
        "lillyAlias": [
            "I1F-JE-RHAT"
        ]
    },
    "NCT00449553": {
        "briefTitle": "Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.",
        "officialTitle": "A Prospective Study of Associations of Changes in HbA1C and Fasting Blood Lipids Due to Treatment With Pioglitazone for 6 Months and Genetic Polymorphism's in PPAR-gamma",
        "lillyAlias": [
            "U1111-1114-2473"
        ]
    },
    "NCT01750853": {
        "briefTitle": "A Study of LY3045697 in Healthy Participants",
        "officialTitle": "A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3045697 After Single Oral Dosing in Healthy Subjects",
        "lillyAlias": [
            "I6S-MC-ASEA",
            "2012-004968-22"
        ]
    },
    "NCT01185353": {
        "briefTitle": "A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy",
        "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2b Study of LY3009104 in Patients With Active Rheumatoid Arthritis on Background Methotrexate Therapy",
        "lillyAlias": [
            "I4V-MC-JADA",
            "CTRI/2011/06/001834"
        ]
    },
    "NCT04497987": {
        "briefTitle": "A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff",
        "officialTitle": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 Alone and in Combination With LY3832479 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Facility Residents and Staff; a NIAID and Lilly Collaborative Study",
        "lillyAlias": [
            "J2X-MC-PYAD",
            "CoVPN #3501"
        ]
    },
    "NCT02614287": {
        "briefTitle": "A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura",
        "officialTitle": "A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 in Patients With Migraine",
        "lillyAlias": [
            "I5Q-MC-CGAJ",
            "2015-001884-38"
        ]
    },
    "NCT05038787": {
        "briefTitle": "A Study of LY3473329 in Healthy Japanese Participants",
        "officialTitle": "A Phase 1, Randomized, Investigator- and Participant-Blind, Placebo-Controlled Study of LY3473329 Multiple-Ascending Dosing in Healthy Japanese Participants",
        "lillyAlias": [
            "J2O-JE-EKBB"
        ]
    },
    "NCT03343587": {
        "briefTitle": "A Study of LY3375880 in Healthy Participants",
        "officialTitle": "A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3375880 in Healthy Subjects",
        "lillyAlias": [
            "I9N-MC-FCAA"
        ]
    },
    "NCT00547287": {
        "briefTitle": "Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations",
        "officialTitle": "Switching From Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Multinational Assessment of Treatment Preference",
        "lillyAlias": [
            "H6D-VI-LVFH"
        ]
    },
    "NCT04178733": {
        "briefTitle": "A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants",
        "officialTitle": "A Single-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3493269 in Healthy Participants",
        "lillyAlias": [
            "J1X-MC-GZHA"
        ]
    },
    "NCT03648554": {
        "briefTitle": "Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)",
        "officialTitle": "A Multicentre Controlled and Randomized Study Assessing the Effect of Dulaglutide add-on to Dietary Reinforcement Versus Dietary Reinforcement Alone in Patients With Type 2 Diabetes and Carriers of a Non-alcoholic Steatohepatitis",
        "lillyAlias": [
            "PSS2018/REALIST-GUERCI/AS"
        ]
    },
    "NCT00077233": {
        "briefTitle": "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum",
        "officialTitle": "A Phase II Trial Of Irinotecan /5-FU/ Leucovorin Or Oxaliplatin /5-FU / Leucovorin With And Without Cetuximab (C225) For Patients With Untreated Metastatic Adenocarcinoma Of The Colon or Rectum",
        "lillyAlias": [
            "U10CA031946",
            "CDR0000350016"
        ]
    },
    "NCT00623233": {
        "briefTitle": "Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer",
        "officialTitle": "A Phase 2 Study of Gemcitabine and Bevacizumab as First-Line Treatment in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer Previously Treated With Taxanes",
        "lillyAlias": [
            "B9E-US-S379"
        ]
    },
    "NCT03449433": {
        "briefTitle": "A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus",
        "officialTitle": "A Mixed Meal Tolerance Test Study to Evaluate the Pharmacokinetics and Pharmacodynamics of LY900014 Compared to Humalog Following a Single Dose in Adults With Type 1 Diabetes",
        "lillyAlias": [
            "I8B-MC-ITSL",
            "2017-003459-47"
        ]
    },
    "NCT00611533": {
        "briefTitle": "Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women",
        "officialTitle": "A Controlled Trial of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women",
        "lillyAlias": []
    },
    "NCT05514054": {
        "briefTitle": "A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer",
        "officialTitle": "EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence",
        "lillyAlias": [
            "J2J-MC-JZLH",
            "2022-501007-28"
        ]
    },
    "NCT03629054": {
        "briefTitle": "This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills",
        "officialTitle": "Bioequivalence of a Low Strength Fixed Dose Combination Tablet of Empagliflozin/Linagliptin/Metformin Extended Release Compared to the Free Combination of Empagliflozin, Linagliptin, and Metformin Extended Release Tablets Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Study)",
        "lillyAlias": [
            "2018-001266-42"
        ]
    },
    "NCT02942654": {
        "briefTitle": "A Study of LY900014 Formulation in Healthy Participants",
        "officialTitle": "Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single-Dose Administration in Healthy Subjects",
        "lillyAlias": [
            "I8B-MC-ITRL"
        ]
    },
    "NCT00386087": {
        "briefTitle": "Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy",
        "officialTitle": "A Phase II Study of Oral Enzastaurin in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane-Containing Regimen",
        "lillyAlias": [
            "H6Q-MC-S015"
        ]
    },
    "NCT01808651": {
        "briefTitle": "A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing",
        "officialTitle": "A Phase 3, Open-label, Long-Term Study to Evaluate the Safety of LY110140 Once Daily Dosing for 52-week in Japanese Patients With Major Depressive Disorder",
        "lillyAlias": [
            "B1Y-JE-HCLW"
        ]
    },
    "NCT02955953": {
        "briefTitle": "A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants",
        "officialTitle": "Bioequivalence Study Comparing the Pharmacokinetics and Glucodynamics of LY2963016 U-200 Formulation With LY2963016 U-100 Formulation in Healthy Subjects",
        "lillyAlias": [
            "I4L-MC-ABEV"
        ]
    },
    "NCT02797951": {
        "briefTitle": "A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache",
        "officialTitle": "A Phase 3b Multicenter, Single-Arm, Open-Label Safety Study of LY2951742 (Galcanezumab) in Patients With Episodic or Chronic Cluster Headache",
        "lillyAlias": [
            "I5Q-MC-CGAR",
            "2015-005234-21"
        ]
    },
    "NCT01668251": {
        "briefTitle": "Turner Syndrome Prenatal Diagnosis Study",
        "officialTitle": "National Collaborative Study of Girls Prenatally Diagnosed With Turner Syndrome Karyotypes",
        "lillyAlias": []
    },
    "NCT04603651": {
        "briefTitle": "Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19",
        "officialTitle": "Expanded Access Information for Physicians for Bamlanivimab (LY3819253) Emergency Investigational New Drug [EIND]",
        "lillyAlias": [
            "J2X-MC-Y001"
        ]
    },
    "NCT06240351": {
        "briefTitle": "A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)",
        "officialTitle": "A Pilot Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)",
        "lillyAlias": []
    },
    "NCT00178451": {
        "briefTitle": "Stroke Prevention With Abciximab in Carotid Endarterectomy",
        "officialTitle": "Stroke Prevention With Abciximab in Carotid Endarterectomy",
        "lillyAlias": [
            "H4S-MC-1018"
        ]
    },
    "NCT05960851": {
        "briefTitle": "A Study of LY3871801 in Healthy Asian and Non-Asian Participants",
        "officialTitle": "A Phase I, Participant- and Investigator-Blind, Single-center Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of LY3871801 in Healthy Asian and Non-Asian Participants",
        "lillyAlias": [
            "J3P-MC-FTAC"
        ]
    },
    "NCT03057951": {
        "briefTitle": "EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)",
        "officialTitle": "A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)",
        "lillyAlias": [
            "2016-002278-11"
        ]
    },
    "NCT04157751": {
        "briefTitle": "A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure",
        "officialTitle": "A Multicentre, Randomised, Double-blind, 90-day Superiority Trial to Evaluate the Effect on Clinical Benefit, Safety and Tolerability of Once Daily Oral EMPagliflozin 10 mg Compared to Placebo, Initiated in Patients Hospitalised for acUte Heart faiLure (de Novo or Decompensated Chronic HF) Who Have Been StabilisEd (EMPULSE)",
        "lillyAlias": [
            "2019-002946-19"
        ]
    },
    "NCT04411654": {
        "briefTitle": "Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)",
        "officialTitle": "An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose LY3884961 in Infants With Type 2 Gaucher Disease",
        "lillyAlias": []
    },
    "NCT02514551": {
        "briefTitle": "A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer",
        "officialTitle": "Randomized Phase 2 Trial Evaluating Alternative Ramucirumab Doses in Combination With Paclitaxel in Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma",
        "lillyAlias": [
            "I4T-MC-JVCZ",
            "2014-005067-32"
        ]
    },
    "NCT00034554": {
        "briefTitle": "Study of gp75 Vaccine in Patients With Stage III and IV Melanoma",
        "officialTitle": "Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma",
        "lillyAlias": []
    },
    "NCT01646177": {
        "briefTitle": "A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)",
        "officialTitle": "A 12-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate to Severe Plaque Psoriasis With a Long-Term Extension Period",
        "lillyAlias": [
            "I1F-MC-RHBC"
        ]
    },
    "NCT03752177": {
        "briefTitle": "A Study of LY3415244 in Participants With Advanced Solid Tumors",
        "officialTitle": "A Phase 1a/1b Study of LY3415244, a Bispecific Antibody in Patients With Advanced Solid Tumors",
        "lillyAlias": [
            "J1C-MC-JZDA",
            "2018-001598-25"
        ]
    },
    "NCT00887354": {
        "briefTitle": "A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture",
        "officialTitle": "Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture",
        "lillyAlias": [
            "B3D-EW-GHDK"
        ]
    },
    "NCT00549887": {
        "briefTitle": "An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching Insulin",
        "officialTitle": "Resource Utilisation and Patient Satisfaction With SWitching INsulin (SWING)",
        "lillyAlias": [
            "F3Z-EW-B003"
        ]
    },
    "NCT01166087": {
        "briefTitle": "Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition",
        "officialTitle": "A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's and Prozac\u00aeWeekly 90 mg Delayed Release Capsules of Eli Lilly and Company, USA in Healthy Adult Human Subjects Under Fed Conditions.",
        "lillyAlias": []
    },
    "NCT00857454": {
        "briefTitle": "A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations",
        "officialTitle": "A Phase III Open-label Extension of the MTE08 Trial (A Phase III Open-label Titration Trial to Evaluate the Effectiveness and Safety of Different Doses of a Dermal Application of Testosterone MD-Lotion\u00ae (Cutaneous Solution) in Hypogonadal Men) to Evaluate Skin-safety",
        "lillyAlias": [
            "MTE09",
            "I5E-MC-TSAI"
        ]
    },
    "NCT02402933": {
        "briefTitle": "Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents",
        "officialTitle": "A Multiple Center, Open Label, Prospective Study to Evaluate the Effectiveness and Ease-Of-Use of AMG504-1 Administered in the Home or School Environments for Treating Hypoglycemia in Children and Adolescents With T1D",
        "lillyAlias": [
            "I8R-MC-B001",
            "AMG109"
        ]
    },
    "NCT00099333": {
        "briefTitle": "Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents",
        "officialTitle": "An Exploratory Study of the Safety of Substituting Exenatide for Insulin in Patients With Type 2 Diabetes Who Have Been Using Insulin in Combination With Oral Antidiabetic Therapy",
        "lillyAlias": []
    },
    "NCT04255433": {
        "briefTitle": "A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes",
        "officialTitle": "The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)",
        "lillyAlias": [
            "I8F-MC-GPGN",
            "2019-002735-28"
        ]
    },
    "NCT00260533": {
        "briefTitle": "Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder",
        "officialTitle": "Double Blind Placebo Controlled Parallel Group Comparison of Atomoxetine (Strattera) for Generalized Social Anxiety Disorder (GSAD)",
        "lillyAlias": []
    },
    "NCT02057133": {
        "briefTitle": "A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread",
        "officialTitle": "A Phase 1b Study of Abemaciclib in Combination With Therapies for Patients With Metastatic Breast Cancer",
        "lillyAlias": [
            "I3Y-MC-JPBH"
        ]
    },
    "NCT00191087": {
        "briefTitle": "Duloxetine in the Treatment of Stress Urinary Incontinence.",
        "officialTitle": "Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence.",
        "lillyAlias": [
            "F1J-MC-SBAU"
        ]
    }
}